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SUMMARY 
INTRODUCTION 
If advising people about the health benefits of exercise and dietary restraint was enough to 
make them change their fattening lifestyles, ours would be a nation of fit and lean people.  
While the knowledge about the causal correlation between physical activity, diet and health is 
ubiquitous in the population, pathogenic sedentism and over-alimentation remain the 
dominant way of life. They have been identified as the major and modifiable causes of today’s 
epidemic of cardiovascular and metabolic diseases.  
The paradox of behaving in a self-harming way, while being fully cognizant of the feared 
consequences, is the definition of addiction in other terms. At its core are neurohormonal 
mechanisms, which resist volitional attempts at behaving contrary to what these mechanisms 
impel the organism to do. The high attrition rates and nearly complete decay of adherence 
observed in lifestyle change interventions suggest that health behaviors are the result of 
autonomous drives, which frustrate volitional interference. The implication for research is to 
abandon the untenable precept of health behaviors being controlled exclusively by reason. 
Rather should research be focused on formulating models with which to explain the 
behavioral paradox, and from which to develop and test strategies for more efficient lifestyle 
change interventions. This is the aim of this study. It presents the case for a homeostatic 
feedback loop in which the organism’s energy flux and energy reserves are the autonomous 
effectors of a drive to eat, the satisfaction of which necessitates considerable amounts of 
physical activity for the procurement of the food available at a distinct energy density in the 
organism’s natural habitat. Shaped by natural selection to maintain energy homeostasis, this 
homeostatic feedback loop malfunctions in the recently emerged modern human 
environment, which lacks the obligatory physical activity cost of food, while presenting the 
latter in a processed form of high energy density to which the human organism remains 
unaccustomed. Runaway weight gain and overweight are the measurable consequences of 
this derailment. Based on these insights this work presents a strategy to reestablish energy 
homeostasis, by instituting a self-correcting cognitively controlled feedback loop with physical 
activity being the loop’s output, and the weight perturbations, which result from its derailed 
autonomous archetype, being the loop’s input. This cognitively controlled negative feedback 
system attempts to attenuate and reverse the runaway weight gain, not by a futile attempt to 
directly manipulate its causative derailed autonomous homeostatic system, but by decreasing 
or reversing the latter’s effect on body weight.  
This paper presents the rationale, the operationalization and the results of this work as well 
as the conclusions drawn therefrom.   
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THEORETICAL BACKGROUND 
Essential to organic life is its ability to maintain homeostasis in the face of external 
challenges. Adequate strategies for the maintenance of energy homeostasis have been 
subject to natural selection, favoring genetic retention of those variants, which ensured 
survival under the given conditions of energy density of procurable food and the obligatory 
energy cost for its procurement. Today’s environment dramatically differs from the one in 
which these mechanisms had been imprinted into the human genome. The physical activity 
cost, obligatory for food procurement in the natural pre-historic human habitat, has been all 
but abolished. Available food is being manufactured towards a substantially larger energy 
density. The negative feedback loops, which are the foundation of homeostatic balance, fail to 
operate under these conditions, leading to the progressive increases in body weight and body 
fat, which in turn initiate atherosclerosis as the causal pathogenic process underlying 
cardiovascular disease. With less than 10% of the adult population being free of the known 
risk factors for this disease, its economic burden is growing at a rate, which outperforms the 
growth of gross national products in developed nations.  
Evidence from epidemiological as well as functional and morphological investigations 
overwhelmingly support the notion that physical activity correlates strongly with 
cardiovascular health. While the pathways of this causal correlation are not fully understood, 
the current body of knowledge suggests that physical activity’s anti-inflammatory effect on the 
endothelial lining of the arterial tree is the major driver of this correlation. Endothelial cells 
respond to PA stimuli by maintaining or restoring the balance between pro-and anti-oxidative 
pathways, thereby maintaining or improving an anti-atherogenic vascular environment.  
The curious fact, however, remains, that many people who are aware of the benefits of 
exercising regularly do not behave in accordance with their knowledge, and fail to adhere to 
exercise interventions, which they had entered voluntarily. Reports of drop-out rates of 50% 
within the first 6 months are frequently encountered in the literature, and almost complete 
reversal of risk factors to their baseline values within 3-5 years from commencement of 
clinical lifestyle change interventions is the status quo of institutionally organized behavior 
change efforts. Behavioral science has formulated a multitude of models explaining human 
behavior.  Common to all models is the implicit assumption of volition as the final authority 
determining an individual’s behavior. However, the evidence is overwhelming that there exists 
some autonomous behavioral drive with the power to override reason and volition. One 
ecological observation to that fact is the inability of obese children and adults to reduce their 
weight through voluntary behavioral change, despite the substantial and measurable agony 
load imposed onto them through societal, economical and health care discrimination.  
The striking similarity of this health behavior paradox with behaviors of addiction is mirrored in 
the hormonal underpinnings observable in both behaviors. The investigations into the 
physiological correlates of feeding behavior, prompted by the insights from addiction 
research, suggest the presence of neuro-hormonal feedback loops with distinct orexigenic 
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and anorexigenic pathways. Coordinately they appear to drive an organism’s feeding 
behavior in response to hormonal signals of energy reserves and of energy flux. These 
pathways have been subject to natural selection in an environment, which placed an 
obligatory physical activity cost before food acquisition and ingestion. That is, the drive to eat 
is primarily a drive to move-to-be-able-to-eat. The important implication of this view is that 
physical activity behavior is the organism’s homeostatically controlled behavioral effector, 
rather than feeding per se, as is currently assumed by biomedical set-point models.  
In the modern environment, which lacks the obligatory physical activity component of food 
acquisition, physical activity has been knocked-out of the homeostatic equation of which it 
forms an integral part. Inaccessible to rational override, humans find these autonomously 
operating behavioral drives to frustrate volitional efforts of modifying them for the prevention 
of the diseases, which are precipitated by these autonomous mechanisms’ derailment.  
The success of behavior change interventions is further constrained by their being typically 
designed along standardized strategies, which disregard the idiosyncrasies of their 
participants.  Modeled around the paradigm of acute care, most, if not all, interventions are of 
a limited period only, after which the participants are left to their own devices. However, 
chronic conditions necessitate chronic care, and the abrogation of the obligatory physical 
activity cost of energy acquisition constitutes a chronic exposure of human homeostasis to a 
pathogen that requires chronic remedial measures. 
Hence, efforts for the development and testing of alternative strategies, modeled around the 
effective principle of the feedback loop, are warranted. Its purpose is to entrain physical 
activity into a habitual response to specific cues. 
METHODS 
The review of evidence of the physiological and behavioral aspects of health behavior change 
suggests the need for an alternative approach to instituting lasting health behavior changes. 
With a view to the self-correcting feedback loop, which underlies and effectively ensures 
homeostasis in biology, it presents itself as the ideal model to be operationalized in health 
behavior change interventions. Continuous self-monitoring is the central principle, with the 
objective of constant actual vs. target assessment of behavior change results. Complemented 
by the principles of individualization and continuity, this strategy is hypothesized to yield (a) 
significant improvements of the adherence rate to a physical activity intervention compared to 
published results, and (b) a significant improvement of vital signs and risk parameters among 
the adherent participants, when compared to their non-adherent peers. 
Hypotheses 
Four hypotheses were tested in this intervention: 
1. Adherence: the proportion of adherent participants will be 75% or better.  
2. Significant improvement of cardiopulmonary fitness, expressed in peak oxygen 
consumption 
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3. Significant Improvement of parameters of weight status, expressed as body weight 
and BMI 
4. Significant improvement of risk factors for cardiovascular disease, specifically blood 
lipids ad PROCAM risk score 
No a priori hypothesis had been formulated with respect to comparison of the adherence rate 
with published adherence rates. The reason being that the principles applied in this 
intervention necessitate an adherence definition, which differs from those reported for other 
intervention trials. The improvements in hypotheses 2-4 refer to significant effects within the 
adherent group from baseline to follow-up, and between groups of adherent and non-
adherent individuals.  
Overall Study Design 
The study was designed as a non-randomized intervention trial in which non-adherent 
subjects served as the controls. The restricted sample size of 120 participants, due to 
logistical and budgetary constraints, had sufficient power to detect the hypothesized effects. 
The 6-months intervention was performed at an electronics industrial estate in the South-
Western German state of Baden-Württemberg, recruiting its participants from among the 
predominantly white-collar employees of the major corporate tenant at that estate. The 
study’s target participants were sedentary adults aged 25 years and older with no physical or 
mental conditions, which would have prevented them from participating in an exercise 
program, or which would have exposed them to an elevated risk.  
Ethics 
Ethics approval for this study was obtained from the ethics committee of the state medical 
board of Baden-Württemberg, and informed consent was obtained from all participants prior 
to enrollment into the study. 
Statistical Measures and Procedures 
Analyses for differences between groups at baseline were performed using unpaired t-test 
and the Chi-square (χ2) test for categorical data. Change from baseline to follow-up within 
groups were tested using paired t-test for continuous data, or the Chi-square test or Fischer’s 
exact test for categorical data. Changes from baseline to follow-up were tested between 
adherence groups using the t-test for continuous data, and the Chi-square test for categorical 
data. Statistical significance was accepted at p<0.05. Two-by-two contingency tables were 
constructed to assess whether dichotomized change in parameter was related to adherence-
group association. In the case of significant findings, odds ratios were calculated and their 
95% CI were assessed using logistic regression. 
Intervention Curriculum 
All participants received a detailed personal appraisal of their baseline measurement results 
during a one-on-one consultation. Participants were then familiarized with the use of their web 
based electronic lifestyle file for monitoring and logging their physical activity and body weight 
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data. A minimum exercise curriculum of thrice weekly 20 continuous minutes of high intensity 
interval training was agreed to by all participants, with encouragement given for aerobic 
and/or resistance exercise to be performed in excess of this minimum requirement. The 
recommendations were based on each participant’s health profile with a view to improving 
specific health parameters. Participants were encouraged to login on a daily basis into their 
electronic lifestyle file.  
RESULTS 
Adherence was defined as meeting all of the following three parameters: (a) Latency of last 
logged exercise of ≤7 days prior to follow-up, (b) weekly volume of ≥ 60 min of exercise, and 
(c) duration of ≥ 90 days (3 months) of consecutive weeks of logged exercise volume. This 
definition of adherence provides an answer to the question, what proportion of study 
participants adheres to the PA protocol at follow-up and has done so for durations and at 
physical activity volumes, which are expected to yield tangible health benefits. 
Baseline Comparisons 
Of the 117 participants (28.2% female) enrolled into this study, 89 (76%) met the adherence 
criterion. No significant differences of baseline parameters were found between adherent and 
non-adherent groups. Comparison with data published for the World Health Organization’s  
MONICA (Multinational MONItoring of trends and determinants in CArdiovascular disease) 
study of a comparable German urban population showed that the study participants had a 
significantly higher BMI compared to the population mean (28.7 vs. 27.3 and 29.3 vs. 26.9 for 
the male and female subgroups respectively), and a minimally but significantly better blood 
lipid profile in the male sub-group.  
Hypotheses Testing 
The group of 89 adherent participants had reported an exercise volume in excess of 2.5 times 
the baseline recommendation of 3x20 min weekly, with a median of 158 min.  
The adherent participants significantly increased their mean peak oxygen consumption by 
close to 1 MET (from 32.8 to 36.1 ml/kg/min), whereas the 28 non-adherent participants 
witnessed a small but non-significant decrease (from 32.5 to 32.1 ml/kg/min). The between-
group difference was significant with p<0.001. 
While the non-adherent group significantly decreased their body weight and BMI (1.5 kg and 
0.4 kg/m2 respectively), the decrease in the adherent group was approximately 3 times larger 
(4.3 kg and 1.4 kg/m2 respectively) and significantly different from the non-adherent group.  
Of the lipid parameters, total cholesterol decreased significantly by 9 mg/dl (p<0.001) in the 
adherent group, and HDL increased significantly by 2.3 mg/dl (p<0.01) in the subgroup of 
adherent males. Small but non-significant increases of total cholesterol and decreases of 
HDL cholesterol were observed in the non-adherent group. The between group differences 
were significant with p=0.02 and p=0.038 for total cholesterol and HDL cholesterol 
respectively. The total cholesterol/HDL-cholesterol ratio decreased significantly by 0.2 units 
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from 4.2 to 4.0 in the adherent group with p<0.001 and increased non-significantly in the non-
adherent group. In the sub-group of the 63 participants with baseline ratio in excess of 4, the 
ratio decreased significantly in the adherent group by 0.4 units from 5.0 to 4.6 (p=0.001), with 
a small but non-significant increase in the non-adherent group from 5.0 to 5.1. Between-group 
difference was significant with p=0.01.  
Significant reductions were found for diastolic blood pressure of 5.9 and 5.3 mmHg in the 
non-adherent and adherent groups respectively, with no significant changes in systolic 
pressures. Since blood pressure correlates with body weight change rather than with changes 
of physical activity and cardiopulmonary fitness, the subgroup of participants who had entered 
the study with a BMI>25 and a systolic and/or diastolic pressure in excess of 129 or 84 mmHg 
respectively were dichotomized into those having achieved a weight reduction of at least 1 kg 
vs. those who did not. The weight-reducing group witnessed a significant reduction of systolic 
and diastolic pressures of 4 and 10 mmHg respectively (p<0.01), whereas non-weight-
reducing participants showed a small significant decrease of 3 mmHg of diastolic pressures, 
with no significant change in systolic pressure. Between-group differences were significant 
with p<0.05. 
Adherent participants showed a significant 14.7% reduction of PROCAM risk score vs. a 
16.6% non-significant increase in the non-adherent group. Between-group difference was 
significant at p<0.01.  
DISCUSSION 
The study results favor the hypotheses of a 75% proportion of adherent subjects (N=89) at 
the end of the intervention. In this study, the term adherence does not relate simply to the 
volume or duration of PA. The adherence definition of latency, volume and duration of the 
physical activity habit considers as adherent only those subjects whose changed physical 
activity habit is (a) operational at follow-up, and (b) has been operational for a long enough 
period und with a large enough exercise volume to yield significant and clinically relevant 
improvements of vital signs which are indicative of cardiovascular health. This substantially 
different way of defining adherence, which emerges from the theory and model underlying 
this intervention strategy, complicates comparison with adherence rates published for other 
studies.  
The substantial increase of physical activity volume over the minimum recommended level in 
the adherent group also favors the contention that engaging a cognitive feedback loop 
stimulates participants to increase the volume of their physical activity as the loop’s effector. 
This increase is reflected in the substantial and significant increase of cardiopulmonary 
fitness of 1 MET, which has been found to correlate with a substantial decrease of 
cardiovascular disease risk.  
Equally relevant were the observed reductions in body weight status with an odds ratio of 8 
(adherent vs. non-adherent subjects) for reducing body weight by ≥5% vs. reductions of less 
than 5% in overweight and obese subjects. This bespeaks a strong effect, given the relatively 
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short observational period of 12 weeks within the 6-months intervention. A minimum weight 
loss of 5% has been suggested to be required for clinically relevant hormonal improvements. 
Of the lipid markers, only the ratio of total cholesterol to HDL cholesterol emerged as being 
not only significantly improved but also to a clinically relevant extent. However, given the 
acknowledged superiority of this ratio over individual lipid fractions as predictive biomarkers, 
the intervention has demonstrated a clinically relevant improvement among adherent 
participants.  
The proportion of adherent participants, who had reduced their PROCAM risk score by at 
least 10% was nearly 3 times the proportion of non-adherent subjects achieving the same 
reduction (58.9% vs. 20%). This result supports the notion that this intervention can be 
benchmarked with a risk assessment tool, which is commonly used in clinical practice. 
 
CONCLUSIONS 
The recognition that (a) autonomously operating homeostatic feedback loops drive the human 
feeding behavior, of which (b) physical activity is an inextricable component, provides for an 
effective reformulation of behavior change strategies to correct the runaway weight gain, 
which results from modern environmental derailment of the homeostatic feedback loop.  
While volitional attempts to interfere with autonomously driven behaviors have remained 
frustratingly ineffective, the results of this study suggest that volition is an effective operator of 
a self-correcting feedback loop. When the latter gears into the evolutionary human system of 
energy homeostasis, accepting as its input the weight gain resulting from its homeostatic 
archetype’s derailment, volition is potentially more effective at arresting and reversing 
pathogenic weight gain than when attempting to directly modulate autonomously driven 
health behaviors.  
Taken together, the results of this study favor the hypothesis that an activated cognitively 
controlled feedback loop for the correction of weight perturbations, yields significant and 
clinically relevant improvements of cardiometabolic risk parameters.  
Condensed into one sentence:  
It may be more important to correct a person’s bio-behavioral malfunction that manifests in 
disease, than to correct the physiological malfunction with which the disease manifests. 
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DEFINITIONS AND ABBREVIATIONS 
DEFINITIONS 
When referred to in comparison to other study populations, the subjects of this study are 
referred to as the ELF sample, based on the naming chosen for the underlying intervention 
tool (the electronic lifestyle file, ELF). 
In the context of this work, the following terms shall have the ascribed meanings: 
 
Atherosclerotic Vascular Disease (AVD) 
refers to the cardiovascular diseases (CVD) resulting from atherosclerosis (coronary heart 
disease, cerebrovascular disease and peripheral arterial disease). 
 
Cardiometabolic disease  
refers to the atherosclerotic vascular diseases (AVD) and type 2 diabetes mellitus (T2DM).  
The rationale for combining both diseases into a disease cluster is provided by the existence 
of common pathways, specifically low-grade inflammation, insulin resistance and endothelial 
dysfunction [1]. The phenomenon of shared pathways has very recently been confirmed in a 
genetic-based investigation into disease relationships and their pathways [2]. The study’s 
finding that hypertriglyceridemia, hypercholesterolemia, hypertension, atherosclerosis and 
T2DM are among the top 20 connected diseases vindicates earlier efforts to recognize “a 
cluster of metabolic risk factors for cardiovascular disease and T2DM” as the metabolic 
syndrome X (definition, in italics, taken from the vocabulary of Medical Subject Headings, 
MeSH).  
With this recognition the use of the term cardiometabolic disease or cardiometabolic 
syndrome has become accepted [3]. 
 
Endothelial Dysfunction 
refers to the impairment of important endothelial functions, including anticoagulant, 
vasodilatory and anti-inflammatory properties [4].  
 
Physical Activity and Fitness 
The following definitions are in line with those formulated in the Physical Activity Guidelines 
Advisory Report of 2008 [5]. 
Exercise 
refers to physical activity that is carried out at an individual’s discretion, that is not 
essential to the tasks of daily living and which is performed with the intent to maintain or 
improve physical health or fitness.  
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Cardio-Respiratory Fitness (CRF) 
refers to the ability of the circulatory, respiratory and muscular systems to take-up, 
transport and use oxygen during sustained physical activity. The objective measurement 
parameter is maximal oxygen uptake (VO2max).  
 
Maximal Oxygen Uptake (VO2max) 
refers to the body’s capacity to take-up, transport and use oxygen during a maximal 
exertion involving dynamic contraction of large muscle groups.  
 
Peak Oxygen Uptake (VO2peak) 
refers to the highest oxygen uptake observed in an individual during a graded maximal 
exercise test. VO2peak may equal VO2max or may remain below, depending on 
attenuating circumstances such as cooperation of the individual or discontinuation of the 
exercise test due to the occurrence of symptoms suggesting increased health risk.    
 
Body Cell Mass (BCM) 
refers to that component of lean body mass which consists of muscle and organ tissue. 
 
Use of personal pronouns, whether male or female, are not to be construed as implying 
gender bias. For reasons of readability, I have used one or the other, without any derogatory 
or biased intent. 
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ABBREVIATIONS 
ACLS   Aerobic Center Longitudinal Study 
ACSM   American College of Sports Medicine 
AHA   American Heart Association 
AIB   Appetitive Ingestive Behavior 
apoE   apo-lipoprotein E 
AT   Anaerobic Threshold 
ATP   Adenosine Triphosphate 
ATP III   Adult Treatment Panel III  
AVD   Atherosclerotic Vascular Disease 
BCM   Body Cell Mass 
BIA   Bio-Impedance Analysis 
BLSA   Baltimore Longitudinal Study of Aging 
BMI   Body Mass Index 
CASS   Coronary Artery Surgery Study 
CDC   U.S. Centers for Disease Control and Prevention 
CFL   Cognitively Controlled Feedback Loop 
CFL+  operant CFL at follow-up (identifying adherent subjects) 
CFL-  no CFL present at follow-up (identifying non-adherent subjects) 
CHD   Coronary Heart Disease 
CI   Confidence Interval 
CIB   Consummatory Ingestive Behavior 
CPET   Cardio Pulmonary Exercise Testing 
CRF   Cardio-Respiratory Fitness 
CRP   C-Reactive Protein 
CVD   Cardiovascular Disease 
DBP   Diastolic Blood Pressure 
DLW   Doubly Labeled Water 
EC   Endothelial Cell 
ED   Endothelial Dysfunction 
EDRF   Endothelial Derived Relaxation Factor 
EGIR   European Group for the Study of Insulin Resistance  
ELF   Electronic Lifestyle File 
EMT   Error Management Theory 
eNOS   endothelial Nitric Oxide Synthase 
FRS   Framingham Risk Score 
GUTS   Growing Up Today Study 
HAPA   Health Action Process Approach 
HBM   Health Belief Model 
HDL   High-Density Lipoprotein 
HEPA   Health Enhancing Physical Activity 
HF   Heart Failure 
HIT   High Intensity Interval Training 
HPA   Hypothalamus-Pituitary-Adrenal 
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hsCRP   high-sensitivity C-Reactive Protein 
HWE   Healthy Worker Effect 
IDF   International Diabetes Federation 
IDL   Intermediate-Density Lipoprotein 
IL   Interleukin 
iNOS   inducible Nitric Oxide Synthase 
IQR   Interquartile Range 
IST   Incentive Sensitization Theory 
KIHDS   Kuopio Ischaemic Heart Disease Risk Factor Study 
LDL   Low-Density Lipoprotein 
Lept   Leptin 
LTPA   Leisure Time Physical Activity 
MCC   MONICA Collaborating Center 
MeSH   Medical Subject Headings 
MET   Metabolic Equivalent 
MetS   Metabolic Syndrome 
MONICA   Multinational MONItoring of trends and determinants in CArdiovascular disease 
NLM   National Library of Medicine 
nNOS   neuronal Nitric Oxide Synthase 
NO   Nitric Oxide 
NOS   Nitric Oxide Synthase 
NPY   Neuropeptide Y 
NWCR   National Weight Control Registry 
OR   Odds Ratio 
PA   Physical Activity 
PAGAC   Physical Activity Guidelines Advisory Committee 
PARS   Physical Activity Referral Scheme 
PMT   Protection Motivation Theory 
PROCAM  Prospective Cardiovascular Munster Study 
PVD   Peripheral Vascular Disease 
QoL   Quality of Life 
REE   Resting Energy Expenditure 
RNS   Reactive Nitrogen Species 
ROS   Reactive Oxygen Species 
SBP   Systolic Blood Pressure 
SCT   Social Cognitive Theory 
SD   Standard Deviation 
SICAM   Soluble Intra-Cellular Adhesion Molecule 
SO   Superoxide 
SOD   Superoxide Dismutase 
T2DM   Typ 2 Diabetes Mellitus 
TCH   Total Cholesterol 
TG   Triglyceride 
TOMHS   Treatment Of Mild Hypertension Study 
TPB   Theory of Planned Behavior 
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TRA   Theory of Reasoned Action 
TTM   Transtheoretical Model of Behavioral Change 
ULSAM   Uppsala Longitudinal Study of Adult Men 
VCAM   Vascular Cell Adhesion Molecule 
VO2max   maximal Ventilatory Oxygen Consumption 
VO2peak  peak Ventilatory Oxygen Consumption 
WHO   World Health Organization 
WHR   Waist-to-Hip Ratio 
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INTRODUCTION 
The aim of studies on physical activity interventions for the prevention of chronic disease is to 
reduce its prevalence in our populations.  
The paradigm underlying most, if not all, such studies is the unsinkable belief in reason and 
volition as the drivers of adherence to physical activity interventions. Neurohormonal 
evidence, however, points to a human model of energy homeostasis in which feeding and 
physical activity behaviors are subject to autononomous control mechanisms, inaccessible to 
a rational override. While this view may be unintuitive and uncomfortable for the reasons 
discussed hereinafter, it holds the key to materially increasing the prevalence of health-
enhancing lifestyle behaviors. The frustratingly low adherence rates to the latter necessitate 
the development of a new approach that is firmly grounded in a new paradigm evolving from 
neurohormonal evidence. This dissertation responds to this need, as well as to the call which 
has been made to shift research efforts from effectiveness towards dissemination studies [6].  
 
The section Theoretical Background discusses the lifestyle origins of cardiovascular disease 
and the evidence for physical activity as an effective means for its prevention.  
This section also presents the evidence for physical activity and dietary behaviors being 
driven by neurohormonal states, which are inaccessible to mental faculties other than self-
observation. A working model is proposed for the understanding of health behavior (physical 
activity and dietary) as the phenotypical representation of autonomously controlled 
neurohormonal feedback loops which evolved from natural selection.  
 
The Methods section discusses the implications of this model for successful behavior change 
strategies and the three essential aspects of an effective behavior change intervention are 
presented: individualization, monitored self-monitoring and continuity. This section closes with 
the development of 4 hypotheses for testing the model in an exploratory intervention: 
(1) the intervention will yield an adherence rate of 75% 
(2) adherent subjects will show a significant and clinically relevant increase in 
cardiorespiratory fitness 
(3) adherent subjects will benefit from improved parameters of body weight status 
(4) adherent subjects will reduce their risk for cardiovascular disease events  
 
The Results section presents the results of this exploratory study investigating the 
hypotheses developed in the preceding sections.  
 
The Discussion section discusses the results and the evidence in support of the hypotheses 
1-4, as well as the arguments for extending this research to investigate the applied tool’s 
ability to engage a cognitively self-correcting feedback loop for reestablishing energy 
homeostasis in its adherent user.  
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THEORETICAL BACKGROUND 
“No biological problem is solved until both the proximate and the evolutionary causation has 
been elucidated.” Ernst W. Mayr 
 
THE EVOLUTIONARY PERSPECTIVE 
“Move or die” is a rule that applies to all vertebrates and probably has shaped their genomes.  
Be it the need to acquire food, to avoid becoming it or to deal with threats and challenges, 
modern society’s lack of the need for physical activity is, in evolutionary terms, a very recent 
phenomenon of the past 200 years [7].  
The resulting high prevalence of sedentary lifestyles strongly associates with the emerging 
epidemic of cardiometabolic diseases, site specific cancers and musculoskeletal disorders 
[8]. Consequently, it has been suggested that the human genome, having been programmed 
for substantially higher levels of physical activity, is inadequately equipped to maintain health 
and function on the cellular and tissue level when confronted with hypokinetic lifestyles [8, 9]. 
This mismatch between genome and environment disturbs or derails human functional 
homeostasis, the sequelae of which have been termed “syndromes of impaired genetic 
homeostasis” by Neel [10]. It is the model which supersedes the author’s original 1962 theory 
of the thrifty genotype [11]. Essential to it is the interaction between the three mutually 
dependent elements, which define an organism: its genotype, its phenotype and its 
environment. 
It is based on the rationale that:   
(1) Feeding and physical activity behaviors have been subject to a process of natural 
selection, favoring genetic retention of those behavioral variants which ensured 
survival under the given conditions of energy density of procurable food and the 
obligatory energy cost for its procurement. 
(2) Sudden, profound and prevailing changes of these aspects of energy cost and 
supply, to which the organism finds itself genetically unaccustomed, will challenge 
the organism’s evolved ability to establish and maintain energy homeostasis with 
potentially pathogenic consequences. 
(3) Reestablishing homeostasis will arrest or reverse the pathogenic process, 
consequently preventing overt disease and thereby substantially improving public 
health.   
To this end, Neel explicitly suggested a euphenic strategy, a term introduced, to the best of 
my knowledge, by Lederberg in 1963 [12]. Euphenics may be defined as the science of 
improving the human phenotype after birth. But applying a 5-dollar word (euphenics) to a 50-
cent concept (exercising more and eating less), does not solve the 50-cent problem, namely 
how to get people to adhere to a more physically active and dietary less indulgent lifestyle. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 22 of 239 
Despite the common knowledge about the detriments of sedentism and hyperalimentation, 
adherence to sufficiently physically active lifestyles remains frustratingly low [13, 14]. That this 
is commonly blamed on lack of willpower bespeaks a human self-perception of being a 
species capable of, and behaviorally driven by, rational thought [15]. However, as I will outline 
hereinafter, an accumulating body of evidence suggests (a) the existence of strong 
autonomous neurohormonal mechanisms which drive human physical activity and dietary 
behaviors, and (b) the inaccessibility of these drives to rational interference.  
While these observations perfectly align with the aforementioned concept of energy 
homeostasis, they rub against the intuitive view of human health behaviors having rational 
rather than instinctive origins.  
However, the formulation of effective behavior change strategies will depend on the 
underlying model’s accuracy, not on its appeal. As the disregard for autonomously operating 
behavioral drives has failed public health efforts to stem the tide of lifestyle disease, the 
development of a new paradigm of human health behavior is warranted.  
Consequently I propose to develop intervention strategies from a modified model of human 
energy homeostasis, which aligns with evolutionary principles, specifically the objective of 
acquiring and maintaining sufficient energy levels to ensure the organism’s survival and 
reproduction. At the core of this model are autonomously driven physical activity and feeding 
behaviors which operate as the effectors of a negative-feedback loop that has been shaped 
by natural selection to establish energy homeostasis under the prevailing environmental 
conditions of (a) a relatively low energy density of the food available to the organism and (b) 
an obligatory physical activity cost for food acquisition. This integration of all the three 
elements which determine an organism’s phenotype, namely its genome, its behavior and its 
environment, achieves three important goals: Firstly, it reconciles with the observed 
phenomenon of energy homeostasis in all organisms which live in their natural habitat, 
including ancestral and some contemporary humans. Secondly, it explains how the sudden 
environmental shift from low to high energy density of food and the elimination of the physical 
activity cost for its acquisition derails this feedback loop, which has, over the course of 
evolution, been genetically programmed to maintain energy homeostasis under reverse 
environmental conditions. Thirdly, it provides for the formulation of testable hypotheses about 
interventional strategies with which to re-establish energy homeostasis within the prevailing 
modern human environment.  
Proof of concept for a disturbed metabolic homeostasis is the observation of progressively 
increasing body weight and body fat in our developed societies [16-20], which has colloquially 
been termed the obesity epidemic. The latter reflects substantial changes in dietary habits, 
which evolved secondary to the industrialization of food production, storage and distribution.  
That this ecological weight gain comes with an apparent bias to preserve fat mass, even in 
intended weight loss, supports the notion of an evolutionary trait that is maladaptive to the 
novel environment. Evidence for this bias has very recently emerged from an elegant 
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experiment that elucidated the relative contribution of body and organ mass loss to reductions 
in resting energy expenditure (REE) following diet-induced weight loss in 45 overweight and 
obese women [21]. The loss of fat-free mass, fat mass and organ mass explained only 60% 
of the observed reduction in REE. The remaining 40% were due to an adaptation in 
thermogenesis. From an evolutionary point of view such a bias protects energy reserves, 
thereby helping the individual to survive in an environment of unpredictable food supplies, the 
acquisition of which demands considerable energy expenditure.  
Only the obese modern human may not consider this evolutionary principle very helpful to her 
attempts at achieving a more healthy body weight. 
If, as has been suggested, sedentism is the common denominator of disturbed energy 
homeostasis [22] and chronic cardiovascular disease (CVD) [9, 23], physical activity will be 
linked to the pathogenesis of CVD, from its early and asymptomatic atherosclerotic 
antecedent to its overt disease endpoints. Interestingly, atherosclerotic lesions, have been 
histologically confirmed in 3,500 years-old Egyptian mummies, in accidentally mummified 400 
years-old bodies of Alaskan Eskimos, and in 18th century mummies of the Aleutian islands 
[24, 25]. Obviously, PA did not necessarily prevent this precursor of cardiovascular disease in 
our ancient forebears. But would their high physical activity levels have protected them 
against developing the cardiovascular complications that plague us in epidemic proportions 
today? We can’t say, because our ancestors simply may not have lived long enough for 
atherosclerotic and diabetic endpoints to manifest in epidemic proportions:  
While the life expectancy in today’s longest lived female cohorts is around 85 years, 
until the mid 1800s it was still just 45 years [26]. And the average lifespan of pre-
agricultural humans appears to have been less than 30 years [27]. In these age 
groups, symptomatic manifestations of the cardiometabolic disease spectrum are not 
very prevalent.  
However, the fact that physical activity and its closest correlate, physical fitness, are powerful 
determinants of arterial health and health in general, is supported by an accumulating body of 
evidence. Before reviewing this evidence it is worthy to reflect on the extent of the burden of 
cardiometabolic disease.  
 
THE BURDEN OF DISEASE 
Cardiometabolic disease has become the leading cause of mortality and morbidity [28] in 
developed and developing nations. It is the single largest contributor to health care 
expenditure [29], the latter now growing 70% faster than GDP across OECD countries [30, 
31].  
The U.S. ‘Public Health Action Plan to Prevent Heart Disease and Stroke’ posits that there 
will be no reversal of the epidemic of cardio-metabolic disease without more effective 
prevention [29]. This plan has become a corner stone of the Healthy People 2010 initiative 
[32]. However, the desired reduction in cardiometablic disease is threatened by a recently 
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observed trend of a decreasing prevalence of low-risk factor status, at least in the U.S. 
population [33]. Only 1 in 12 adult Americans currently meets the 5-criterion low-risk profile, 
which has been defined as (1) not currently smoking, (2) total cholesterol <5.17 mmol/L (<200 
mg/dL) and not using cholesterol-lowering medications, (3) systolic blood pressure <120 
mmHg and diastolic blood pressure <80 mmHg and not using antihypertensive medications, 
(4) BMI <25 kg/m2, and (5) not having been previously diagnosed with diabetes.  
The prevalence of low-risk status is now on a decrease from its peak in the late eighties. 
While the future impact of this trend on cardiovascular health cannot reliably be extrapolated, 
the three factors responsible for the reversal, specifically blood pressure, diabetes and BMI 
are all well correlated with the complications of atherosclerosis. After all, in 60% of the cases 
of sudden coronary death, acute luminal thrombosis from vulnerable atherosclerotic plaque is 
the triggering event, and total atherosclerotic occlusion accounts for the majority of the 
remaining 40% [34]. 
The current (2007) prevalence of adolescent overweight in the U.S. translates into cumulative 
direct and indirect morbidity- and mortality-related costs for coronary heart disease (CHD) for 
the period 2020-2050 of between 43” to 63” Billion U.S.$, depending on which treatment 
scenario is applied [35]. The most frustrating aspect of this crystal-ball gazing exercise is 
probably not the mind staggering figure, but the fact that the sum total of indirect and direct 
medical cost will only marginally benefit when the most aggressive treatment procedures are 
applied [35].  
That is, the benefit in indirect costs is almost fully wiped out by the extra treatment cost.     
 
PHYSICAL ACTIVITY PREVENTS CARDIOMETABOLIC DISEASE, BUT WHAT PREVENTS PHYSICAL 
ACTIVITY? A REVIEW OF THE SCIENCE 
 
The Physiological Aspects: Physical Activity Prevents Cardiometabolic Disease 
The following is a review of the epidemiologic as wells as physiologic evidence for the 
association between physical activity, its close correlate physical fitness and cardiovascular 
health. 
 
The Epidemiological Evidence 
Physical activity has been widely recognized to lower diabetes risk [36] as well as 
cardiovascular morbidity and mortality [23, 37]. Specifically, the impact of physical activity on 
the traditional risk factors for atherosclerotic vascular disease has been well documented [38].  
Just a year ago, the U.S. Physical Activity Guidelines Advisory Committee (PAGAC) 
summarized the currently available evidence for a correlation between physical activity and 
morbidity and mortality [5]. The 73 reviewed studies covered more than 830,000 men and 
women aged 16 years and older, who were predominantly recruited from apparently healthy 
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populations. The median follow-up was 12 years and the median reduction of relative risk 
between the most and least active groups was 31% with no significant difference between the 
genders.  
Consequently, PA has become a cornerstone of governmental recommendations for prudent 
lifestyles [39]. 
These epidemiological evaluations fail to answer the important question, through which 
pathways PA affects health. In a most convenient scenario, the effects of PA on morbidity and 
mortality should be reflected in the biomarkers used to measure risk. However, there is 
compelling evidence for PA to modify risk independently, that is, via pathways, which have 
yet to be elucidated and which do not necessarily affect traditional biomarkers of risk.  
 
Physical Activity As An Independent Modifier Of Health Status  
When compared to their sedentary peers, engaging in vigorous-intensity exercise, at least 
thrice per week, associated with a 50% reduced 6-year mortality rate in cancer patients 
registered in the Scottish Health Survey [40].  
In a 15-year follow-up of 25,000 patients of the U.S Coronary Artery Surgery Study (CASS), 
those participants, who reported vigorous physical activity, had a significantly lower mortality 
rate than their sedentary peers [41]. This relation remained significant even after adjusting for 
age, gender, smoking status, hypertension, diabetes, body mass index, left-ventricular 
ejection fraction and serum total cholesterol. 
A study of 2,678 elderly men of Japanese extraction in the Honolulu Heart Program 
demonstrated that those whose daily walking distance was less than 400 meters had twice 
the risk of fatal and non-fatal CVD compared to those who walked in excess of 2.4 km per 
day [42]. This risk ratio was unaffected by adjustments for the conventional risk factors age, 
total and HDL cholesterol, hypertension, diabetes, alcohol use, performed physical function 
score, and number of years lived in Japan during childhood, as well as for the use of beta-
blocking medication, aspirin and insulin.  
In the Harvard Alumni Study of 12,516 middle-aged and elderly men, those whose estimated 
weekly energy expenditure through exercise exceeded 1,000 kcal showed a significant and 
substantial risk reduction for CVD mortality and morbidity across all risk factors and their 
combinations [43]. 
 
Physical Activity As An Effect Modifier In Obesity 
An investigation into physical activity as an effect modifier of the correlations between BMI, fat 
and fat-free mass and all-cause death was conducted in a randomly selected middle-aged 
subgroup of the Danish MONICA population [44]. Among the men of the 2,800 participants, 
physical activity abolished the U-shaped relationship between BMI and 13-year mortality 
observed among sedentary men. While in women there was no statistically significant relation 
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between BMI and mortality, the physically active normal-weight women (BMI 19-24.9) 
enjoyed the lowest mortality rate.   
In a somewhat older cohort of 37,000 Swedish men, followed over 10 years, the elimination of 
BMI-associated risk elevation observed in the active Danish men could not be replicated [45]. 
However, when compared to lean active men, the relative risk of obese active men tended to 
be lower than that in lean inactive men.  
A similar effect was observed in a 10-year prospective study of the 185,000 male and female 
participants of the U.S. National Institutes of Health-AARP Diet and Health Investigation [46]. 
Using the most active normal-weight (BMI 18.5-<25) participants as the reference group, 
similarly active participants with a BMI between 30 and 35 had the same hazard ratio (1.62) 
for all-cause mortality as the sedentary normal-weight group.  
In a selection of over 21,000 women from the Women’s Health Study, PA showed a strong 
inverse association with CVD risk independently of the observed correlation between BMI and 
disease risk [47].  
 
Physical Activity And The Compression Of Morbidity 
PA appears to contribute to a compression of morbidity, as observed in the reduced need for 
hospital care and nursing home care in the last year of life. In a Finnish study of 846 persons 
aged 66 and above, the risk for all-cause hospital care was halved in the men classified as 
continuously physically active from middle age onwards, when compared to their least active 
peers [48]. The same degree of risk reduction was observed for nursing home care in women. 
In a study of the very old (aged 70-88), those who had been physically active in their 
seventies were substantially more likely to be functionally independent at age 85 [49].  
 
Physical Activity And Genetics  
The FinTwin16 study investigated the ability of PA to attenuate the genetic influence on BMI 
and waist circumference [50]. The results show that the genetic factors on BMI and waist 
circumference are less dominant in physically active subjects, indicating that particularly 
those with a genetic predisposition for obesity would benefit from increased levels of PA. 
These results were confirmed in the Danish-Finnish GEMINAKAR study of over 1,000 
complete twin pairs [51]. The study demonstrated that a high level of physical activity 
moderates the genetic variation in weight and waist circumference, which again suggests that 
even in individuals who are genetically predisposed to obesity, physical activity may moderate 
the adiposity risk.  
In a recent attempt to calculate the potential of preventing or postponing death from heart 
disease by means of a hypothetical delivery of perfect primary preventive care, PA appeared 
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as the single largest contributor, followed by prudent dietary habits and abstinence from 
tobacco use [52].  
 
Morphological And Functional Evidence 
While the epidemiological evidence for an inverse association between PA and 
cardiovascular health is persuasive, our knowledge about the biological effects of PA on CVD 
risk remains incomplete. However, the emerging understanding of the pathogenesis of CVD 
provides some important insights into the mechanisms by which PA exerts its protective role.  
 
The Inflammatory Origin Of Cardiovascular Disease 
Inflammation has begun to emerge as one such potentially important mechanism. In an 11-
year follow-up of over 27,000 apparently healthy women of the Women’s Health Study the 
inverse PA-to-CVD-risk association was explained to almost 60% by PA’s effect on traditional 
and known risk factors [53]. Of these, the markers of inflammation (high-sensitivity C-reactive 
protein (hsCRP), fibrinogen, soluble Intracellular Adhesion Molecule 1 (sICAM-1)) made the 
single largest contribution.  
These epidemiological observations align elegantly with the recently emerging understanding 
of atherosclerosis being an inflammatory disease rather than a disease of lipid deposition 
[54]. Approximately 50% of all atherosclerotic patients do not show the hallmark of disturbed 
lipid metabolism: hypercholesterolemia [55]. Also two thirds of all first cases of non-fatal and 
fatal CVD occur in individuals who do not meet the diagnostic criteria of the metabolic 
syndrome (MetS) [56, 57], which contains hypercholesterolemia and/or hypertriglyceridimia 
as a component criterion in all the 4 currently used sets of criteria as variably proposed by the 
World Health Organization (WHO), the International Diabetes Federation (IDF), the Adult 
Treatment Panel III (ATP III), and the European Group for the Study of Insulin Resistance 
(EGIR) [58]. In patients with the MS the risk for future peripheral vascular disease (PVD), 
however, is largely mediated through inflammation and endothelial dysfunction [59]. 
Hence, a new understanding of atherosclerosis as an inflammatory disease has replaced the 
previous emphasis on dyslipidemia as its primary cause [60, 61].  
If atherosclerotic vascular disease (AVD) is mediated through inflammatory pathways, PA’s 
cardioprotective value may well be the result of an anti-inflammatory effect.  
A 2005 review of cross-sectional and longitudinal investigations concludes that PA owes its 
cardioprotective effect largely to the lasting anti-inflammatory response of the organism to 
chronic exercise challenge [62].  
Further evidence for the PA-inflammation association comes from longitudinal, interventional 
and cross-sectional investigations. In a study of 3,810 elderly men, aged 60-79 after a 20-
year follow-up, strong and inverse relations were observed between markers of inflammation 
and coagulation and PA levels at follow-up [63]. The strength and significance of these 
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associations remained unaffected by controlling for prevalent CVD, smoking status and 
obesity.  
Exposure to a 6-months PA intervention yielded a significant reduction of inflammatory status 
in 60 T2DM patients irrespective of weight-loss [64].   
In a recent cross-sectional observation of a middle-aged healthy 800-strong subpopulation of 
the German MONICA study, PA showed a strong and inverse relation with the inflammatory 
markers fibrinogen, CRP and Interleukin 6 (IL-6) [65]. These associations remained strong 
after adjustment for Body Mass Index (BMI), Waist-to-Hip ratio (WHR), smoking status, 
hypertension, diabetes and total-to-HDL cholesterol ratio. Specifically smokers and ex-
smokers benefited the most from PA.  
Evidently, the case for an association between inflammation, atherosclerosis and PA is 
compelling.  
In the following section I attempt to merge these lines of evidence into a coherent view of 
AVD as an inflammatory disorder and PA as its anti-inflammatory remedy. 
 
Genesis Of The Atherosclerotic Plaque 
Among the initial steps of atherosclerotic lesion formation is the production of vascular cell 
adhesion molecules (VCAM), soluble intracellular cell adhesion molecules (sICAM) and other 
chemoattractant proteins, which promote leukocyte (specifically monocytes and T-
lymphocytes) adhesion to the endothelial cell [66, 67].  Monocytes then penetrate the 
endothelial lining, where they differentiate into macrophages, engulf modified lipoproteins and 
mature into lipid laden foam cells [68].  
These are the early manifestations of atherosclerotic fatty streaks, a process which begins 
early in life and which may already be clinically manifest in life’s second decade [69, 70]. 
While the aforementioned biochemical reactions are characteristic for atherogenesis, they are 
fundamentally not different from other inflammatory responses to tissue injury. The purpose of 
inflammation is the removal or inactivation of the injurious cause. If this cause, however, 
persists, the ensuing fibroproliferative response may alter the morphology and function of the 
affected tissue, which is what we observe in typical chronic inflammatory diseases, such as 
cirrhosis of the liver, rheumatoid arthritis, renal glomerulosclerosis, pulmonary fibrosis and, 
q.e.d., in atheroslcerosis [67]. It is this inflammatory response, which dominates 
atherogenesis throughout its disease stages. 
Obviously, it is difficult, if not impossible, to directly observe plaque genesis in any given 
individual over the 3-4 decades, which it takes for an early fatty streak to mature into an 
initiator of an acute coronary event. However, a morphological classification scheme has 
been developed which allows the determination of risk, based on plaque characteristics [71].  
In this scheme, the event most often liable for an acute coronary event is thrombus formation 
secondary to the rupture of the fibrous cap that covers mature atherosclerotic lesions [72]. In 
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these  “fibrous cap atheromata” a layer of smooth muscle cells and collagenuous tissue 
separates the lipid core from the luminal blood flow. Once this protective layer becomes 
compromised, the risk of platelet aggregation, thrombosis and its consequences are high. 
While a differentiation is being made between ruptured plaque and plaque erosion as the 
thrombosis triggering events, our current understanding of their etiology remains fragmentary.  
Today’s consensus view, though, is that (a) atherosclerosis develops over 4-5 decades 
before becoming symptomatic [73], (b) inflammatory processes operate throughout all stages 
of disease progression [74], and (c) distinct types of atherosclerotic lesions exist which 
correspond to distinct disease stages and which associate with different degrees of risk for 
terminal events [75]. It is now also widely accepted that a dysfunctional endothelium, unable 
to maintain the necessary anti-inflammatory, anti-coagulant and vasodilatory properties that 
protect the vasculature from atherosclerotic insult [76], is the initiator of plaque development 
[67]. 
Correspondingly, disturbances to these endothelial functions have been termed endothelial 
dysfunction (ED), which is now thought of as the central mechanism underlying the initiation 
and progression of atherosclerosis [4].  
Before examining the effects of PA on ED and atherosclerosis, it is worthy to briefly review 
the mechanisms that are instrumental in endothelial dysfunction.  
The current body of knowledge supports a reduced production or bioavailability of nitric oxide 
(NO), a member of the reactive nitrogen species (RNS) and formerly known as endothelium 
derived relaxation factor (EDRF), as the main mechanism underlying ED.  
The necessity of a functional endothelium for vasodilation to occur had (accidentally) been 
discovered and described in 1980 by Furchgott et al. [77]. Subsequent research efforts 
identified the gaseous nitric oxide molecule as the vasoactive substance [78, 79]. In our 
current understanding, the role of NO extends to inhibiting platelet aggregation [80], leukocyte 
adhesion [81] and vascular smooth muscle cell proliferation [82].  
NO is produced by nitric oxide synthase (NOS) of which three major isoforms are known: 
eNOS – endothelial nitric oxide synthase; nNOS – neuronal nitric oxide synthase; iNOS – 
inducible nitric oxide synthase [83]. Both nNOS and eNOS are constitutively expressed in 
many cells, not only the ones from which they derive their names. However, iNOS is inducibly 
expressed in activated macrophages [83]. 
To a large extent, our understanding of the role of NOSs in atherosclerotic disease originates 
from experiments with genetically altered mice, in which either a NOS gene or the gene 
expressing apolipoprotein E (apoE) or both have been knocked out. ApoE is a necessary 
ligand for hepatic absorption of intermediate density lipoprotein (IDL) and of chylomicron 
remnants prior to their metabolization to LDL [84]. Consequently apoE dysfunction leads to 
elevated circulating cholesterol levels promoting atherosclerotic plaque formation.  
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The apoE/eNOS double knockout mice develop atherosclerosis substantially faster and with a 
larger yield of plaque than apoE knockout mice living under similar dietary conditions [85]. 
From these experiments it has been suggested that reduced bioavailability of NO, secondary 
to an impairment of eNOS function, promotes and accelerates the progression of 
atherosclerosis.  
However, the association between NO and atherosclerotic disease is not as simple and 
straightforward as these experiments suggest. Knocking out the iNOS instead of the eNOS 
gene produces atherosclerotic lesions in apoE/iNOS double-knockout mice which are 
significantly smaller than those in comparable apoE knockout mice [86]. The fact that eNOS 
produces low amounts of NO whereas iNOS, expressed in response to inflammatory 
processes in macrophages, endothelial and smooth muscle cells, generates large amounts of 
NO, has led to the hypothesis that it is the net concentration of NO at the tissue level which 
determines whether it is of physiological or pathological consequence [87].  
In support of this hypothesis is the observation that excessive iNOS activity in the 
macrophages of existing atherosclerotic lesions facilitates the production of the oxidant 
peroxynitrite resulting from an NO reaction with superoxide (SO), a member of the reactive 
oxygen species (ROS). This cascade promotes the oxidation of LDL, thereby aggravating the 
inflammatory response [88]. 
In this scheme, the reaction of NO with SO to form peroxynitrite, plays a central role. 
Peroxynitrite is a powerful agent for tyrosine nitration, which generally leads to a loss of 
function of the nitrated protein [89]. If that protein happens to be superoxide dismutase 
(SOD), the primary scavenger and inactivator of SO [90], the resulting increase in SO 
concentration may further exacerbate the production of peroxynitrite, indicating that it is the 
balance between NO and SO which determines whether the downstream consequences are 
protective or detrimental to the tissue [91].  
In vitro experiments have demonstrated that the oxidation of lipids caused by peroxynitrite 
resulting from the reaction of NO and SO can be completely halted if the 1:1 substrate ratio is 
sufficiently shifted in favor of NO, as it effectively inhibits lipid peroxidation [92]. Put simply, 
while NO in reaction with SO produces a generally detrimental substance, peroxynitrite, a 
relative increase in NO keeps these detrimental effects in check. Or phrased another way: At 
any given concentration of SO, a relatively low SOD activity will leave proportionally more SO 
molecules ready for reaction with NO to form peroxynitrite. Hence, an increase in SOD 
activity, will reduce peroxynitrite formation thereby alleviating nitrosative stress while at the 
same time leaving a higher concentration of NO to amplify its physiological effect. 
Given these insights, optimal preventive or curative intervention would first require an 
analysis of this NO/SO imbalance to (a) determine whether an impairment of NO or SO 
production is the cause, and in which tissue compartment the imbalance occurs, and to (b) 
administer the appropriate corrective treatment. However, our knowledge is currently 
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insufficient to disentangle the complexities of the ROS/RNS pathways for the development of 
interventions to effectively prevent or cure AVD [91].  
What we do know is that the restoration and maintenance of physiological ROS/RNS function 
is an important goal in the prevention of atherosclerosis and its complications. Which leaves 
the question: is there any evidence to suggest that PA contributes to the structural and 
functional integrity of the endothelium, and thereby stabilizes atherosclerotic plaque, prevents 
its formation or even regresses its precursor fatty streak lesions? And if so, what are the 
implications for the prescription of exercise? 
 
Physical Activity As A Mediator Of Endothelial Health 
The apparent paradox, that acute exercise, though increasing the production of ROS, also 
chronically improves endothelial function, has long puzzled investigators [93]. Similarly 
fascinating is the observation that exercise training, in CVD patients, dramatically increases 
myocardial perfusion and lowers risk with no or little visible regression of coronary stenoses 
[94]. This gap between PA associated modification of risk factors and morphometric changes 
on one hand, and actual risk reduction on the other, has recently been termed the “risk factor 
gap”, which has become an area of intense research [95]. 
One obvious effect of exercise is a change in haemodynamics, generating flow patterns, 
which are substantially different from those of the resting state. That these flow patterns are 
causally correlated with endothelial function and, by extension, atherogenesis is a relatively 
new discovery.   
Since the early Eighties it is known that plaque distribution is non-randomized with 
preferential development on the outer walls at arterial bifurcation points and downstream of 
existing plaques [96, 97]. The common denominator of these locations is a low shear stress 
experienced by the endothelial cells (ECs) [97, 98]. Shear stress is defined as the blood-
flow’s frictional force acting on the cell surface in the direction of the vessel wall.  
It has been shown that the promoter regions of the genes expressing VCAM and sICAM 
proteins contain elements, which respond to alterations in shear stress [99, 100]. 
Obviously, the EC’s mechanoreceptors respond to haemodynamic forces by initiating distinct 
molecular signaling cascades which either inhibit or promote inflammatory responses [101]. In 
the case of physiological shear stress, these cascades are anti-inflammatory and anti-
adhesive, whereas the opposite is the case in areas of oscillating or low shear stresses [74]. 
Changes in haemodynamics, such as those resulting from exercise of appropriate intensity, 
can rescue the EC from unfavorable blood flow patterns. Mathematical modeling of 
abdominal aorta haemodynamics has demonstrated that the atherogenic blood flow patterns 
prevailing at arterial branch points under resting conditions can be eliminated by exercise 
[102]. 
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Interestingly, a threshold seems to exist for exercise intensity, below which no beneficial 
change in EC response to exercise can be observed.  
These observations, however, beg the question, how the relatively limited time spent in 
exercise of adequate intensity may possibly generate an effect on the vasculature that lasts 
long enough to be of atheroprotective significance.  
Current evidence supports the notion of an indirect pathway via the activation of nitric oxide 
(NO) production, the bioavailability of which extends beyond the period of acute exercise. In 
contrast, a disturbed bioavailability of nitric oxide, formerly known as the endothelial derived 
relaxation factor (EDRF), promotes inflammation and thrombosis, thereby initiating and 
accelerating the formation of atherosclerotic plaque as well as its destabilization [103].  
Further support for the notion of PA as a means to redress the SO/NO balance comes from 
animal and human studies. In wild-type mice, exercise training substantially increases NO as 
well as the expression of eNOS and ecSOD genes, leading to a net increase of NO compared 
to SO [104]. However, the same experiment with eNOS knockout mice, failed to increase NO, 
as expected, but also did not increase ecSOD expression, which suggests that NO is also a 
modulator of ecSOD gene expression, and hence the mediator of the anti-oxidant effects of 
exercise.  
In CVD patients, 10-minute bouts of supervised exercise, performed 6 times daily on row and 
bicycle ergometers over 4 weeks, dramatically improved endothelial function, measured in-
vivo and in-vitro [105]. In the exercise group, acetylcholine-mediated vasodilation and blood 
flow increased 2-fold and 8-fold respectively, whereas no change from baseline was evident 
in the sedentary control group. Also, eNOS-mRNA and eNOS protein concentration increased 
two-fold in the exercise group compared with the control group. 
In middle-aged apparently healthy overweight and obese men, a 12 weeks exercise program 
significantly increased carotid artery compliance and plasma NO concentration [106].  
 
An Interim Summary 
Endothelial health depends on a finely tuned balance between pro- and anti-oxidative 
pathways. The disturbance of this balance has been appropriately termed endothelial 
dysfunction (ED) [107, 108]. It is the precursor of a pro-inflammatory state that promotes 
atherosclerotic vascular disease (AVD) and its endpoints. Hence ED is a primary target of 
interventions aimed at preventing AVD. 
Endothelial cells respond to PA stimuli by maintaining or restoring the balance between pro-
and anti-oxidative pathways, thereby maintaining or improving the anti-atherogenic vascular 
environment. Accumulating evidence supports the view that chronic intermittent exercise 
training improves endothelial function by increasing NO bioavailability [109] and that exercise 
is an effective atheroprotective therapy [109, 110]. 
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Since there is compelling evidence for the strong and independent inverse association 
between PA and ED, increasing PA in sedentary at-risk populations is a promising strategy in 
the battle against AVD. 
On a population level, however, this effectiveness is mitigated by low adherence rates to PA 
recommendations and interventions, a problem addressed in the following section.     
 
The Behavioral Aspects: The Failure Of Free Will In Behavior Change 
“In the mature sciences the prelude to much discovery and to all novel theory is not 
ignorance, but the recognition that something has gone wrong with existing knowledge and 
beliefs” Thomas S. Kuhn 
 
It is an acknowledged fact that many people who are aware of the benefits of a healthy diet or 
of exercising regularly do not behave in accordance with their beliefs despite repeated 
resolutions to remedy this inconsistency.  
The resolution to take up exercise is generally driven by (a) the awareness of its ultimate 
health benefits and (b) the anticipation that, at the planned point in time one will be motivated 
to choose exercise over a sedentary alternative. That however is self-contradictory. If one 
would innately prefer exercise to its sedentary alternative, one would not need a rational 
resolution. The very fact that one needs a rational resolution bespeaks an innate preference 
for remaining sedentary. This begs two questions: 
First, why would one expect to prefer exercise over its unhealthy alternative in the future 
when one doesn’t prefer it right now?  
And second, if reason was the ultimate driver of our health behavior, why do we witness not 
only the anecdotal evaporation of new-year resolutions but also the stupendous degree of 
non-adherence to PA recommendations and interventions across interventions and 
populations?  
Obviously, there exists some behavioral drive with the power to override reason and volition, 
the two mental-faculty champions of the volition-health camp.  
But before presenting the evidence for the autonomous drive of physical and dietary behavior 
it is worthy to review the degree to which the belief in a rational control of health behavior is 
failing public health.  
 
Non-Adherence To Physical Activity Recommendations – The Magnitude Of The Problem 
Intervention effectiveness depends on the efficacy of the intervention and on the degree of 
adherence to it.  
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Despite several decades of public health messages about the benefits of physical activity, a 
majority of the population remains non-adherent to public recommendations and below the 
recommended levels of health enhancing physical activity (HEPA).  
In a survey conducted in 2002 across EU countries, the percentage of sufficiently active 
adults averaged just 29% [14]. The guidelines used to define the threshold of health 
enhancing physical activity were drawn from the then valid CDC-ACSM recommendations 
(U.S. Centers for Disease Control and Prevention, and the American College of Sports 
Medicine) of accumulating at least 150 minutes of moderate-intensity exercise over 5 days 
per week or 60 minutes of vigorous-intensity exercise over 3 days per week [111].  
In Germany 60% of the adult population falls below this threshold [14]. Whether these figures 
represent any improvement over the past decades is difficult to ascertain due to changes in 
measurement methodology and PA recommendations over the past 4-5 decades. An 
evaluation of the population of the Baltimore Longitudinal Study of Aging (BLSA) concludes, 
that public health recommendations had only a minor and transient impact on the prevalence 
of sedentism during the 70s and 80s and none thereafter [112]. However, with a 24% 
prevalence of sedentism in the 1960s and a 14% prevalence in the 1990s (all assuming the 
aforementioned CDC-ACSM guidelines) this self-enrolled and admittedly very health-
conscious study population is hardly representative of the general population. 
 
More telling are the effects of recent and current interventions. No reduction in morbidity or 
mortality was observed following a community-wide 5-6 year education intervention in the 
U.S., with only minimal improvements of risk factors [113]. In Germany, a similar 7-year 
intervention was conducted with the population of three large-city districts in Bremen, Berlin 
and Stuttgart, the entire medium-sized city of Karlsruhe (population ≈ 275,000) and two of its 
bordering communities, plus the rural district of Traunstein [114].  A statistically significant 
lowering of blood pressure by 2% (systolic and diastolic) was observed in the intervention vs. 
the reference population. However, given the large number of observations, statistical 
significance of this relatively minor change is unsurprising, and the clinical relevance of these 
results is questionable, as the study does not report on morbidity or mortality incidence. While 
the investigators observed a 21% reduction in untreated hypertension, this effect may well be 
due to an intervention-triggered sensitization of individuals, who subsequently sought medical 
attention, and who would otherwise have remained ignorant about their hypertensive state. It 
is also telling, that the prevalence of BMI >25 increased in the intervention population by 2% 
despite the targeted 5% reduction. 
 
In the UK the ACTIVE for LIFE campaign, which aimed at promoting increases in physical 
activity, yielded no measurable behavioral change at a cost of £ 3’ Mio [115]. 
Again in the UK, physical activity referral schemes (PARSs) have become a widely used 
primary care tool to encourage sedentary adults to take up exercise [116]. PARSs generally 
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entail the referral of a primary care patient to a 10-12 weeks supervised exercise program 
[117]. Of the 75% of referred patients who took up the referral, 48% completed the program, 
with completion defined as having attended at least 80% of the prescribed exercise sessions 
[116]. This translates into only 36% of referred patients completing a physical activity 
program, which had been specifically prescribed by a primary care physician to reduce a 
diagnosed health risk.  
Smaller-scale clinical and commercial interventions do not fare much better. 
Dropout rates from physical activity programs are typically 50% within the first 6 months [118-
120].  
Taking weight loss in obese persons as an outcome measure of exercise and diet based 
weight reduction trials, an almost entire reversal of initially achieved weight loss is observed 
within 3-5 years post-intervention [121, 122]. When defining long-term weight-loss success as 
losing initially ≥ 10% of bodyweight and maintaining at least 10% bodyweight reduction at 12 
months, the most optimistic estimates of success rates are 20% [123]. 
Amazingly, even with the agony load of having suffered a myocardial infarction, at 6 months 
post-infarction, 60% of patients have been found to be insufficiently physically active to lower 
the risk for a repeat event [124].  
Using the internet as a tool to reach larger numbers of individuals does not seem to help 
much either. Active-online is a web-based, German-language, individually tailored physical 
activity program that had been developed by a group of experts drawn from various health 
sciences [125]. This program is directed at adults aged 30 to 60 years. In a 13-months follow 
up of 1,500 users, self-reported PA increased significantly, however, these data are in conflict 
with objectively measured PA, which showed no increase at all [125].   
A Danish 20-weeks work-site PA program using pedometers and a 10,000-steps-a-day 
program goal resulted in no change of PA in the intervention and control groups [126]. To 
make things worse, those intervention group participants whose daily step count exceeded 
10,000 steps at baseline demonstrated a statistically significant 13% drop in step counts at 
follow-up. No changes were observed among participants whose daily step-counts had 
remained below 10,000 steps at baseline, regardless of intervention or control group. While 
the drop in step-count may be explained by seasonal effects (follow-up was in February) the 
overall result does not give reason for enthusiasm.     
The aforementioned intervention examples are an illustrative rather than an exhaustive list, 
which highlights the extent of the non-adherence issue. Non-adherence has become such a 
sizeable problem that the WHO has recognized it, in its 2003 action paper on adherence, to 
compromise the public health effectiveness, not only of lifestyle change interventions, but 
across all therapeutic areas [127]. The WHO also criticizes that adherence can’t be measured 
and compared across interventions as there are no specific adherence standards against 
which participant behavior can be compared. This is particularly problematic in physical 
activity interventions, where adherence has been variably defined as attendance at the final 
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session, or by variable percentages (generally 75% - 80%) of sessions attended, either on the 
participant or the group level [116]. Neither of these definitions reliably tells us whether the 
label “adherent” reflects (a) adherence throughout the intervention, or (b) stable change of PA 
behavior, the latter being the primary objective of public health efforts to increase PA levels.  
Taken together, the discussed evidence supports the WHO view that non-adherence is such 
a substantial confounder of intervention effectiveness, that improvement of adherence is 
expected to have a larger impact on public health than advances in specific medical 
treatments [127]. That begs the question: What are we doing about it? 
 
Non-Adherence to Physical Activity Recommendations – Current Strategies To Solve The Problem 
Any discussion about adherence necessitates first a definition of the term. The WHO has 
defined adherence [127] as “the extent to which a person’s behavior – taking medication, 
following a diet, and/or executing lifestyle changes - corresponds with agreed 
recommendations from a health care provider.”  
The emphasis on the term “agreed” acknowledges the importance of the role of the patient as 
a consenting party to a therapeutic or preventive curriculum, and to differentiate adherence 
from compliance. 
While adherence is a measurable behavior of the patient, its drivers do not exclusively rest 
with the patient. The WHO recognizes health care providers and health care systems as 
important contributors to adherence behavior [127]. I will briefly summarize the role of these 
external drivers of adherence before discussing its behavioral aspects in greater detail.  
 
The Public Health Strategies 
Health care providers’ communication skills, from history taking to discussing the therapeutic 
intervention, have been found to somewhat correlate with functional and physiological 
outcome [128]. However, this statement needs to be viewed in the context of a lack of 
standardized instruments to reliably evaluate doctor-patient communication and relatively little 
published data on this subject [129].  
A Cochrane review of clinical trials showed inconclusive evidence that simply counseling 
adults in the primary care setting is effective in increasing physical activity [130]. However, 
common sense suggests, that a well-informed patient, whose doctor treats her as a partner in 
the treatment process, will be a patient more willing to adhere to the treatment program.  
As long-term adherence to changed behavior is required to maintain its benefits, relapse 
prevention is essential but, again, requires provider follow-up. At which intensity such 
encouragement needs to be delivered is less clear [131].  
The American Heart Association (AHA) exhorts physicians to provide their patients with this 
encouragement in the form of individualized exercise prescriptions and familiarization with 
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behavioral change strategies [38]. But expecting health care providers to follow this call, 
without the health care system providing the necessary incentives, appears naïve. A recent 
survey of primary care physicians confirms this view [132].  
After all, it is the health care system which directs (a) duration and frequency of doctor-patient 
interaction, (b) efforts for maintenance of care, and (c) the financial reimbursements. These 
directions have evolved from a need to treat acute disease, not from a need to prevent the 
chronic variety. Inevitably, with resources already stretched to meet the demands for acute 
care, current health care systems would be overwhelmed by the demand for preventive 
services. The WHO has therefore recognized these systems as falling “remarkably short” 
when tasked with preventing and managing chronic diseases [133].  
The good news is that the WHO has acknowledged the need to move towards an integrated 
preventive health care system, but also, that this requires nothing less than a paradigm shift 
[133]. The bad news is the glacial pace at which such restructuring happens.  
However, every problem also presents an opportunity. The opportunity in this case is for a 
tool that allows (a) a cost-efficient dissemination of variably designed PA interventions across 
large populations, that (b) provides for standardization of adherence and outcome 
measurement across interventions, and which (c) increases the prevalence of health 
enhancing physical activity. Before conceptualizing such a tool, it is necessary to review the 
behavioral mechanisms underlying PA habits.  
 
The Strategies Of Behavioral Science 
While extensive efforts have been made to identify personality traits that help predict 
adherence, there is no evidence of adherence being associated with any specific trait [127, 
134]. Equally futile has been the search for a behavioral model, which would not only explain 
patient behavior but also facilitate its modification to promote adherence. These efforts have 
produced an array of models and theories, which I will briefly summarize on their key aspects 
as these relate to the acquisition of HEPA habits. One conclusion that can be safely drawn 
from this proliferation of models is, that obviously nobody has uncovered the heart of the 
matter.   
Therefore I antedate this discussion with its essential result that, while all these models have 
their advantages and deficiencies, none has proved to be superior, and a call for their 
integration into one combined approach has been made [135].  
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The Health Belief Model (HBM) 
The HBM [136] posits that an individual will make a health behavior change if she/he believes 
that: 
• negative health consequences can be avoided 
• the recommended behavior change prevents the feared health consequences 
• she/he has the ability and resources to carry out the recommended behavior change    
The HBM is built on four constructs representing an individual’s perception of susceptibility to 
the disease, severity of the disease, benefits of preventing it and barriers to the 
recommended behavior change. Taken together, these four constructs determine an 
individual’s readiness to act, which requires a cue to action to set the behavior change in 
progress.  
A 1992 meta-analysis of the HBM found it to have been, until then, the most frequently cited 
model in health research [137]. However, the authors also reported inconclusive evidence to 
recommend for or against the usefulness of the model. As none of the underlying studies was 
concerned with HEPA as the dependent variable and only one with dietary behavior in 
obesity, the usefulness of the model as a framework to guide PA intervention protocols 
remains uncertain. Since the aforementioned meta-analysis, several cross-sectional studies 
have reported on the usefulness of HBM constructs to predict exercise behavior in college 
women for the prevention of osteoporosis [138, 139], in type-1 diabetic college students for 
the prevention of complications [140], and in type-2 diabetes mellitus (T2DM) amputees [141].  
In a retrospective study of 69 clients of a community centered 6-months CVD exercise 
program, HBM constructs had shown only modest association, no association and a counter-
intuitive association with exercise behavior [142]. However, this study had serious 
weaknesses such as the facts that all subjects were attendees of an exercise program and 
that health belief questions had been answered retrospectively after conclusion of the 
program. Overall, published data on the utility of the HBM for PA interventions are sparse, all 
studies are cross-sectional and hence no data are available to answer the question whether a 
change in the HBM constructs yields a change in exercise behavior in the expected direction.  
 
The Theory Of Reasoned Action (TRA) 
The focus of TRA is on an individual’s attitudes towards the outcome of a behavior as the 
major determinant of the intent to carry out the behavior [143, 144]. As such, TRA applies 
best to behaviors, which are entirely under volitional control. That assumption does not 
necessarily apply to lifestyle behaviors, specifically the acquisition of HEPA, which are also 
influenced by factors outside of an individual’s purely volitional control, as discussed in the 
next section. To accommodate for this fact, TRA has been refined into the Theory of Planned 
Behavior.   
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 39 of 239 
The Theory Of Planned Behavior (TPB) 
The theory of planned behavior (TPB) is an extension of TRA [143]. It acknowledges the 
importance of assessing the amount of control an individual has over the target behavior. 
Control factors relevant to HEPA are internal factors, such as skills, abilities, information and 
emotions, as well as external environmental factors.  
 
The Transtheoretical Model Of Behavioral Change (TTM) 
The transtheoretical model of intentional behavior change describes the process of behavior 
change as evolving through 5 distinct stages: pre-contemplation (not ready to take action); 
contemplation (getting ready); preparation (ready); action (overt change) and maintenance 
(sustained change) [145]. In each stage specific processes of change are required to facilitate 
the move to the next stage. Recidivism to an earlier stage is always possible and individuals 
may cycle through these stages several times before a stable habit keeps them in the 
maintenance stage. The model also incorporates a series of intervening or outcome 
variables, such as decisional balance (the pros and cons of change) and self-efficacy (the 
perceived ability to perform a task).  
A 2008 systematic review investigated 21 randomized controlled trials and 3 non-randomized 
controlled trials, all conducted between 1996 and 2005, which had applied TTM to develop 
PA behavior change interventions under the hypotheses that these interventions are effective 
in promoting PA behavior [146]. The authors report that only 7 interventions were tailored to 
all four dimensions of TTM (specifically stages of change, processes of change, decisional 
balance and self-efficacy). However, all of these reported statistically significant short-term 
findings, and 1 intervention statistically significant long-term findings. Since also 12 of the 
remaining 17 interventions reported significant short-term findings, the reviewers felt unable 
to conclude whether studies, which do not deploy all TTM constructs are any less efficient 
than ‘full-model’ interventions. Particularly relevant to HEPA as the outcome measure is, that 
only one of the reviewed trials reported on statistically significant long-term findings over 12 
months.   
One study, not included in the aforementioned review, conducted with Chinese adolescents 
found only weak correlation of the TTM to predict exercise behavior [147].   
 
The Social Cognitive Theory (SCT) 
Perceived efficacy is the key determinant of social cognitive theory [148]. This theory 
suggests, that the stronger the perceived efficacy in changing lifestyles, the higher the goals 
the people set for themselves, and the greater their trust in their ability to overcome obstacles 
to achieve the desired outcome. In this model, a patient’s adherence to lifestyle change 
depends largely on his self-regulatory skills, which includes self-monitoring and self-
management. There is some evidence to suggest that constructs of social cognitive theory 
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associate moderately with uptake of HEPA in diseased [149, 150] and healthy [151, 152] 
populations.  
A proactive approach by the provider necessitates imparting the requisite physical activity and 
lifestyle change skills as much as instilling the patient’s belief in having them.   
 
The Protection Motivation Theory (PMT) 
The Protection Motivation Theory is built on four constructs, which are thought to underlie an 
individual’s decision how to deal with a potential health threat. These four constructs are:  
1) The perceived severity of a disease outcome (e.g., a heart attack)  
2) The perceived vulnerability (the probability to suffer a heart attack)  
3) The perceived response efficacy (the efficacy of the recommended preventive action)  
4) The perceived self-efficacy (the degree of confidence in one’s ability to perform the 
preventive action).  
Protection motivation is the result of the threat appraisal (constructs 1 & 2) and the coping 
appraisal (constructs 3 & 4). In the context of HEPA protection motivation refers to the 
intention to take up exercise and to maintain it for preventive purposes. To judge the 
usefulness of this model for promoting the uptake of HEPA is difficult as there are insufficient 
studies available to draw any conclusion.   
 
The Health Action Process Approach (HAPA) 
HAPA is based on the staging of health behavior, and consequently health behavior change, 
from pre-intentional motivation processes which generate behavioral intention, to post-
intentional volition processes which promote the actual health behavior [153]. 
In the motivation phase the constructs of self-efficacy and outcome expectancies are seen as 
the most relevant predictors of intentions. In the volition phase the perception of self-
efficiency becomes the determining element as action plans and their realization depend 
largely on one’s perceived competence to execute them.  
 
A General Criticism Of the Models 
What is striking in these models is not their diversity but their common denominator: the 
elements of reason, perception and volition.  
Common to all models is the implicit assumption of volition as the final authority determining 
an individual’s behavior, while all other model-specific determinants affect the likelihood of 
this behavior to happen in the predicted direction. Discrepancies between observed and 
predicted behavior may consequently be ascribed either to the inadequacy of a model’s 
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constructs to predict behavior, or, in a less benevolent view, to an inadequacy of volition, or 
more colloquially, lack of willpower.  
The beauty of the latter view is that it enables public health actors to place the 
responsibility for the consequences of detrimental health behaviors squarely on the 
“aberrant” patient. Aside from other nuisances, this relieves the health care actor from 
inconvenient confrontations with industries who derive their economical successes 
from tempting people into unhealthy patterns of consumption and behavior, thereby 
contributing substantially to the health care actors’ taxation revenues.  
 
In the following I will present evidence, which is irreconcilable with the view of health 
behaviors being driven by reason and volition.    
 
The Reason For Non-Adherence: Evidence For The Failure Of Free Will 
Health Behavior In Children 
Children are too young to choose being overweight or obese. But if the volition-health 
assumption were true, children would be able to change once the agony load from being 
overweight crosses a threshold that motivates them to replace obesogenic behaviors with 
healthier alternatives.  
The bodyweight related agony load is indeed high for obese children. They suffer not only in 
terms of poor health related quality of life (QoL), which has been found to be equivalent to 
that of child cancer patients receiving chemotherapy [154], but also in terms of peer 
victimization and stigmatization [155]. Yet, the prevalence of overweight among U.S. children 
and adolescents has nearly tripled over the past thirty years from 5% in 1971 to 13.9% in 
2004 [156]. The steepest increase was in the bracket of 6-11 year-olds in which overweight 
prevalence climbed from 4% to almost 19%.  
Today these kids face substantially more stigmatization and negative stereotyping than obese 
children did 40 years ago. In a 2003 replication [157] of a 1967s experiment [158] 458 5th and 
6th graders were asked to rank their liking for (a) a healthy child, (b) one with clutches and a 
leg brace, (c) one without a left hand, (d) one sitting in a wheel chair, (e) one with a facial 
disfigurement and (f) one obese child. In both experiments the kids ranked the healthy child 
highest and the obese lowest. The bias against the obese child, though, had increased by 
over 40% in the 40 years that separated the two experiments. Interestingly, while boys and 
girls agreed on a strong dislike for the overweight child, boys had a clear preference for 
functional ability whereas girls for physical appearance. This anti-obesity bias translates into 
overt and relational peer victimization, from which overweight youths suffer more than normal-
weight children [159].  
It is therefore not surprising that low self-esteem is more prevalent in overweight children, 
specifically those who self-attribute their weight status [160]. The dislike for a fat physique is 
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so prevalent that 50% of 2nd – 6th graders express dissatisfaction with their body weight and 
16% report past or present attempts at weight loss [161].  
Despite all the suffering and all the remedial efforts, behavioral change programs for weight 
reduction in obese children and adolescents have remained remarkably inefficient. While 
improvements in knowledge and self-reported health behaviors are tangible, effects on BMI 
are not [162].  
If obesity was a result of behavior and behavior a matter of choice then the volition-health 
camp owes us an answer to the question why children and adolescents choose to be 
ostracized, victimized and to suffer from low QoL.    
 
Health Behavior in Adults 
Discrimination and mistreatment continue into the adult years of the obese person [163].  
The disadvantages of being obese are most tangible in the areas of health care, employment, 
and social life. One in 4 nurses reports being repulsed by obese patients [164]. The 
percentages of biased health care professionals may vary depending on study design, but a 
generally more negative attitude of nurses towards the obese patient is apparent across 
studies [165].  
The obese person pays a substantial penalty on wages, at least in the first two decades of 
professional life [166]. Obese persons are also less likely to find a sex partner, with men 
showing a strong selection bias against overweight/obese females [167]. The stereotyping 
and stigmatizing even pervades the very professionals, who deal with preventing and 
reversing obesity. Exercise science students show a strong bias against obese people, again 
equating obesity with laziness and bad attitude [168]. 
Ironically, diet advertisements reinforce the stigmatization and stereotyping of the 
overweight/obese individual. The frequently used before-after portraits of weight-reduced 
individuals appear to strengthen the belief that weightloss is a matter of volition and effort, 
thereby reinforcing the stereotyping of obese individuals as lazy [169]. This stigmatization is 
so pervasive, that even obese people themselves endorse the stereotypical fat-lazy equation 
[170].    
If the volition-health assumption was true, then, with the prospect of a substantial increase in 
QoL added to the well-known health benefits, obese people should be particularly motivated 
to adhere to PA interventions. The evidence says otherwise. In a community-based program 
of behavioral change for overweight and obese persons 53% of participants had dropped out 
within the first 6 months [120]. This is a particularly telling figure, given the vested interest of 
the participants, who had to pay a US$ 350.- enrollment and orientation fee plus a US$ 135.- 
monthly retainer. Unsurprisingly, participants had an above-average socio-economic 
background with over two thirds being college graduates and more than half having an annual 
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income in excess of US$ 60,000.-. That is not exactly the profile that fits the supposedly 
weak-willed, uneducated and unaware person.  
Confronted with this ubiquitous behavior, which does not reconcile with the view of humans 
as a rationally acting species, impulsivity has emerged as a more palatable term in efforts to 
keep volition and reason the champions of health behavior.  
 
Impulsivity And Behavioral Economics 
Irrational health behavior can be described as impulsively choosing an immediate smaller 
reward (e.g. pleasure of remaining sedentary) over a larger but later reward (health benefit, 
QoL), despite having previously expressed a preference for the latter.  
Behavioral economists have been puzzled by a very similar phenomenon. 
When given a choice between a larger later payoff and a sooner smaller payoff, people 
generally express a preference for the larger payoff, if both payoffs are reasonably distant in 
time from the time of making the choice [171]. However, given the choice between the same 
payoffs and the same time lag between these payoffs, but with the smaller payoff being 
offered immediately, people generally opt for the smaller payoff. To illustrate this behavior in a 
hypothetical experiment, given the choice of receiving €100,- in 5 months or € 120,- in 6 
months, most individuals will choose the 6-months €120,- option. However, if given the choice 
between receiving €100,- right now or € 120,- in one month, the same individuals will prefer 
the immediate payoff of €100,-. Since both inter-payoff periods and both amount options are 
the same, individuals’ choices are obviously not based on constant-rate discounting, which 
would compel them to consistently choose one option over the other regardless of the time-
lag between decision and pay-out. When attempting to express these empirical data 
mathematically, hyperbolic functions emerged as the best fit [172].  
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Impulsive Discounting – An Attempt to Explain Irrational Behavior with Rational Tools 
From these observations Ainslie [173] developed the discounting model of impulsiveness. At 
its core is the theory of “hyperbolic discounting” of rewards which pitches a larger-later reward 
(e.g. good health) against a smaller-sooner reward (e.g. gratification from a sedentary 
activity) in hyperbolic discounting curves (Figure 1).  
 
 
Figure 1. Hyperbolic Discounting 
 
 
An individual might find himself in this situation after having made the new-year resolution of 
taking up health promoting exercise after the holidays. Hyperbolic discounting predicts that 
this individual will likely switch reward preference from health benefit to sedentary bliss when 
the latter is up for immediate consumption, as at that time he will have passed the cross-over 
point of the two discounting curves.  
While the model of impulsive discounting nicely matches empirical and experimental evidence 
in humans and animals [171, 174-177], given the current level of understanding, I consider it 
to be of descriptive rather than explanatory value, and hence of little practical use in the arena 
of health behavior modification. For two reasons:  
First, there is the problem of determining reward values and discounting rates. Even in 
experiments with monetary rewards, where the determination of reward value is relatively 
straight forward, there appear inconsistencies and changes across age and income groups 
[178]. It is easy to see how this problem may be compounded by the need to assign values 
and discount rates to immaterial rewards.  
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Secondly, while hyperbolic discounting is a useful description of the choices people make, the 
direction of a causal relationship, if any, between hyperbolic discounting and behavior 
remains uncertain [172]. In other words, does the phenomenon of hyperbolic discounting 
precede people’s methods of making impulsive choices, or is it a chance mathematical 
observation that emerges as a consequence of some other underlying process which 
compels people to make choices in ways that are simply inconsistent with other discounting 
methods. The jury is still out on this question.  
 
Recall that I began this discussion with the intent to challenge the prevailing belief in reason 
and free will as the drivers of human health-related behavior. While Ainslee’s model neatly 
describes frequently observed and seemingly irrational behavior, it does not dethrone volition 
and reason as its ultimate ruler. Evidence emerging from addiction research, however, does, 
which is ironical, since it is addictive behavior, to which Ainslie’s model is a near perfect fit.   
 
Addiction – A Keyhole View to Neurohormonal Behavioral Drives 
One does not need to elaborate the fact that addicts consistently choose the smaller reward 
of drug consumption over the larger and definite reward of not ruining their lives and their 
wellbeing. The urge to choose the drug reward is known to overpower even intense desires to 
kick the habit. Robinson and Berridge have dissected the neurohormonal underpinnings of 
this behavior into a model that not only reconciles with ‘hyperbolic discounting’, but from 
which we can also generate a strategy for health behavior modification [179].  
In a theory, which originated from an attempt to explain the idiosyncrasies of addictive 
behavior, Robinson and Berridge implicated dopamine as the core neural substance that 
drives the “wanting” of the hedonic experience, which an organism has learned to associate 
with a certain drug [179]. What differentiates this Incentive Sensitization Theory (IST) from 
other addiction theories is the distinction of the “wanting” from the “liking” elements of 
addiction. The authors provide unequivocal evidence for each element to be associated with 
a separate neural architecture and neural substance.  Briefly, the core elements of IST are 
the following: 
(a) Dopamine: enhanced dopamine transmission is the common effect of addictive 
substances. 
(b) Incentive salience: Dopamine’s psychological function is the attribution of incentive 
salience to stimuli which the addict has learned to associate with the hedonic 
experience of drug taking, i.e. dopamine increases the “wanting” of the drug 
independently of the “liking” 
(c) Hypersensitization: Repeated activation of the dopaminergic system, as a 
consequence of repeated drug taking, leads to the system’s long-term, and possibly 
permanent hypersensitization, thereby increasing incentive salience  
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(d) “Wanting” - “Liking” Dichotomy: sensitization of the dopaminergic system is 
independent of the drug’s hedonic effect, thereby driving a persistent drug craving 
and consumption despite unchanged or even diminished hedonic pleasures and 
greatly increased negative consequences to health and wellbeing.     
 
It is particularly the last point, which unveils a striking similarity between drug addiction and 
dietary behaviors: Persistence of a detrimental habit despite awareness of its consequences, 
and habit relapse despite temporary habit change.  
Within the IST paradigm, the difference between a heroin addict and a compulsive chocolate 
eater is merely the substance of choice not the habit’s underlying physiology.  
This similarity has not been lost on the theory’s authors who support its applicability to 
feeding behaviors [180].  
 
The Dopaminergic System And Feeding Behavior 
The targets of food cravings are generally the sweet & fatty [181] and, to some extent, the 
salty varieties. Their power to generate hedonic pleasure is evident in the unconditioned facial 
responses of newborns demonstrating an innate preference for sweet foods [182]. This 
preference is shared by other primates such as chimpanzees [183], which suggests some 
evolutionary advantage for this preference. The pre-industrialized, pre-agricultural 
environment is characterized by an absence of processed food. Of the non-processed foods 
sweet-taste sensations are primarily evoked by fruits and other carbohydrate-rich foods, 
which are also rich in essential micronutrients and anti-oxidants [184]. An organism’s innate 
hedonic drive to consume these foods would have ensured it’s seeking them out to repeat the 
pleasurable experience. Similar mechanisms may reasonably be suspected behind the 
human preference for foods with fatty texture, which signals high energy content. On the 
other hand, an innate dislike for bitter tastes has obvious protective functions against the 
consumption of plants containing potentially poisonous, bitter tasting alkaloids.  
And so it is conceivable that the dopaminergic system, being effective in driving an organism 
to the food, which ensures survival, evolved as a consequence of natural selection.  
That mechanism however has become maladaptive in the context of today’s food 
environment, which can summarily be described with the adjectives “aplenty”, “available” and 
“energy dense”, with high concentrations in sugar and fat.  
Their “dopaminergic appeal” fuels a human “wanting” of these foods with an intensity that 
frustrates conscious attempts to replace them with healthier but less stimulating alternatives.  
The addictive power of sweet tastes has been demonstrated in mice, genetically altered to 
reduce synaptic dopamine clearance by 90%, exposing the rodents to a persistently higher 
dopamine level than wild-type mice. In these mutants the “wanting” of a sweet reinforcer was 
substantially greater despite no elevation in the “liking” of a sweet reward [185].  
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There is also considerable evidence to show that sucrose feeding can activate the 
dopaminergic system in a dependency producing manner [186, 187]. 
 
A more recent experiment demonstrated that nucleus accumbens corticotropin releasing 
factor, which initiates the stress-triggered cascade of hormones of the hypothalamus-pituitary-
adrenal axis (HPA-axis), amplifies dopaminergic incentive salience [188]. This may explain 
the observation that chronic stress leads to increased food consumption thereby promoting 
obesity [189].  
 
It has also been observed that under conditions of classical conditioning, in which a hitherto 
unrelated stimulus is paired with food presentation, food intake increases when hunger and 
the now conditioned cue are paired subsequently [190]. It is easy to see the relevance of this 
phenomenon, which has been termed conditioned potentiation of feeding, to human feeding 
behavior. Once stimuli, such as time of day, physical location or presence of friends have 
been conditioned into cues for food intake, dopaminergic drives to eat in excess of 
physiological need are aroused. The obvious consequence is overweight and obesity and a 
conditioned resistance against rational attempts at reversing this situation through health 
behavior change.  
 
These observations have finally begun to be recognized by practicing physicians as 
evidenced in the recent discussion of neuroendocrine drives of obesogenic behavior and its 
striking similarity with addiction [191]. Still, the belief in reason as the desired driver of health 
behavior shines through in the author’s implied endorsement of current considerations to 
classify obesity as a psychological disorder. With this I disagree. If obesogenic behavior is 
driven by evolutionary conditioned neurohormonal mechanisms, it is not a psychological 
disorder. Rather is it the temptations of the modern environment to which these mechanisms 
are maladapted. With respect to health behavior, these mechanisms are the genie in the 
bottle. From within its bottle, this genie has served humans well throughout evolution. But the 
profound environmental changes of the past 50-100 years have released the genie, which 
now wracks havoc with our health. How difficult it is to tame through pharmacological means 
becomes evident in the very moderate success of the first pharmacological anti-obesity 
agent, which directly manipulates the homeostatic hypothalamic drive, Sibutramine [192], and 
the near disastrous consequences of another modulator of feeding behavior,  Rimonabant, a 
cannabinoid receptor antagonist, which has been withdrawn from EU markets barely two 
years after its introduction.    
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A New Model For Physical Activity Behavior – Accounting For Its Neurohormonal Underpinnings  
Does the dopaminergic system play a role in physical activity behavior? Probably not. The 
purpose of briefly diverting the discussion into the arena of obesogenic feeding behavior was 
to illustrate, that neurohormonal states are very powerful drivers of health behavior, virtually 
unopposed by reason and volition.  
PA behavior is distinct from feeding behavior in that there is no conceivable dopaminergic 
attachment to sedentism.  
However, PA is also driven by neurohormonal states, which are tightly interconnected with 
feeding behavior. The evidence in support of this originates from an array of animal and 
human studies into the effects of the two neuropeptides, which have emerged as major 
orexigenic and anorexigenic players: neuropeptide Y (NPY) and leptin. To understand the 
intricacies of their antagonistic interaction, we need to first dissect human feeding behavior 
into two distinct activities: appetitive ingestive behavior (AIB) and consummatory ingestive 
behavior (CIB). AIB is all activity related to foraging and hoarding of food, whereas CIB is the 
act of feeding. This distinction is 90 years old and had, to the best of my knowledge, first been 
documented by Wallace Craig in his 1917 publication about the feeding behavior of doves 
[193]. It is immensely important when dissecting the orexigenic effects of NPY, which had first 
been sequenced in 1982 [194], and which has subsequently been found to be the only true, 
and very potent, appetite signaling molecule in the brain currently known to science [195]. 
Until then, most studies on the effects of NPY on rodent feeding behavior did not differentiate 
between the two behavioral components – AIB and CIB. More recent investigations, however, 
have facilitated a more detailed view about the effects of NPY and leptin on AIB and CIB.  
To summarize the current body of knowledge as it is relevant for this discussion: NPY is 
produced in the brainstem and the hypothalamus. Its expression is regulated by various 
neuronal and hormonal pathways, such as the circadian clock, insulin and leptin, and 
glucocorticoids [195].  Conversely, leptin is chiefly produced by fat cells in proportion to their 
fat content. Its production follows a circadian pattern, with a low during the inactive period and 
rising to a high during the active period of the day. As this pattern coincides with the circadian 
pattern of feeding and fasting, leptin is currently assumed to be a hormonal transmitter, 
which, in an anticipatory fashion, signals to the brain to reduce and eventually terminate the 
drive to eat [195]. Without distinguishing feeding behavior into its two components, NPY is an 
orexigenic peptide, stimulating food intake, whereas leptin has the opposite effect. However, 
this view turns out to be too simplistic, as both hormones exert distinct and opposing effects 
on the AIB and CIB components of feeding behavior. Elegant experiments with rodents have 
demonstrated, that NPY exerts its orexigenic effect by powerfully driving foraging behavior, 
while weakly inhibiting CIB, whereas leptin administration strongly reduces the drive to forage 
but increases consummatory behavior [196]. That is, NPY drives the organism to “move to 
eat” whereas leptin opposes this effect.  
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The complexity of the interaction between the orexigenic and anorexigenic pathways of NPY 
and leptin is beyond the scope of this dissertation. Hence I attempt to summarize this 
interaction as it is relevant to the search for a working model of human health behavior, 
specifically that of physical activity and dietary behavior. It could be said that leptin represents 
an energy status signal. Its absolute concentration informs the brain about the level of energy 
reserves, and through its stable circadian fluctuation, it establishes a feeding pattern. 
Conversely, the rise and fall of brain-derived NPY concentrations reflects the current direction 
of energy flux. That is, diminishing energy reserves initiate appetitive ingestive behaviors with 
the goal of reserve restoration, the strength of this drive being somewhat modulated by 
reserve size. The latter is encoded in the strength of the leptin signal. This feedback loop 
inextricably integrates the organism to its environment in which the PA cost of food and its 
energy density represent environmental effector signals which modulate the behavioral 
response of the organism. In this model of homeostatic control the behavior of the organism 
is the target of feedback control. This does not reconcile with currently favored biomedical 
models, which are based on the assumption that body weight is the target of an 
autonomously operating homeostatic control, as suggested by set-point theory [197]. The 
latter model however, runs into problems with the observations of a steadily increasing 
bodyweight cross-sectionally in our society, and in most individuals longitudinally. Both 
observations violate the theory’s prediction of weight stability.  
In an attempt to reconcile theory with observation, the failure of this system has been blamed 
on a “purely cognitive/executive decision”-override of homeostatic body weight control [198].  
Contrary to this view, the proposed new model, in which behavior, rather than bodyweight, is 
the homeostatically controlled parameter, does not require reason and volition as a 
convenient scapegoat. It resolves this issue on three levels:  
 
First, the evolutionary point of view: It is easy to see how distinct behavioral patterns, 
which enable an individual to overcome the supply challenges of a variable environment, 
carry a survival value. A strong drive to forage when energy supplies dwindle has a definite 
survival value. It is probably therefore that the NPY system is active in all vertebrates and 
even in some fish [199, 200].  
In contrast, an ability to cap body weight would have increased inclusive fitness only if 
environmental conditions had facilitated pathological weight increase to the point of affecting 
an individual’s chances to reproduce and survive. This is hardly reconcilable with our current 
understanding of the scarcity, fluctuation and unpredictability of food supplies that has 
characterized the environment throughout evolution. 
 
Second, resolution of the prediction-observation mismatch: Figure 2a is an illustration of 
the proposed model as it would be operant under the environmental conditions, which 
prevailed during formation of the human genome. 
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Figure 2a. Negative Feedback Loop Of Energy Homeostasis 
 
 
In this model leptin and NPY represent the signals received by the loop’s receptors, which 
inform the control center (brain) about the current reserves and flux of energy. The control 
center initiates the adequate behavioral response, which consists of an obligatory PA 
behavior as its appetitive component, followed by the ingestive component. This behavioral 
response will vary with the cost of food and its energy density, thereby maintaining 
homeostasis within a range of environmental conditions. The system will only fail when the 
food ingested in CIB is insufficient to replenish the energy expended for its acquisition. In 
other words, if the cost of food exceeds the organism’s “capital” over a sufficient number of 
cycle revolutions, the depletion of capital will result in death. In rodent experiments, limiting 
food access to below a certain time threshold causes some animals to reduce food intake to 
below what the organism requires to compensate for the excess energy expended during 
NPY driven hyperactivity (increase in AIB), even if a sufficient amount of food is being made 
available during the access time [201, 202]. A similar phenomenon has been observed in 
human starvation and in anorexia nervosa [22]. 
 
How this system fails in our contemporary affluent society is shown in Figure 2b.  
The only difference to the situation in Figure 2a is the removal of the obligatory AIB 
component, which exposes the CIB component directly to the receptor signals leptin and 
NPY, and their stimulating and inhibiting effects respectively, as these have been 
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demonstrated in laboratory animals [196]. Feeding in excess of energy need is pre-
programmed in this loop, as the energy-status signal leptin more strongly stimulates CIB than 
NPY attenuates it.  
 
 
Figure 2b: Disturbed Feedback Loop w/o Physical Activity 
 
 
Indirect support for this view comes from studies on the association between leptin and 
weight change in obese individuals who attempt to lose weight. It has been shown that the 
leptin/BMI ratio is a very strong predictor of weight loss success with an inverse relationship 
between baseline leptin/BMI ratio and weight loss at follow up [203]. The rate at which the 
inevitable weight gain will happen is determined solely by the net effect of the balance 
between the strength of the drive to eat, the energy density of the self-selected food and the 
energy expended through some independently (and voluntarily) performed PA.  
 
Third, resolution of the cognition-behavior gap: the proposed model does not require a 
cognitive element, neither in its intact configuration (Figure 2a) to explain self-starvation, nor 
in the incapacitated configuration (Figure 2b) as the culprit driver of eating in excess of need. 
Excess food consumption is the naturally occurring consequence of a homeostatic loop in 
which its effector (PA) has been knocked out. Cognition may enter this model as the potential 
rescuer, reestablishing weight homeostasis through the introduction of voluntarily performed 
exercise as a means of energy expenditure. Indirect evidence in support of this concept 
comes from several investigations.  
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In a prospective 5-year survey of almost 10,000 Swedish individuals, BMI increase was 
absent only in the group of respondents who reported having implemented an exercise 
routine since baseline assessment [204]. BMI increase was lowest in the group who reported 
being physically active at baseline and at follow-up. Significant weight gain affected all other 
groups across age and BMI.  
The U.S. National Weight Control Registry (NWCR) maintains the records of exceptionally 
successful “losers” with an average weight loss of 33 kg maintained over at least 5 years 
[123]. Entry requirements into the NWCR are a minimum weight loss of at least 30 pounds 
maintained over at least 12 months (http://www.nwcr.ws/).   
A 1-hr daily exercise regimen has been found to be a key criterion behind this success [205], 
together with a behavioral strategy of self-monitoring of weight [206].   
  
If neurohormonal pathways are the drivers of exercise behavior, this effect is heritable and 
should be confirmed in genetic linkage studies. In fact it is. A study of 37,000 complete 
Caucasian twin pairs from 7 countries (Australia, Denmark, Finland, Netherlands, Norway, 
Sweden and the U.K.) showed a heritability ranging from 27% to 71% with a median of 62 % 
[207]. In Pima Indians, a native American population with a high prevalence of diabetes, a 
specific polymorphism of the gene encoding the leptin receptor has been found to be 
associated with 24-hr energy expenditure [208]. This specific polymorphism is thought to 
decrease the receptors’ binding capacity for leptin, which, in this investigation was linked to 
lower 24-hr energy expenditure measured in a respiratory chamber. While this does not 
explain any potential effect on “voluntary” exercise-based energy expenditure, it shows that 
energy metabolism is genetically linked to the very same hormone, which is an instrumental 
effector in the above proposed model. In a genome-wide association study of 2,700 U.S. and 
Dutch adults, that particular polymorphism showed a marginal association with PA behavior, 
the latter being additionally and more strongly associated with polymorphisms in two 
intergenic regions [209]. The small size of the effect is potentially due to the limited number of 
study subjects, which gives the study a low power to detect small effect sizes, with the latter 
being expected in a behavior, which is very likely associated with multiple genetic drivers.  
  
What I hope to have made obvious in this discussion is the pivotal role of PA behavior, not 
only for the prevention of CVD, as I have argued in the introductory section, but also as the 
effector of a controlled feedback loop for maintaining human energy homeostasis within an 
environment that places an energy cost before energy supply. The essential difference 
between this proposed model and the current biomedical view is (a) the differentiation of 
feeding behavior into its appetitive and consummatory aspects, and (b) the replacement of 
body weight with energy status and energy flux. The latter also makes intuitive sense. While 
there are hormonal and neuronal signals, which provide the brain with information about 
energy reserves and energy flux, we obviously have no sensors for body weight per se. 
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While inter-individual variability exists for the association between bodyweight and disease 
risk, continuous body weight gain is a strong indicator for the hypokinetic lifestyle, which 
presages CVD, and which is the hallmark of an environment from which the autonomously 
controlled PA cost of food has been eliminated.  
In this environment the PA behavior, which is necessary to reestablish weight balance, is not 
part of any autonomously operating human homeostatic feedback loop. It therefore depends 
on cognitive supervision and control. That is, for PA behavior to be effective and sustained, 
the implementation of a feedback loop is required, with a cognitive receptor and control 
function to continuously match the effector PA behavior with rationally determined health 
goals.  
Unless an intervention succeeds in:  
(a) modulating the effector PA to the point where it re-establishes energy balance and  
(b) maintaining the individual in this situation,  
the intervention will fail, and the individual’s eventual reversion to pre-intervention weight and 
sedentary status is inevitable.  
The implications of these observations for the objective of improving adherence are obvious. 
It requires the:   
(a) definition of behavioral goals in agreement with the individual’s health profile, her 
preferences, abilities and environmental demands,  
(b) definition of measurable behavioral goals to facilitate a comparison of actual progress 
vs. goal achievement 
(c) periodic re-adjustment of the behavioral goals to optimize outcome and to 
accommodate changes in health and other profile parameters.   
 
For convenience, I will use the terms individualization, self-monitoring and continuity to refer 
to these three demands in the above sequence.  
The concluding part of this section will discuss the rationale behind these three aspects and 
the evidence supporting it. The section will conclude with a hypothesis for testing a tool 
designed to enable researchers and clinicians to translate the model into practice.   
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METHODS: TRANSLATING THE NEW MODEL INTO BEHAVIOR CHANGE PRACTICE  
THE THREE ESSENTIAL ELEMENTS 
Individualization  
General Considerations 
 
The one-size-fits-all approach of public health efforts has been criticized as a major cause of 
the failure to produce lasting health behavior change in the population [15].  
This, however, is not necessarily due to public health actors’ neglect of or disregard for 
interindividual differences within target populations, as has been suggested [15]. Rather is it 
the methodology of the research from which our knowledge about the health enhancing 
effects of PA has emerged.  
The evaluation of randomized controlled clinical trials is based on intention-to-treat analyses, 
which depend on standardized group-specific protocols and predetermined dependent 
parameters, both applicable across all participants, to assess and measure intervention 
effects. But standardized intervention protocols likely conflict to varying degrees with 
participants’ idiosyncrasies of expectations, abilities, preferences and the environmental 
demands imposed on them. The greater this conflict, the more likely is a participant’s drop-out 
or post-interventional discontinuation.  
In comparison to our knowledge about the health effects of changed physical activity 
behaviors, we know very little about how the disparity between intervention features and 
people’s profiles affects their adherence. Surprisingly, the ones who could provide 
researchers with an answer to this question – the intervention participants - are rarely asked. 
Evidence from the DPP population suggests the disparity between participant-desired 
program attributes and actual design to be indeed substantial [210]. It appears to discourage 
participants from repeating their experience. In a follow-up intervention for subjects of the 
DPP trials, those who had participated in the lifestyle intervention arm were substantially less 
likely than their treatment-naïve peers to enroll in and continue with an offered follow-up 
intervention [211]. While the authors speculate about the possible reasons, asking the 
participants was apparently not part of their study methods.  
One observation was, that those lifestyle intervention participants, who had been the least 
successful with respect to the outcome parameter of weight loss, were also the least likely to 
enroll in and attend to the follow-up intervention. Inter-individual difference in response to 
weight loss efforts is an acknowledged issue. When increased physical activity is the mode of 
choice, the effects range from dramatic weight loss to slight weight gain, the latter of which 
may be the result of a favorable reduction in fat mass with a concomitant increase in lean 
mass [212].  
Such differential effects are not limited to body weight. Changes in maximal oxygen 
consumption, following a PA intervention, may range from dramatic improvement to no 
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improvement at all [213, 214]. If failure to achieve a change in the predetermined outcome 
parameter is discouraging participants from acquiring a lasting PA habit, the quitters will also 
miss out on other benefits which associate with increased PA, but which simply remain 
“below the radar” as they had not been predetermined as outcome parameters. 
This narrow focus on a limited number of parameters is borne out of the need of clinical 
practice for the greatest possible parsimony in determining disease risk, using risk 
stratification tools such as the Framingham Risk Score (FRS), the metabolic syndrome 
(MetS) or the PROCAM risk score.  
There are however two sides to this coin. A diagnosis of high CVD risk may increase an 
individual‘s motivation to participate in a preventive intervention, as evidenced in studies 
which support the notion that the perceived degree of risk is indeed one determinant for 
participation [210]. The flip side to this is that a diagnosis of low risk potentially reinforces the 
perception that nothing is wrong with one’s lifestyle, thereby negatively affecting the 
motivation to change it. That would still be tolerable, if our risk prediction tools were 
sufficiently accurate. But they are not. Most first cases of heart disease and stroke happen in 
individuals with low to moderate risk, irrespective of the applied risk prediction tool: the 
metabolic syndrome [56], the PROCAM [57] or the Framingham risk scores [215].  
Therefore it could be said that the public health strategy of risk profiling to institute healthy 
behaviors, may ironically prevent the adoption of such behaviors in the sub-population, which 
contributes most of the disease cases.  
I therefore suggest to substitute, in the sedentary target population, a health profiling, based 
on a comprehensive set of parameters, for risk profiling. The objective is to account for the 
multiplicity of phenotypic responses to a HEPA intervention, thereby making visible to the 
participant (and his health care provider) his moving towards the health end on the health-
disease continuum, regardless of where baseline profiling had originally positioned the 
participant on that continuum. Health profiling thereby carries the potential to exert a greater 
motivational appeal than the conventional risk-centered approach to health behavior change.  
Adding an intervention protocol, which is tailored to each participant’s abilities and 
preferences, will provide for a degree of individualization, the limits of which are set by the 
boundaries of scientific evidence and operational practicability.  
Within these boundaries individualization extends to all aspects of an intervention:  
• intervention objective: its alignment with each participant’s health objective 
• intervention protocol: its tailoring to each participant’s the unique profile  
o her health profile of biophysiological parameters and genetic predispositions  
o her unique set of abilities, skills and preferences 
o the unique profile of environmental demands imposed on her  
• outcome parameters: a comprehensive spectrum of parameters associated with the 
health objective, and always including intervention adherence as an essential 
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outcome parameter in its own right, as PA’s effects on health may not necessarily 
manifest within the chosen physiological outcome parameters  
 
Obviously it is difficult, if not impossible, to realize the proposed degree of individualization 
within the boundaries set by clinical trial methods and intention-to-treat analyses. But it is 
precisely because of the latter’s stupendous evidence for the benefits of PA that it has now 
become necessary to translate this evidence into effective PA interventions, even if that 
demands a deviation from the cherished clinical intervention paradigm. I have argued this 
case in an earlier publication [216], which coincides with other researchers’ calls for 
redirecting the focus of research from evidence towards dissemination studies [6].  
 
A note of caution: One must keep in mind that public health efforts are directed towards 
“selling” people on taking up exercise. What makes this sale so difficult is, that physical 
exercise carries with it the worst possible combination of product attributes any salesman can 
think of: immediate and continuing cost and a delayed reward.  
This problem is essential to all preventive efforts of public health, which I take the 
liberty of distinguishing from medical science in the following way: medicine being the 
science of treating disease with the objective to cure it, public health is the science of 
treating health with the objective to maintain it. 
The one immediate corollary to this distinction is, that public health will always be at a 
disadvantage when comparing its successes with those of medicine: it is far more 
difficult to demonstrate who has been spared a disease than it is to show who has 
been cured from it. 
Within this framework the proposed individualization holds the key to (a) reducing the 
perception of cost (e.g. by matching the target activity to each participant’s preferences, skills 
and abilities) and to (b) accentuating the reward aspect (e.g. by making progress, and hence 
success, more tangible). With this view, individualization becomes not only a legitimate but an 
obligate strategy to improve the efficacy of preventive public health efforts.  
 
Practical Implications 
Translating the principles of individualization into requirements for the research tool 
developed for this work, I have defined 5 criteria to be met by each parameter, for it to be 
considered as a legitimate outcome variable: 
• biological plausibility: a causal relation must tie the biomarker to the health status in  
“dose – response” or threshold association  
• significance: published evidence must support the criterion of plausibility  
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• measurability: standardized assays must permit valid and reliable assessment across 
laboratories 
• modifiability: the biomarker must be modifiable through lifestyle intervention 
• utility: parameter measurement and monitoring must be suitable for routine use in 
clinical practice 
 
Self-Monitoring 
General Considerations  
Self monitoring is an acknowledged and efficient means to promote adherence to behavior 
change [217]. In cardiac rehabilitation patients, self-monitoring has shown to increase 
objectively measured adherence to an outpatient exercise program [218].  
It is easy to see how internet-based self-monitoring and record-keeping can provide the key 
to real-time adherence monitoring by the researcher or clinician. Generally, third-party 
monitoring has been actively desired by patients in cardiac rehabilitation programs [219], and 
it has shown to substantially improve adherence in primary care patients who had been 
prescribed HEPA [220].  
The almost ubiquitous reach of the internet has encouraged researchers to evaluate its 
usefulness to enhance the effects of self-monitoring, with respective trials currently underway 
[221].  
In extension of this idea, internet technology also facilitates telemetry in real-time and across 
geographic boundaries. The combination of real-time telemetry and telemonitoring is just 
beginning to emerge as a feasible and cost-effective tool for the remote supervision of heart 
failure patients’ vital parameters [222] and of blood pressure in hypertensives [223]. In these 
set-ups the internet facilitates the operation of an effective early-warning system with the 
potential to prevent emergencies and in-hospital treatments.  
It is easy to see how real-time monitoring can alert the healthcare provider to adherence 
decay before the patient/participant is lost to drop-out. Provider efforts to maintain adherence 
can therefore be focused on exactly those patients/participants who need it, without being 
wasted on others who don’t, as is the case in conventional interventions with periodic group 
or one-on-one interactions for all. 
Internet-based third-party monitoring also gives patients/participants the perception of being 
watched, a sensation which has shown to strongly influence human behavior [224]. An 
attractive explanation for this phenomenon is offered by the relatively new error management 
theory (EMT). EMT proposes that if the survival costs of type-1 and type-2 errors of decision 
making have been consistently biased over evolutionary history, then ancestral organisms 
would have been subject to natural selection based on their psychological tendency to make 
such errors [225]. Mistaking a rustling sound in the forest for leaves in the wind, when the 
source of the sound is in fact an approaching predator (a type-2 error from the view point of 
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the predator’s soon-to-be lunch), would be far more costly, than mistakenly fleeing from a 
sound of rustling leaves (a type-1 error).  
One can easily translate EMT into the framework of an adherence-monitored HEPA 
intervention, if we suppose that reputation, being an acknowledged factor in the evolution of 
human societal interaction [226], is subject to an innate error bias. To the participant, whose 
reputation of honoring his commitment to intervention goals comes under the perceived 
scrutiny of a monitoring third party, this scrutiny may engage the participant’s type-1 error 
bias, according to which, adherence to the intervention protocol, when actually not being 
watched (monitored), is less costly than its type-2 alternative. A further discussion of the 
potential evolutionary background to this thought is beyond the scope of this manuscript. 
However, anecdotal evidence suggests, that when third-party monitoring is obviously non-
existent, as is the case with automatically and unsupervised generated reminder mails in 
automated internet-based behavior change programs, adherence to such programs is poor.  
    
A note of caution: When presenting the idea of real-time telemonitoring for the first 
time to an audience of medical practitioners [227], I was faced with the objection of 
generating an Orwellian intrusion into the privacy of the patient/participant. On first 
blush this objection is valid. However, since it is the participant/patient who decides 
whether, when and to which extent she will avail herself of this monitoring feature, it 
is reconcilable with valid ethics principles. 
 
Taken together, these observations suggest, that an integration of monitoring principles with 
modern internet-based telemonitoring abilities will provide a useful aid to improve and 
maintain adherence in behavior change interventions. A description of the self-monitoring and 
third-party monitoring is provided in the appendix.   
 
Practical Aspects – What To Monitor 
In the model of human energy homeostasis, the brain translates the hormonal signals leptin 
and NPY into information about caloric reserves and flux. The cognitive model requires 
parameters that are accessible to rational interpretation. For practical reasons, these 
parameters ought to be easily measurable by the individual. 
Exercise is defined across four dimensions: intensity, duration, frequency and type, the latter 
consisting of resistance and aerobic modes of exercise.  
Intensity is an important determinant for the benefit of exercise, with higher intensity yielding 
significantly better cardioprotection against CVD [228]. Similar positive associations generally 
hold true across the dimensions of duration and frequency. 
For obvious practical reasons, frequency and duration are the dimensions of aerobic exercise 
most accessible for measurement by the individual. Objective monitoring of intensity requires 
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the use of measurement devices, such as heart rate monitors or accelerometers, which 
complicate the process of self-monitoring, unless and until suitable interfaces have been 
developed to directly transport the measurement data onto the internet-based monitoring tool. 
Hence, under current prevailing conditions, it will be more feasible to code the desirable 
exercise intensity into the volume and frequency prescription which simplifies the monitoring 
process.  
If resistance training is a behavioral goal, frequency of sets and repetitions will be the 
monitoring parameters. Again, intensity expressed as weight or resistance, can be coded into 
the prescription to achieve the desired volume.  
 
Continuity 
General Considerations 
It has been suggested that the high prevalence of sedentism is at least partly attributable to 
research being focused mainly on the adoption of exercise rather than its maintenance [229]. 
The predominance of limited-duration interventions clearly supports this contention. This is 
unsurprising, given that acute care continues to be the paradigm of our health care system, 
which has evolved from the need to treat acute diseases, not to prevent the chronic varieties. 
However, inherent to the proposed model of human energy homeostasis is the perpetuation 
of a cognitively controlled feedback loop as an essential prerogative for its maintenance. 
Given the constant exposure to the seductions of sedentary lifestyles, intervention continuity 
is a necessity for sustained success. This argument is strengthened by the observations that 
(a) large numbers of attendees drop out within latest 3-5 years after a one-time intervention 
[121] and (b) long-term change in metabolic risk factors is as informative and predictive of risk 
as are absolute values of risk factors [230]. 
There are two obvious caveats to these considerations: cost and resource constraints.   
The costs for conventional interventions are indeed high [231, 232]. That, however, must not 
distract us from the need for lifelong intervention, as outlined above. Rather should it 
stimulate research into the utility of newly emerging technologies, such as the internet and 
telemetry, and their potential contribution to optimize the cost-benefit ratio of open-ended 
HEPA interventions.  
Specifically the internet, with its unique communication platforms, has demonstrated the 
ability to amalgamate the input of geographically dispersed experts into coherent outputs, as 
is the case in networks such as wikipedia. There is no reason to assume, that we will not be 
able to consolidate the contributions of varied health science specialists and care and service 
providers into one network of preventive lifestyle change interventions, in which each expert 
group provides the care and services of its competence domain, thereby relieving the primary 
care physicians from tasks which would otherwise impose on their resources, if such 
interventions were to be delivered within the conventional framework of health care. 
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Practical Implications 
In the proposed open-ended interventions, the objective is to keep the cognitively controlled 
feedback loop operational with the intended consequence of maintaining a PA behavior that 
has been agreed to by the participant. Active self-monitoring is the indicator of this feedback 
loop being operant. Its parameters (discussed in the preceding paragraph) provide the 
quantitative PA data that are necessary to investigate the strength of their correlation, if any, 
with health outcome parameters (discussed under the subject “individualization” above) and 
to consequently inform optimization strategies. Hence, the parameters of self-monitoring 
become the independent variables, with which the research questions shall be addressed, 
specifically whether:    
(a) during an initially limited period of observation, self-monitoring generates a degree of 
adherence to HEPA behavior which is sufficiently large to suggest that the 
intervention model will, in an intervention of unlimited duration, improve effectiveness 
compared to conventional interventions.  
(b) self-monitoring correlates with clinically relevant health benefits in self-monitoring 
participants 
 
If the results indicate positive answers to both questions, follow-up research in an intervention 
of unlimited duration is warranted.  
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 61 of 239 
 
AIMS AND OBJECTIVES 
This work pursues two investigative objectives: namely (a) the translatability of the principles 
of individualization and self-monitoring into a practically feasible intervention which yields 
significant improvements of physical activity habits in previously sedentary adults, and (b) the 
evaluation of measurable intervention effects (if any) and their comparison between follow-up 
and baseline and between participant groups.  
With a specific view to the underlying model of a cognitively controlled feedback loop, which 
is hypothesized to be necessary for the activation and maintenance of adequate physical 
activity habits, the study has been designed to answer the following research questions:  
(1) Under conditions closely approximating feasible real-life program delivery, will an 
intervention, which is based on the aforementioned principles of individualization and 
self-monitoring, activate and maintain the required cognitively controlled feedback 
loops in a sufficient number of participants to: 
a. compare favorably with published adherence rates for physical activity 
interventions? 
b. justify investigating the effects of intervention continuity in a larger and longer 
term follow-up investigation?   
(2) Will participants with an activated feedback loop witness statistically significant and 
clinically meaningful improvements of physiological CVD risk parameters compared 
to  
a. baseline measurements? 
b. non-adherent participants?  
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DEVELOPMENT OF THE HYPOTHESES 
The objective is to formulate testable hypotheses, which refute or favor the proposed theory 
and tool. Systematic self-monitoring ought to engage a cognitively controlled feedback loop, 
which facilitates the uptake and maintenance of an agreed individualized exercise curriculum 
in a large enough proportion of the study population to suggest potential public health merit.  
The effect of the intervention on parameters of physical fitness (the objectively measurable 
and risk relevant correlate of PA) and energy homeostasis ought to be large enough to 
suggest significance and clinical relevance.  
 
The hypotheses specified hereinafter were tested in a PA intervention, the details of which 
are described and discussed in a subsequent section of this paper. The following are the 
intervention details required to understand the hypotheses that were tested in this 
intervention, which lasted for 6 months.  
The study population consisted of 117 Caucasian participants (33 women), who were 
enrolled into this prospective, nonrandomized exploratory intervention designed to 
improve physical activity status in sedentary adults through individually prescribed 
exercise programs. Individual health profile parameters, exercise goals and progress 
were monitored in an internet based application, which was specifically developed to 
deliver this intervention, with a view to making available the use of this tool to other 
research groups in the future. To facilitate the self-monitoring of exercise progress, 
the exercise curriculum, which had been individually agreed with every participant at 
the start of the intervention, was translated into a point score. Participants earned one 
point for every 5 minutes of endurance exercise performed at an individually 
prescribed intensity based on an ergospirometrically determined exercise capacity. 
The minimum volume and frequency of endurance exercise, which had been agreed 
with every participant, consisted of thrice weekly 20 minutes of high-intensity interval 
training (HIT), the rationale for which is explained in the methods section.  
Participants whose body composition analysis had suggested potential health 
benefits to be accrued from resistance exercise had been encouraged to perform the 
latter in addition to their agreed curriculum of endurance exercise. Within the relevant 
point scoring system, participants earned one point for every set (consisting of a 
target number of repetitions) of exercise, with typically 2 sets of 8 different exercises 
to be performed at least twice weekly.  
Participants could enter their point score either directly via access to a secured 
website or via a mobile-phone based applet. Points were cumulatively entered for 4 
consecutive 6-week periods. Automated and preset alarm functions (email) alerted 
the investigator about lack of a participant’s login (7 consecutive days without login 
prompted an alarm) and/or probable failure to reach the agreed 6-week point score. 
Each prompt initiated a direct and personal follow-up (email, phone call) with the 
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participant to investigate the reasons. At the end of each 6-week period a review of 
achieved point scores determined whether the exercise goals needed re-adjustment.  
All analyses performed at baseline were repeated at follow-up.       
 
Hypothesis 1: Adherence  
The proportion of actively self-monitoring participants at the end of intervention is 75% or 
better, with the minimum criterion being a recorded weekly duration of endurance exercise 
(volume aspect of adherence) of 60 minutes (3 x 20 minutes of high intensity interval training) 
or more for at least 12 consecutive weeks (duration aspect of adherence), with the last self-
reported login not earlier than 1 week (latency aspect of adherence) prior to the date of final 
assessment.  
 
Rationale For The Definition Of Adherence 
Typically the degree of adherence to an intervention trial determines the intervention dose to 
which a subject will have exposed himself at the time of follow-up. This is an important aspect 
of establishing the strength of the association between the intervention and its hypothesized 
outcome. It does not answer the question whether and to which degree adherence is 
sustainable in free-living individuals. That is the question of this intervention trial. It a priori 
accepts an association to exist between PA and health outcome. What it attempts to answer 
is whether the intervention strategy which is specifically aimed at making adherence to PA 
sustainable, will, at the time of follow-up, see a large enough proportion of participants 
availing themselves at follow-up to PA at a large enough dose and having done so over a 
long enough duration that the accrued measurable health benefits support subjecting this 
intervention to larger and longer-term prospective follow-up investigations upon its chronic 
public health benefits. 
To put it simply: while preceding trials have established the effect of taking the medicine (PA), 
this trial begins to investigate how to make people keep taking it. 
 
Underlying this hypothesis is the proposed model’s postulate that self-monitoring reflects an 
operant controlled feedback loop (CFL+), the engagement of which is essential to maintain 
human energy homeostasis. The objective is to increase the prevalence of CFL+ in a given 
population to markedly reduce the burden of hypokinetic diseases.  
The three-quarter adherence rate is admittedly an arbitrary value, as there are, to the best of 
my knowledge, no data available which would provide a comparison benchmark from similar 
study designs and objectives.  
CFL+ is also quantifiable by virtue of the underlying parameters of duration and volume of PA. 
To investigate the association of CFL duration with the outcome parameters of hypotheses 2 
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and 3, the relevant analyses were performed with participants being stratified according to 
three different periods of CFL duration (90 days, 120days and 150 days). The terms CFL+ 
and CFL- were used to describe the groups of participants meeting or not meeting the 
adherence criteria respectively, being synonymous with the terms “adherent” (CFL+) and 
“non-adherent” (CFL-).   
 
The platform developed for this research effort, is to be used as a tool for the delivery of 
open-ended PA interventions in varied populations. In these populations, the prevalence of 
CFL+ as the drivers of HEPA behaviors can serve as an essential correlate for disease 
prevalence.  
This will provide for more detailed insights into the association of CFLs and PA with disease 
incidence and prevalence in target populations. The latter may be the patients of a primary 
care practice, post-event rehabilitation patients of a hospital, the employees of a corporation, 
or a health insurer’s policy holders. In any case, the populations are open, with new members 
entering, and existing members leaving them over any period of time.  
Measurable changes in modifiable biochemical and anthropometric parameters of risk are a 
desirable intervention effect. Hence the secondary hypotheses will address intervention 
effects on such parameters.  
 
Hypothesis 2: Intervention Effect On Physical Fitness 
CFL+ participants (adherent) will show significant improvements of measures of physical 
fitness from baseline to follow-up, with these changes being significantly different from 
changes (if any) observed in the CFL- group (non-adherent).  
 
Hypothesis 3: Intervention Effect On Parameters Of Body Weight 
Overweight CFL+ participants (BMI>=25) will show significant improvements in weight status 
from baseline to follow-up, with these changes being significantly different from changes (if 
any) observed in the CFL- group over the same observation period.  
 
Hypothesis 4: Intervention Effects On Parameters Of Cardiovascular Risk 
CFL+ participants will show significant improvements in blood lipid measures and related 
measures of CVD risk (PROCAM risk score) with these changes being significantly different 
from changes (if any) observed in the CFL- group over the same observation period.  
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OVERALL STUDY DESIGN 
“If you want to truly understand something, try to change it”  Kurt Lewin 
 
This study is a non-randomized exploratory intervention trial that tests the efficacy of a web-
based lifestyle intervention tool (Electronic Lifestyle File – ELF) designed to  
(a) promote adherence to individualized lifestyle change interventions through monitored 
self-monitoring with the objective to … 
(b) reduce the risk of cardiometabolic disease.  
Subjects were recruited from among German holders of a compulsory health insurance policy 
who had taken up their insurer’s invitation to participate in a subsidized fitness and physical 
activity examination.  
Main inclusion criterion was a self-reported current volume of leisure time physical activity 
(LTPA) of 1 hour or less per week. All participants were Caucasians of German extraction.  
Following enrollment, participants were assessed at baseline and after 6 months on 
biochemical parameters, parameters of physical fitness and body composition. Throughout 
the intervention, participants’ adherence to an individualized LTPA protocol was monitored via 
a web-based electronic lifestyle file (ELF). Personalized prompts were given to participants 
whose lack of progress reporting suggested decay of adherence. 
 
DETERMINATION OF SAMPLE SIZE  
For the calculation of sample size and power, two aspects of the study design need to be 
considered: 
• A recruitment strategy potentially engaging self-selection bias.  
• An a priori sample size of 120 participants, which was based primarily on budgetary 
constraints and logistical considerations.  
These two aspects warrant sample size and power calculations which address the questions 
of (a) whether and to which degree any potential difference between the sample population 
and the underlying population is detectable, and (b) whether the hypothesized changes of 
outcome parameters can be reasonably detected within the given sample size constraints. 
 
Sample Size Calculations to Asses Potential Selection Bias  
Based on the given sample size of 120 participants, power calculation was used to determine 
the minimum parameter difference detectable as constituting a significant difference between 
the ELF sample and the reference population.  
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Parameter values for the reference population were taken from data published by the World 
Health Organization (WHO) and drawn from the MONICA study populations as published in 
the MONICA Population Survey Data Book [233]. The MONICA (Multinational MONItoring of 
trends and determinants in CArdiovascular disease) Project was established in the early 
1980s in 21 nations with altogether 32 collaborating centers, 4 of which had been set up in 
Germany (Augsburg, Bremen, East Germany and Rhein-Neckar/Heidelberg). The project’s 
objective was to investigate diverse trends in cardiovascular disease mortality and morbidity. 
BMI data were cross-checked with data published by the German Federal Demographic 
Authority (Statistisches Bundesamt) and accessible online [234]. The reference age group of 
45-54 years was selected based on information about mean age obtained from the personnel 
department of Siemens AG about the mean age of employees on location (45 years). Table 
1a presents the minimum parameter differences, necessary to determine significance of 
difference between the MONICA cohort and the ELF sample (at baseline). MONICA 
reference values were taken from the male cohorts aged 45-54 years, as the ELF participants 
were expected to be predominantly men in that age bracket. 
All calculations were carried out using Intercooled STATA 11 for Macintosh (Stata Corp. 
Texas, U.S.A.), which uses the following formula for determining the required sample sizes 
for two-sample tests of equality of means:  
Equation 1: 
€ 
n1 =
δ1
2 +δ2
2 /r( ) z1−α / 2 + z1−β( )
2
µ1 − µ2( )
2  
where α is the significance level, 1-β is the power, z1-α/2 is the (1-α/2) quantile of the normal 
distribution and r=n2/n1 is the ratio of the sample sizes. 
 
Table 1:  
Determination of power and minimum parameter differences, necessary to determine significance of 
difference between the MONICA population and the ELF sample 
 MONICA Mean (SD) a Minimum Difference Powerb 
BMI (kg/m2) 27.3 (3.5) 1.2 0.85 
HDL-C (mg/dL) 47.5 (14.7) 5 0.84 
TCH (mg/dL) 241.3 (47.5) 16 0.83 
Proportion  
(%) of HDL-C in TCH 
20.27 (6.99) 2.5 0.87 
a: Reference values taken from the German MONICA Augsburg urban Reporting Unit Aggregate [233] for men aged 45-54 
b: given the sample size of 120 participants, and calculated for α=0.05, two-sided 
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Sample Size Calculations for Hypothesis Testing 
The primary outcome variables of this investigation are (a) the proportion of subjects with an 
operant cognitively controlled feed back loop (CFL+) at follow-up (adherence), and (b) the 
change of peak oxygen consumption (VO2peak) and body weight parameters from baseline 
to follow-up within and between CFL groups (adherent vs. non-adherent). Secondary 
outcome variables are the within- and between group changes of HDL-C, TCH, TCH/HDL 
ratio LDL-C and Triglycerides.  
Sample size and power calculations require assumptions to be made about the effect size 
and the standard deviation of the change of parameters under investigation.  
These assumptions are as follows:  
1. Hypothesis 1: Percentage of CFL+ participants at follow-up is 75%  
The alternative hypothesis (refer to hypothesis 1 above) of 75% adherence is 
contrasted with (a) a 50% drop-out, typically observed across clinical exercise 
interventions within the first 6 months (as discussed in the preceding sections), and 
(b) with the close to 60% adherence rate observed in a comparable 24-weeks 
worksite intervention, which consisted of 3 weekly 20-minutes high intensity aerobic 
workouts in addition to strength training [235]. 
2. Hypothesis 2: Improvement of VO2peak 
At 1 MET increments, cardiorespiratory fitness (CRF) has been found to linearly 
correlate with a decreased risk of CVD events in a population of Finnish men (1294 
men) of similar mean age of 51.8 years [236]. The mean and SD of VO2peak in this 
population was 32.5 and 7.5 ml/kg/min respectively.  
The power calculation for within and between group changes are based on the 
assumptions of an approximate 1-MET change in the CFL+ group vs. no change in 
the CFL- group. The SD for the 1-MET change is expected to be 4 ml/kg/min. This 
value is based on personal experience from several years of CPET practice and 
evaluations of practice data. It was chosen because most published studies provide 
dispersion statistics for pre and post means but not for the paired differences.   
3. Hypothesis 3: Improvement of body weight status 
A reduction of 1 BMI unit was considered the desirable minimum effect size to be 
detectable in the CFL+ group of participants. This value was based on several 
assumptions. Since the recruitment strategy was focused on enrolling primarily 
sedentary and overweight adults the mean BMI at baseline was expected to be at 
least 28 kg/m2. Based on the mean height for the underlying population as published 
by the German Federal Office of Statistics (Statistisches Bundesamt) from the 2005 
German Microcensus, the mean height for German men in the 45-54 age cohort is 
1.78 m. This translates into a mean body weight of 88.7 kg, given the expected BMI. 
The minimum weekly PA requirement of 60 minutes of moderate intensity aerobic 
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exercise was expected to be performed predominantly by jogging/running, the energy 
expenditure of which has been estimated to be 7 MET [237], one MET being 
equivalent of 3.5 ml/kg/min oxygen consumption. Thus, an approximate weekly 
energy expenditure of 60’ x 7 METs = 420 MET-minutes, or 130 liters of Oxygen, 
would be expected. With 1 L O2 being the equivalent of 5 kcal [238], this translates 
into a weekly energy expenditure of approximately 650 kcal. Thus, over a period of 
24 weeks 16,000 kcal could be expended. With the calorific value of 1 kg of fat being 
approximately 7,000 kcal, a weight loss of ≈ 2.5 kg could be expected. This weight 
loss equals 0.8 BMI units for a person of the aforementioned height and weight. The 
published results of the DEW-IT weight loss trial suggest a SD of 0.6 for a BMI 
change of -1.9 in the intervention group [239]. For the sample size calculation this 
reference SD value was arbitrarily doubled to 1.2. The rationale being, that, while 
weight loss was the DEW-IT intervention’s target outcome, in the ELF intervention 
weight loss is hypothesized to be a coincidental outcome and secondary to a targeted 
increase of CRF. Under these circumstances, a greater variance of BMI change 
values is to be expected. Also, the DEW-IT intervention group size was very small 
(N=22). Taken together, these aspects warrant the assumption of a larger variance of 
the weight change parameters in the ELF sample.  
4. Hypotheses 4: Improvement of Blood Lipid Parameters  
Desired effect size was defined as a 10% change from baseline values. The 
underlying rationale is the observation that studies of physical activity interventions 
report modest and often non-significant improvements of blood lipid parameters of 
generally less than 10% from baseline [240-242]. HDL was chosen as the sole test 
parameter, as improvements of blood lipid parameters have been reported in 
response to higher caloric exercise for HDL and TCH/HDL ratio, with TCH and LDL 
not changing significantly [241, 243]. Published studies typically report the dispersion 
statistics at baseline and follow-up, but not the variances for change of lipid 
parameters nor the t-values of the paired analyses. For reference purposes the 
variance values for paired differences were taken from an investigation into the 
effects of physical activity on HDL in 269 men and women aged >=50 [244].  
 
To investigate adequacy of the sample size to detect significance of the difference in 
proportion of adherent subjects (defined as the number of participants meeting the CFL+ 
criteria) between the ELF sample and the aforementioned reference worksite intervention 
[235], a one-sample test of proportion was conducted using Intercooled STATA software.  
The underlying formula is shown in equation 2 
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Equation 2: 
€ 
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1/ 2
+ z1−β pA 1− pA{ }( )
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⎣ 
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⎢ 
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⎥ 
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2
 
Where n is the sample size, the null hypothesis is p=p0 and the alternative hypothesis is p=pA, 
1-β is the power, and z1-α/2 is the (1-α/2) quantile of the normal distribution. 
The proportion of 0.6 was set as the null hypothesis, with the alternative hypothesis being 
0.75.  
At α=0.025 and power of 0.9, two-sided the required sample size is 114.  
 
To investigate whether the a priori sample size was adequate to detect significance of the 
expected differences of means compared to the null hypothesis, one-sample tests for power 
and sample size were conducted using Intercooled STATA software. The underlying formula 
for calculating sample size and power is as follows: 
Equation 3a: 
€ 
n1 =
δ1
2 +δ2
2 /r( ) z1−α / 2 + z1−β( )
2
µ1 − µ2( )
2  
where δ is the standard deviation, µ is the mean, n2=rn1, 1-β is the power, and z1-α/2 is the (1-
α/2) quantile of the normal distribution.  
Power was set to 0.9 with a one-tailed significance level α=0.05 
Table 2 presents the results of the analyses expressed as (a) sample sizes required to detect 
the hypothesized intervention effect sizes, and (b) power provided by the given size of the 
study sample (N=120), with both calculations based on the hypothesized ratio between 
adherent and non-adherent participants r=3.  
Table 2: 
Sample Size And Power Calculations For Hypothesized Between-Group Differences Of Means 
 Difference in Changea required sample size powerc 
  non-adherent adherent at given N=120 
Adherence (%)b 15% 21 62 0.97 
VO2peak (ml/kg/min) 3.5 15 45 0.98 
BMI (kg/m2) 0.8 26 78 0.99 
HDL (mg/dL) 4 58 74 0.61 
Note:  
a: for hypothesized between-group differences of change from baseline to follow-up, with within-group change of = 0 for non-
adherent group; does not apply to the parameter “adherence”, see note b 
b: 75% hypothesized adherence compared to the 60% evidence-based postulate   
c: for given sample size N=120 
* α=0.05, β=0.1, one-tailed 
 
The results of the power and sample size analyses demonstrate that, though logistically 
restricted, the sample size was adequate to detect clinically meaningful changes of this 
study’s primary outcome parameters of cardiopulmonary fitness and body weight status.  
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The power calculation for HDL indicated inadequate power to detect an intervention effect of 
the minimally expected effect size on adherent participants, compared to their non-adherent 
peers. However, the power calculations were based on simple t-test, not taking into 
consideration the correlation between intra-individual baseline and follow-up measurements, 
which improves the variance of the estimate of the intervention effect. Assuming such 
correlation to be 0.7, instead of the 0.5 as assumed by t-testing, the power is increased to 
80%. This estimation is based on the following equation for the calculation of improvement of 
variance in repeated-measures designs [245]: 
Equation 3b: variance improvement = 
€ 
1+ (r −1)ρ post
r +
1+ (p −1)ρ pre
p − 2ρmix  
where p is the number of measurements at baseline, ρ is the correlation between 
measurements at baseline (pre), at follow-up (post) and between measurements at baseline 
and at follow-up (mix) respectively.  
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EXECUTION 
This study was conducted at an industrial park (Siemens Industriepark Karlrsuhe, SIK) 
located in the city of Karlsruhe of the South-Western German state of Baden-Württemberg. 
During the study period, approximately 5.000 white and blue collar employees were working 
on-site, most of which had enrolled in the health insurance plan of Siemens 
Betriebskrankenkasse (SBK), a German provider of a comprehensive health insurance 
coverage that is compulsory to have for every resident in Germany. The study participants 
were recruited from among the 200 individuals who had accepted an offer of SBK to 
participate in a fitness assessment campaign at a subsidized rate. The campaign was 
directed at sedentary individuals insured with SBK and interested in a sports-physiological 
assessment of their physical fitness levels through cardiopulmonary exercise testing (CPET).  
 
ETHICAL COMMITTEE AND INFORMED CONSENT 
The study protocol was approved by the ethics committee of the state medical board 
(Landesärztekammer) of Baden-Württemberg. Informed consent was obtained in writing from 
all participants at the initial consultation and prior to the baseline assessment . 
 
RECRUITMENT 
SBK invited all 200 respondents to three public 60-minutes presentations delivered by the 
author on subjects of physical activity, diet and health over 2 months at an on-site venue. The 
purpose of these presentations was to raise participants’ awareness of physical activity being 
a determinant of cardiovascular health. At the same time the purpose of the study 
intervention, its exclusion and inclusion criteria were explained and attendees’ questions were 
answered. Attendees were also provided a set of enrollment forms, consisting of a detailed 
explanation of the study purpose and procedures, a health history questionnaire, an informed-
consent form and a declaration-of-participation form (see appendix 3). The invitation was 
expressed to all attendees who were interested to participate in the study and who believed to 
meet the inclusion criteria to make an appointment with the investigator for a personal 
consultation and assessment of suitability to enroll.  
Altogether 150 persons responded to the invitation. Of these, 33 individuals could not be 
enrolled in the study, primarily for not meeting the condition of being sedentary, with 60 
minutes or less of weekly structured leisure time PA (28 individuals), for having been notified 
of an impending transfer to another city (4 individuals) or for being physically handicapped (1 
individual). The remaining 117 individuals were enrolled into this study.  
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PARTICIPATION CRITERIA 
Principles applied to the selection of participants:  
• to ensure selection of sedentary participants  
• to ensure selection of participants with the ability to participate in and comply with a 
physical activity intervention 
• to avoid confounding effects on the primary outcome measures (adherence and 
biological effects) 
• to prevent adverse events from participation in the physical activity intervention 
 
Inclusion Criteria 
• Ethnicity: Caucasian  
• Gender: male and female 
• Age: lower age limit of 25 years with no upper age limit 
• Physical activity level: self reported LTPA of less than 1 hour per week  
• BMI: lower limit of 19 with no upper limit 
 
 
Exclusion Criteria 
Objective Exclusion criteria 
to ensure selection of sedentary participants 
currently exercising at a level that equals or 
exceeds the intended volume and intensity of 
exercise 
Recent (within past three months) history of 
myocardial infarction, stroke or TIA or major 
surgery  
orthopedic limitations which would prevent from 
participation in an exercise program 
Asthma and or other lung disease which limits the 
ability to perform exercise at high intensity (80-
95% of VO2peak 
Osteoporosis, arthritis, diseases of the liver, 
kidney or thyroid which would prevent from 
participation in an exercise program 
to ensure subjects’ ability to participate in a 
physical activity intervention 
peripheral arterial disease which limits the ability 
to walk  
pregnancy 
drug or alcohol abuse to avoid confounding of or interference with study 
results independently of subjects’ participation  current participation in another lifestyle change 
intervention 
uncontrolled or poorly controlled hypertension 
(SBP >= 160 mmHg and/or DBP >= 100 mmHg) to avoid exposing subjects to health risk  
uncontrolled or poorly controlled diabetes mellitus  
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MEASUREMENTS 
All measurements described hereinafter were performed in accordance with the study 
schedule presented in Figures 3a &b.  
 
Figure 3a. Overall Study Execution and Time Table of Measurements 
 
 
 
Figure 3b. Study Execution and Timetable of Measurements as Experienced by the Participants  
 
 
Determination Of Levels Of LTPA 
The gold standard for the objective measurement of volume and intensity of physical activity 
is the doubly labeled water method.   
While the assessment of physical activity levels through questionnaires is an accepted tool in 
epidemiological studies, low correlation between questionnaire data and objectively 
measured energy expenditure has been found on the level of the individual [246, 247]. The 
suggestion has therefore been made to use questionnaires as a tool for classification of 
physical activity levels rather than for the purpose of estimating energy expenditure [248].  As 
such, simple one- or two-item questionnaires have shown to provide suitable reliability in 
classifying the respondent as a sedentary or more active individual [249]. As it was the 
objective of this study to recruit sedentary individuals a question was used, which, from the 
author’s working experience, provides reasonably reliable indication about the time spent in 
moderate- to high-intensity LTPA: “Think of an exercise for which you usually wear exercise 
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clothing and which you perform at an intensity that forces you to increase your breathing rate 
to the point at which you would find it difficult or impossible to maintain a normal conversation. 
Do you spend more than one hour per week in such exercise at the described intensity? A 
negative answer to the question was a necessary inclusion criterion.  
 
With respect to the assessment of subjects’ LTPA habits it is imperative to recall what is the 
study aim and what it is not. The research aim is not a comparative objective assessment of 
subjects’ volume and intensity of LTPA before and after intervention. Rather is it the question 
whether the studied intervention is (a) able to promote adherence to an LTPA curriculum 
whose beneficial health effects have been established in peer reviewed research, and (b) 
whether a self-reported degree of adherence to this curriculum correlates with clinically 
relevant improvements of objectively measurable markers of cardiometabolic health. This 
distancing from objective LTPA assessment would be superfluous if the latter was a 
straightforward exercise of measuring a vital parameter, economically and practically feasible 
for large-scale application. However, valid and reliable measurement of (a) physical activity 
and (b) the intensity at which it is performed has remained a difficult issue with several 
available methods each having its own advantages, draw-backs and limitations. The following 
discussion is to highlight these issues and to support the contention implicitly made here, 
namely that neither of the available techniques will add clinical or practical value to the study 
results. 
PA measurement techniques may be grouped into three categories: direct and indirect 
objective measurement, and subjective measurement techniques. The underlying principle of 
the direct objective measurement is that all physical activity inevitably requires the 
expenditure of energy.  
Direct calorimetry, the most accurate method of determining energy expenditure, measures 
the heat into which the chemical energy utilized for physical activity is degraded, thereby 
providing a direct measurement of a body’s metabolic rate.  
Indirect calorimetry measures oxygen consumption, carbon dioxide production and nitrogen 
excretion to calculate energy expenditure. 
For both methods metabolic chambers can be deployed in which study subjects may remain 
for any extended period of time. Cost and logistical considerations limit the application of 
metabolic chambers to specific study questions, which require relatively few study subjects.  
These techniques are certainly of no use in research projects where intervention effects in 
free-living individuals are the outcome measure.  
Indirect calorimetry can be performed through breath-by-breath analysis of gas expired 
through a face mask and connected to suitable oxygen and carbon dioxide sensors. This 
technique also requires costly laboratory equipment, the attendance and operation of suitably 
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skilled clinicians and is therefore limited to clinician supervised study situations, though 
suitable for higher subject throughput than metabolic chambers.  
Another form of indirect calorimetry is the doubly labeled water (DLW) technique, mentioned 
above [250]. With this method, subjects are to ingest a standardized amount of the two stable 
isotopes deuterium and oxygen(18) as water. The isotopes equilibrate with body water and 
are eliminated from the body at different rates: deuterium leaving the body as water only, 
whereas O(18) leaving as water and as CO2. The greater the difference in the elimination 
rates the greater the CO2 production, hence the larger the energy expenditure. While this 
method provides reasonably accurate estimates of energy expenditure [251], it only 
measures total energy expenditure and does not provide for a differentiation of energy spent 
at various intensity levels of PA. Furthermore, production and analysis of the isotopes is 
expensive. All these factors make the DLW technique unsuitable for the project at hand.  
 
Measurements Of Vital Signs At Baseline And At Follow-Up 
Blood pressure measurement was made in duplicate after 5 minutes of rest in a well-
ventilated room at about 240 C on both arms with the participant in the supine position. The 
mean of both measurements was considered for analysis. 
 
Body weight and standing height were measured in light sports clothing and without shoes to 
the nearest 0.1 kg and 1 cm, using an anthropometer and a calibrated electronic scale, 
respectively. BMI was calculated as the ratio between weight and height squared (kg/m2).  
 
Body composition was measured using an impedance analyzer device and software (BIA 
2000-S, Data Input, Frankfurt, Germany) for tetrapolar BIA measurement of resistance (R) 
and reactance (Xc) at frequencies of 5, 50 and 100 kHz. Measurements were made at the 
right side of the subject between the wrist and ankle while in a supine position and after 
having rested for 5 minutes. The equipment, analytic algorithms and the measurement 
protocol have been validated previously in comparable populations [252, 253].  
 
All biochemical parameters were determined by standard laboratory methods using certified 
assays in a local clinical laboratory. The Siemens company medical officer sampled venous 
blood in EDTA tubes in the morning between 07:30 and 08:45 after an overnight fast for the 
analysis of total cholesterol, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) 
cholesterol, triglycerides and fasting glucose.   
Venous blood sampling was repeated for the first 61 subjects within 7-10 days following the 
initial assessment. Subjects were instructed not to change any of their lifestyle habits during 
this period.  
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Rationale For Repeated Blood Measurements 
The purpose of this repeated measurement was to determine the variability of standard 
biochemical parameters and to subsequently assess the reliability of before-and-after 
measurements of such parameters as markers of intervention effects.  
Intra-individual variability of lipids, lipoproteins and apolipoproteins contributes to the less 
than reliable prediction of cardiovascular risk [254-260]. This may complicate efforts to 
correlate changes in PA with changes in cholesterol levels [261], the latter being of rather 
modest magnitude of <10% for blood lipids [241, 242] and lipoproteins [240]. 
 
Exercise Testing  
Exercise testing, performed as cardiopulmonary exercise test (CPET) on a cycle ergometer, 
was the integral component of the health insurer’s fitness testing promotion for the execution 
of which the author’s laboratory had been contracted on-site. Each exercise test had been 
carried out under proper medical supervision. 
All exercise tests were performed in a well ventilated room at a temperature of about 240 C. 
Participants had been instructed not to consume alcoholic beverages and not to eat a heavy 
meal or participate in any vigorous physical activity 24 h before the test. Before each test, 
subjects were also instructed on how to perform the exercise test.  
Special emphasis was placed on the instruction to alert the tester immediately to any 
untoward sensation such as dizziness, chest pain, joint pain or to any other reason for which 
the participant would want to terminate the test immediately. Participants were also informed 
that the tester would terminate the test if observed clinical evidence were suggestive of 
distress.  
Indicators for distress were defined in accordance with current ACSM guidelines [262], 
specifically 
• onset of angina-like symptoms 
• >= 20 mmHg drop in systolic blood pressure or failure of systolic blood pressure to 
rise with increased exercise intensity 
• excessive rise in systolic (>260 mmHg) or diastolic (>115 mmHg) blood pressure 
• signs of poor perfusion  
• failure of heart rate to increase with increasing exercise intensity 
• non-physiological change in heart rhythm   
 
Barring any such event, participants were encouraged to continue the test until they reached 
exhaustion. 
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Tests followed a ramp protocol to exhaustion on a cycle ergometer (Customed, Germany) 
with the ramp increment chosen, based on age, weight, height and training history, as to 
reach exhaustion within 8 to 12 minutes [263]. For the first 3 minutes the workload was fixed 
at 5 W. After termination of the test, regardless of reason, participants continued to cycle at 
minimal resistance of 5 W for another 2 minutes to monitor recovery of heart rate and blood 
pressure.  
The resistance on the cycle ergometer was controlled by the ergospirometric software 
(Cortex, Leipzig, Germany) to be independent of pedal cadence.  
Spiroergometry was carried out using a breath-by-breath-system (Cortex MetaLyzer 3B, 
Leipzig, Germany), which has been validated previously [264]. Expired air was collected 
continuously using a facemask. The system was calibrated prior to each test in accordance 
with manufacturer’s guidelines using a 3-L syringe for volume calibration and ambient air 
measure for gas calibration. 
During all tests heart rate was recorded with a wireless chest strap telemetry system (Polar, 
Kempele, Finland). Blood pressure was measured every three minutes oscillometrically using 
a Customed BP measuring device integrated into the CPET equipment and software.  
Simultaneous gas exchange measurements consisted of minute ventilation (V’E), oxygen 
uptake (V’O2; electrochemical cell), and carbon dioxide output (V’CO2; infrared analyzer). For 
calculations, data were averaged over every 20 seconds.  
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Determination Of VO2peak 
Peak oxygen uptake (VO2peak) was defined as the highest value for oxygen uptake averaged 
over 20 seconds. The most common reasons for stopping the exercise test were leg fatigue 
and breathlessness.  
 
Determination Of Anaerobic Threshold 
The anaerobic threshold (AT) is defined as the exercise rate above which the aerobic 
mitochondrial production of ATP is supplemented by ATP production from incomplete 
anaerobic breakdown of glycogen to pyruvate [265]. Buffering of the resulting increase in 
lactic acid leads to a net increase in CO2 in the blood within a few seconds of reaching this 
threshold. In expiratory gas analysis this event manifests (a) as an acceleration of CO2 
expiration in comparison to O2 consumption, providing for the “V-slope method” of threshold 
determination, and (b) as an increase in ventilatory volume relative to O2 consumption while 
initially maintaining the ratio of ventilatory volume to CO2 expiration, thereby providing for the 
“ventilatory equivalent method” of threshold determination [265].  
To determine the participants’ individual anaerobic thresholds, the following steps were 
performed sequentially after each exercise test: 
(1) 20-seconds averaging of all ergospirometric data 
(2) initiating the ergospirometric analysis software’s automatic V-slope calculation 
function to perform a regression analysis of the slopes of the VCO2/VO2 curve  
(3) visual inspection of the ventilatory curves and of the position of the automatically 
calculated AT  
(4) manual correction of the calculated AT if visual inspection indicated a discrepancy 
between automatic calculation and true AT. 
Samples for a automatically calculated AT and manual corrections are provided for illustrative 
purposes in Annex “X”.  
 
STATISTICAL MEASURES & PROCEDURES 
The statistical methods were chosen in accordance with accepted principles as described by 
Altman [266] and Rosner [267].  
 
Baseline Comparisons 
To evaluate the effect of small sample sizes on the power to detect significance of parameter 
differences between the adherent and non-adherent groups at baseline, effect sizes were 
calculated and expressed as Cohen’s d using equation 4.  
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Equation 4: 
€ 
d = m1−m2
n1 −1( )s12 + n2 −1( )s22
n1+ n2
 
where m1 = mean of group 1; m2 = mean of group 2; n1 = number of observations in group 1; 
n2 = number of observations in group 2; s1 = SD of group 1; s2 = SD of group 2; and the 
expression in the denominator is the pooled standard deviation, “pooled SD”. 
Cohen suggested to categorize effect sizes as “small”, “medium” and “large” for d values of 
0.2, 0.5 and 0.8 respectively [268]. 
This line of investigation served to identify potential insufficiencies of sample size to detect 
true parameter differences between non-adherent and adherent groups at baseline. The 
combination of large effect size with a t-test returning non-significance of difference was taken 
as such indication, warranting further investigation.  
This comparison of baseline parameters between adherent (CFL+) and non-adherent (CFL-) 
groups was deemed necessary to answer the question whether these two groups differed 
from the outset by some parameter, which may have had a causative effect on the adherence 
status at follow-up. Given the 13 parameters (age, VO2peakweight, body fat, BMI, TCH, LDL, 
HDL, TG, TCH/HDL ratio, systolic and diastolic blood pressure,  PROCAM score) the 
possibility of the family-wise type I error needed to be considered. In the context of this 
investigation, it is the probability that even if the adherent group does not differ from the non-
adherent group at baseline (the null hypothesis), the chance of finding one of the 13 
comparisons being significant is no longer 0.05 but 0.48, with the formula for the error rate 
across the study being [269]: 
Equation 5: 
€ 
1− 1−α( )n  
where α is the significance level and n is the number of tests performed. 
Accepting the Bonferroni adjustment would require a significance level of p<0.0039,which is 
derived from the formula: 
Equation 6: 
€ 
1− 1−α( )
1
n  
Despite these considerations, Bonferroni adjustment was omitted for the number of tests (13) 
performed for significance of baseline differences between CFL- and CFL+ groups for the 
reasons that (a) no null-hypothesis with respect to between-group baseline differences had 
been formulated a priori, (b) the parameters cannot be considered to be independent of each 
other (e.g. lipid levels and blood pressure correlate with weight status) and therefore the tests 
are not truly independent tests, (c) significance of difference between CFL groups in one or 
more baseline values constitutes a finding worthy of further investigation and interpretation, 
which (d) would be otherwise missed, simply due to the inflation of type II errors being the 
inevitable consequence of reducing type I error rate.  
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Bonferroni adjustments, however, were applied to the gender-stratified investigations of 
baseline differences. Gender stratification was deemed necessary to investigate whether the 
baseline difference in body weight between the adherent and non-adherent groups was 
attributable to the difference in the proportion of female participants. This fulfills the criterion 
of repeated testing of sub-samples without prior hypotheses that these samples should differ 
[270]. Hence, the p-value for accepting significance of differences between CFL groups at 
baseline was set to 0.025 based on Equation 6 with n=2 and p=0.05.  
 
Hypothesis Testing 
Table 3 presents the methods of statistical inference as they were applied to answering the 
study questions.  
Continuous variables are presented as mean and standard deviation (SD) or geometric mean 
and factor between means for non-normal distributed data after log-transformation. 
Categorical variables are presented with frequency and the relative frequency. Analyses for 
differences between groups at baseline were performed using unpaired t-test and the Chi-
square (χ2) test for categorical data. Change from baseline to follow-up within groups were 
tested using paired t-test for continuous data, or the Chi-square test or Fischer’s exact test for 
categorical data. Changes from baseline to follow-up were tested between CFL groups using 
the t-test for continuous data, and the Chi-square test for categorical data. Statistical 
significance was accepted at p<0.05.  
 
Table 3:  
Methods of Statistical Inference 
 Type of 
Variable 
Type of statistical problem Method applied 
Interval  Two-sample t-test Comparison of the means of baseline values 
between CFL+ & CFL- groups nominal 
Two independent samples, 
one variable Fisher’s Exact Test 
Proportion of CFL+ subjects in the sample 
population 
 Comparison with specified 
proportion  
Test of Proportions 
Change in parameters from baseline to follow-
up within each CFL group 
interval One variable, two dependent 
samples  
Paired t-test 
Comparison of the mean changes from 
baseline to follow-up between CFL groups 
interval One variable, two independent 
samples  
Two-sample t-test 
Odds Ratio (OR)   One binomial variable, two 
independent samples  
2x2 contingency table 
methods, χ2 test 
 
 
The following parameters were assessed continuously, as the primary and secondary 
outcome variables of interest: VO2peak, body weight, BMI, body fat, TCH, HDL, LDL, TG, 
BPsys, BPdia, PROCAM risk score. The lipid ratio TCH/HDL was also calculated and 
assessed continuously.  
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 81 of 239 
Ratio- and interval-type baseline and follow-up data were tested for normality of the 
distribution using skewness-kurtosis and Shapiro-Wilk tests.  
All variables were visually inspected for normality using Q-Q Plots. In the case of Shapiro-
Wilk tests and Q-Q plots suggesting violation of the normality assumption, attempts were 
made to normalize the distributions through suitable transformations. If successful, analyses 
were performed on transformed and natural data. This was done with a specific view to 
examining significance in all cases where the combination of medium or large effect sizes 
(between groups or within groups from baseline to follow-up) with the between- or within-
group differences approaching, but not reaching, significance suggested insufficient power of 
the parametric analyses when performed on the untransformed data. Nonparametric tests 
were used when data were non-normally distributed and no suitable transformation for 
establishing normality could be found. 
Independent samples t-tests were conducted as univariate analyses to compare the 
parameters at baseline between adherent and non-adherent subject groups (CFL+ and CFL- 
groups respectively, see definition under the section “adherence”). Within-group changes 
from baseline to follow-up were evaluated using paired t-tests. Between-group changes from 
baseline to follow-up were compared using t-tests assuming unequal variances wherever 
appropriate.  
To evaluate whether the probability of modifying outcome parameters to a clinically relevant 
extent was significantly different between CFL groups, outcome parameters were first 
dichotomized along clinically relevant minimum values of change. Subsequently, two-by-two 
contingency tables were constructed to assess whether a change in parameter was related to 
CFL-group association. Significance of the relation was assessed using Chi-squared tests for 
all tables in which all expected cell frequencies exceeded 5. In cases of expected cell 
frequencies being <5, the results of Fisher’s exact tests were accepted to determine 
significance. In the case of significant findings, odds ratios were calculated and their 95% CI 
were assessed using logistic regression.   
 
All tests were performed on raw and transformed data to determine whether the findings of 
significance derived from analyses of the raw data could be confirmed from the transformed 
data as well. If analyses performed on transformed data did not support the findings derived 
from analyses of raw data, null hypotheses of significance were accepted.  
 
Tests for equality of variances were performed using a robust test originally suggested by 
Levene [271]. This test, found to be robust under non-normality and further improved by 
Brown and Forsythe [272], has been implemented as a test statistic in the statistical software 
STATA which was used to carry out all analyses (see below). 
To determine whether findings of statistical significance translated into clinical relevance, the 
interval-type data for changes of VO2peak, total and HDL cholesterol, TCH/HDL ratio, body 
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fat percent and body weight (expressed as percent change) were first dichotomized along 
evidence-based demarcations for clinical relevance (clinical relevance defined as VO2peak 
change >= 3.5 ml/kg/min, body weight change >=5% of baseline weight, change of body fat, 
TCH and HDL  >=10% respectively). Logistic regression was conducted to calculate odds 
ratios (ORs) and 95% CIs of these dichotomized variables associated with CFL group status 
in CFL strata (see following section).  
Statistical significance was accepted with P < 0.05. Analyses were carried out with 
Intercooled STATA 11 for Macintosh (Stata Corp. Texas, U.S.A.) and all data are expressed 
as means ± 1SD unless noted otherwise.  
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DEFINING ADHERENCE – THE DETERMINANTS OF THE CONTROLLED FEEDBACK LOOP 
Typically the degree of adherence to an intervention determines the cumulative intervention 
dose to which a subject will have exposed himself at the time of follow-up. This is an 
important aspect to consider when investigating the strength of the association between the 
intervention and its hypothesized outcome. In behavior modification interventions, this does 
not answer the question what proportion of individuals leaves the intervention with a suitably 
modified lifestyle behavior. For example, an 80% adherence rate to a physical activity 
curriculum may not be so impressive if the 20% non-adherence has been accumulated 
through consecutively missed sessions prior to the intervention end, suggesting non-
sustainability of the curriculum. One of this trial’s objectives is to answer the question whether 
and to which degree adherence to its curriculum has been sustained in free-living individuals 
by trial’s end. It a priori accepts an association to exist between PA and health outcome (as 
discussed in the preceding sections). What it attempts to answer is whether the intervention 
strategy which is specifically aimed at making adherence to PA sustainable, will, at the time of 
follow-up, see a large enough proportion of participants acutely availing themselves to PA at 
a large enough dose and having done so over a long enough duration that the accrued 
measurable health benefits support subjecting this intervention to larger and longer-term 
prospective follow-up investigations upon its chronic public health benefits. 
To put it simple: while preceding trials have established the effect of taking the medicine (PA), 
this trial begins to investigate how to make people keep taking it.  
 
Lack of time is the most frequently cited obstacle to the cultivation of a regular exercise habit 
[273-275]. Whether real or imagined, this concern needs to be resolved if the high prevalence 
of sedentism and its associated diseases are to be substantially reduced [276].  
It is conceivable that the conflict between time available and time required for exercise 
freezes an individual into a sedentary lifestyle. The current exercise recommendations may 
inadvertently promote this conflict. In its 2009 position statement, the ACSM states that 150-
250 minutes of moderate-intensity exercise per week may just be sufficient to prevent weight 
gain, whereas PA in excess of 250 minutes is required to achieve clinically significant weight 
losses in overweight and obese persons [277]. The Institute of Medicine advocates at least 60 
minutes of moderate physical activity 7 days per week [278].  
To many currently sedentary individuals these recommendations are in conflict with their real 
or imagined time constraints.  
Recent research has shown that clinically relevant health benefits accrue from exercise of 
shorter duration but higher intensity, which may more easily fit into individuals’ time budgets 
[279, 280]. Specifically high intensity interval training (HIT) has emerged as astonishingly 
effective in relatively small doses. HIT typically consists of sequences of high intensity 
training, such as running or cycling at or above 80% of VO2max or near maximal heart rate 
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for 1 to 4 minutes, followed by a period of active recovery, such as running or cycling at or 
above the anaerobic threshold.  
Insulin action and glucose metabolism appear to markedly benefit from such routines [281]. 
One potential reason for this effect is that while type-1 (fast-twitch) muscle fibers replenish 
their glycogen stores during recovery, regardless of the type of recovery, type-2 (slow-twitch 
oxygenating) fibers continue to deplete their glycogen stores, but only during active and not 
during passive recovery [282].  
HIT also improves fitness and the metabolic syndrome substantially better than continuous 
moderate exercise [283]. Even for chronic heart failure patients, HIT has emerged as an 
effective medicine for improving cardiac function, quality of life (QoL) and survival [284, 285].  
With respect to endothelial function, moderate intensity exercise my be insufficient to elicit an 
anti-inflammatory response [286], whereas HIT exerts a strong protective effect against 
endothelial dysfunction resulting from post-prandial lipemia [287].  
 
With thrice weekly 15-minute HIT bouts yielding significant improvements of parameters of 
metabolism and exercise capacity [281], I defined as minimum PA volume for this trial a thrice 
weekly 20-minute HIT routine consisting of 4 one-minute all-out PA periods each followed by 
a 4-minute active recovery period of moderate-to-high-intensity PA to be performed 
consecutively on alternating weekdays. Hence, 60 weekly minutes of exercise performed in 
HIT mode constituted the minimum requirement for exercise volume in this trial. This is also in 
line with U.S. government recommendations, published under the “Healthy People 2010” 
initiative, and calling for moderate intensity exercise of at least 30 minutes on at least 5 days 
per week, or alternatively, for 20 minutes high intensity exercise at least thrice weekly [288].  
I rationalized that even if no measurable benefits would accrue over the trial period, 
participants would probably find it relatively easy to establish a PA routine based on these 
minimal time requirements from which a subsequent increase in weekly exercise volume 
would be perceived as less demanding, than to begin with a larger volume right from the start. 
I therefore designed the protocol to be minimally invasive with respect to subjects’ perceived 
time constraints while at the same time capable of producing clinically relevant health benefits 
as suggested by published evidence.  
Hence, adherence (having an operant cognitive controlled feedback loop) was defined as 
meeting or exceeding the minimum requirements of having performed the 60-minutes weekly 
volume of HIT for at least 12 consecutive weeks, with the last recorded entry into the self-
monitoring tool having occurred not longer than 7 days prior to the follow-up assessment. 
Subjects are henceforth dichotomized into CFL+ (adherent, based on the aforementioned 
criteria) and CFL- groups. With physical fitness being the primary and measurable health 
outcome, the 12 weeks duration is in keeping with published evidence, which suggests that 
measurable effects accrue to VO2max after such durations [106] with decay of the effect 
being observable within 14 days of discontinuation of the exercise regimen [289].  
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DESCRIPTION OF THE PHYSICAL ACTIVITY INTERVENTION 
All participants received a detailed personal appraisal of their baseline measurement results 
by the author. A standardized summary of the results with explanations of how to interpret 
them was made available for download from the web-based electronic lifestyle file (ELF) for 
each participant (see attachment). Participants were then familiarized with the use of their 
web based electronic lifestyle file for monitoring and logging their PA data (see attachment). A 
minimum PA curriculum of thrice weekly 20 continuous minutes of HIT was agreed to by all 
participants, with recommendations given for aerobic and/or resistance exercise to be 
performed in excess of this minimum requirement. These recommendations were based on 
each participant’s health profile with a view to improving specific health parameters. The 
mode of exercise to be performed was left to the participants in accordance with their 
preferences and abilities. Jogging (as distinct from walking) was the type of activity preferred 
by most participants, followed by cycling or a combination of both exercise types. Only two 
participants chose swimming as the primary mode of exercise, both of these participants 
however, emerged among the CFL- group.  
All participants who opted for the use of heart rate monitors during exercise were given target 
heart rates for the HIT exercises and recommendations for the optimal heart rates during 
continuous aerobic exercise based on their individual CEPT results. Participants who decided 
against the use of heart rate monitors were familiarized with the use of the 10-point OMNI 
rating scale of perceived exertion [290] (translated into the German language by the author) 
and instructed to perform the high-intensity intervals at an approximate rating of 8 and the 
recovery phase at a rating of 5-6 (see appendix). The OMNI scale has been validated for use 
in equivalent populations [291, 292].  
 
Exercise Curriculum  
The common denominator for all participants was a high intensity interval (HIT) protocol of 
thrice weekly 20 minutes of interval exercise (either running or cycling). Each 20-minute 
session consisted of 4 repeated  60-s  sprints at a heart rate commensurate with 85% to 95% 
of participants’ individual VO2max  (as assessed for each participant at baseline) with  a 4-
min recovery phase between sprints. During recovery, subjects were to continue their mode 
of exercise at an intensity level commensurate with their anaerobic threshold. Subjects were 
instructed not to perform HIT on consecutive days, but were encouraged to engage in other 
exercise, such as resistance training or moderate intensity endurance training at 95-115% of 
their individual anaerobic threshold. The exercise volume to which a participant had agreed 
during the individual appraisal session was expressed in a simple point system, in which 1 
point reflected 5 minutes of exercise. The ELF facilitates a 6-weeks cumulative graphical 
display of actual vs. target performance. Thus a point score of 72 reflects the minimum 
curriculum of thrice weekly 20-minutes of HIT. Target point scores for the initial 6-weeks 
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period were based on the PA volume which each participant voluntarily agreed to perform. 
Participants were encouraged to log their actual PA performance on an as-and-when-
performed basis, either by direct access to their secured web-page or through an applet 
installed on their mobile phone facilitating SMS-based reporting of point scores.  
 
Monitored Self-Monitoring  
Participants were informed that the author/investigator continuously monitors each 
participant’s self-reported progress and that (a) failure to report progress for more than 7 
consecutive days, or (b) foreseeable failure to achieve the target point score will prompt the 
investigator to contact the participant personally (via phone or email) to enquire about the 
reasons. Verbal agreement to this procedure had been obtained by the author from all 
participants during the initial appraisal session.  
Automated alarm features of the ELF (described in the attachment) provide for forecasting of 
actual progress vs. target progress and the definition of a variance which will trigger the 
alarm. Alarms trigger the sending of email, fax or SMS to operator-defined recipients (in this 
case, the author) to inform about the fact and type of triggering event.   
After the completion of each 6-weeks period, the ELF automatically issues a new training plan 
adjusting the target point-scores based on self-reported results achieved during the 
completed cycle (see attachment). The automatically issued training targets are increased 
over the previously achieved actual score by a fixed percentage, so as to motivate the 
participants to increase their exercise curriculum up to a pre-set maximum of 60 minutes per 
day.   
There was no monitoring of actual intensity at which participants performed the HIT sessions. 
However, participants were encouraged to contact the author/investigator in case of any 
questions or doubts pertaining to the exercise routines or other aspects of the intervention 
program.   
 
Active self-monitoring was defined as meeting all three of the following conditions: 
• latency:  7 days or less between last logged PA and follow-up examination  
• duration:  90 consecutive days of continuous weekly self-monitoring  
• volume:  60 minutes of weekly volume of recorded exercise  
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RESULTS 
Of the 117 participants enrolled into this study 89 individuals met all three criteria for being 
actively self-monitoring at follow-up (CFL+), thereby qualifying as adherent. Of these 89 CFL+ 
subjects 8 individuals performed self-monitoring off-line using manual record books. Reasons 
given for not using the internet tool were  
• having no or only occasional internet access (5 subjects) 
• being inconvenienced by internet recording (3 subjects) 
The manual PA logs of all 8 offline self-monitoring subjects were verifiable against attendance 
records in the on-site fitness center at which most subjects performed their PA sessions. 
Of the 28 subjects who did not meet the CFL+ requirements (CFL- participants, or non-
adherent), 5 subjects had sustained injuries (unrelated to the intervention protocol), which 
had prevented them from continuing their PA curriculum.  
One subject felt unable to maintain a regular exercise schedule, owing to a new assignment, 
which required extended and frequent overseas’ business trips.  
Of the remaining 22 subjects  
• 5 subjects (4 males) had exceeded the volume and duration requirements but had 
failed to meet the latency requirement due to their discontinuation of self-monitoring 
of physical activity between 9 to 20 days prior to the follow-up assessment. The 
reason given by all 5 subjects was their confidence in their ability to maintain the 
newly acquired PA habit without any further need to record it.  
• 15 subjects had displayed an “on-off” adherence and did not meet the volume, 
duration and latency criteria to various degrees. 
• 2 male participants did not meet any of the latency, volume and duration 
requirements and failed to attend the follow-up assessments. Both participants had 
expressed a loss of interest in the program as the reason for discontinuation.  
 
Adherence Stratification 
To facilitate analyses of the associations between intervention duration and intervention 
effects, CFL status was dichotomized into three strata CFL90, CFL120 and CFL 150, with the 
only inter-category difference being the duration of recorded self-monitoring (90 days, 120 
days and 150 days respectively). The latency and volume aspects of the adherence definition 
remained the same for all three strata, with 7 days or less between last logged PA and follow-
up examination, and a minimum of 60 weekly minutes of reported PA. 
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DATA ACQUISITION 
Availability of valid data for statistical analyses by adherence status and by CFL strata is 
presented in Figure 4. 
 
Figure 4. Data availability for ELF participants by CFL (adherence) status by CFL Strata. 
 
Cardiopulmonary Exercise Testing (CPET) 
Ergospirometric exercise tests had been performed on all 117 subjects at baseline and for 
115 subjects at follow-up (2 CFL- - subjects had failed to participate in the follow-up 
evaluations). For 19 subjects (3 CFL- participants and 16 CFL+ participants) one or both of the 
tests had to be terminated prematurely due to blood pressure excursions (7 subjects), 
musculoskeletal complaints (11 subjects) or both (1 subject). As a result, the complete 
ergospirometric data (baseline and follow-up) of 23 CFL- subjects and 73 CFL+ subjects were 
available for statistical evaluation to test hypothesis 2a.  
 
Body Composition And Weight Status  
Body weight data from baseline and follow-up assessment were available for 115 subjects. 
Follow-up data were missing for the 2 subjects who had failed to participate in the follow-up 
assessment.  
 
Laboratory Analyses 
Complete data for blood cholesterol and lipid values were available for 23 CFL- subjects and 
87 CFL+ subjects. 5 CFL- subjects had refused participation in the sampling of blood at follow-
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up. One CFL+ subject had refused participation in the sampling of blood at baseline and 
follow-up, and for one CFL+ subject the baseline data had to be ignored due to self-reported 
violation of the fasting requirement prior to blood sampling.  
 
COMPARISONS AT BASELINE 
Table 4a presents the baseline values by adherence strata. 
 
Table 4a:  
Baseline Values By Adherence Strata 
 CFL90a CFL120a CFL150a  
statusb 
non-adherent 
(N=28) 
adherent 
(N=89) 
non-adherent 
 (N=31) 
adherent 
 (N=86) 
non-adherent 
 (N=51) 
adherent 
 (N=66) 
total 
(N=117) 
proportionc 
% 
23.9 
(16.1 to 31.8) 
76.1 
(68.2 to 83.9) 
26.5 
(18.4 to 34.6) 
73.5 
(65.4 to 81.6) 
43.6 
(34.5 to 52.7) 
56.4 
(47.3 to 65.5) 
100 
femalec % 
21.4 
(5.8 to 37) 
30.3 
(20.6 to 40) 
19.3 
(5.1 to 33.6) 
31.4 
(21.4 to 41.4) 
21.6 
(10 to 33.1) 
33.3 
(21.7 to 44.9) 
28.2 
(19.9 – 36.4) 
age 48.3 ±7.6 50.5 ±9.7 49 ±7.5 50.3 ±9.8 50.5 ±9.6 49.5 ±9 50 ±9.3 
weight 93 ±13.6 86.7 ±15.1 93.4 ±13.7 86.4 ±15 90.8 ±14.7 86.3 ±14.9 88.2 ±14.9 
BMI 29.8 ±4.5 28.6 ±4.1 29.9 ±4.4 28.6 ±4.1 29.2 ±4.3 28.7 ±4.1 28.9 ±4.2 
%body fat 28.7 ±8.2 28.9 ±7.5 28.6 ±8.1 29 ±7.5 28.3 ±8.4 29.3 ±7.1 28.9 ±7.7 
VO2peak 31.8 ±7.8 32 ±8.2 31.8 ±7.7 32 ±8.2 31.3 ±8.5 32.5 ±7.7 32 ±8 
TCH 221.3 ±54.6 224 ±49.2 221 ±52 224.2 ±50 225.2 ±54.7 221.9 ±46.9 223.4 ±50.3 
HDL 55.2 ±16.4 54.5 ±13 54.4 ±15.9 54.8 ±13.1 55.6 ±14 54 ±13.8 54.7 ±13.8 
LDL 137.4 ±47.5 138.5 ±44.6 136.2 ±45.5 139 ±45.2 138.4 ±45.6 138.1 ±45.1 138.2 ±45.1 
TCH/HDL 4.3 ±1.2 4.3 ±1.2 4.3 ±1.2 4.3 ±1.2 4.3 ±1.2 4.3 ±1.2 4.3 ±1.2 
TG 143.7 ±71.7 155.3 ±104.9 151.7 ±81.2 152.8 ±103.5 156.5 ±117.5 149.3 ±79.2 152.5 ±97.7 
BPsys 136.1 ±12 142.6 ±16.3 136.8 ±12 142.5 ±16.5 138.8 ±12.9 142.7 ±17.3 141 ±15.6 
BPdia 82.9 ±8.5 82.8 ±10 83.3 ±8.3 82.6 ±10.1 81.3 ±10.4 84.1 ±8.8 82.8 ±9.6 
PROCAM 3.8 ±4.7 5.2 ±6.6 4.6 ±5.8 4.9 ±6.4 5.4 ±7.9 4.4 ±4.4 4.9 ±6.2 
Note: Data are means ± SD unless otherwise noted. 
TCH: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides; VO2peak: peak oxygen consumption: 
BMI: body mass index (kg/m2) BPsys: systolic blood pressure (mmHg); BPdia: diastolic blood pressure (mmHg); PROCAM: PROCAM risk 
score;  
a - CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
b – values in brackets: numbers of subjects 
c -  values in brackets: 95% confidence interval 
 
To test the hypothesis of no significant baseline differences between active and inactive 
groups within each adherence strata, independent-samples t tests were conducted on all 
variables. Independent-samples t tests are based on the assumptions of a normally 
distributed variable and equal variances of the variables for the populations under 
comparison. Therefore all test variables were inspected for normality using Shapiro-Wilk tests 
and Q-Q plots. In case of violations of the assumption of normality (age, triglycerides, 
PROCAM score) suitable transformations were performed to create a more normally 
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distributed variable. Levene’s tests for equal variances were subsequently performed on the 
raw and transformed variables, following which, t-tests were conducted on the raw and 
transformed variables, assuming unequal variance in all cases where the assumption of 
equality of variance was found to be violated (triglycerides only). Results of the t-tests 
(performed on the untransformed raw variable data, except for PROCAM score) are 
presented in Tables 4b-d and explained thereafter.  
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Table 4b:  
CFL90 Strata Baseline Values by CFL Group 
  CFL- 
Nmale=22 
Nfemale=6 
CFL+ 
Nmale=62 
Nfemale=27 
Δ significance Pooled 
SD 
Effect Size 
(Cohen’s d) 
Gender  
(95% CI) 
Female (%) 21.4 % 
6.2 to 36.6 
30.3 % 
20.7 to 39.8 
8.9 z=-0.91, p=0.36   
Male  49.3 ±7.6 51.2 ±8.1 1.9 t(39.4)=-0.97, p=0.33 7.88 0.24 
Female  44.3 ±6.37 48.6 ±12.37 4.3 t(14.8)=-1.2, p=0.24 11.2 0.38 
Age 
total 48.3 ±7.6 50.4 ±9.6 2.1 t(115)=-1.08, p=0.28 9.09 0.23 
Male  93.3 ±12.4 90.6 ±13.7 -2.7 t(82)=0.82, p=0.41 13.2 0.2 
Female  91.7 ±18.5 77.7 ±14.1 -14 t(31)=2.07, p=0.04 14.4 0.9 
Weight 
kg 
total 93.0 ±13.6 86.7 ±15.0 -6.3 t(115)=-1.98, p=0.05 14.5 0.43 
Male  28.8 ±3.1 28.6 ±3.7 -0.2 t(82)=0.16, p=0.87 3.5 0.05 
Female  33.4 ±6.7 28.4 ±4.6 -5 t(31)=2.17, p=0.03 4.8 1.0 
BMI 
kg/m2 
total 29.8 ±4.4 28.6 ±4.0 -1.2 t(115)=-1.34, p=0.18 4.0 0.29 
Male  25.3 ±4.4 25.5 ±5.0 0.2 t(82)=-0.21, p=0.82 4.8 0.04 
Female  41.1 ±6.3 36.5 ±6.5 -4.6 t(31)=1.59, p=0.12 6.3 0.7 
%Body fat 
total 28.7 ±8.2 28.9 ±7.5 0.2 t(115)=-0.11, p=0.91 7.6 0.03 
Male  34.2 ±6.4 34.7 ±7.4 0.5 t(82)=-0.27, p=0.78 7.1 0.07 
Female  22.6 ±4.3 25.6 ±5.4 3.0 t(31)=-1.23, p=0.22 5.1 0.59 
VO2peak 
ml/kg/min 
total 31.8 ±7.7 32.0 ±8.1 0.2 t(115)=-0.12, p=0.90 7.9 0.02 
Male  52.4 ±14.9 50.2 ±9.1 -2.2 t(82)=0.82, p=0.4 10.7 0.2 
Female1 65.3 ±18.5 65.1 ±15.0 -0.2 t(29)=0.02, p=0.97 15.1 0.01 
HDLa 
mg/dL 
total 55.2 ±16.3 54.5 ±13.0 -0.7 t(113)=0.23, p=0.81 13.7 0.05 
Male  219 ±58 226 ±50 7 t(82)=-0.51, p=0.6 51.5 0.1 
Female 229 ±41 219 ±48 -10 t(29)=0.44, p=0.66 45 0.22 
TCha 
mg/dL 
total 221.2 ±54.5 224.0 ±49.1 2.8 t(113)=-0.25, p=0.80 50.0 0.05 
Male  136 ±51 142 ±44 6 t(82)=-0.51, p=0.6 45.3 0.1 
Female 140 ±35 129 ±44 -11 t(29)=0.59, p=0.55 41.2 0.26 
LDLa 
mg/dL 
total 137.3 ±47.5 138.5 ±44.6 1.2 t(113)=-0.11, p=0.90 44.9 0.03 
Male  4.3 ±1.0 4.5 ±1.0 0.2 t(82)=-0.91, p=0.36 0.99 0.2 
Female1 3.8 ±1.3 3.5 ±0.9 -0.3 t(29)=0.61, p=0.54 0.95 0.31 
TCh/HDLa 
ratio 
total 4.2 ±1.2 4.3 ±1.2 0.1 t(113)=-0.21, p=0.83 1.19 0.08 
Male  151 ±77 166 ±116 15 t(56.3)=-0.69, p=0.49 106 0.1 
Female 116 ±42 127 ±61 11 t(10.7)=-0.54, p=0.59 56.3 0.19 
TGa 
total 143.6 ±71.7 155.3 ±104.8 11.7 t(66.9)=-0.66, p=0.51 97.2 0.12 
Male  136 ±12 144 ±16 8 t(79)=-2.03, p=0.05 14.9 0.5 
Female  137 ±12 140 ±17 3 t(27)=-0.4, p=0.69 15.8 0.18 
BPsysb 
total 136 ±12 143 ±16 7 t(108)=-1.89, p=0.06 15 0.46 
Male  83 ±9 85 ±9 2 t(79)=-0.83, p=0.4 8.9 0.22 
Female  84 ±7 78 ±11 -6 t(27)=1.04, p=0.3 10.1 0.59 
BPdiab 
total 83 ±8 83 ±10 0 t(108)=0.06, p=0.95 9.5 0 
Male  
N=22/58 
2.81 
(1.7 to 4.65) 
4.7 
(3.73 to 5.93) 
1.67 t(78)=2.15, p=0.03   
Female  
N=5/23 
0.03 
(0 to 0.1) 
0.04 
(0 to 0.1) 
1.5 t(26)=0.46, p=0.6   
PROCAMc 
total 
1.19 
(0.51 to 2.77) 
1.22 
(0.7 to 2.13) 
1.03 t(106)=0.05, p=0.9   
Note: Data are means ± SD unless otherwise noted. 
TCH: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides; VO2peak: peak oxygen 
consumption; BMI: body mass index (kg/m2) BPsys: systolic blood pressure (mmHg); BPdia: diastolic blood pressure (mmHg); 
PROCAM: PROCAM risk score; 
a: number of female participants for whom blood analysis data were available: 31 
b: 81 male and 29 female participants for whom valid blood pressure data were available 
c: means are geometric means, and Δ is the factor between means (after antilog of the log-transformed data); values in 
brackets are 95% CI 
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Table 4c:  
CFL120 Strata Baseline Values by CFL Group 
  CFL- 
Nmale=25 
Nfemale=6 
CFL+ 
Nmale=59 
Nfemale=27 
Δ significance Pooled 
SD 
Effect Size 
(Cohen’s d) 
Male  50.1 ±7.4 51 ±8.3 0.9 t(50.4)=-0.51, p=0.6 7.9 0.11 
Female  44.3 ±6.37 48.6 ±12.37 4.3 t(14.8)=-1.2, p=0.24 11.2 0.38 
Age 
total 49.0 ±7.5 50.3 ±9.8 1.3 t(68.8)=-0.76, p=0.44 9.2 0.14 
Male  93.7 ±12.6 90.3 ±13.6 -3.4 t(82)=1.07, p=0.28 13.1 0.25 
Female  91.7 ±18.5 77.7 ±14.1 -14 t(31)=2.07, p=0.04 14.4 0.9 
Weight 
kg 
total 93.3 ±13.6 86.3 ±14.9 7 t(115)=2.28, p=0.02 14.4 0.48 
Male  29.0 ±3.2 28.5 ±3.7 -0.5 t(82)=0.57, p=0.56 3.5 0.1 
Female  33.4 ±6.7 28.4 ±4.6 -5 t(31)=2.17, p=0.03 4.8 1.0 
BMI 
kg/m2 
total 29.9 ±4.4 28.5 ±4.0 1.4 t(115)=1.58, p=0.11 4.07 0.34 
Male  25.5 ±4.7 25.5 ±4.9 0 t(82)=-0.017, p=0.98 4.8 0 
Female  41.1 ±6.3 36.5 ±6.5 -4.6 t(31)=1.59, p=0.12 6.3 0.7 
%Body fat 
total 28.5 ±8.0 28.9 ±7.5 0.4 t(115)=-0.27, p=0.78 7.6 0.05 
Male  33.9 ±6.6 34.9 ±7.5 1.0 t(82)=-0.54, p=0.58 7.1 0.1 
Female  22.6 ±4.3 25.6 ±5.4 3.0 t(31)=-1.23, p=0.22 5.1 0.59 
VO2peak 
ml/kg/min 
total 31.8 ±7.7 32.0 ±8.1 0.2 t(115)=-0.12, p=0.89 7.9 0.02 
Male  51.7 ±14.3 50.3 ±9.2 -1.4 t(82)=0.55, p=0.58 10.8 0.1 
Female 65.3 ±18.5 65.1 ±15.0 -0.2 t(29)=0.02, p=0.97 15.1 0.01 
HDLa 
mg/dL 
total 54.4 ±15.8 54.7 ±13.1 0.3 t(113)=-0.11, p=0.90 13.7 0.02 
Male  219 ±54.8 226.2 ±51 7.2 t(82)=-0.58, p=0.56 45.5 0.15 
Female 229 ±41 219 ±48 -10 t(29)=0.44, p=0.66 45 0.22 
TCha 
mg/dL 
total 220.9 ±51.9 224.2 ±49.9 3.3 t(113)=-0.31, p=0.75 50 0.06 
Male  135 ±48 143 ±45 8 t(82)=-0.72, p=0.47 45.3 0.17 
Female 140 ±35 129 ±44 -11 t(29)=0.59, p=0.55 41.2 0.26 
LDLa 
mg/dL 
total 136.2 ±45.5 138.9 ±45.2 2.7 t(113)=-0.28, p=0.77 44.8 0.06 
Male  4.4 ±1.1 4.6 ±1.1 0.2 t(82)=-0.74, p=0.46 1.08 0.18 
Female 3.8 ±1.3 3.5 ±0.9 -0.3 t(29)=0.61, p=0.54 0.95 0.31 
TCh/HDLa 
ratio 
total 4.3 ±1.1 4.3 ±1.2 0.0 t(113)=-0.05, p=0.95 1.16 0.0 
Male  160.2 ±86.4 163.5 ±115.6 3.3 t(82)=0.14, p=0.88 106.5 0.03 
Female 116 ±42 127 ±61 11 t(10.7)=-0.54, p=0.59 56.3 0.19 
TGa 
total 151.6 ±81.2 152.7 ±103.5 1.1 t(66.9)=-0.05, p=0.95 97.2 0.01 
Male  137 ±12 144 ±16 7 t(79)=-1.85, p=0.06 14.7 0.47 
Female  137 ±13 140 ±17 3 t(27)=-0.4, p=0.69 15.9 0.18 
BPsysb 
total 137 ±12 142 ±16 5 t(108)=-1.72, p=0.08 14.9 0.33 
Male  83 ±9 85 ±9 2 t(79)=-0.56, p=0.57 8.9 0.22 
Female  84 ±7 78 ±11 -6 t(27)=1.04, p=0.3 10.1 0.59 
BPdiab 
total 83 ±8 83 ±10 0 t(108)=0.33, p=0.73 9.4 0.0 
Male  
N=25/55 
3.22 
(2.01 to 5.2) 
4.52 
(3.56 to 5.7) 
1.39 t(78)=1.41, p=0.16   
Female  
N=5/23 
0.02 
(0 to 0.1) 
0.04 
(0 to 0.1) 
1.53 t(26)=0.46, p=0.6   
PROCAMc 
total 
N=30/78 
1.46 
(0.66 to 3.22) 
1.12 
(0.65 to 2.0) 
1.28 t(106)=0.49, p=0.6   
Note: Data are means ± SD unless otherwise noted. 
TCH: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides; VO2peak: peak oxygen 
consumption; BMI: body mass index (kg/m2) BPsys: systolic blood pressure (mmHg); BPdia: diastolic blood pressure (mmHg); 
PROCAM: PROCAM risk score; 
 
a: number of female participants for whom blood analysis data were available: 31 
b: 81 male and 29 female participants for whom valid blood pressure data were available 
c: means are geometric means, and Δ is the factor between means (after antilog of the log-transformed data); values in 
brackets are 95% CI 
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Table 4d:  
CFL150 Strata Baseline Values by CFL Group 
  CFL- 
Nmale=40 
Nfemale=11 
CFL+ 
Nmale=44 
Nfemale=22 
Δ significance Pooled 
SD 
Effect Size 
(Cohen’s d) 
Male  50.3 ±9.4 51.1 ±6.6 0.8 t(69.2)=-0.42, p=0.6 7.9 0.1 
Female  51 ±10.5 46.3 ±11.9 -4.7 t(22.4)=1.15, p=0.25 11.1 0.4 
Age 
total 50.5 ± 9.6 49.5 ±9.0 1.0 t(115)=0.57, p=0.56 9.2 0.1 
Male  91.7 ±13.8 90.8 ±13.1 -0.9 t(82)=0.29, p=0.7 13.2 0.06 
Female  86.9 ±17.5 76.9 ±13.9 -10 t(31)=1.79, p=0.08 14.6 0.68 
Weight 
kg 
total 90.7 ±14.7 86.2 ±14.9 4.5 t(115)=1.63, p=0.1 14.6 0.3 
Male  28.5 ±3.5 28.9 ±3.6 0.4 t(82)=-0.55, p=0.57 3.5 0.11 
Female  31.4 ±5.9 28.2 ±4.8 -3.2 t(31)=1.66, p=0.1 5.0 0.6 
BMI 
kg/m2 
total 29.1 ±4.3 28.7 ±4.1 0.4 t(115)=0.54, p=0.58 4.2 0.09 
Male  25 ±5.3 25.9 ±4.3 0.9 t(82)=0.88, p=0.37 4.7 0.18 
Female  40.1 ±6.2 35.9 ±6.5 6.5 t(31)=1.76, p=0.08 6.2 0.67 
%Body fat 
total 28.3 ±8.3 29.3 ±7.0 1.0% t(115)=-0.71, p=0.47 7.5 0.13 
Male  33.5 ±7.7 35.6  ±6.6 2.1 t(82)=-1.35, p=0.17 7.0 0.29 
Female  23 ±5.0 26 ±5.3 3.0 t(31)=-1.59, p=0.11 5.0 0.59 
VO2peak 
ml/kg/min 
total 31.2 ±8.4 32.5 ±7.7 1.3 t(115)=-0.81, p=0.41 7.9 0.16 
Male  52.9 ±12.8 48.8 ±8.4 4.1 t(82)=1.74, p=0.08 10.5 0.38 
Female  65.0 ±14.1 65.2 ±16.4 0.2 t(29)=-0.04, p=0.96 15.1 0.01 
HDLa 
mg/dL 
total 55.5 ±13.9 53.9 ±13.8 1.6 t(113)=-0.6, p=0.54 13.7 0.11 
Male  225.8 ±58 222.4 ±46.3 -3.4 t(82)=0.3, p=0.76 51.5 0.06 
Female 222.3 ±42 220.6 ±49.2 -1.7 t(29)=0.1, p=0.92 45 0.03 
TCha 
mg/dL 
total 225.1 ±54.6 221.9 ±46.9 3.2 t(113)=-0.34, p=0.73 50.0 0.06 
Male  139.1 ±48.3 142.3 ±44.3 3.2 t(82)=-0.32, p=0.74 45.6 0.07 
Female 135.5 ±35.4 128.6 ±46.2 -6.9 t(29)=0.42, p=0.67 41.3 0.16 
LDLa 
mg/dL 
total 138.3 ±45.6 138.1 ±45.1 0.2 t(113)=-0.02, p=0.97 44.9 0.004 
Male  4.4 ±1.16 4.6 ±1.01 0.2 t(82)=-1.01, p=0.31 1.07 0.18 
Female 3.5 ±1.03 3.5 ±1.0 0.0 t(29)=0.09 p=0.92 0.97 0.0 
TCh/HDLa 
ratio 
total 4.2 ±1.2 4.3 ±1.1 0.1 t(113)=-0.34, p=0.73 1.1 0.08 
Male  169.4 ±128.7 156.3 ±84.2 -13.1 t(82)=0.55, p=0.57 106.3 0.12 
Female 109.2 ±35.7 133.5 ±65.7 24.3 t(29)=-1.1, p=0.26 55.2 0.43 
TGa 
total 156.5 ±117.5 149.2 ±79.1 7.3 t(83.9)=-0.37, p=0.7 97.1 0.07 
BPsysb Male  139 ±13 144 ±17 5 t(79)=-1.29, p=0.2 15 0.33 
 Female  137 ±14 141 ±18 4 t(27)=-0.5, p=0.59 16.3 0.24 
 total 139 ±13 143 ±17 4 t(108)=-1.31, p=0.19 15.2 0.26 
BPdiab Male  83 ±10 85 ±8 2 t(79)=-1.43, p=0.15 8.9 0.22 
 Female  76 ±11 81 ±10 5 t(27)=-1.23, p=0.2 10 0.49 
 total 81 ±10 84 ±9 3 t(108)=-1.52, p=0.12 9.4 0.32 
PROCAMc Male  
N=38/42 
3.49 
(2.41 to 5.05) 
4.66 
(3.63 to 5.98) 
1.33 t(78)=1.33, p=0.18   
 Female  
N=10/18 
0.05 
(0.02 to 0.14) 
0.03 
(0 to 0.08) 
0.6 t(26)=0.79, p=0.4   
 total 
N=48/60 
1.47 
(0.81 to 2.66) 
1.04 
(1.89 to 2.05) 
0.68 t(106)=0.74, p=0.45   
Note: Data are means ± SD unless otherwise noted. 
TCH: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides; VO2peak: peak oxygen 
consumption; BMI: body mass index (kg/m2) BPsys: systolic blood pressure (mmHg); BPdia: diastolic blood pressure (mmHg); 
PROCAM: PROCAM risk score; 
a: number of female participants for whom blood analysis data were available: 31 
b: 81 male and 29 female participants for whom valid blood pressure data were available 
c: means are geometric means, and Δ is the factor between means (after antilog of the log-transformed data); values in 
brackets are 95% CI 
 
Between-group differences in each strata were non significant, with the exception of body 
weight and BMI approaching significance among females in the CFL90 and CFL120 strata.  
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Gender  
The proportion of females was not significantly different between the CFL groups of each CFL 
strata. In the CFL90 strata the proportions were 21.4% (95% CI 6.2 to 36.6) and 30.3% (95% 
CI 20.7 to 39.8) for the CFL- and CFL+ groups respectively, with z=-0.91, p=0.36. In the 
CFL120 strata the proportions were 19.3% (95% CI 5.4 to 33.2) and 31.4% (95% CI 21.5 to 
41.2) for the CFL- and CFL+ groups respectively, with z=-1.27, p=0.2. In the CFL150 strata 
the proportions were 21.5% (95% CI 10.2 to 32.8) and 33.3% (95% CI 21.9 to 44.7) for the 
CFL- and CFL+ groups respectively, with z=-1.4, p=0.16. 
Age 
While the CFL+ groups tended to be older than the CFL-groups the difference remained non-
significant. In an attempt to normalize the distribution, age was log and square transformed 
and t-tests were repeated on each transformation. The between-group differences remained 
non-significant for the total as well as for the gender-specific subgroups.  
Body Weight 
Log-transformation achieved distributions to be not different from normal for all sub-groups.  
t-tests performed on the log-transformed data confirmed the finding of p=0.04 of the between-
group difference for females, with t(31)02.07 p=0.046. The between-group difference for the 
total mixed gender CFL groups became borderline significant with t(115)=2.06, p=0.0416.  
Owing to the small sample sizes it is difficult to refute the hypothesis that body weight at 
baseline is a determinant for intervention adherence to a PA protocol.  
If so, it is reasonable to assume that the degree of overweight, rather than absolute weight 
itself, might correlate with adherence to a PA intervention.  
BMI 
Between-group difference of BMI for the male subjects was small (0.2) and not significant, 
whereas the difference was large and significant in the female subgroup with a difference 
between means of 5 (33.4 vs. 28.4 in the CFL- and CFL+ groups respectively) and p<0.05.  
However, one of the 6 female CFL- participants belonged to the group of 5 physically active 
subjects at follow-up who had failed to meet the latency requirement, but who had reported 
continued PA. This female participant had entered the study with a BMI of 39. To test the 
influence of this subject’s values on the baseline comparison, t-test for significance of 
difference was performed with the data of this subject being reclassified into the female CFL+ 
group. Under these conditions the difference in BMI means was reduced to 3.56 between 
female CFL groups at baseline, and became non-significant with t(31)=1.35, p=0.18.  
These observations suggest that if overweight status at baseline positively correlates with, or 
is a determinant of adherence to a PA intervention, the ELF sample may not have contained 
a sufficient number of individuals with a BMI in excess of the demarcation line, which 
separates the adherent from the non-adherent groups.  
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Body Fat 
As with BMI, differences in percent body fat were small and not significant in the male 
subgroup as well in the total mixed-gender group, with a relatively large, but non-significant 
difference between the female subgroups. The latter remained non-significant after log and 
square-root transformations. 
VO2peak 
There were no significant differences between groups at baseline. The moderate difference 
between the female groups is not significant. 
Blood Lipids 
There were no significant differences between CFL groups. 
Blood Pressure 
The male-only CFL+ group had a higher systolic blood pressure at baseline than the CFL- 
group (144 vs. 136 mmHg) which approached significance. Log transformation did not 
change the significance level with t(79)=2.02, p=0.0465. The difference in mean systolic 
pressure between the mixed gender groups also remained approaching, but not reaching 
significance, with t(108)=1.86, p=0.065 for the log-transformed data.  
PROCAM Score 
The risk score for both mixed-gender CFL groups remained well below the 10% cut-off, which 
is used to arbitrarily dichotomize between low and elevated risk categories. Due to the 
substantial deviation of the distribution from normality, PROCAM risk scores were log 
transformed, after which Shapiro-Wilk tests suggested normality of the distributions for the 
gender-specific sub-groups.  Visual inspection of the histograms and Q-Q plots confirmed 
that, while the distributions were less skewed and closer to normality after log-transformation, 
deviation from normality was still considerable. Independent samples t-tests performed on the 
log-transformed values of the male subgroups approached significance (after consideration of 
the Bonferroni correction) for the difference between the two male CFL groups. Anti-log of the 
log transformed test results produces the geometric means (antilog of the means), the ratio of 
the geometric means (antilog of the difference between the means) and the confidence 
intervals for this ratio (antilog of the CI of the difference). For the male subgroups of the 
CFL90 strata the difference between geometric means of 2.8 and 4.7 for the CFL- and CFL+ 
groups respectively approached significance, with the t(78)=-2.15, p=0.034 two-tailed, 
indicating a ratio of 1.7 for the mean PROCAM risk scores between CFL groups. For the 
CFL120 and CFL150 strata no significance of difference was observed, neither for the 
comparisons of gender-specific subgroups nor of the mixed-gender groups.   
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Comparison with the underlying population 
With the given recruitment strategy the baseline distribution of health parameters in the study 
population may not reflect those of the general population. However, it is essential to know to 
which extent the study findings can be generalized to the underlying population from which 
the subjects had been drawn. In the context of this investigation, the comparison of the 
distribution of health parameters assessed at baseline with their distribution in the underlying 
general population, was expected to answer the question whether and to which degree the 
recruited subjects differed from the general population to which the intervention strategy may 
be applied in future public health efforts. Therefore, an attempt was made to draw 
comparisons between the ELF population and published data for relevant reference 
populations.  
For this purpose the following published data were used to provide the relevant benchmark 
values:  
Comparison with German population data from the MONICA investigation 
The World Health Organization’s  MONICA (Multinational MONItoring of trends and 
determinants in CArdiovascular disease) Project had been established in the early 1980s 
across 21 countries, with 32 MONICA Collaborating Centers (MCC), four of which had been 
set up in Germany [233]). The purpose of the MONICA project was to identify trends in 
cardiovascular disease mortality. Each MCC had been tasked to carry out two or three 
surveys, 5 years apart, of independent random samples drawn from the population of each 
center’s geographic area. Of the 4 German MCCs (Bremen, East Germany, Augsburg and 
Heidelberg), the data of the latest survey performed in the urban Augsburg population was 
selected for comparison with the predominantly urban ELF study population. While the 
Rhein/Neckar population of the Heidelberg MCC was of closer geographic proximity to the 
ELF study population, the Heidelberg MCC had only carried out the initial survey between 
September 1983 and July 1987 whereas for the Augsburg urban population the latest data 
available are from the third survey conducted between October 1994 and July 1995. The age 
range of the surveyed population included those between 25 and 64 years of age, with no 
overlap in the subjects sampled for each survey. All MONICA data, selected for the relevant 
age strata of 45-54 years, are presented together with the ELF equivalents in Table 5a. The 
MONICA data had been gathered through physical examinations and laboratory analysis 
using one single dedicated laboratory. The MONICA data have been published in the form of 
an internet handbook (available at http://www.ktl.fi/publications/monica/surveydb/title.htm).  
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Table 5a:  
Baseline Comparison Of The ELF Sample With The MONICA Study Population 
ELF MONICA AUUa Δ (p)  
value (SD) N value (SD) N  
Male 178.2 (6.4) 84 174.7 (5.5) 212 3.5 p<0.001 Height 
cm 
Female 165.3 (5.1) 33 162.2 (6.2) 217 3.1 p<0.01 
Male 91.3 (13.4) 84 83.5 (11.7) 212 7.8 p<0.001 Weight 
Kg 
Female 80.2 (15.7) 33 70.8 (13.9) 217 9.4 p<0.001 
Male 28.7 (3.6) 84 27.3 (3.5) 212 1.4 p<0.01 BMI 
Kg/m2 
Female 29.3 (5.3) 33 26.9 (5.3) 217 2.4 p<0.05 
Male 50.7 (10.9) 84 47.5 (14.7) 210 3.2 p=0.07 HDL 
mg/dL 
Female 65.1 (15.4) 31 61.5 (17) 210 3.6 p=0.26 
Male 224.1 (51.9) 84 241.3 (47.5) 210 -17.2 p<0.01 TCh 
mg/dL 
Female 221.2 (46.1) 31 235.1 (42.5) 210 -13.9 p=0.09 
Male 23.54 (6.42) 84 20.27 (6.99) 210 3.27 p<0.001 TCh/HDL 
ratio 
Female 30.14 (7.35) 31 26.98 (8.47) 210 3.16 p=0.05 
BPsys (mmHg) Male 141.4 (15.2) 81 137.8 (19.0) 212 3.6 p=0.12 
 Female 139.5 (16.4) 29 133.0 (20.1) 219 6.5 p=0.09 
BPdia (mmHg) Male 84.1 (8.9) 81 86.2 (11.9) 212 2.1 p=0.14 
 Female 79.2 (10.4) 29 82.2 (11.1) 219 3.0 p=0.16 
Note:  
Data are means ± SD unless otherwise noted. 
TCH: total cholesterol; HDL: high-density lipoprotein; BMI: body mass index (kg/m2) BPsys: systolic blood pressure (mmHg); 
BPdia: diastolic blood pressure (mmHg);  
a: Data are taken from the MONICA Study (Multinational MONItoring of trends and determinants in CArdiovascular disease 
MONICA) for the Augsburg urban population third survey conducted between October 1994 and July 1995 and for the age 
strata 45-54 years [233]. 
 
The comparison of baseline values with the MONICA study population suggests that ELF 
subjects are significantly taller than the MONICA population. While body height is of little 
relevance to the study objective, it was nevertheless investigated whether this difference 
might simply reflect a chance finding, or an underlying factor, which may or may not be 
relevant to the comparison of the two populations. The data of the MONICA population had 
been sampled from October 1994 to July 1995 and are therefore approximately 15 years 
older than the data of the ELF study population. Hence, for height, the 15-years younger 
MONICA cohort provides a more appropriate comparison group, as its years of birth coincide 
more closely with those of the ELF subjects. The mean height in the 35-44 MONICA age 
cohort was 176.9 cm and 162.8 cm for men and women respectively. For the men the 
difference of 1.3 cm between the MONICA and ELF samples was non-significant, with 
t(280)=1.50 and p=0.13. For the women the 2.5 cm difference between samples remained 
significant with t(256)=2.2 and p=0.03. These data suggest that there exists a significant 
difference in height between the two female study populations only, a comparison with the 
data published from the latest 2005 German Microcensus, however, does not support this 
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conclusion [293]. For the 45-50 age cohorts, the Microcensus reports mean height for men 
and women of 178 cm and 166 cm respectively, which are almost identical to the mean 
values of the ELF sample. While tests of significance cannot be performed, as no values for 
SD have been published for the Microcensus, the difference in height between the two female 
study populations was attributed to a chance finding with no relevance for this study’ 
objectives and hypotheses.     
That the ELF subjects have a significantly elevated BMI is supported not only by comparison 
with the MONICA study population but also by comparison with the Microcensus publication, 
which reports population mean BMI values of 26.6 and 24.8 for the male and female 45-50 
age cohorts respectively. Despite this elevated body weight status, cholesterol values of the 
ELF population appear marginally better than those reported for the MONICA population. 
With a higher level of HDL cholesterol (50.7 vs. 47.5), a significantly lower level of total 
cholesterol and a significantly lower TCH/HDL ratio, ELF males presented a slightly but 
significantly more favorable lipid profile. Probably due to the small sample size, this finding 
could not be replicated in the female ELF participants, who showed the same trends but 
reaching significance only for TCH and TCH/HDL ratio.  
Blood pressure values were not significantly different between the ELF and the MONICA 
samples, neither for systolic nor for diastolic values.  
 
Comparison with the Finnish Kuopio Ischaemic Heart Disease Risk Factor Study (KIHDS) 
Owing to a lack of published population data on VO2peak values for German population 
groups, available data from the ongoing Kuopio Ischaemic Heart Disease Risk Factor Study 
(KIHDS) were used for comparison purposes [236]. The data are presented in Table 5b. In 
analogy to the MONICA study, the KIHDS investigates risk factors, including parameters of 
physical fitness, and their correlation with atherosclerotic vascular disease. Contrary to the 
MONICA design, the KIHDS is a longitudinal investigation of a representative random sample 
of Finnish men aged between 42 and 60 years at study entry between 1984 and 1989. This 
study provides VO2peak data for 2351 individuals who were grouped according to their CVD 
health status at baseline into a healthy and an unhealthy group of 1294 and 1057 individuals 
respectively.  
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Table 5b:  
Baseline Comparison Of The ELF Sample With The Finnish KIHDS Study Population 
 ELF KIHDSa healthy men KIHDSa unhealthy men 
 (n=84)b (n=1294) Δ (p) (n=1057) Δ (p) 
Age 50.8 (8.0) 51.8 (5.4) -1 p=0.11 54.2 (4.2) -3.4 p<0.001 
BMI 28.7 (3.6) 26.6 (3.4) 2.1 p<0.001 27.1 (3.6) 1.6 p<0.001 
VO2peak ml/kg/min 34.6 (7.2) 32.5 (7.5) 2.1 p<0.05 27.3 (7.6) 7.3 p<0.001 
HDL mg/dL 50.7 (10.9) 50.6 (11.6) 0.1 p=0.9 49.1 (11.9) 1.6 p=0.23 
TCh mg/dL 224.1 (51.9) 226.6 (39.4) -2.5 p=0.5 230.5 (43.3) -6.4 p=0.19 
LDL mg/dL 140.8 (46) 155 (37.5) -14.2 p<0.001 158.2 (41) -17.4 p<0.001 
TG mg/dL 162.5 (107.3) 108.9 (67.3) 53.6 p<0.001 120.4 (77.9) 42.1 p<0.001 
BPsysb 141.4 (15.27) 133.8 (16.1) 7.6 p<0.001 134.4 (17.8) 7.0 p<0.001 
BPdiab 84.1 (8.96) 88.8 (10.4) -4.7 p<0.001 88.9 (10.6) -4.7 p<0.001 
Note:  
TCH: total cholesterol; LDL: low-density lipoprotein; HDL: high-density lipoprotein; TG: Triglycerides; BMI: body mass index 
(kg/m2); VO2peak: peak oxygen consumption;  BPsys: systolic blood pressure (mmHg); BPdia: diastolic blood pressure 
(mmHg);  
 
a: data from the ongoing Kuopio Ischaemic Heart Disease Risk Factor Study (KIHDS) [236]. 
b: Blood pressure values were available for 81 participants of the ELF population;  
 
These data show that the male ELF participants were similarly aged as the healthy Finnish 
men but approximately 3.5 years younger than the unhealthy Finnish cohort. The ELF men 
were significantly more overweight with a BMI of 28.7 vs. 26.6 and 27.1 in the Finnish healthy 
and unhealthy cohorts respectively. Compared with the healthy Finnish cohort VO2peak of 
the ELF men was only marginally (2.1 ml/kg/min) but significantly higher. The difference to 
the unhealthy Finnish men however was in excess of 2 METs (7.3 ml/kg/min).  
Contrary to the comparison with the MONICA population, the TCH and HDL values of the 
ELF men were almost identical to those observed in both Finnish groups, with a significantly 
lower concentration of LDL cholesterol in the ELF men, and a substantially higher 
concentration of TG, the latter possibly reflecting the overweight status of the ELF subjects.  
Systolic blood pressure was significantly higher in the ELF men whereas diastolic blood 
pressure was significantly lower. Both differences were of a magnitude of clinical relevance.  
 
HYPOTHESES TESTING 
Testing for effects between baseline and follow-up shifts the focus from avoiding type II to 
avoiding type I errors. Consequently, all within-group tests for significance of change from 
baseline to follow-up, and for between-group tests of significance of the difference of changes 
were repeated on transformed data when the raw data were found to violate the normality 
assumption. 
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Hypothesis 1: Adherence 
As presented in Table 4a, 89 participants (76%, CI: 68.3% to 83.7%) satisfied all three criteria 
required for being classified as having an operational controlled feedback loop (CFL+) at 
follow-up: 
• latency: last-login not more than 7 days prior to date of follow-up assessment 
• duration: having maintained an active log with weekly logins for 3 or more 
consecutive months (90 days)  
• volume: having recorded 60 minutes or more of weekly high-intensity exercise 
performed in bouts of each 20 minutes or more  
To determine the effect of the latency condition on the parameter of adherence, a comparison 
was made between the proportion of individuals who met the CFL+ conditions and the 
proportion who achieved at least 80% of the prescribed cumulative 25-weeks PA volume of 
1,500 minutes (25 weeks x 60’/week), and irrespective of meeting the latency condition. 
Expressing adherence as a percentage of prescribed exercise volume, and/or dichotomizing 
adherence along an arbitrary %-of-volume cutoff is frequently used in published studies on 
exercise interventions [294-296]. The results of the comparison are presented in Table 6a. 
While the conventional adherence definition yields a higher but not significantly different 
proportion of adherent subjects (82% vs, 76%), it incorrectly identifies the CFL status of 17 
individuals. Of these, 12 subjects who did not meet the latency requirement at the end of the 
intervention would have been identified as adherent, and 5 CFL+ subjects would have been 
identified as non-adherent.   
 
Table 6a:  
Comparison Of Adherence By Definitions Of CFL-Status vs. Exercise Volume 
Adherence Definition    
CFL+ 
N=89 
80% of Volumea 
N=96 
p value for difference Misclassified 
N=17 
0.76 (CI 0.68 – 0.84) 0.82 (CI 0.75 – 0.89) p(z=-1.12) = 0.26  0.14 (CI 0.08 – 0.21) 
a: Proportion of adherent individuals if cut-off for adherence is defined as 80% of prescribed exercise volume  
 
The proportion of CFL+ subjects is significantly better than the 55% (CI 0.39-0.72) adherence 
rate achieved in a comparable worksite intervention, in which 36 out of 73 enrolled individuals 
had been randomized to a 24-weeks PA intervention consisting of 3 weekly 20-minutes high 
intensity aerobic workouts in addition to strength training [235]. The difference in adherence 
was significant, two-tailed, at p(z=2.37)<0.05. 
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Maintaining the latency condition, while simultaneously increasing the volume and duration 
conditions, helps to determine (a) the proportion of individuals who have accumulated a larger 
intervention dose, and (b) whether this dose correlates with an increased health benefit. 
Stratification of participants into CFL+ and CFL- groups based on continuous login records of   
4 and 5 months (120 and 150 days respectively), with latency and volume conditions as 
defined for the 3-months strata, yielded proportions of CFL+ groups of 73.5% and 56.4% 
respectively (see Table 3).  
In this context it was desirable to investigate the actual amount of time spent on exercise vs. 
the specified minimum requirement of 3x20 minutes weekly on interval training. Table 6b 
presents the data as medians and IQR due to the substantial deviation from the normal 
distribution as evidenced in Figure 5. 
Table 6b 
Self-reported Time Spent (Minutes Per Week) In Aerobic Exercise 
 Median IQRa Smallest - Largest 
CFL90 
N=89 
158.8 112.0 to 241.8 60.0 – 528.5 
CFL120 
N=86 
158.8 112.0 to 241.8 60.0 – 464.1 
CFL150 
N=66 
163.1 113.6 to 250.2 67.0 – 464.1 
Note 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months  
a: IQR = Inter-Quartile Range 
 
 
 
Figure 5. Self-reported weekly time spent on exercise by the 89 adherent subjects 
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These data demonstrate that the majority of CFL+ participants spent a substantially larger 
amount of time exercising than what had been prescribed as the minimum of 60’ per week. 
Since the self-reporting technique did not enable participants to differentiate between levels of 
exercise intensity, the calorific equivalent of the reported exercise volume cannot be 
determined.  
 
Hypothesis 2: Peak Oxygen Uptake 
VO2peak values were normally distributed within both CFL groups of each strata.  
Paired samples t-tests were conducted to evaluate whether the participants had increased 
VO2peak significantly from baseline to follow-up. Data of those participants for whom one or 
both tests had to be terminated prematurely, were not considered for analysis.  
The results indicate that the CFL+ participants of all strata increased their cardiopulmonary 
fitness significantly by close to 1 MET, whereas no significant change was observable among 
the CFL- participants. The test results are displayed in Table 7. 
Independent samples t-tests were conducted to evaluate the hypothesis that the mean 
improvement in VO2peak from baseline to follow-up was significantly higher in the CFL+ 
group compared to the CFL- group of each strata. The results indicate that the increase in 
cardiopulmonary fitness observed among the CFL+ participants was significantly different 
from the change of this parameter observed in the corresponding CFL- groups of each strata. 
The results are shown in Table 7.  
 
Table 7 
Change In VO2peak  
 CFL- (non-adherent) CFL+ (adherent)  
 pre post change pre post change 
diff of change* 
(SE) 
CFL90 
(N: 23/73)a 
32.51 
±7.96 
32.09 
±7.92 
-0.42 
NS 
32.8 
±8.1 
36.1 
±9.2 
3.3 
t(72) = 7.13, p<0.001 
3.7 (0.66) 
t(70.27)=-5.67, p<0.001 
CFL120 
(N: 26/70)b 
32.43 
±7.88 
32.62  
±7.91 
0.19 
NS 
32.8 
±8.1 
36.1 
±9.3 
3.2 
t(69)=6.73, p<0.001 
3.0 (0.73) 
t(68.6)=-4.22, p<0.001 
CFL150 
(N: 42/54)c 
32.4 
±8.5 
33.5  
±9.9 
1.1 
NS 
32.9 
±7.6 
36.4 
±8.2 
3.5 
t(53)=6.82, p<0.001 
2.4 (0.79) 
t(88.2)=-3.01, p<0.01 
Note: Data are means ± SD unless otherwise noted. 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months  
* Unequal variances were assumed and Welch’s approximation for estimating degrees of freedom was applied 
a: 23 non-adherent subjects vs. 73 adherent subjects; b: 26 non-adherent subjects vs. 70 adherent subjects;  
c: 42 non-adherent subjects vs. 54 adherent subjects; 
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Improvement in CRF: A True Intervention Effect Or An Arithmetic Artifact? 
VO2peak is conventionally expressed in milliliters of oxygen consumption per minute and per 
kilogram of bodyweight. Hence, any post-weight loss increase in VO2peak could be merely an 
arithmetic artifact without any concomitant real increase of CRF. Since it is a body’s lean 
mass, not its fat content, which delivers the muscular work and power output, the correlation 
of VO2 consumption with lean body mass provides a more adequate value to assess the true 
change in cardiopulmonary fitness. As these values are hardly reported in published 
literature, a comparison with reference populations is currently impossible. However, it is still 
useful to investigate in this study population, whether the measured increase in VO2peak 
represented a true increase in cardiopulmonary fitness or merely an arithmetic artifact of 
weight loss. If the latter was true, there would be no increase in the LBM-based VO2peak 
value. For this purpose the aforementioned calculations were repeated using the modified 
VO2peak value for lean body mass, the latter having been determined by psBIA analysis. In 
the CFL90 strata, CFL+ subjects showed an increase of VO2peak of 5.3 ml/kg/min whereas 
the CFL- participants showed a non-significant decrease of 1.8 ml/kg/min. 
The results for all strata are presented in Table 8, which shows that across all three CFL 
strata, there were no significant changes observed in the CFL- groups, whereas the CFL+ 
participants had significantly increased their VO2peak values. The differences of change 
between groups remained significant for all strata.  
Table 8 
Change Of VO2peak Per Kg Lean Body Mass 
 CFL- (non-adherent) CFL+ (adherent)  
 pre post change pre post change 
diff of change* 
(SE) 
CFL90 
(N: 23/73)a 
85.12 
±14.08 
83.25 
±14.08 
-1.8 
NS 
86.78 
±16.12 
92.10 
±16.53 
5.31 
t(72)=5.11, 
p<0.001 
7.18 (0.90) 
t(94)=-3.59, 
p<0.001 
CFL120 
(N: 26/70)b 
84.82 
±15.01 
84.43 
±15.25 
-0.39 
NS 
86.96 
±15.88 
92.04 
±16.38 
5.07 
t(69)=4.72, 
p<0.001 
5.46 (1.78) 
t(55.1)=-3.06, 
p<0.01 
CFL150 
(N: 42/54)c 
85.16 
±16.13 
85.84 
±17.36 
0.68 
NS 
87.34 
±15.27 
93.19 ±14.9 
5.85 
t(53)=4.64, 
p<0.001 
5.17 (1.75) 
t(93.8)=-3.03, 
p<0.01 
Note: 
Data are means ± SD unless otherwise noted. 
* Unequal variances were assumed and Welch’s approximation for estimating degrees of freedom was applied 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months  
a: 23 non-adherent subjects vs. 73 adherent subjects; b: 26 non-adherent subjects vs. 70 adherent subjects;  
c: 42 non-adherent subjects vs. 54 adherent subjects; 
 
 
The boxplot of the VO2peak values (Figure 6), based on body weight and on LBM, indicated 
that two outliers (VO2peak per body weight) may have influenced the results. These outliers 
represented two highly motivated individuals whose self-imposed training intensity and 
volume exceeded the prescription substantially. To test whether the changes in VO2peak 
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observed intra-group (baseline to follow-up for the CFL+ groups) and inter-group (CFL+ vs. 
CFL- for each strata) remained significant after removal of these outliers, all analyses were 
repeated not considering the data of these two individuals. 
 
 
Figure 6: Change Of Maximal Oxygen Consumption In The CFL90 Strata 
 
After removal of the outliers, changes in VO2peak from baseline to follow-up, though 
marginally attenuated, remained significant in the CFL+ groups of each strata and non-
significant in the CFL- groups. Between-group differences in change of VO2peak, though 
marginally attenuated, remained significant for all 3 strata. As one of the two individuals had 
not met the duration criterion for inclusion in the CFL+ group of the CFL150 strata, the values 
of this individual were removed from the CFL- group of this strata.  
Table 9 displays the results of these analyses, and Figure 7 illustrates the effect of removing 
the outliers from the sample.  
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 105 of 239 
Table 9 
Change Of VO2peak after removal of outliers  
 CFL- (non-adherent) CFL+ (adherent)  
 pre post change pre post change diff of change* 
(SE) 
CFL90 
(N: 23/71)a 
32.51 
±7.96 
32.09 
±7.92 
-0.42 
NS 32.68 ±8.1 
35.71 
±9.02 
3.03 
t(70) = 7.12, 
p<0.001 
3.45 (0.63) 
t(59.98)=-5.44, 
p<0.001 
CFL120 
(N: 26/68)b 
32.43 
±7.88 
32.62  
±7.91 
0.19 
NS 
32.72 
±8.19 
35.67 
±9.11 
2.94 
t(67)=6.68, 
p<0.001 
2.74 (0.69) 
t(59.1)=-3.93, 
p<0.001 
CFL150 
(N: 41/53)c 
32.2 
±8.52 
32.96 
±9.43 
0.76 
NS 
32.98 
±7.76 
36.27 
±8.19 
3.28 
t(52)=6.86, 
p<0.001 
2.5 (0.70) 
t(88.3)=-3.59, 
p<0.001 
Data are means ± SD unless otherwise noted. 
* Unequal variances were assumed and Welch’s approximation for estimating degrees of freedom was applied 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months  
a: 23 non-adherent subjects vs. 71 adherent subjects; b: 26 non-adherent subjects vs. 68 adherent subjects;  
c: 41 non-adherent subjects vs. 53 adherent subjects; 
 
 
 
 
Figure 7: Change Of Maximal Oxygen Consumption In The CFL90 Strata w/o Outliers 
 
Addressing the Issue of Gender Specific Differences in CRF  
The evaluation of cardiopulmonary fitness in mixed-gender groups may be affected by gender 
specific differences in muscle fiber composition and muscle mass. These differences are 
typically reflected in lower mean values of VO2peak in women, when VO2peak is expressed in 
minute oxygen consumption per kg body weight. Compared to men, women have a larger 
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proportion of fat mass and consequently a smaller proportion of muscle mass, which partly 
explains the lower VO2peak values in females.   
Figure 8 displays the boxplots for VO2peak based on body weight as well as on LBM at 
baseline by gender. Visual inspection suggests that the gender difference in VO2peak is 
attenuated when the latter is calculated based on LBM rather than on body weight. While the 
between-gender difference remains significant (see Table 10), Cohen’s d, as a measure of 
effect size, is dramatically lower in the LBM-based VO2peak calculation. This observation 
suggests that, when evaluating intervention effects on cardiopulmonary fitness as the 
dependent variable in mixed-gender samples with insufficiently sized gender-specific sub-
groups, using lean body mass as the reference base for the calculation of VO2peak may be 
preferable to the conventionally used base of total body weight.  
 
Table 10 
Peak Oxygen Consumption In Relation To Body Weight And Lean Body Mass 
 male (N=72) female (N=29) difference Cohen’s d 
VO2peak by body weight 35.41 ±6.85 25.35 ±5.40 10.05 
t(99)=7.05, p<0.001 
1.56 
VO2peak by lean body mass 88.45 ±15.53 81.14 ±13.76 7.30 
t(99)=2.20, p<0.05 
0.49 
Note: Values for all participants with valid peak oxygen consumption data from tests at baseline to volitional exhaustion 
 
 
 
Figure 8. Gender comparison of peak Oxygen consumption by body weight and lean body mass 
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Intervention Effect on VO2peak expressed as Percent of Normal Values 
To eliminate the gender specific differences from the evaluation of intervention effects on 
VO2peak, the latter was expressed as a percentage of gender- and age-specific normal 
values. The formula, published and validated by Cooper et al. [297], were used for this 
analysis. 
 
Equation 7: 
€ 
VO2 max(men) = 50.02 − 0.394 × age( )ml /kg /min
VO2max(women) = 42.83 − (0.371× age)ml /kg /min
 
 
Independent-samples t-tests were conducted to evaluate whether CFL+ and CFL- groups 
differed significantly at baseline when expressing cardiopulmonary fitness as a percentage of 
the age and gender based normal values. Again, the data of those participants for whom one 
or both tests had to be terminated prematurely, were not considered for analysis.  
Shapiro-Wilk tests confirmed normality of the distributions of VO2peak as a percentage of 
normal values for all CFL groups in each strata and at baseline and follow-up.  
The results of the independent samples t-tests are presented in Table 11. 
 
Table 11. 
Baseline Comparison Of VO2peak Expressed As Percent Of Age And Gender Specific Normal Values. 
 CFL- (non-adherent) 
VO2peak 
as % of normal value (SD) 
CFL+ (adherent) 
VO2peak 
as % of normal value (SD) 
difference 
 
p-value, 
two-tailed 
CFL90 strataa 109.29 (19.52) 115.09 (21.88) 5.8 0.25 
CFL120 stratab 109.77 (20.96) 115.15 (21.5) 5.38 0.27 
CFL150 stratac 112.06 (21.38) 114.97 (21.49) 2.91 0.51 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
a: 23 non-adherent subjects vs. 73 adherent subjects; b: 26 non-adherent subjects vs. 70 adherent subjects;  
c: 42 non-adherent subjects vs. 54 adherent subjects; 
 
While the CFL+ groups tended to be slightly fitter, the differences between mean values of 
VO2peak, the latter being expressed as % of normal values, were not significant. 
Subsequently, paired samples t-tests were conducted to evaluate whether the participants 
had increased VO2peak, expressed as percent of normal values, significantly from baseline 
to follow-up. Independent samples t-tests were conducted to investigate the significance of 
inter-group differences of these changes from baseline to follow-up. The results of the 
analyses are presented in Table 12 and Figure 9.    
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Table 12 
Change in VO2peak (expressed as percent of normal value) from baseline to follow-up 
 CFL- (non-adherent) CFL+ (adherent)  
 Mean (SD) 95% CI Mean (SD) 95% CI p-value 
CFL90 -1.33 (7.74) -4.68 to 2.0 11.60 (13.89) 8.36 to 14.84 <0.001 
CFL120 0.83 (9.55) -3.02 to 4.69 11.35 (14.12) 7.98 to 14.71 <0.001 
CFL150 3.42 (13.28) -0.72 to 7.58 12.44 (12.98) 8.9 to 15.99 <0.001 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
a: 23 non-adherent subjects vs. 73 adherent subjects; b: 26 non-adherent subjects vs. 70 adherent subjects;  
c: 42 non-adherent subjects vs. 54 adherent subjects 
 
 
 
Figure 9. Relative Change of VO2peak From Baseline To Follow-Up For All Strata 
 
With no significant differences between CFL groups at baseline, the group of actively self-
monitoring participants witnessed a mean increase in VO2peak (expressed as a percentage 
of age and gender predicted normal values) of close to 12 %, whereas no significant change 
of VO2peak increase was observed in the CFL-groups of the CFL90 and CFL 120 strata. The 
CFL- group of the CFL150 strata witnessed a 4.3% increase which was borderline significant 
at p=0.046. This reflects the inclusion of participants into this strata’s CFL- group, who are 
considered actively self-monitoring in the CFL90 strata but who had not met the duration 
criterion of the CFL150 strata for inclusion into the strata’s CFL+ group. These individuals’ 
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improvements of cardiorespiratory fitness increased the group mean of the CFL- group in this 
strata.  
A two-way contingency table analysis was conducted to evaluate the odds ratio of improving 
cardiorespiratory fitness to a clinically relevant degree between the two CFL± groups within 
each strata. The two variables were improvement of CRF (dichotomized to < or ≥ 3.5 ml 
O2/min/kg of body weight) and CFL status (CFL+ or CFL-). Table 13 presents the results. 
While 32 of the 73 CFL+ participants had increased the CRF by at least 3.5 ml O2/min/kg, 
none of the CFL- participants had achieved such increase. As none of the expected cell 
frequencies was less than 5, results of the chi-squared test were accepted for the evaluation 
of significance of differences. CFL status and CRF improvement in excess of 3.5ml O2/min/kg 
were found to be significantly related, Pearson χ2 (1, N=96)=15.12, p<0.001. As none of the 
CFL- participants had achieved the CRF increase, the odds ratio was not calculated.  
 
Table 13. 
Odds Ratio For Change Of VO2peak by ≥ 1 MET or < 1MET And By CFL Group 
 CFL- 
(non-adherent) 
CFL+ 
(adherent) 
p value OR 95% CI 
CFL90 (N: 23/73) 0 (0 of 23) 43.8% (32 of 73)    
CFL120 (N: 26/70 11.5% (3 of 26) 41.4% (29 of 70) p<0.01 5.42 1.48 to 19.77 
CFL150 (N: 42/54) 19.0% (8 of 42) 44.4% (24 of 54) p<0.01 3.4 1.32 to 8.69 
Note: 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
a: 23 non-adherent subjects vs. 73 adherent subjects; b: 26 non-adherent subjects vs. 70 adherent subjects;  
c: 42 non-adherent subjects vs. 54 adherent subjects; 
 
Hypothesis 3: Body Weight Status 
Inspection of the anthropometric and body composition parameters for normality, using 
Shapiro-Wilk tests, histograms and Q-Q plots, confirmed normal distributions for BMI and 
body weight, and minor deviations from normality for body fat at follow-up.  
Figure 10 shows the box plots of BMI values (at baseline and at follow-up) for participants 
with baseline BMI ≥ 25 for the CFL90 strata. Visual inspection suggests a reduction in BMI in 
the CFL+ group compared to no reduction in the CFL- group.  
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Figure 10. BMI At Baseline And Follow-Up By CFL Group 
 
Figure 11 displays the box plots for BMI change in the CFL90 strata. As was the case for 
VO2peak, outliers affected the distribution, which deviated from normal in the CFL+ groups.   
Removal of the three outliers for BMI change normalized the distribution of weight change, 
BMI change and fat change in all groups of all strata. The outliers represent two individuals 
who had reduced their BMI by 4.8 points and one individual who had reduced his BMI by 9.8 
points. Two of these three outliers represent the same two individuals mentioned in the 
discussion of VO2peak analysis.   
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Figure 11. BMI Change By CFL Group 
 
 
Paired samples t-tests were conducted for both CFL groups of each CFL strata to evaluate 
whether the participants had decreased body weight, body fat and BMI from baseline to 
follow-up. Table 14 demonstrates that the changes in body weight, BMI and body fat were 
significant for all CFL groups within each strata, with the CFL+ groups witnessing a 
substantially larger decrease for all three variables.  
Independent-sample t-tests, conducted under the assumption of equal variances (Levene’s 
tests for equality of variances were non-significant for all three variables of change), 
confirmed the hypothesis that the between-group differences were significant. The results for 
changes in body weight, BMI and body fat are presented Table 14. 
To test whether the between-group changes in body weight and fat and BMI remained 
significant after removal of the three outliers, all analyses were repeated for the CFL90 strata 
not considering the data of these three individuals. The results are presented in Table 15. 
After removal of the outliers, between-group changes in BMI, body fat and weight, though 
marginally attenuated, remained significant favoring the hypothesis of significant differences 
between CFL groups.  
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Table 14:  
Parameters Of Body Weight Status (for subjects with baseline BMI ≥ 25) 
 CFL- (inactive) CFL+ (active)  
Body 
Weight (kg) pre post change pre post change 
diff of change* 
(SE) 
CFL90 
(N: 24/73)a 
94.1 
±13.6 
92.6 
±12.1 
-1.5 
t(23)=-2.75, 
p<0.05 
90.8 
±13.0 
86.5 
±12.4 
-4.3  
t(72)=-7.33, 
p<0.001 
2.8 (0.8) 
t(76.8)=3.4, 
p<0.01 
CFL120 
(N: 27/70)b 
94.4 
±13.7 
92.5 
±11.8 
-1.9 
t(26)=-3.11, 
p<0.001 
90.5 
±12.9 
86.2 
±12.4 
-4.3  
t(69)=-7.11, 
p<0.001 
2.4 (0.8) 
t(77.5)=2.8, 
p<0.01 
CFL150 
(N: 43/54)c 
93.4 
±13.2 
91.0 
±12.1 
-2.4 
t(42)=-4.25, 
p<0.001 
90.1 
±13.1 
85.5 
±12.4 
-4.6 
t(53)=-6.48, 
p<0.001 
2.2 (0.9) 
t(95.7)=2.4, 
p<0.05 
BMI (kg/m2)        
CFL90 
(N: 24/73)a 
30.3 
±4.3 
29.9 
±3.9 
-0.4 
t(23)=2.53, 
p<0.05 
29.7 
±3.4 
28.3 
±3.3 
-1.4 
t(72)=-7.33, 
p<0.001 
0.9 (0.2) 
t(77)=3.59, 
p<0.001 
CFL120 
(N: 27/70)b 
30.4 
±4.2 
29.8 
±3.8 
-0.6 
t(26)=-2.9, 
p<0.05 
29.7 
±3.3 
28.3 
±3.3 
-1.4 
t(69)=-7.12, 
p<0.001 
0.8 (0.2) 
t(79.3)=3.01, 
p<0.01 
CFL150 
(N: 43/54)c 
30.0 
±3.7 
29.3 
±3.5 
-0.7 
t(42)=-4.2, 
p<0.001 
29.8 
±3.6 
28.3 
±3.4 
-1.5 
t(53)=-6.45, 
p<0.001 
0.8 (0.3) 
t(94.3)=2.62, 
p<0.05 
Body Fat 
(kg) 
      
 
CFL90 
(N: 24/73)a 
28.6 
±10.0 
27.4 
±9.1 
-1.2 
t(23)=-2.75, 
p<0.05 
27.3 
±8.1 
24.0 
±8.2 
-3.3 
t(72)=-7.42, 
p<0.001 
2.1 (0.6) 
t(73.2)=3.3, 
p<0.01 
CFL120 
(N: 27/70)b 
28.3 
±10.0 
26.8 
±9.0 
-1.5 
t(26)=-3.11, 
p<0.01 
27.4 
±8.0 
24.1 
±8.3 
-3.3 
t(69)=-7.19, 
p<0.001 
1.7 (0.6) 
t(73.8)=2.6, 
p<0.01 
CFL150 
(N: 43/54)c 
28.2 
±9.3 
26.4 
±8.8 
-1.8 
t(42)=-4.4, 
p<0.001 
27.2 
±8.1 
23.7 
±8.1 
-3.5 
t(53)=-6.5, 
p<0.001 
1.6 (0.6) 
t(95.2)=2.4, 
p<0.05 
Note: 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
BMI: body mass index (kg/m2) 
a: 24 inactive subjects vs. 73 active subjects; b: 27 inactive subjects vs. 70 active subjects; c: 43 inactive subjects vs. 54 active subjects; 
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Table 15 
Absolute Changes Of Body Weight Status By CFL Group (for subjects with baseline BMI ≥25)  
With and W/O Outliers. 
 CFL- (non-adherent) CFL+ (adherent) difference 
 Mean (SD) 95% CI Mean (SD) 95% CI Mean (SE) 
p-value 
(two-tailed) 
BMI (kg/m2)       
CFL90 
(N: 24/73)a 
-1.4 (1.64) -1.79 to -1.02 0.95 (0.35) 
p<0.01 
t(95)=2.7 
CFL90 w/o outliers 
(24/70) 
-0.45 (0.88) -0.83 to -0.08 
-1.19 (1.17) -1.47 to -0.9 0.73 (0.26) 
p<0.01 
t(92)=2.78 
CFL120 
(N: 27/70)b 
-0.57 (1.01) -0.97 to -0.17 -1.4 (1.65) -1.79 to -1.01 0.83 (0.34) 
p<0.05 
t(95)=2.45 
CFL150 
(N: 43/54)c 
-0.74 (1.15) -1.1 to -0.38 -1.5 (1.72) -1.98 to -1.04 0.77 (0.30) 
p<0.05 
t(95)=2.51 
Body Weight (Kg)       
CFL90 
(N: 24/73)a 
-4.32 (5.04) -4.58 to -2.68 2.78 (1.08) 
p<0.05 
t(95)=2.58 
CFL90 w/o outliers 
(N: 24/70) 
-1.53 (2.73) -2.69 to -0.38 
-3.65 (3.67) -4.53 to -2.77 2.11 (0.82) 
p<0.05 
t(92)=2.58 
CFL120 
(N: 27/70)b 
-1.90 (3.17) -3.16 to -0.64 -4.30 (5.06) -5.51 to -3.09 2.4 (1.04) 
p<0.05 
t(95)=2.29 
CFL150 
(N: 43/54)c 
-2.41 (3.71) -3.55 to -1.26 -4.66 (5.22) -6.03 to -3.18 2.19 (0.94) 
p<0.05 
t(95)=2.32 
Body Fat (Kg)       
CFL90 
(N: 24/73)a 
-3.28 (3.77) -4.16 to -2.4 2.07 (0.81) 
p<0.05 
t(95)=2.55 
CFL90 w/o outliers 
(N: 24/70) 
-1.20 (2.15) -2.11 to -0.29 
-2.77 (2.70) -3.41 to -2.12 1.56 (0.61) 
p<0.05 
t(92)=2.55 
CFL120 
(N: 27/70)b 
-1.50 (2.50) -2.49 to -0.51 -3.25 (3.78) -4.15 to -2.35 1.75 (0.78) 
p<0.05 
t(95)=2.22 
CFL150 
(N: 43/54)c 
-1.84 (2.75) -2.69 to -1.0 -3.50 (3.95) -4.58 to -2.42 1.65 (0.70) 
p<0.05 
t(95)=2.32 
Note: 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
BMI: body mass index (kg/m2) 
a: 24 inactive subjects vs. 73 active subjects; b: 27 inactive subjects vs. 70 active subjects; c: 43 inactive subjects vs. 54 active subjects; 
 
Contribution of Body Fat to Weight Loss 
Body fat is the target tissue of body weight reduction efforts, which ideally maintain lean body 
mass. It is therefore desirable to investigate whether those participants, who had lost a 
clinically relevant amount of body weight, had achieved this weight reduction primarily 
through loss of body fat. The minimum amount of body weight reduction was set at 4 kg or 
more, based on published evidence that this amount of weight loss generated measurable 
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reductions of blood pressure [298, 299] and blood lipids [300]. For the 41 participants who 
met this weight loss criterion, the mean proportion of fat loss of the total weight loss in this 
sample was 76.3% (SD= 16.09%, 95% CI 71.8% to 82.0%).  
This 76.3% contribution of fat loss to overall weight loss is not significantly different from the 
published 80% observed in a 3-months energy-deficit controlled exercise intervention among 
16 obese (mean BMI and body weight of 32.3 and 101.5 kg respectively) men [301]. One-
sample t-test was not significant with t(40)=-1.6, p=0.11. 
Figure 12 was created to illustrate the relative proportion of fat from total weight loss in a 
clinically interesting subgroup of the 28 CFL+ participants who had entered the study with a 
BMI of 30 or greater. Each pair of bars represents the weight and fat change (in kg) of one 
participant. This chart illustrates, that loss of body fat was the predominant cause of the 
overall weight loss in almost all weight-reducing individuals. 
 
 
Figure 12. Contribution of body fat to weight loss 
 
A two-way contingency table analysis was conducted to evaluate whether weight loss of a 
clinically relevant degree was different between the two CFL groups within each strata. The 
two variables were weight loss (dichotomized to < or ≥ 5% of body weight at baseline) and 
CFL status (CFL+ or CFL-). As none of the expected cell frequencies was less than 5, results 
of the chi-squared test were accepted for the evaluation of significance of differences. CFL 
status and weight loss in excess of 5% body weight were found to be significantly related, 
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Pearson χ2 (1, N=115)=9.37, p<0.01. Follow-up logistic regression was conducted to 
determine the 95% confidence interval of the odds ratio. The results are presented in Table 
16.  
 
Table 16. 
Odds Ratio For Change Of Body Weight by ≥ 5% or < 5% And By CFL Group 
 CFL-  
(non-adherent) 
CFL+ 
(adherent) 
p value OR 95% CI 
CFL90 8.3% (2 of 24) 42.4% (31 of 73) p<0.01 8.11 1.77 to 37.12 
CFL120 14.8% (4 of 27) 41.4% (29 of 70) p<0.05 4.06 1.27 to 13.01 
CFL150 20.9% (9 of 43) 44.4% (24 of 54) p<0.05 3.02 1.21 to 7.5 
Note: 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
 
 
Hypothesis 4: Cardiovascular Risk Factors 
Lipids 
The results for the within- and between-group evaluations of intervention effects on the lipid 
outcome parameters are presented in Tables 17a & b and explained subsequently. 
Table 17a.  
Changes of Cholesterol Fractions 
 CFL- (non-adherent) CFL+ (adherent) CFL- vs. CFL+ 
 pre post change pre post 
change (95% CI) 
p  one-tailed 
diff of change (95% CI) 
p  one-tailed 
TCH  
alla 
225.9  
(54.4) 
228.4  
(56.2) 
2.5 
NS 
223.9 
(49.1) 
215 
(46.0) 
-8.9 (-3.8 to -14.0) 
t(86)=3.5, p<0.001 
-11.5 (-22.5 to -0.5) 
t(108)=-2.0, p=0.02 
≥ 200 
mg/dlb 
247.7 
(44.2) 
250.1 
(46.7) 
2.4 
NS 
241.3 
(39.3) 
229.7 
(39.3) 
-11.5 (-5.3 to -17.7) 
t(66)=3.7, p<0.001 
-13.9 (-0.1 to -27.8) 
t(82)=-2.0, p=0.02 
        
HDL  
allc 
57.2 
(16.3) 
55.8 
(15.5) 
-1.3 
NS 
54.4 
(12.9) 
55.4 
(12.0) 
0.9 
NS 
2.2 (-0.96 to 5.5) 
t(109)=1.3, p=0.08 
malesd 
54.5 
(15.1) 
53.6 
(15.2) 
-0.8 
NS 
50.1 
(9.1) 
52.4 
(9.9) 
2.3 (0.6 to 4.0) 
t(61)=2.6, p<0.01 
3.2 (-0.3 to 6.7) 
t(78)=1.7, p=0.038 
        
TCH/HDL 
alle 
4.1 
(1.1) 
4.2 
(1.2) 
0.1 
NS 
4.2 
(1.1) 
4.0 
(1.0) 
-0.2 (-0.1 to -0.3) 
t(86)=3.6, p<0.001 
-0.3 (-0.06 to -0.6) 
t(108)=2.4, p<0.01 
> 4f 
5.0 
(0.8) 
5.1 
(0.9) 
0.1 
NS 
5.0 
(0.8) 
4.6 
(0.9) 
-0.4 (-0.2 to -0.6) 
t(50)=4.5, p<0.001 
-0.5 (-0.07 to -0.9) 
t(61)=2.3, p=0.01 
        
LDL 
allg 
141.9 
(48.7) 
145.4 
(46.7) 
3.5 
NS 
138.4 
(44.5) 
133.2 
(41.8) 
-5.2 (-0.1 to -10) 
t(86)=2.0, p=0.02 
-8.7 (1.9 to -19.2) 
t(108)=1.6, p=0.05 
malesh 
142.6 
(52.1) 
148.1 
(51.0) 
5.5 
NS 
142.3 
(44.5) 
136.8 
(40.8) 
-5.5 (0.8 to -11.9) 
t(61)=1.7, p=0.04 
-11.0 (1.7 to -23.8) 
t(78)=1.7, p=0.04 
        
a – for all subjects with valid baseline and follow-up data on TCH; 23 inactive subjects vs. 87 active subjects 
b – for all subjects with baseline TCH >=200 mg/dL; 17 inactive subjects vs. 67 active subjects 
c - for all subjects with valid baseline and follow-up data on HDL; 24 inactive subjects vs. 87 active subjects 
d – for all male subjects; 18 inactive subjects vs. 62 active subjects 
e – for all subjects with valid data for TCH & HDL at baseline & follow-up; 23 inactive subjects vs. 87 active subjects 
f - for all subjects with baseline TCH/HDL ratio >4; 12 inactive subjects vs. 51 active subjects 
g– for all subjects with valid baseline and follow-up data on LDL; 23 inactive subjects vs. 87 active subjects 
h – for all male subjects; 18 inactive subjects vs. 62 active subjects 
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Total Cholesterol  
Shapiro-Wilk tests suggested normal distributions at baseline and at follow-up except for a 
minor deviation in the CFL+ group at baseline. Visual inspection of the histograms and Q-Q 
plots confirmed the deviation to be minor. Log transformation did marginally improve the 
normality of the baseline distribution in the CFL+ group, but introduced non-normality in the 
follow-up distribution. Consequently all analyses were performed as parametric tests on the 
untransformed raw data. The results for the within- and between-group changes are 
presented in Table 17a. While TCH remained virtually unchanged in the CFL- group, with a 
non-significant increase of 2.5 mg/dl from a baseline value of 226 mg/dl, the CFL+ group 
witnessed a reduction of TCH by 9 mg/dl from a baseline value of 224 mg/dl to 215 mg/dl, 
which was highly significant with t(86)=3.5, p<0.001. 
Performing the same analysis not including the 12 participants who had reported taking 
cholesterol lowering medication at baseline did not alter the results substantially, with a non-
significant increase of 0.9mg/dl in the CFL- group and a significant decrease of 10.7 mg/dl in 
the CFL+ group. The latter was highly significant, with t(78)=4.0, p<0.001. 
To investigate whether there was a differential effect of the intervention on those participants 
whose TCH concentration was equal to or in excess of a 200 mg/dl threshold at baseline, the 
analysis was repeated for all participants whose baseline TCH values were ≥ 200 mg/dl, 
regardless of medication status. Again, the CFL- group witnessed a non-significant marginal 
increase of 2.4 mg/dl from a baseline value of 247.7 mg/dl, whereas the CFL+ group 
experienced a significant reduction of 11.7 mg/dl from a baseline value of 241.4 mg/dl, with 
t(66)=3.7, p<0.001.  
Independent-samples t-test was used to test for the between-group difference, performed on 
the data of all participants irrespective of medication status. The one-tailed t-test returned 
significance of the between-group difference of change, with t(108)=-2.0, p=0.02. 
These indicate a small, but significant, reduction of TCH in the CFL+ group.  
 
HDL Cholesterol 
Shapiro-Wilk tests and visual inspection of the histograms and Q-Q plots suggested normal 
distributions for the CFL- group at baseline and at follow-up, but strong deviations from 
normality in the CFL+ group. Log transformation restored normality to the distribution of HDL 
in the CFL+ group at baseline and at follow-up. To investigate whether the data of female 
outliers affected the distribution, the normality tests were repeated on the untransformed data 
for male participants, for whom the data were found to be normally distributed in both CFL 
groups at baseline and at follow-up.  
Since the hypothesis was not gender specific, tests for significance of changes from baseline 
to follow-up were first performed using paired-samples t-tests on the log-transformed data of 
all participants, followed by the same tests performed on the raw data. All tests remained 
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non-significant, for the 1.3 mg/dl reduction from a baseline level of 57.2 mg/dl HDL in the 
CFL- group, and the 0.9 mg/dl increase in the CFL+ group from a baseline concentration of 
54.4 mg/dl.  
Paired samples t-tests performed on the male-only data showed a significant increase of HDL 
of 2.3 mg/dl from a baseline concentration of 50.1 mg/dl in the CFL+ group, with t(61)=2.6, 
p<0.01 two-tailed. A small but non-significant reduction of HDL was evident in the CFL- 
group. Considering the Bonferroni adjustment for additionally testing on gender strata, the 
independent-samples t-test for significance of the between-group difference of the changes of 
3.2 mg/dl approached significance one-tailed, with t(78)=-1.78, p=0.038 vs. a Bonferroni 
adjusted significance level of p=0.025. 
No significance of difference was found between groups when the same analyses were 
performed excluding participants with a baseline HDL concentration ≥ 60 mg/dl, neither for 
the male-only subgroup nor for the mixed-gender groups. 
Taken together, these data indicate a small and significant increase of HDL in the male CFL+ 
group.  
 
TCH/HDL ratio 
Shapiro-Wilk tests and visual inspection of the histograms and Q-Q plots suggested normal 
distribution of the TCH/HDL ratio data at baseline and at follow-up in both CFL strata.  
Testing for significance of difference between baseline and follow-up showed a non-
significant 0.1 increase of the ratio, from 4.1 to 4.2, in the CFL- group. The decrease of the 
ratio from 4.2 to 4.0 in the CFL+ group was significant, with t(86)=3.6, p<0.001. 
The combined between-group difference of 0.3 was significant two-tailed, with t(108)=2.4, 
p=0.01.  
Repeating the tests on the data of those participants who had entered the study with a 
baseline ratio >4, yielded a 0.4 reduction of the ratio in the CFL+ group, which was significant 
with t(50)=4.5, p<0.001. The change of ratio observed in the CFL- group remained a non-
significant 0.1 increase. The between group difference of 0.5 was significant, two-tailed with 
t(61)=2.3, p=0.02. 
These results indicate an improvement of TCH-HDL ratio in the CFL+ group.  
 
LDL Cholesterol 
Shapiro-Wilk tests and visual inspection of the histograms and Q-Q plots suggested normal 
distributions for the CFL- group at baseline and at follow-up, but strong deviations from 
normality in the CFL+ group. Log transformation failed to restore normality in the CFL+ group 
at baseline and at follow-up. Similarly to the observations of HDL, the distributions were 
normal in the male-only subgroup of participants. Consequently, parametric tests of 
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significance for within-group and between-group differences were first performed on the data 
of all participants, and repeated for the male participants only. 
Paired-sample t-tests showed a non-significant increase of 3.5mg/dl of LDL in the CFL- group 
and a decrease of 5.1 mg/dl in the CFL+ group, which was significant one-tailed, with 
t(86)=2.0, p=0.02. The between-group difference of 8.6 mg/dl approached one-tailed 
significance, with t(108)=1.6, p=0.5. 
Repeating the test for the males only showed a non-significant 5mg/dl increase of LDL from a 
baseline concentration of 142 mg/dl in the CFL- group and a significant decrease of equal 
magnitude in the CFL+ group, with t(61)=1.7, p=0.04 (one-tailed). The between-group 
difference approached one-tailed significance, given the Bonferroni adjusted significance 
value of 0.025, with t(78)=1.7, p=0.04. 
Taken together, these data suggest a trivial effect on LDL concentration. 
 
Triglycerides 
Inspection for normality of the distribution, using Shapiro-Wilk tests and visual inspections of 
the histograms revealed substantial right-skewing, leading to severe violation of the normality 
assumption. Log-transformation established normality at baseline and at follow-up in both 
groups. Therefore, means for TG are presented in Table 17b as geometric means (resulting 
from antilog of the means of the log-transformed data). For the CFL- group, the within-group 
factor between geometric means of 0.96, representing an absolute difference of 4.9 mg/dl, is 
not significant. In the CFL+ group the reduction of TG by a factor of 0.84 represented a 
negative difference in geometric means of 20.6 mg/dl, which was highly significant two-tailed, 
with t(86)=3.9 and p<0.001.  
To illustrate the effects, expressed in the untransformed data, Table 17b presents the results 
of the significance tests performed on the the raw data and after log-transformation.  
The between group difference, though approaching one-tailed significance, remained non 
significant, with t(109)=1.3 and t(109)=1.4 for the analysis performed on log-transformed and 
on raw data respectively, with p=0.08 for both cases. 
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Table 17b. 
Within- and Between-Group changes of Triglycerides  
 Significance Tests for log-transformed data Significance Tests for raw data 
 Baselinea 
Mean (95% CI) 
Follow-Upa 
Mean (95% CI) 
Δ 
(factor) 
p* 
Baselineb 
Mean (95% CI) 
Follow-Upb 
Mean (95% CI) 
Δ p** 
CFL- 
N=24 
118.7 mg/dl 
(96.4 - 146.2) 
113.8 mg/dl 
(90.7 – 142.8) 
0.96 NS 
132.6 mg/dl 
(106.7 - 158.4) 
133.4 mg/dl 
(94.5 - 172.4) 
0.8 NS 
CFL+ 
N=87 
132.3 mg/dl 
(117.8 – 148.6) 
111.7 mg/dl 
(99.3 – 125.6) 
0.84 <0.001 
155.2 mg/dl 
(132.9 - 177.5) 
131.5 mg/dl 
(111.7 - 151.4) 
-23.7 <0.01 
CFL+ vs. 
CFL- 
  1.14 0.08  
24.5 
(-9.8 - 58.8) 
 0.08 
Note: 
CFL+ = adherent subjects; CFL- = non-adherent subjects 
a: geometric mean resulting from antilog of the t-tests on log-transformed data 
b. arithmetic mean 
* p-values for paired-samples t-test on log-transformed data 
** p-values for paired-samples t-test on raw data 
 
 
While these observations indicate a triglyceride lowering effect in the CFL+ group, a 
significant between-group difference could not be confirmed, which is potentially due to the 
small sample size given the relatively large variance for this lipid parameter. 
 
Interim Summary on Lipids 
Summarizing the above, the inspection of intervention effects on the lipid parameters 
confirms a significant and clinically relevant within- and between-group reduction of TCH and 
TCH/HDL ratio.  
While a borderline significant reduction for LDL was observed, the magnitude of the effect 
appears to remain trivial and clinically irrelevant. The TG-lowering effect of the intervention, 
though apparent in the CFL+ group, remains inconclusive as the between-group difference 
did not reach statistical significance.   
 
The Issue of Intra-Subject Variances 
The relatively moderate improvements of lipid parameters have to be viewed in the context of 
intra-individual variances which were assessed in 61 individuals, randomly selected at 
baseline for repeated measurement of blood lipids, with a period of 7-10 days between 
measurements and no change of lifestyle during that period. The results are presented in 
Table 18 and compared with those of a similar investigation performed by Marcovina et al. in 
20 subjects (50% female) [259].  
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Table 18. 
Variability of Lipid Parameters at Baseline 
 mean 
(mg/dL) 
CV, % CV, % Percentiles 
   5 25 50 75 95 Range 
TCH Marcovina* 186 6.7 2.2 4.1 5.3 7.9 10.5 1.7 – 11.6 
TCH 220 4.7 0.3 1.4 4.2 7.0 10.3 0.3 – 18.1 
TG Marcovina* 98 28.3 6.4 12.2 19.1 29.2 57.6 5.3 – 74.0 
TG 136 16.8 0 8.8 15.5 23.8 34.6 0 – 58.6 
LDL Marcovina* 115 9.3 2.5 4.6 8.3 11.4 14.1 2.0 – 15.3 
LDL 137 6.8 0.8 3.2 5.8 10.0 19.0 0 – 20.1 
HDL Marcovina* 51 7.6 2.6 4.2 6.5 8.4 12.5 2.2 – 13.7 
HDL 56 4.6 1.0 1.7 4.2 6.6 11.1 0 – 11.8 
TCH/HDL 4.1 4.8 0.7 1.7 4.0 6.5 12.3 0.03 – 18.9 
Note:  
Values from Marcovina et al (total variability) [259]; values in bold print are values of the ELF sample 
TCH: total cholesterol; HDL: high-density lipoprotein; LDL: low-density lipoprotein; TG: triglycerides; CV: coefficient of variation 
 
The variability in the ELF sample is somewhat less severe than the one observed by 
Marcovina et al. These differences in variability have to be viewed in the context of 
methodological differences between the studies. Marcovina et al. used 4 blood samplings 
performed at 2-week intervals between samplings. Considering the results of both 
investigations, it makes intuitive sense to demarcate parameter changes from baseline to 
follow-up along an intra-individual threshold of 10% for a change of parameter to be 
considered clinically relevant. Consequently, participants were dichotomized into successes 
and failures depending on having or not having improved their baseline lipid values through a 
10% reduction (TCH, LDL, TG, TCH/HDL ratio) or increase (HDL) at follow-up.  
Two-way contingency table analysis was conducted to evaluate whether the number of 
participants with a clinically relevant improvement of lipid values was different between the 
two CFL± groups. The two variables for each table were those of Tables 17a&b 
(dichotomized to < or ≥ 10% of parameter value at baseline) and CFL status (CFL+ or CFL-). 
For tables in which none of the expected cell frequencies was less than 5, results of the chi-
squared test were accepted for the evaluation of significance of differences. In all other cases 
the results of Fisher’s exact tests were accepted for significance [302]. 
No significant relations were found between CFL status and change in lipid parameters in 
excess of 10% of baseline values. , Pearson χ2 (1, N=115)=9.37, p<0.01. Follow-up logistic 
regression was conducted to determine the 95% confidence interval of the odds ratio. The 
results are presented in Table 19.  
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Table 19.  
Odds Ratio (OR) For Improvements Of Lipid Parameters  >= 10% Of Baseline Values 
 CFL- CFL+ p value 
(one sided) 
OR 95% CI 
TCHa all 8.7% (2 of 23) 22.9% (20 of 87) 0.1§ 3.13 0.67 to 14.5 
TCHb ≥200 mg/dl 11.7% (2 of 17) 26.8% (18 of 67) 0.1§ 2.75 0.57 to 13.2 
HDLc all 12.5% (3 of 24) 22.9% (20 of 87) 0.2$ 2.08 0.56 to 7.7 
HDLd males 11.1% (2 of 18) 29.0% (18 of 62) 0.1§ 3.27 0.68 to 15.7 
TCH/HDLe all 13.0% (3 of 23) 33.3% (29 of 87) 0.05$ 3.33 0.91 to 12.1 
TCH/HDLf >4 8.3% (1 of 12) 45.1% (23 of 51) 0.01§ 9.03 1.08 to 75.2 
LDLg all 21.7% (5 of 23) 31.0% (27 of 87) 0.38$ 1.62 0.54 to 4.8 
LDLh males 22.2% (4 of 18) 29.0% (18 of 62) 0.5§ 1.43 0.41 to 4.9 
TGi all 45.8% (11 of 24) 51.7% (45 of 87) 0.6$ 1.26 0.51 to 3.1 
§ Fisher’s exact test 
$ Pearson’s χ2 test 
a – for all subjects with valid baseline and follow-up data on TCH; 23 non-adherent subjects vs. 87 adherent subjects 
b – for all subjects with baseline TCH >=200 mg/dL; 17 non-adherent subjects vs. 67 adherent subjects 
c - for all subjects with valid baseline and follow-up data on HDL; 24 non-adherent subjects vs. 87 adherent subjects 
d – for all male subjects; 18 non-adherent subjects vs. 62 adherent subjects 
e – for all subjects with valid data for TCH & HDL at baseline & follow-up; 23 non-adherent subjects vs. 87 adherent subjects 
f - for all subjects with baseline TCH/HDL ratio >4; 12 non-adherent subjects vs. 51 adherent subjects 
g– for all subjects with valid baseline and follow-up data on LDL; 23 non-adherent subjects vs. 87 adherent subjects 
h – for all male subjects; 18 non-adherent subjects vs. 62 adherent subjects 
i– for all subjects with valid baseline and follow-up data on TG; 24 non-adherent subjects vs. 87 adherent subjects 
 
The observations presented in Table 19 indicate that the most recognizable intervention 
effect is a reduction of the TCH/HDL ratio.  
 
Blood Pressure 
It has to be noted that no a priori hypothesis had been formulated with respect to a potential 
intervention effect on blood pressure. However, since systolic blood pressure is an integral 
part of the PROCAM score, an evaluation of the collected data is warranted. 
Shapiro-Wilk tests suggested normality of the distributions of systolic and diastolic blood 
pressure values within both CFL groups of each CFL strata. Visual inspection of the 
histograms confirmed the normality assumption. Levene’s robust test confirmed equality of 
variances between the CFL± groups of each strata and for systolic and diastolic blood 
pressure respectively. While the difference in systolic blood pressure between the CFL± 
groups of the CFL90 and CFL120 strata had approached significance (see Tables 4b & c), 
there were no significant intra-group changes from baseline to follow-up.  
Conversely, with no significant intergroup difference of baseline values for diastolic blood 
pressure, the latter decreased significantly from baseline to follow-up in all CFL± groups 
across all CFL strata. However, the changes from baseline to follow-up were not significantly 
different between the CFL± groups of the CFL strata. The results of the analyses are 
presented in Table 20.  
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Table 20. 
Absolute changes in blood pressure from baseline to 6-month follow-up in the CFL- and CFL+ groups  
  CFL- group 
(adherent) 
CFL+ group 
(non-adherent) 
p-value* 
  Mean mmHg 
(SD) 
95% CI Mean mmHg 
(SD) 
95% CI  
CFL901 BPsys -1.0 (10.0) -5.2 to 3.2 -1.3 (11.4) -3.8 to 1.3 0.92 
 BPdia -5.9 (8.8) -9.7 to -2.2 -3.4 (8.5) -5.3 to -1.5 0.2 
CFL1202 BPsys -0.3 (10.8) -4.6 to 3.9 -1.5 (11.2) -4.1 to 0.99 0.61 
 BPdia -5.2 (9.0) -8.8 to -1.7 -3.5 (8.4) -5.5 to-1.6 0.37 
CFL1503 BPsys 0.45 (12.0) -3.1 to 4.0 -2.5 (10.1) -5.2 to 0.1 0.17 
 BPdia -2.9 (9.3) -5.7 to -0.2 -4.8 (7.9) -6.9 to -2.7 0.27 
* p-values were determined by two-tailed t-tests for differences between the groups 
1: n=24 for CFL- group (non-adherent); n=80 for CFL+ group (adherent) 
2: n=27 for CFL- group (non-adherent); n=77 for CFL+ group (adherent) 
3: n=46 for CFL- group (non-adherent); n=58 for CFL+ group (adherent) 
 
Since it is body weight change rather than a change in CRF which affects blood pressure in 
hypertensive subjects, the effects of a minimum weight loss of 1 kg on blood pressure was 
investigated. Participants were dichotomized into those having achieved a weight reduction of 
at least 1 kg vs. those who did not. Since reductions of body weight and blood pressure are 
clinically relevant specifically for overweight individuals and those with elevated blood 
pressure levels, the analyses were performed on the 68 participants who had entered the 
study with a BMI>25 and a systolic and/or diastolic pressure in excess of 129 or 84 mmHg 
respectively. The categorization of blood pressure follows the current definitions of the 
American Heart Association (AHA) as the cut-off between normal and elevated blood 
pressure levels [303].Table 21 presents the results of the paired t-tests and independent-
samples t-tests for the within- and between group changes of blood pressure values. 
 
Table 21. 
Blood Pressure Change in Weight-Reducing vs. non-Weight-Reducing Overweight  Participants With 
Elevated Blood Pressure At Baseline 
 No Weight Loss Weight Loss between-groups 
 Mean Change 
(95% CI) 
p value* Mean Change 
(95% CI) 
p value* 
 
p value** 
 
BPsysa (mmHg) 1.2 (-5.2 to 7.7) 0.6 -4.3 (-1.5 to -7.2) <0.01 0.03 
BPdiab (mmHg) -3.4 (-7.2 to 0.4) 0.07 -10.5 (-5.6 to -15.5) <0.001 0.01 
Note: Analyses were performed on overweight participants (BMI>25) with systolic and/or diastolic pressure in excess of 129 or 
84 mmHg respectively. 
* p-values for paired-samples t-test, 2-tailed 
** p-values were determined by one-tailed t-tests for differences between the groups 
a: 16 non-weight-reducing participants vs. 52 weight reducing participants 
b: 13 non-weight-reducing participants vs. 21 weight reducing participants 
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Evidently, there is a significant reduction of blood pressure observable in the overweight 
participants with elevated pressure at baseline. The median weight loss achieved in this 
group was 4.4 kg, which correlates well with the approximately 1mmHg reduction of systolic 
and diastolic pressure, achievable for every 1 kg of loss of body weight reduction [304]. 
Unexpectedly, though, is the observation that diastolic pressure was reduced to a 
substantially greater degree than systolic pressure.  
Since it has been suggested that the effect of weight reduction on diastolic blood pressure is 
significantly larger in groups taking antihypertensive drugs than in untreated groups [304], the 
proportion of individuals having reported taking antihypertensive medications was assessed 
differentially for the groups of individuals with elevated systolic pressure and those with 
elevated diastolic pressures. No significant difference was evident between the groups, with 
33% vs. 34% of participants with elevated diastolic or elevated systolic pressures respectively 
reporting being treated for hypertension.  
To evaluate whether participants differed significantly across the dichotomized weight-loss 
groups with respect to changes in blood pressure classification from baseline to follow-up, all 
participants for whom valid measurements were available (baseline and follow-up) were 
stratified into one of five categories according to AHA classification [303]: 
Category 1 (normal):   systolic < 130 mmHg & diastolic < 85 mmHg 
Category 2 (high normal):  systolic 130 – 139 mmHg & diastolic 85 – 89 mmHg 
Category 3 (stage 1 HPT):  systolic 140 – 159 mmHg & diastolic 90 – 99 mmHg 
Category 4 (stage 2 HPT): systolic 160 – 179 mmHg & diastolic 100 – 109 mmHg 
Category 5 (stage 3 HPT):  systolic ≥ 180 mmHg & diastolic ≥ 110 mmHg 
In the CFL90 strata 33.75% and 33.3% of the CFL+ and CFL- groups respectively showed an 
improvement in blood pressure category from baseline to follow up, with 16.25% and 16.66% 
respectively showing a deterioration.  
While 40.3% (N=57) of the weight-reduced overweight participants with baseline elevated 
blood pressure had reduced their blood pressure category, 23.8% of the weight-stable 
participants showed a category drop (N=21). This difference, though approaching 
significance, remained non significant (one-tailed), with z=-1.35, p=0.088. 
 
PROCAM Risk Score  
Inspection for normality of the distribution, using Shapiro-Wilk tests and visual inspections of 
the histograms, revealed substantial positive skewing, leading to a severe violation of the 
normality assumption. Log-transformation established normality at baseline and at follow-up 
in both groups, whereas restriction of the analysis to the male-only raw data did not. 
Therefore, means for the PROCAM score are presented in Table 22a as geometric means 
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(resulting from antilog of the means of the log-transformed data). For the CFL- group, the 
within-group factor between geometric means of 1.08 is not significant. In the CFL+ group the 
risk reduction by a factor of 0.79 represented a negative difference in geometric means which 
was highly significant two-tailed, with t(55)=4.08 and p<0.001.  
To illustrate the effects, expressed in the untransformed data, Table 22a presents the results 
of the significance tests performed on the log-transformed and on the raw data. In the 
evaluation of the raw data, the significance is preserved, though attenuated.  
Table 22b and Figure 13 show the mean values of the relative change of the scores, 
expressed as percentage change of the scores, for both CFL groups in each strata. While 
CFL- subjects of the CFL90 strata showed a mean 16.6% relative increase in the score, the 
CFL+ subjects of that strata decreased their score on average by 14.7%.  
These results indicate a significant effect of the intervention on cardiovascular risk factors as 
expressed in the PROCAM score.  
 
Table 22a:  
PROCAM Risk Score: Within- And Between Group Differences From Baseline To Follow-Up 
 Significance Tests for log-transformed data Significance Tests for raw data 
 Baselinea 
(95% CI) 
Follow-Upa 
(95% CI) 
Δ (factor) p* 
Baselineb 
(95% CI) 
Follow-Upb 
(95% CI) 
Δ p** 
CFL- c 
N=15 
4.36 
(2.92 to 6.5) 
4.73 
(2.95 – 7.59) 
1.08 NS 
5.72 
(2.8 – 8.6) 
6.5 
(3.5 – 9.5) 
0.78 NS 
CFL+ c 
N=56 
5.24 
(4.31 - 6.38) 
4.13 
(3.37 – 5.06) 
0.79 <0.001 
6.8 
(5.3 – 8.2) 
5.5 
(4.2 – 6.7) 
-1.3 <0.01 
Between
-Group 
  
1.36 
(1.09 – 1.73) 
<0.01   
2.08 
(0.33 – 3.79) 
<0.05 
a: geometric mean resulting from antilog of the t-tests on log-transformed data 
b. arithmetic mean 
c: CFL- = non-adherent; CFL+ = adherent 
* p-values (one-tailed) for paired-samples t-test on log-transformed data 
** p-values (one-tailed) for paired-samples t-test on raw data 
 
Table 22b 
Relative Change Of PROCAM Risk Score  
 % - Change   
 CFL- CFL+ Δ, p-value* 95% CI 
CFL90 (N=15/56)a 16.6 -14.7 31.3 (p<0.01) 10.2 to 52.4 
CFL120 (N=18/53)b 13.1 -15.2 28.3 (p<0.01) 8.4 to 48.2 
CFL150 (N=30/41)c 8.1 -19.8 27.9 (p<0.01) 10.6 to 45.1 
* p-values (one-tailed) 
a: n=15 for CFL- group (non-adherent); n=56 for CFL+ group (adherent) 
b: n=18 for CFL- group (non-adherent); n=53 for CFL+ group (adherent) 
c: n=30 for CFL- group (non-adherent); n=41 for CFL+ group (adherent) 
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Figure 13. Relative Change of PROCAM Risk Scores 
 
 
Two-way contingency table analysis was conducted to evaluate whether the number of 
participants with a relative reduction of PROCAM risk score of ≥10% was different between 
the CFL± groups. For all tables, the expected cell frequencies were in excess of 5. Therefore 
the results of the chi-squared tests were accepted for the evaluation of significance of 
differences [302]. 
Follow-up logistic regression was conducted to determine the 95% confidence interval of the 
odds ratio. The results are presented in Table 23. 
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Table 23 
Odds Ratio (OR) For A Relative Decrease Of PROCAM Risk Score ≥10% (CFL+ vs. CFL-) by CFL strata 
 CFL-  
(non-adherent) 
CFL+  
(adherent) 
p value OR 95% CI 
CFL90a 20% (3 of 15) 58.9% (33 of 56) p<0.01 5.7 1.4 to 22.6 
CFL120b 22.2% (4 of 18 60.3% (32 of 53) p<0.01 5.3 1.5 to 18.4 
CFL150c 30% (9 of 30) 65.8% (27 of 41) p<0.01 4.5 1.6 to 12.3 
Note: 
for all subjects with baseline PROCAM risk score >1% 
CFL90: criterion active duration = 3 months; CFL120: criterion active duration = 4 months; CFL150: criterion active duration = 5 months 
PROCAM: Prospective Cardiovascular Münster Study 
a: 15 non-adherent subjects vs. 56 adherent subjects; b: 18 non-adherent subjects vs. 53 adherent subjects;  
c: 30 non-adherent subjects vs. 41 adherent subjects; 
 
 
Intervention Effects on the Overweight Participants 
Sedentary, overweight individuals are the primary target group of the studied intervention. 
Hence, it is informative to evaluate whether the intervention had affected the outcome 
parameters of this group and what was the magnitude of these effects. Table 24 and Figure 
14 present the intervention effects on all parameters for which within- and between-group 
differences have been found to be significant and which had been hypothesized to correlate 
directly with adherence to the exercise protocol. The data are analyzed for all participants 
with a BMI >25 at baseline and irrespective of the outcome parameters’ values at baseline.  
 
Table 24. 
Main Intervention Effects On The Overweight & Obese Participants 
 Mean change 
from baseline to follow-up 
Mean change 
between-group difference 
 CFL- 
(non-adherent) 
CFL+ 
(adherent) 
absolute p value 95% CI 
VO2peaka 
ml/kg/min 
-0.59 (p=0.2) 3.72 (p<0.001) 4.3 p<0.001 2.55 to 6.08 
weightb  
kg 
-1.5 (p<0.05) -4.3 (p<0.001) 2.8 p<0.05 0.6 to 4.9 
BMIb 
kg/m2 
-0.45 (p<0.05) -1.4 (p<0.001) 0.95 p<0.01 0.25 to 1.6 
TCH/HDLc +0.13 (p=0.3) -0.23 (p<0.001) 0.37 p<0.01 0.1 to 0.6 
PROCAMd score 
% absolute 
+0.68 (p=0.1) -0.8 (p<0.01) 1.48 p<0.05 0.28 to 2.68 
Note: 
a: 22 non-adherent subjects vs. 60 adherent subjects; b: 24 non-adherent subjects vs. 73 adherent subjects;  
c: 21 non-adherent subjects vs. 71 adherent subjects; d: 19 non-adherent subjects vs. 68 adherent subjects 
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Figure 14. Main Intervention Effects On Overweight Participants 
*p-values for difference between CFL groups 
 
 
PEER COMPARISON OF THE INTERVENTION  
Since optimizing intervention efficiency was an objective of this study, comparisons with trials 
using similar exercise curricula is warranted.   
To this end, the ELF intervention effects were compared to the results published for an 
exercise intervention in 21 overweight, apparently healthy men [106]. The men had been 
studied before and after a 12 weeks exercise intervention (no dietary intervention), which 
consisted of thrice-weekly supervised exercise sessions of 40-60 minutes of moderate 
intensity treadmill walking & jogging. This study of Miyaki et al. was chosen for its close 
similarity of key aspects with the ELF intervention, specifically  
• the similarity of baseline parameters as outlined in Table 25,   
• the 12-weeks duration of the intervention which equals the 12 weeks duration aspect 
of the CFL90 group 
• assessment of VO2peak by ergospirometrie 
• availability of data on a per subject basis 
Table 25 presents the comparison of baseline values between the two study populations. 
Since one of the men in the study of Miyaki et al. had a baseline BMI less than 25, the values 
of this subject were not considered in the analyses.  
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The significantly smaller height and weight and higher body fat content, with concomitant non-
significant difference in BMI, reflect the fact that the sample of Miyaki et al. consisted of 
Japanese subjects. Compared to Europeans, Asians have a higher body fat content at the 
same BMI value [305, 306]. VO2peak values were only available as a group mean, which 
prevented analyses of VO2peak per kg of lean body mass.  
 
Table 25:  
Baseline Comparison Of Overweight ELF Men (BMI>25) With The Male Study Population Of Miyaki et al. 
 Miyaki et al. 
N=20 
ELF study 
N=73 
p-value 
for difference 
Age 49.3 (9.66) 50.6 (8.06) 0.59 
Height (cm) 169 (7.2) 178 (6.6) <0.001 
Weight (kg) 87.4 (12.1) 94.1 (11.9) <0.001 
BMI 30.3 (3.2) 29.5 (3.0) 0.31 
Body Fat (%) 32.6 (3.7) 26.4 (4.06) <0.001 
VO2peak ml/kg/min 29.0 (4.12) 33.9 (7.03) <0.01 
TCH mg/dl 237 (45.8) 224 (54.4) 0.29 
HDL mg/dl 51 (15.8) 50 (10.8) 0.67 
TCH/HDL ratio 4.87 (1.47) 4.58 (1.1) 0.42 
 
Figure 15 compares the changes in vital signs achieved in both study samples.  
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Figure 15. Comparison of the ELF sample with the sample of Miyaki et al 
 
No significant differences were found between the two study samples. 
The context and implications of these observations are discussed in the following section.   
 
 
DISCUSSION 
BASELINE COMPARISONS 
Efforts to detect true between-group differences and to avoid chance findings  
This study investigated the effects of a “minimally invasive” self-monitored exercise protocol 
on adherence to a physical activity intervention, which was designed to improve various 
parameters of cardiovascular health in a predominantly sedentary and overweight, but 
otherwise apparently healthy population of working adults. As the intervention was carried out 
under the evidence-based a priori assumption of tangible health benefits accruing to adherent 
participants, the study had been designed to test its hypotheses through comparison of 
adherent with non-adherent subjects rather than through intention-to-treat analyses based on 
a randomized controlled design. This given study design necessitates a thorough 
investigation into potential baseline differences between the two comparison groups, which 
had been stratified according to their adherence status in participants who did or did not meet 
the pre-defined adherence criteria of latency of self-reporting, volume and duration of 
reported exercise.  
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Any systematic difference between these two groups at baseline potentially affects the 
interpretation of the outcome analyses. Similarly, chance findings of significant baseline 
differences, when there are actually none, may equally flaw the interpretation of study results. 
The severity of these issues had been highlighted 30 years ago by Lee et al. who simulated a 
clinical trial randomizing the clinical records of 1073 consecutive cardiac patients into two 
mock treatment groups [307]. As expected, the outcome analysis showed no significant 
difference in survival between the groups. However, post hoc stratification of the patients into 
subgroups according to variables which affect prognosis (the number of diseased coronary 
vessels) yielded significant differences in survival between the two mock treatments. In a real 
intervention, this obvious chance finding might have been interpreted as a treatment effect 
becoming clinically relevant in the more severely ill patients.  
Correspondingly, a baseline difference between the two ELF participant groups, may 
theoretically (a) have systematically moderated a true intervention effect such that no 
significant between-group difference would have been observed or may (b) have 
systematically affected the baseline-to-follow up progression of parameter values to suggest 
an intervention effect when there was none.  
Given these considerations the investigation into potential baseline differences was 
conducted with a bias towards avoiding type II errors rather than type I errors. Hence, the 
type I error-minimizing Bonferroni corrections were applied judiciously, that is, no Bonferroni 
corrections were used across the 13 investigated variables, which can also not be considered 
as truly independent variables, a prerequisite for correct use of the correction. However, the 
investigation into gender specific baseline differences warranted a Bonferroni correction, as 
this stratification was not based on a priori hypotheses, but arose merely from the need to 
investigate whether the different proportions of female CFL± group members were a potential 
source of the differences in body weight observed between the two groups at baseline. This 
line of investigation is justified for parameters for which gender-specific differences are known 
to exist, such as VO2peak, body weight, body fat, lipids and PROCAM risk score.  
Owing to the relatively small comparison groups, effect size calculations were carried out with 
the view that, when a relatively large effect size (for between-group baseline differences) 
coincides with the finding of no significance, the sample size may in itself affect the 
interpretation. In this context, it is important to conduct the analyses to be as sensitive as 
possible for the detection of significant differences. While the applied independent-samples t-
tests are known to be relatively robust to small violations of the assumptions of normality of 
the distributions and equality of variance, data were transformed for closer conformation with 
the normality assumption in all instances where the raw data (a) showed clear violations of 
this assumption through pronounced skewness, and (b) t-tests did not return significance of 
between-group differences. The rationale being, that the most likely effect of these violations 
is a loss of power to detect a true difference, while type 1 errors are unlikely [308].  
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The preferred transformation was the log-transformation, the anti-log of which yields 
interpretable results, whereas all other transformations may simply be used as a test to 
indicate significance.  
Given the aforementioned considerations, the baseline evaluations confirmed that there were 
no differences between the CFL+ and CFL- groups which my have systematically affected the 
interpretation of the follow-up analyses. While the proportion of females was higher in the 
CFL+ group than in the CFL- group, with 30% vs. 21% respectively, this difference was not 
significant. Due to it, however, the between-group difference in body weight of 6.3 kg at 
baseline approached significance, with the CFL+ group being lighter than the CFL- group. 
Since this difference was not reflected in BMI it can be ascribed to the large difference of 14 
kg between the female-only CFL groups. The small sample size of the female CFL- group 
however defies a meaningful interpretation of this difference. 
There is some published evidence to suggest, that BMI correlates inversely with adherence to 
exercise interventions [309, 310]. While the mean BMI in the CFL- group was 1.2 units higher 
than that in the CFL+ group (29.8 and 28.6 for the CFL- and CFL+ groups respectively), this 
difference remained not significant. The distribution of the data was equally normal in both 
groups and no transformation achieved improvement of the distribution to the extent that t-
test statistics would have increased, thereby indicating increased power. Hence, no 
correlation between BMI and adherence can be confirmed in this sample, which may be due 
to the fact that mean BMI remained below 30, and very few participants had entered the 
intervention at a BMI sufficiently high to affect adherence. 
Worthy of note is the difference in PROCAM score, which approached significance in the 
male subgroup. While the overall score remains substantially below the 10% cut-off, which is 
used to differentiate the low-risk from the moderate-risk individual, the achievable score of 1% 
for a reference 50-year old male remains substantially lower than the observed group mean.  
That the female strata displayed a substantially lower risk level than the male strata reflects 
published evidence of CVD risk being dramatically lower in pre- and perimenopausal women 
compared to their age-matched male peers. 
Owing to the small sample sizes and the very low PROCAM risk scores for the female 
subgroups, the results of the t-tests performed on the log-transformed data of these groups 
defy any meaningful interpretation. 
Taken together, these results suggest that there were no significant differences in PROCAM 
risk scores at baseline between the CFL groups. The difference in scores observed in the 
male subgroup, though approaching significance, is to be considered clinically not relevant, 
as the scores remained within the lower half of the low-risk bandwidth of the score. Hence, 
the assumption of baseline differences, which affect the interpretation of intervention effects 
on the groups at follow-up, can be rejected. This observation holds equally true for the 
baseline differences presented in tables 3c&d for the CFL120 and CFL150 strata 
respectively.  
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Effort to compare the ELF sample with relevant underlying populations  
With the given recruitment strategy and the potential selection biases engaged by it, it was 
unlikely for the study population to be representative of the general population.  
First, there is bias related to the self-selection process. Owing to this volunteer bias, the more 
health-conscious individuals of a population are almost inevitably over-represented in the 
study population [311, 312]. This bias potentially shifts the distribution of health related vital 
signs within the study population towards the healthier end of the spectrum compared with 
the general population. However, there is evidence to the fact that this bias does not 
necessarily generate a study population, whose health parameters substantially and 
significantly differ from those of the general population. An attempt to quantify the differences 
in total cholesterol and blood pressure levels between men who self-enrolled into a 12-
months exercise program for the prevention of CVD and those of the general population from 
which the subjects had been drawn, did not show any significant differences between the 
volunteers and the general population [313]. 
Second, there is bias related to the population of employed individuals, from which the study 
population was drawn. McMichael had suggested, that to be employable an individual must 
be relatively healthy and that therefore, the workforce of an industrial enterprise without 
significant health hazards presents a lower mortality rate than that which is observed in the 
general population [314]. The author had termed this effect the “healthy worker effect” (HWE), 
which he had observed in the context of studying the vocation-specific mortality rates in 
rubber workers. These observations may extend to parameters of morbidity and to vital signs, 
skewing their distribution towards the healthier end of the population spectrum.  
As unavoidable as this may be in self-selected samples of intervention participants, it is 
probably of negligible effect when extrapolating the intervention results to future interventions 
using similar protocols in different populations, as the latter will similarly be affected by 
volunteer bias. Hence, the suggestion has been made to explain meaningful distinctions 
between the sample and the general populations rather than to be overly concerned with the 
healthy worker effect [315]. 
To investigate the possible extent of these biases’ effect on the ELF sample, an attempt was 
made to compare its baseline values with those in a representative population sample, drawn 
under the MONICA investigation into correlates and trends of cardiovascular health [233].  
For this comparison, the German MONICA population of the urban Augsburg reporting unit 
was chosen as the one for which cross-sectional data were available and which most closely 
resembled the urban South-West German population from which the ELF sample had been 
drawn. As expected from the preceding discussion, the ELF sample tended to represent a 
slightly healthier spectrum of the population. Despite a significantly and substantially elevated 
BMI (28.7 and 29.3 for the male and female ELF samples respectively), which was located 
towards the upper end of the overweight range, the significantly lower concentration of TCH 
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and the significantly reduced TCH/HDL ratio are indicative of a better health status.  
Blood pressure values were not significantly different between the samples. This comparison, 
however, has to be viewed in the context of the regional (Bavarian vs. Baden-Wuerttemberg 
locations) and temporal (mid-nineties vs. 2009) distance between the two sampling 
processes. Therefore, the comparison of the ELF sample data with the MONICA population 
was cross-checked with the more recent data published for the German Microcensus 
conducted in 2005. This comparison confirms the conclusion drawn from the comparison with 
the MONICA sample, namely that the ELF sample presented with a substantially higher BMI 
than the general population, and with a marginally better lipid profile than that of a 
comparable age cohort of the mid-nineties.   
 
One of the study objectives was to enroll sedentary adults and to investigate the effect of the 
intervention on cardiorespiratory fitness as the main outcome parameter, owing to its strong 
inverse correlation with cardiovascular risk as discussed in the preceding sections. Since no 
published data from cross-sectional evaluations of German reference populations could be 
identified, the criteria for the selection of acceptable representative study populations were 
extended to include those of similar ethnic background, age bracket, health status and 
measurement protocol for the assessment of VO2peak. The Finnish Kuopio Ischaemic Heart 
Disease Risk Factor Study (KIHDS) was chosen for its close similarity to the specified 
parameters [236] and for its purpose of investigating the prognostic value of VO2peak for 
cardiovascular disease incidence.   
While the primary focus of this comparison was on the VO2peak values, it incidentally 
provided for a further comparison of selected lipid parameters.  
Again, The ELF men were significantly more overweight than the Finnish male cohort, with a 
BMI of 28.7 vs. 26.6 and 27.1 in the Finnish healthy and unhealthy men respectively. The 
ELF men were marginally but significantly fitter than the healthy Finnish cohort, with a 
difference in VO2peak of 2.1 ml/kg/min, and substantially and significantly fitter than the 
unhealthy Finnish men, with a VO2peak difference in excess of 2 MET (7.3 ml/kg/min). In this 
Finnish population VO2peak was found to decrease non-fatal and fatal cardiac events by 17-
29% and by 28-51% respectively for every one MET increment. Hence, the difference to the 
unhealthy Finnish men constitutes a clinically relevant difference, given the observation by 
others that every MET increase in aerobic capacity may confer a 12% reduction of 
cardiovascular mortality risk [316].  This observation reinforces the importance of CRF as a 
clinically powerful, relevant, and modifiable risk factor for CVD.  
The comparison with the KIHDS men suggests, that the ELF sample presents with a level of 
CRF which is typical for a healthy but sedentary population, and which is substantially better 
than that of a diseased population.  
Any reasoning on the observations of similar values for TCH and HDL, significantly lower 
concentrations of LDL and significantly higher concentrations of TG among the ELF men, 
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would be speculative at best and may well be a chance finding. While that may apply mutatis 
mutandis to the differences in blood pressure values, with systolic pressures being higher and 
diastolic pressures being lower in the ELF men, a closer look at the differences between the 
Finnish and the MONICA populations is illustrative of potential underlying population 
differences.   
The reason for this difference possibly reflects a greater prevalence of hypertension in the 
German compared to the Finnish population. 38.2% of the male MONICA subjects had a 
history of hypertension, whereas the equivalent figure for the KIHDS population was reported 
with 24%. Moreover, 8.5% of the male MONICA subjects had systolic and diastolic blood 
pressure value of >= 160 mmHg or DBP >= 95 mmHg respectively and had been told about 
high blood pressure previously but did not take any medication. Another 10.5% had systolic 
and diastolic blood pressure values of >= 160 mmHg or DBP >= 95 mmHg respectively, did 
not take any medication and had never been told about having high blood pressure. Hence, 
the non-significant differences in blood pressure values between the ELF and the MONICA 
samples, with both being significantly different from the Finnish population, may reflect 
underlying population differences rather than specific differences between the ELF and the 
KIHDS population. 
Taken together, the baseline comparisons suggest that the ELF population probably 
represents a more health conscious strata of the population, which nevertheless displays the 
risk factors which are typical for a predominantly sedentary lifestyle, namely moderate CRF, 
pronounced overweight and concomitant lipid and haemodynamic profiles in the sub-optimal 
range, all of which adds up to a low to moderate CVD risk as evidenced by a relatively low, 
but far from optimal PROCAM risk score.  
 
HYPOTHESES TESTING 
Adherence 
As the hypothesized 75% adherence is within the confidence interval of the proportion of 
adherent subjects, the data support hypothesis 1. 
The proportion of 76% of subjects completing the study as actively self-monitoring 
participants needs to be discussed in the context of adherence. Over the longer term, the 
degree of adherence is inevitably subject to fluctuations, owing to disruptive external and 
internal (seasonal, occupational, health and other) constraints. It is essential to rescue the 
health habit over any hiatus that may be caused by these external factors. Self-monitoring is 
the essential tool to achieve this. Hence, active self-monitoring, if suitably defined along the 
dimensions of latency, volume and duration will serve as an important tool to maintain 
adherence.   
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The three aspects defining active self-monitoring in this study were: 
• latency of last reporting event not exceeding 7 days to follow-up assessment 
• duration of continuously recorded self-monitoring of 12 weeks  
• volume of PA of weekly 60 minutes of HIT or more   
As discussed in the introductory sections, these minimum requirements had been developed 
from the evidence-based expectation that (a) measurable health benefits would accrue to the 
adherent subjects, and that (b) these benefits would emerge as statistically significant 
differences between CFL+ und CFL- groups.  
The latency aspect of this definition differentiates it from those adherence definitions, which 
are exclusively based on any combination of percentages of volume, of duration or of 
attendance. It provides an answer to the question, what proportion of study participants 
currently adheres to the PA protocol and has done so for durations and at PA volumes, which 
are expected to yield tangible health benefits. Hence, the latency aspect is essential for 
determining how successful an intervention has been at releasing its participants with a 
modified health habit. With a view to continuous interventions, the latency aspect is essential 
in recognizing individuals who are at risk of drop-out or whose adherence begins to decay. In 
this context latency assessment provides the means to direct attention to those individuals 
whose current adherence status warrants additional motivational efforts.    
 
Extending the duration component without modifying the latency and volume components (as 
done by defining the CFL120 and CFL150 status) does not result in a reduction of adherent 
subjects, as the main aspect of adherence is the presence of an operant CFL at the time of 
assessment. Rather does it differentiate adherent subjects into different strata of duration of 
continuous adherence history. It is important to keep this aspect in mind when interpreting the 
results of comparative evaluations of the measured parameters of physical fitness and 
biochemistry between the strata. The progressively smaller intra-strata differences between 
CFL- and CFL+ group-means of parameter values (VO2peak, body weight, BMI body fat and 
lipids) are a result of these improvements being measurably evident in the adherent individual 
after 12 weeks of changed PA levels. Grouping some of these individuals into CFL- groups in 
the CFL120 and CFL150 strata inevitably leads to a progressive attenuation of the differences 
of group means. Hence, the latter must not be considered a decay of intervention effect over 
time, but a merely statistics related artifact.  
As I have elaborated in the introductory sections, the absence of adherence standards 
complicates inter-study comparisons. In this study, the term adherence does not relate to the 
volume or duration of PA, but to the presence of an operant cognitively controlled feedback 
cycle at the end of a 6-months observation period. This constitutes a small, but substantially 
different way of defining adherence, which emerges from the theory and model underlying 
this intervention strategy.  
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Hence, comparisons with published adherence rates are difficult, if not meaningless. 
Adherence in time-limited trials simply identifies the dose of PA medicine taken by the 
participants. It has helped us to discover the dose-response relationship between the 
medicine, that is PA, and health. With a view to the acknowledged decay of taking the 
medicine, we now need to work out how to prevent this decay in the first place.  
Therefore it is far more instructive to see whether the intervention protocol, which emphasizes 
monitored self-monitoring of a minimally invasive curriculum with substantial inter-individual 
differences of PA intensity and volume, has demonstrated the potential to produce significant 
and clinically relevant improvements of objectively measurable health parameters, such as 
the ones examined in this study. 
Namely, that instituting and maintaining a health enhancing physical activity habit critically 
depends on reactivating physical activity as the effector in a feedback loop of human energy 
homeostasis through cognitive control. The latter being required as a substitute for the 
autonomous control mechanisms, which have been imprinted through evolution to balance 
human energy intake with the PA cost for the acquisition of food and its energy density. The 
massive disruption of these autonomous control mechanisms, which is typical for modern 
human societies, has emerged as a major pathogen to the human phenotype. In this context, 
this trial may represent the beginning of a new intervention paradigm, the essence of which is 
continuity of the PA intervention through facilitated and monitored self-monitoring.  
Support for this view comes from a recent meta-analysis of 122 lifestyle change interventions, 
in which the combination of self-monitoring with one or more other theory based techniques 
had a substantially and significantly larger effect on the outcome parameters than 
interventions which lacked self-monitoring techniques [317].   
Simple techniques, such as frequent self-weighing in weight loss trials, have shown to 
substantially improve target outcomes, with frequently self-weighing participants achieving 
double the weight loss compared to their not self-monitoring intervention peers [318].  
The worksite intervention of Atlantis et al. had used a very similar intervention protocol 
(minimum 3x20 minutes of moderate to high intensity aerobic training), duration (24 weeks) 
and setting (worksite), but did dot deploy any self-monitoring technique [235]. Given the 
discussed considerations about the correlation of the latter with adherence and outcome, it is 
tempting to speculate that the substantially and significantly better adherence in the ELF trial 
(76% vs. 58%) may be due to the technique of self-monitoring. However, with 73% of the 
Atlantis intervention participants being shift workers, the work environment with its 
commensurate time constraints may also have affected the adherence rate. 
Extension of the ELF trial, in terms of duration and study populations, will help to substantiate 
(a) the underlying strategy’s ability to substantially enhance the prevalence of HEPA habits 
within target populations, and (b) how to optimize this strategy for maximum public health 
benefit.  
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Maximal Oxygen Uptake 
The results favor the hypothesis that the group of participants with an operant controlled 
feedback loop, as evidenced by their active self-monitoring of PA, improved cardiopulmonary 
fitness significantly and to a clinically relevant extent, whereas lack of self-monitoring 
correlates with lack of change in cardiopulmonary fitness. The difference between the two 
groups is significant and clinically relevant. 
The Phenomenon of the Highly Motivated Outliers 
The phenomenon of few highly motivated intervention participants skewing the outcome 
parameters is an observation reported in published evidence. In a comparable work-site 
intervention of 24 weeks duration, Atlantis et al. report the case of one highly motivated 
female participant who reduced her baseline BMI of 40 by 12.6 kg/m2 and her body weight by 
33.7 Kg [235], which makes that individual’s intervention effect comparable to that of the male 
subject in this study. Similar observations have been published for an investigation into the 
inter-individual differences in weight change resulting from a controlled 12-week exercise 
intervention in a group of 35 overweight and obese subjects [212].  While the reported mean 
weight loss was 3.7 Kg, one individual had reduced his weight by 14.7 Kg or 3.4 SD above 
the group mean.  
These observations suggest that the highly motivated individual, who “super-achieves” 
intervention targets, is a common phenomenon, which needs to be accounted for when 
presenting the data. Data interpretation becomes problematic when the analyses with and 
without the overachieving outliers are contradictory in significance. This was not the case in 
the ELF population where within- and between-group differences remained significant, though 
moderately attenuated, when analyses were conducted with and without the outliers.  
 
Relevance of the intervention effect on cardiorespiratory fitness 
The data support the hypothesis that actively self-monitoring subjects witness a significant 
increase of maximal oxygen consumption capacity over their non-self-monitoring peers.  
Baseline value of VO2peak of this study population places it approximately into the 50th 
percentile of published reference populations [238]. This leaves substantial room for 
improvement, which promises an equally substantial gain in health benefits.  
In the Finnish study population cardiorespiratory fitness (expressed in VO2peak) emerged as 
the strongest predictor of non-fatal CVD events over the 13.7-year median follow-up. At 1-
MET increments of VO2peak the risk of non-fatal and fatal coronary events was reduced by a 
constant proportion, regardless of existing CVD, and with a threshold effect observed 
between very low and moderate fitness levels. Similar reductions of disease risk have been 
observed in other investigations of mixed-gender populations which confirmed the risk-
reducing effect of cardiorespiratory fitness similarly in men and women [319]. Hence, the 
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increase of VO2peak observed in this study population constitutes a significant and clinically 
relevant effect.  
With a view to the concurrent weight losses observed in the CFL+ subjects (discussed in the 
succeeding section), it was necessary to investigate whether the observed increase in 
VO2peak relative to body weight was a true increase of CRF or simply an arithmetic artifact. 
That is, if weight loss is primarily achieved through reduction in body fat, with concomitant 
preservation of muscle mass, the increase in VO2peak does not necessarily reflect an 
improvement of the oxygen uptake dynamics in the working muscle tissues. This is an 
important caveat when evaluating concurrent dietary and PA intervention effects, as it has 
been shown that weight loss alone does not improve fat oxidation efficiency in working 
muscle mitochondria, but only exercise does [320]. 
However, Table 8 and Figure 6 demonstrate that VO2peak improved significantly relative to 
BCM, thereby confirming a net increase in cardiorespiratory exercise capacity.  
Irrespective of the goal of improving CRF, PA in itself is a correlate of health worth 
monitoring.  
Of the 4,456 young females of the U.S. Growing Up Today Study (GUTS) who were aged 14-
22 at baseline, 24% and 54% reported efforts to maintain or to lose weight respectively [321]. 
Despite these efforts a mean weight gain of 3.3 kg was observed over the 4-years follow-up 
from 2001 to 2005. Of the various weight management strategies, which were evaluated, only 
the combination of limiting portion sizes and exercising at least 5 times/week emerged as a 
significantly protective strategy against weight gain. In this context, self-monitoring of PA is an 
essential tool to maintain PA levels, the eventual decay of which otherwise precipitate weight 
(re-)gain. 
Specifically, the post-intervention, weight-reduced individual is vulnerable to weight re-gain. It 
has been shown that the maintenance of body weight at approximately 10% below a pre-
weight-loss status leads to a decrease of energy metabolism, specifically in low-intensity 
activities, below what would be predicted by weight change alone [322]. Hence, the 
maintenance of higher levels of PA, specifically at higher intensity, becomes a sine qua non 
for successful maintenance of a reduced body weight.  
More importantly, recent results from aging research suggest that PA and its related energy 
expenditure not only strongly correlate with longevity, but that PA may in itself be regarded as 
a biomarker for senescence and death [323]. So has it been proposed that timed exercise 
may contribute to the stabilization and improvement of the circadian rhythm in aging 
organisms, thereby delaying senescence and death [324].  
Indirect evidence for the association of PA with longevity comes from population studies of 
the correlation between PA and older-age associated disease. In a large prospective follow 
up of 28,842 men and 30,336 women over a 30 years period from 1972 to 2002, PA was 
strongly and inversely correlated with the risk of heart failure (HF) [325]. In this study sample, 
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which had been stratified in 1982 according to the WHO MONICA protocol, the protective 
effect of PA was evident across the entire range of BMI values.  
Obviously, self-monitoring of this supremely modifiable biomarker not only makes sense, but 
not to avail oneself of the leverage it provides for increasing health and life span, does not 
make sense at all. 
Given these observations, the improvement of CRF in a predominantly sedentary population 
such as ours, and the introduction of a self-monitoring tool for improving the biomarker PA, is 
of primary public health value.  
Unsurprisingly, the U.S. government’s “Healthy People 2010” initiative has recognized PA as 
the top health indicator, followed by overweight/obesity, in its list of the 10 leading health 
indicators [288]. These indicators and their prioritized sequence had been chosen to (a) 
reflect the government’s major public health concerns and (b) highlight their relevance in 
improving public health.  
If translatable into a larger public health context, the improvements of CRF achieved in the 
ELF study sample, and the self-monitoring tool developed to facilitate this improvement, could 
provide a significant contribution to public health and the reduction of CVD. 
 
Parameters Of Body Weight Status 
It needs to be kept in mind that the primary objective of this intervention was the activation of 
an operant CFL, the primary purpose of which was to increase cardiorespiratory fitness. 
While the individualized exercise prescription to achieve this goal was set at a minimum of 
3x20 minutes of moderate- to high-intensity interval training per week, subjects were free to 
exercise in excess of this minimum requirement. The hypothesized and expected weight-loss 
of 2.5 kg had been based on the assumption that the actual time spent exercising would be 
close to the required minimum for most of the active participants.  
The median of the actual time spent exercising, however, was ∼2.5 times the 60’ minimum 
requirement. The same factor applied to the hypothesized weight loss would translate into a 
6.2 kg reduction of body weight, which is higher than the mean of 4.6 kg achieved in the 
CFL150 strata. However, this difference needs to viewed in context. Firstly, the applied 
method of reporting the time spent exercising did not provide for a quantification of its calorific 
equivalent, as the intensity at which exercise was performed could not be captured. Secondly, 
substantial inter-individual differences in weight response to exercise are known to exist, 
which span the range from compensatory dietary increase in caloric intake to no dietary 
compensation at all [212]. 
Nonetheless, the observed odds ratio of 8 (CFL+ vs. CFL- group) in the CFL90 strata for 
reducing body weight by ≥5% vs. reductions of less than 5% in overweight and obese 
subjects bespeaks a strong effect, given the relatively short observational period of 12 weeks 
within the 6-months intervention. A minimum weight loss of 5% has been suggested to be 
required for clinically relevant hormonal improvements [326], with others arbitrarily setting the 
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bar somewhat lower at 3% for the definition of successful long-term maintenance of weight 
loss [327]. The fact that approximately ¾ of the active participants’ weight loss originates from 
a reduction of body fat, bespeaks a clinically desirable effect, as it is the hormonal products of 
fat tissue which exert the deleterious effects of excess weight on physical health [328, 329].  
The correlation of excess body weight with cardiovascular risk for the ELF age cohort has 
recently been confirmed in the Uppsala Longitudinal Study of Adult Men (ULSAM) [330]. The 
1,758 men aged 50 years at study entry in the early 1970s were followed up over 30 years to 
investigate the correlation between BMI, MetS and cardiovascular morbidity and mortality. 
Compared to their normal-weight peers without the MetS, overweight and obese men without 
the MetS had a 1.52 and 1.95 hazard ratio respectively for cardiovascular events. 
Taken together, the results of the analyses support the hypotheses of significant changes in 
anthropometric parameters and body composition from baseline to follow-up and of significant 
differences between CFL groups. Unexpectedly, a significant change in these parameters 
was also observed in the CFL- group from baseline to follow-up. However, the magnitude of 
these changes is of questionable clinical relevance.  
 
Changes In Blood Lipids 
The results of the “double-take” on baseline blood lipid measurements in 61 participants, with 
a period of 7-10 days between measurements, confirmed earlier observations of substantial 
intra-individual variability of these risk markers [259]. The variability in the ELF sample is 
somewhat less severe than the one observed by Marcovina et al. These differences in 
variability have to be viewed in the context of methodological differences between the studies. 
Marcovina et al. used 4 blood samplings performed at 2-week intervals between samplings. 
This variability potentially affects the interpretations of intervention effects on lipid parameters 
and the risk scores derived therefrom. Specifically in clinical practice, where the individual 
patient’s health profile is the benchmark for guiding a personalized intervention, the existence 
of substantial variability complicates the appraisal of intervention effects.  
Considering the results of both investigations, it made intuitive sense to demarcate along an 
intra-individual threshold of 10% for a change of parameter to be considered clinically 
relevant from baseline to follow-up. Consequently, participants were dichotomized into 
successes and failures depending on having or not having improved their baseline lipid 
values through a 10% reduction (TCH, LDL, TG, TCH/HDL ratio) or increase (HDL) at follow-
up.  
Of the 5 examined lipid markers (TCH, HDL, LDL, TG, TCH/HDL-ratio) only TCH and 
TCH/HDL ratio emerged as being significantly improved within- and between-groups.  
Changes in HDL were significant in the CFL+ group only when excluding subjects with a 
baseline HDL value of >= 60 mg/dL. The inter-group changes remained non-significant. 
However, HDL per se has been found to be of little use in the prediction of CVD risk [331], 
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which makes its clinical utility as a stand-alone marker questionable. Complementary to this 
view is the earlier observation that TCH/HDL ratio is of superior value in predicting risk [332].  
However, given (a) the relatively short duration of the observation period of 6 months, and (b) 
the acknowledged small effect of changes in PA habits on lipid profiles, known from cross-
sectional investigations into the correlation between PA levels and levels of blood lipids [261], 
the results observed in the ELF sample may nevertheless indicate a positive intervention 
effect. Whether this effect is reproducible remains questionable, as no effect of PA levels on 
the cholesterol variables has been observed in another recent investigation into 128 men of 
comparable mean age (51) as in this study [333]. 
The small effect observed in the ELF sample, however, is to be examined from a clinical 
practitioner’s viewpoint. The latter’s patients are the individuals, not a population as is the 
case for the public health operator. The clinician’s view is probably better served with the 
odds ratio, which provides for a dichotomization of outcome along clinically meaningful strata 
of parameter change. Given the 10% threshold for dichotomizing the subjects into strata of 
presence or absence of meaningful parameter change, the odds ratio of 9 for the TCH/HDL 
ratio in all subjects with a baseline ratio >4 emerges as the only statistically significant and 
clinically relevant improvement of lipid profile. Admittedly arbitrary, the 10% threshold 
emerges naturally from the observation of intra-individual variability, and the ratio cut-off of 4 
is supported in published evidence from the Framingham population. In a 20-year follow-up of 
this population sample of 5251 men and women aged 30-74 years a significant increase of 
fatal and non-fatal cardiovascular events was observed at each increasing tertile of the 
TCH/HDL ratio, with a ratio of 4.21, being the cut-off for the lower tertile [334]. Interestingly, 
the level of the lipids that compose the ratio appeared to have little influence on CVD risk 
when the ratio itself was favorable. The authors therefore suggested that conservative and 
less aggressive approaches to optimizing lipid levels are warranted in patients whose 
TCH/HDL ratio is within the “green” range. The relevance of these observations for the results 
observed in the ELF sample is obvious: The predictive power of the TCH/HDL ratio for 
differential diagnosis of risk, given an individual’s known levels of lipid fractions, makes the 
TCH/HDL ratio a suitable biomarker to assess the impact of individual lifestyle changes. The 
effects of the ELF intervention on this biomarker favor the hypothesis of the underlying 
strategy being able to positively modify this biomarker.  
It will be interesting to see in follow-up investigations whether these effects show more clearly 
in a ratio which has only very recently emerged as potentially more powerful in risk prediction 
than the “classic” TCH/HDl ratio: The apoB/apoA ratio of the apo-lipoprotein constituents of 
the cholesterol fractions, which provide additional information about the size and number of 
the cholesterol particles, appeared distinctly superior to the TCH/HDL ratio in predicting CVD 
risk [335].  
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Nevertheless, the fact remains that even a modest lowering of blood lipids in the range 
observed here, will have a sizeable public health impact if this lowering happens across large 
enough groups of the population [336]. 
 
Blood Pressure 
In this study, blood pressure was measured simply as a component of the PROCAM risk 
score, not as a hypothesis generating vital sign in its own right.   
CRF being the primary outcome parameter, has shown to have no significant relation with 
blood pressure, with evidence to this extent being reported in population surveys [337], and in 
clinical trials [338]. Hence, a direct and differential effect of the intervention on blood pressure 
levels, secondary to the primary outcome of CRF, could not have been formulated a priori.  
This in itself may be construed as a null-hypothesis, which can be subjected to evaluation 
with the sample data. The finding of a significant and clinically relevant lowering of diastolic 
blood pressure, could be construed as a potential rejection of this null hypothesis. This result, 
however, needs to be assessed in the wider context of this trial. 
Hence, the seemingly counterintuitive observation of a significant, and clinically relevant 
reduction of diastolic pressure by 5 mmHg across CFL groups, with no concomitant reduction 
in systolic pressure, warranted a closer inspection.  
While CRF may not have a direct correlation with blood pressure, the secondary effect – 
weight loss in response to increased PA - is known to correlate with blood pressure and the 
hypertensive state.  
The Treatment Of Mild Hypertension Study (TOMHS), which randomized its 902 male and 
female participants (aged 45-69 years) into either lifestyle only or lifestyle combined with 1 of 
5 different medications, reported significant changes of blood pressure correlating with weight 
loss for the lifestyle only participants [339]. Interestingly, the weekly physical activity target, 
when expressed in calories spent on exercise, was 600 kcal, which makes it very similar to 
the ELF minimum requirement. The 109 lifestyle-only participants who had lost up to 4.5 kg at 
the 1-year interim-follow-up had seen a mean reduction of systolic and diastolic pressure of 
8.8 and 7.8 mmHg respectively.  
These reductions are in excess of what has been reported from meta-analyses by others, 
which indicate an approximate 1 mmHg reduction for every 1 kg of body weight lost [304, 
340].  
Stevens et al. reported a mean reduction of 7 and 5 mmHg for systolic and diastolic blood 
pressure in response to a weight reduction of >4.4 kg after 6 months of a weight loss 
intervention in 1191 male and female participants [298]. 
In these contexts, the 4.3 mmHg reduction of systolic blood pressure, experienced by the 
weight-reducing overweight participants with baseline elevated blood pressure, corresponds 
with published evidence.  
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A reduction in CVD, stroke and all-cause mortality of 9%, 14% and 7% respectively had been 
suggested as the potential effect of a 5mmHg reduction of systolic pressure in the 45-64 year 
age population [341]. This makes the reduction of blood pressure, witnessed in the Elf 
sample, of significance to public health. Further investigations with larger sample sizes are 
warranted to investigate the ELF strategy with respect to blood-pressure specific hypotheses.  
 
PROCAM Score 
The PROCAM score, which has been developed from German reference populations [342-
344], is widely accepted for risk calculation in this population. The risk factors included in its 
algorithm are gender, age, HDL, LDL, TG, systolic blood pressure, smoking (yes/no), 
diabetes (yes/no) and family history of myocardial infarction.  
The small absolute changes of this score, observed with within- and between-group 
significance, need to be viewed relative to the low risk with which the ELF participants had 
entered the study. While this small absolute reduction of risk may not appear to be of 
substantial clinical relevance, its statistical significance indicates that the ELF intervention is 
able to reduce cardiovascular risk, as measured and expressed with the PROCAM score, in 
its participants. These may be more pronounced at higher risk levels than those presented by 
the ELF sample.  
With respect to the relative changes observed in all three strata, it is worthy to keep in mind 
that the adherence strata reflect a progressive increase of the duration of self-monitoring 
(presence of an active controlled feedback loop) from CFL90 to CFL150. It is therefore 
necessary to keep in mind that the CFL- group of the CFL120 and CFL150 strata contain the 
data of subjects who met the latency and volume conditions but not the duration condition for 
the respective strata. These subjects’ improved risk scores moderate the effects of 
unchanged or deteriorating risk scores of the non-adherent subjects in the CFL- groups of the 
CFL120 & CFL150 strata.  
It is tempting to suggest that the progressively moderating gap between the CFL- and CFL+ 
groups, with a concomitant increase of the risk reduction in the CFL+ groups, is the result of 
an inverse dose-response relationship between duration of the PA intervention and PROCAM 
risk score. However, the difference in mean %-risk reduction between the CFL+ groups 
remained non-significant, which leaves any interpretation speculative only. 
It is also informative to compare an individual’s actual risk, with achievable minimal risk, given 
optimal levels of risk factors. For a 50 year old non-diabetic, non-smoking man, with levels of 
HDL, LDL, TG and systolic pressure of 60 mg/dl, 100 mg/dl, 100 mg/dl and 120 mmHg 
respectively, the risk of suffering a coronary event within the next 10 years is 1.1% and 1.6%, 
in the absence respectively presence of a family history of myocardial infarction. Based on 
this consideration, the change in risk score had been evaluated excluding those participants 
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whose risk score was below the 1% mark. Given these benchmarks, even the low-risk ELF 
participants presented a significant potential for further risk reduction.  
The proportion of CFL+ participants, who had reduced their PROCAM risk score by at least 
10% was nearly 3 times the proportion of CFL- subjects achieving the same reduction (58.9% 
vs. 20%). This result supports the notion that the ELF intervention effect can be benchmarked 
with, and expressed in, terms of a risk assessment tool which is commonly used in clinical 
practice.  
 
The Intervention Effects On The Overweight Participants 
The primary target for the ELF behavior change intervention is the sedentary overweight 
adult. With 51.3% (95% CI 42.0% - 60.5%) of the ELF participants being overweight 
(25<BMI<30) at baseline, and another 33.9% (95% CI 25.1% - 42.6%) being obese, 
altogether 85.2% of the ELF sample matched the target profile. The 73.7% of this group who 
had met the CFL+ criteria in the CFL 90 strata achieved clinically meaningful improvements of 
CRF and reductions of BMI and of bodyweight, which were approximately 3 times the 
magnitude of their inactive peers’ results. TCH/HDL ratio and PROCAM score improved 
significantly and to a clinically relevant degree, with non-significant deterioration of the same 
in the overweight CFL- participants. It is worthy to recall, that this intervention’s primary 
objective was not weight reduction, but improvement of CRF. The expected intervention effect 
on body weight, as estimated a priori, and based on the minimum physical activity target of 
3x20’ of high intensity interval training per week, was exceeded in this group by a factor of 2. 
The most important aspect of this observation, however, is not the magnitude of the effect, 
rather than the reason for its occurrence. The median time spent in exercise (158 minutes 
weekly) exceeded the minimum requirement by a factor of 2.6.  
Contrary to frequently encountered intervention strategies, this trial did neither specify a fixed 
amount of time to be spent exercising, nor did it set the goal at the 150-minute mark for 
moderate intensity exercise currently recommended as the weekly minimum to generate 
health benefits [277]. The intention of this trial’s strategy was to define an exercise mode 
(HIT), which was both short and effective enough to initiate (a) good adherence by being 
“minimally invasive” with respect to the participants’ lifestyles, and thereby (b) stimulate a 
voluntary gradual expansion of the exercising effort. The adherence rate and self-reported 
time spent exercising support the validity of this notion.  
Of particular interest in this respect is the response obtained from a considerable number of 
participants, who reported experiencing a marked increase in physical fitness after 3-4 HIT 
sessions. This improvement manifested either as the ability to perform an increased number 
of consecutive HIT intervals, or as an increase in power output. In any case, this experience 
stimulated a subsequently increasing commitment to exercise.   
Admittedly qualitative, this observation is in line with published evidence that achieving 
tangible results relatively quickly after commencing lifestyle change is an important 
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contributor to success. So has the degree of weight reduction in the first few weeks of a 
weight loss intervention emerged as a determinant of longer term adherence and weight loss 
success [345].  
 
Comparison With Peers 
One reason for implementing high-intensity interval training as the recommended mode of 
exercise was the expected time-efficiency of this protocol. As discussed in the introductory 
section, the protocol of thrice-weekly 20 minutes high-intensity interval training has shown to 
yield cardiovascular benefits, which are comparable to those achieved with continuous 
aerobic training of substantially longer duration. 
The significantly smaller height and weight and higher body fat content, with concomitant non-
significant difference in BMI, reflect the fact that the sample of Miyaki et al. consisted of 
Japanese subjects. Compared to Europeans, Asians have a higher body fat content at the 
same BMI value [305, 306]. This may partly explain the significantly lower VO2peak value 
observed in this Japanese sample. This, however remains speculative, as, though the data 
for this sample have been published on a per-subject basis, VO2peak values were only 
available as a group mean, which prevented analyses of VO2peak per kg of lean body mass.  
The striking similarity of the intervention effects, with no significant difference other than 
those, which were expected to be observed for the different ethnic backgrounds, is important 
for two considerations. Firstly, it indirectly confirms the reliability of the participants’ self-
reports on exercise volume, which correlates with intervention effect on CRF as measured in 
VO2peak. Secondly, it bespeaks the efficiency of the ELF intervention, which left the 
curriculum implementation to the participants without any need or requirement for 
supervision.  
Contrary to clinically supervised PA programs, such as the one of Miyaki et al., ELF 
participants were instructed to self-monitor, with the objective to engage a controlled 
feedback loop for the initiation and maintenance of a PA habit in the participant’s lifestyle. The 
results observed and presented in this section support the notion that this strategy yields 
comparable effects on parameters of cardiovascular health, with adherence rates equal to or 
better than what has been reported for PA interventions of similar duration. 
 
An Interim Summary  
The results of the ELF intervention favor the 4 hypotheses to varying degrees. Adherence to 
the intervention at follow-up was well within the hypothesized proportion of 75%. Follow-up 
trials are now warranted to investigate how the applied principles of individualization, 
monitored self-monitoring and continuity can be applied to preserve this relatively high 
retention rate and prevent attrition in the longer term. 
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The intervention effect on cardiorespiratory fitness supports the hypothesis of a significant 
improvement within- as well as between-groups which is of clinical and public health 
relevance.  
The larger than expected effect on body weight status was secondary to a voluntary 2.5 fold 
increase of PA over the initially recommended minimum commitment.  
Of the lipid profile, only TCH/HDL ratio emerged as a beneficiary with a clinically relevant and 
significant decrease. Longer-term follow-up trials of the ELF strategy with larger participant 
numbers are warranted to obtain a more precise estimate of the potential magnitude of this 
intervention’s effect on lipid parameters. That includes the addition of the apolipoprotein ratios 
as outcome measures, which may be more suitable to determine the intervention effects on 
blood lipids.  
Systolic and diastolic blood pressure showed a somewhat paradoxical response to the 
intervention with mean diastolic pressure being reduced to a substantially greater degree than 
systolic pressure. As this parameter was not subject of an a priori hypothesis, specific 
hypothesis testing should be conducted in follow-up investigations.   
The overall risk profile, as expressed in the PROCAM score was reduced with within- and 
between-group significance. The moderate effect, in absolute terms, needs to be viewed in 
the context of a relatively low mean risk profile in this ELF sample. The trial, however, 
provides evidence for the utility of the ELF intervention effect to be benchmarked with the 
widely applied PROCAM score in any given subject population.   
 
EXPERIENCES WITH AND LESSONS DRAWN FROM THE OPERATIONALIZATION OF INTERVENTION 
PRINCIPLES  
A call has been made very recently for the EU to develop national physical activity 
recommendations along the new guidelines formulated by the U.S. American Heart 
Association (AHA) and the American College of Sports Medicine (ACSM) [346]. These 
guidelines specifically acknowledge the evidence-based need for all healthy adults aged 18-
65 to perform either moderate-intensity aerobic exercise for a minimum of 30 min five times 
weekly, or 20 min of vigorous exercise 3 times weekly or any combination thereof [347].  
 
Individualization 
The ELF intervention incorporated this minimum requirement of 3x20 minutes as the basis 
from which the individualized exercise program was then developed. The latter consisted of 
(a) CPET-based heart rate controlled exercise recommendation, (b) self-determination of 
initial exercise targets, which had been (c) agreed upon during a one-to-one initial 
consultation with the investigator, in which each participant received a detailed assessment of 
the relevance of PA to his/her individual baseline profile. Individualizing the exercise 
prescription to each participant’s personal cardiopulmonary dynamics maximizes the training 
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effect. This manifested in tangible and subjectively felt improvements of performance 
relatively quickly (within the first two weeks after commencing the exercise program), which is 
a powerful promoter of continued adherence.  
Letting participants self-determine their PA volume, given the minimum weekly requirement of 
3x20 minutes of high-intensity interval training, yielded a substantially larger actually 
performed volume of exercise. It is therefore tempting to suggest, that it may not so much be 
participants’ fidelity to a pre-conceived one-size-fits-all exercise curriculum, which lifestyle 
change program providers should be concerned with. Rather is it getting people to commit to 
and commence with a physical activity habit, which, if prescribed individually to yield some 
quick tangible effect, will develop its own momentum. It will be interesting for future research 
to contrast these two strategies under the a priori hypothesis of a significant difference in 
outcome.  
 
Self-monitoring 
Participants were given access to a personal web based file, the electronic lifestyle file (ELF), 
and were encouraged to self-report the volume of PA performed. The file provides a graphic 
actual-vs-target feedback on exercise performance. The file also provides for the monitoring 
of various vital signs, such as body weight, blood pressure and blood sugar either through 
manual data entry or through telemetric data link with selected measuring equipments. 
Graphic representations of trends and actual-vs-target performance are presented.  
Participants’ adherence to the self-monitoring process, expressed as login to the web based 
personal file, and adherence to the agreed exercise curriculum, were monitored and followed-
up through personal contacts, either by phone or by email, in cases of login latency in excess 
of 7 days, or in cases of potentially under-achieving the 6-weeks cumulative interim targets. 
While this monitored self-monitoring was referred to by many participants as a strong 
incentive for staying the intervention course, it generated a substantial work-load which had 
been underestimated in the trial design. However, from informal group meetings with 
participants the impression emerged, that it is not so much who “looks over the participant’s 
shoulder” rather than the fact that there is someone, to whom the participant feels 
accountable to, who does the looking. This suggests that delegating the function of 
monitoring to participant-selected peers may equally well serve the purpose of encouraging 
and promoting adherence to behavior change, at least during the critical period of habituating 
a new behavior. Follow-up trials may therefore contrast modes and combinations of 
monitoring and feedback, using non-monitored self-monitoring as the control condition.  
Self-monitoring however ought to be deployed as recognized promoter of intervention 
adherence for which there exists substantial and growing published evidence. Reports from 
the U.S. national weight loss registry, whose registrants present a mean 30 kg weight loss 
maintained over >5 years, have found self-monitoring, a high level of PA and a low-calorie-
low-fat diet as the three most important determinants of weight loss and maintenance of 
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reduced body weight [123, 205]. In a cross-sectional study, others have found that daily or 
almost-daily self-monitoring of energy intake and body weight differentiates the successfully 
weight-reducing individuals from their less successful peers [348].  
Self-monitoring based on daily self weighing has been tested as a maintenance strategy in its 
own right and produced significantly greater success in maintaining weight loss than control 
[206]. 
At the time of designing this trial, the focus was on the increase of CRF in a sedentary 
population. This focus was rooted in the discussed evidence for the substantial health 
benefits to be derived from enhanced cardiorespiratory function, secondary to sufficiently 
increased physical activity of moderate-to-high intensity, and independent of BMI. 
Correspondingly, physical activity was chosen as the primary target for self-monitoring. The 
intervention’s effect on body weight had been substantially underestimated, as much as the 
voluntary increase of actually performed PA over the intervention’s minimum requirement. 
With a view to the motivating power of quick and tangible achievements for persevering in a 
behavior change effort, it therefore appears desirable to include daily weighing as the main 
focus of self-monitoring. A review of the participants’ login records has shown that none of the 
participants had reported body weight on a daily basis. While that does not necessarily 
translate into a lack of daily weighing, recording of body weight, and the graphic presentation 
of averaged weight trends, may provide a powerful additional incentive to persevere with the 
behavior change effort. After all, weight loss is a major objective of most overweight 
participants in the ELF program.  
Body weight is also the central element of the cognitive feedback loop, the two effectors of 
which are physical activity and dietary intake. The latter is currently being incorporated for 
self-monitoring into the ELF architecture. With respect to the dose of PA received, a 
differentiation into its components of intensity, duration and frequency will be provided.  
Once completed, the ELF will facilitate self-monitoring of all effectors (PA and dietary intake) 
as well as all related outcomes (vital signs). Thereby the ELF lends itself to follow-up studies, 
which investigate its effects in larger and different populations, over longer terms and 
exploring the hypotheses suggested here.  
 
Continuity 
Continuity is a principle of the ELF strategy and emerges from the cycle of diagnostic health 
profiling, individualized intervention prescription and self-monitoring guided implementation. 
This trial has seen one revolution of this cycle. Hence, in follow-up studies of longer duration 
the effectiveness of this cycle over several revolutions will need to be investigated. One 
essential feature, though, is the unique ability of the ELF to alert investigators to adherence 
decay in its very early stage. The freely definable alarm functions can be set to identify the 
latency of login as well as the potential of under- (or over-)achieving individual PA targets. 
Thereby investigators may concentrate their motivational efforts on those participants who 
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need them, and avoid wasting such efforts on those who don’t. The latter is inevitable in 
intervention designs of periodic group- or one-on-one interactions between investigators and 
participants, regardless of the latter’s needs or adherence status.  
As mentioned in the introductory section, the idea of tele-monitoring individuals had been 
questioned by some medical practitioners as an Orwellian intrusion into participants lives. The 
experience with this group of participants refutes this notion. Not only did none of the 
participants object to having their progress and adherence monitored, many expressly 
welcomed it as a stimulus to show adherence to the volume of exercise, which they had 
voluntarily submitted to in the initial consultation. Participants for whom the latency and 
volume alarms were never raised, occasionally received a personal “keep it up” message, 
acknowledging their commitment and performance. Coming unexpectedly, these messages 
turned out to be very well received, with almost all recipients expressing thanks and feelings 
of strengthened motivation. These messages were not originally planned in the design phase, 
but incorporated rather ad hoc on a sudden insight. 
 
SPECIFIC LESSON DRAWN FROM A WORKSITE INTERVENTION 
One advantage of recruiting study participants from within a sufficiently sized industrial 
complex is the accessibility of subjects to the investigator as well as the accessibility of on-
site facilities (laboratory testing, fitness center, corporate medical center) to the subjects. 
However the concentration of subjects within one such complex has one distinct 
disadvantage: a high degree of interaction between subjects, either on a professional work-
related level or leisure-time related through joint usage of the common fitness facilities. This 
interconnectedness between intervention participants fosters an inter-subject exchange of 
personal experiences with the intervention.  
In the case of controlled randomized interventions this may affect the outcome of the 
intervention, specifically when individuals with a high motivation to participate in the 
intervention arm had been randomized to the control group. These subjects may inevitably 
learn from their intervention-group peers the details of the intervention curriculum, which the 
control subjects then consequently may follow on their own and without the knowledge of the 
investigator. It is easy to see how such a situation potentially attenuates the intervention’s 
effect size. While this did neither affect the outcome nor design of this study, it is a qualitative 
observation, which was made as an unexpected by-product of having carried out the study, 
and to which fellow researchers ought to be alerted.  
Within the context of the model and theory underlying this intervention, the achieved 
reduction in bodyweight secondary to a PA intervention is clinically relevant and justifies 
future investigations, in which the principles of monitored self-monitoring are extended to 
targets of dietary habits. 
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STUDY STRENGTHS AND WEAKNESSES 
The strengths and weaknesses of this exploratory trial are best discussed in relation to the 
well-established concepts of validity and reliability.  
 
Validity 
Criterion validity refers to a measure’s ability to predict a future event. In the larger context of 
this work, the objective is to reduce the prevalence and incidents of CVD in our population. 
Clearly, to establish criterion validity for the target behavior (increased physical activity) in 
achieving this objective is beyond the scope of this trial. On a smaller scale, criterion validity 
being the degree to which CFL+ subjects maintain their acquired HEPA levels, can only be 
appraised in extensions of this intervention into longer term follow-up studies. These are 
planned as a consequence of the results discussed in this paper. Hence, on the score of 
criterion validity, this work certainly leaves much to desire. 
  
Construct validity is judged by assessing the patterns of correlation between the investigated 
instrument and outcome variables of known cause-effect associations wit the instrument. 
VO2peak is the primary measure for this score, and the study results indicate a sufficient 
validity. This argument extends to the secondary outcomes of body weight and body fat 
status as well as on the biochemical parameters.  
 
Content validity answers the question whether the measurement tool comprehensively 
represents all relevant dimensions of the outcome variable. With respect to physical activity, 
this intervention’s measurement is objectionable on the grounds that frequency and duration, 
having been the subject of participants’ self-reports, do not comprehensively measure PA 
volume when intensity is not measured alongside. This is not the result of neglect but of 
logistic considerations, which necessitated the weighing of desired measurement detail 
against technological aspects and those of participant acceptability. In a perfect world, low-
cost intensity measurement tools (such as heart rate monitors) report their data directly into a 
participant’s web-based lifestyle file, and participants are well motivated to buy and use these 
tools appropriately. It is certainly not for lack of effort of the author who has contacted 
altogether 6 manufacturers of heart rate and other activity monitors with offers to assist in the 
realization of such tele-monitoring features. However, the response has been negative, which 
is hoped to change when researchers and others join in availing themselves of the tool 
developed not only for this research effort, but with the intention to make it available for public 
health research in general. The subject of acceptability touches on the last but not least 
aspect of validity… 
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…Face validity which refers to the acceptability of the intervention to the participants. The 
76% adherence rate bespeaks a reasonable degree of face validity. So do the responses of 
the active participants who had been invited into three focus groups with the aim to elicit 
responses to the questions what worked for them and why and what adjustments need to be 
made to the ELF as the central tool. Aside from a variety of issues pertaining to the interactive 
surface of the tool, the uniform response was, that the simple fact of being monitored was the 
single most important driver of initiating and maintaining the PA curriculum into the previously 
sedentary lifestyle. I admit culpability of not having performed the focus group sessions in a 
format that would have allowed their systematic appraisals, a failure which is to be rectified in 
follow-up investigations.  
 
Reliability 
Internal reliability in this context refers to the consistency of self-monitoring (self-reported) 
physical activity volume. Follow-up investigations need to include an assessment of this 
matter in sub-groups randomly selected from among intervention participants. The appraisal 
of test-retest and intersetting reliability is evidently beyond the scope and purpose of theis 
exploratory trial. Nevertheless these are important aspects to consider when extending this 
intervention to longer term studies in larger populations.  
 
In addition, it is worth remembering that this study population may not be representative of 
the population at large. While it does not suffer appreciably from the healthy-participant effect, 
adherence and outcome may not be replicable to the same extent when this trial’s curriculum 
is translated into populations whose subjects’ motivations to participate may differ from this 
non-randomly selected participant group. However, I contend, that future applications of the 
tool and the strategies investigated herein will yield similarly encouraging results in 
participants who have recognized the need for and importance of lifestyle changes to extend 
health expectancy. I take this optimism from one particular strength of this study, namely its 
simulation of a real-life application of the intervention within a corporate environment. While 
participation was subsidized, participants had to contribute from their own financial resources. 
This reflects what I expect to be the only realistic way of attracting large “multipliers” such as 
employers and insurers into promoting lifestyle change interventions to the populations under 
their care. These multipliers operate under the dictum of economic benefit, which extends to 
investments into health and productivity.   
While the economic benefits may be difficult to express in real dollar terms, the benefits 
accruing to the motivated participant are large and they are known. Non-smoking, normal 
weight and higher amounts of PA have been identified as contributing the bulk to the 
reduction of risk for CVD. Evaluations of the Framingham data indicate that high levels of PA, 
compared to low levels, add 3. 5 years of life expectancy and 3 years of life expectancy free 
of CVD at age 50 to both men and women [349].  
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Examining possibly for the first time the combined effects of not-smoking, high physical 
fitness (as measured by treadmill test) and normal weight status on life expectancy and CVD 
risk, Lee et al. followed 23 657 men aged 30 and older for a mean of 15 years in the Aerobics 
Center Longitudinal Study (ACLS) [350]. The authors report relative risks of 0.41, 0.23 and 
0.31 for CVD events, CVD mortality and all-cause mortality for men meeting all three 
conditions compared to men who smoked, were inactive, and who had a waist girth >94 cm. 
The life expectancy of the latter was also 14 years shorter. According to the authors’ estimate 
only 2-3% of the adult U.S. population meets the three health enhancing criteria, which 
makes evident the potential economic benefit of interventions which increase this proportion.  
I will close this discussion with some insights for the continuation of this line of research as 
they have emerged from this work and the study results.  
 
IN PURSUIT OF A MODEL FOR THE BEHAVIORAL MECHANISMS THAT GENERATE ENERGY 
HOMEOSTASIS 
One can hardly discuss health in general, and the chronic diseases in particular, without 
engaging the concept of homeostasis.  
The medical subject headings (MeSH) of the U.S. National Library of Medicine (NLM) define 
homeostasis as “The processes whereby the internal environment of an organism tends to 
remain balanced and stable”. While this captures the phenomenon of homeostasis in the 
sense as initially described, though not in name, by Claude Bernard [351] and further 
developed by Walter B. Cannon [352], it has two specific implications for the context of this 
study: 
• The biology-behavior dependency 
If homeostasis is the principle of maintaining an organism’s internal stability against 
externally induced perturbations, the organism’s behavior is the required mediator 
between the two. Be it the fight-or-flight response to a stress induced outpouring of 
catecholamines or the hunting/gathering activities precipitated by the coordinated 
actions of Leptin and NPY, it is always the appropriate behavioral response, which 
mediates the resolution of the very perturbations that activated the behavioral drives. 
The principles of natural selection and adaptation imply that these bio-behavioral 
feedback loops must have evolved into the variants, which best ensured the 
organism’s survival and reproductive success within its natural habitat.  
This entails the second aspect, namely the behavioral drives’ autonomy of operation.  
• The autonomy of the behavioral drives 
If survival depends on homeostatic balance and stability, its behavioral mediators 
ought to have been operating autonomously throughout evolution from the inception 
of life. As such it should be verifiable as a genetic imprint, manifesting in similarities 
of behavior across species including humans. The way behavioral research is being 
conducted supports this notion. By using laboratory animals in experiments, which 
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simulate specific external stimuli and internal environments, we not only replicate one 
species’ behavioral phenomena, such as impulsive discounting or ingestive 
behaviors, in another. We also observe the concordance of these animals’ 
autonomously driven behaviors with their human parallels, which we steadfastly 
believe to originate from, and therefore also to yield to, our cognitive faculties and 
free will. 
 
Intuitively it may be difficult to reconcile the dominance of the autonomous behavioral drives 
with the obvious success of survival and reproduction, conferred upon humans by the 
uniquely human mental faculties of volition and cognition. In fact, by their mind, humans have 
bested adaptation to the point where they increase their fitness (in terms of evolution) not by 
their ability to adapt to a given environment, but by adapting the environment to their abilities. 
One detrimental consequence, in the context of this study’ subject, is the elimination of 
obligatory physical activity from the self-correcting feedback loops which guard the human 
organism against homeostatic imbalance. Consequently, initial perturbations potentially 
develop into chronic imbalances leading to the disease endpoints, which make up the current 
epidemics of lifestyle disease.  
It is here where the human volitional and cognitive faculties need to be engaged to re-
establish a salutogenic balance between behavior and physiology. The form of engagement 
may be best described within the concept of allostasis, introduced by McEwen et al. [353].  
It is based on the recognition that there is rarely a single and steady homeostatic state. By 
way of example: If blood glucose is the homeostatic system of interest, changes in its 
mediators may induce an allostatic state in which blood glucose levels become either 
elevated or suppressed. A stress-induced increase in catecholamine production is one 
sample scenario. In it an elevated glucose level is the consequence of an epinephrine-
induced down-regulation of the mediator insulin, of insulin sensitivity and up-regulation of 
hepatic glucose production [354]. At the same time, norepinephrine increases non-insulin 
mediated glucose uptake into muscle and fat tissue. The resulting allostatic load of elevated 
blood sugar makes perfect sense in a stress situation, where the need for a fight-or-flight 
reaction necessitates the release and availability of glucose to fuel the physical reaction. It 
serves the organism well in the short term, when the release of stress hormones drives the 
appropriate behavioral fight-or-flight response, ultimately relieving the stress inducing 
situation. Allostatic load turns into a potentially pathogenic allostatic overload, however, if the 
behavioral response is inadequate, does not happen or if the triggering environmental 
situation persists over extended periods of time. The common denominator for these 
pathogenic scenarios is the disconnect between the physiologic drive and the behavioral 
response.  
Similarly, if an organism, primed for physical activity by the hormonal states, which respond to 
decreasing energy stores, does not engage in the target behavior, which removes the 
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hormonal allostatic load, physiologic imbalance is the inevitable result. In this sense allostasis 
refers to the self-correcting feedback loop in which the physical activity behaviors, with which 
a human will pay the PA costs imposed by its natural habitat on energy acquisition, re-
establish homeostasis as an automatic response to the autonomously operating hormonal 
excursions, which have cued the human into performing these behaviors.  
The sophistication of the human mind has allowed us to (a) remove from our environment the 
obligatory PA element of this feedback loop, but also to (b) elucidate the mechanisms that 
drive this loop and the pathogenic consequences of its derailment. While it is tempting to our 
cognitive faculties to gear into this loop with pharmacological attempts at reestablishing 
homeostasis, the complexities of neuro-hormonal interaction and the multiplicity of effects of 
PA on these interactions confound our capability to manipulate them towards the desired 
results.  
These observations suggest not only the need for re-introducing PA and dietary constraints 
into the modern lifestyle. They also suggest that this reintroduction be modeled along the 
principles of the self-correcting feedback loop, which has proved to be nature’s successful 
way of maintaining its organisms in homeostatic balance.  
Interventions aimed at re-instituting homeostasis need to be framed within the paradigm of 
the biology-behavior continuum. Essential to these efforts is an appreciation of the fact that 
specific behavioral inadequacies are inextricably linked to a given individual’s physiologic 
imbalances of which they are causative.    
As such, we simply need to insert our cognitive faculties into this self-correcting feedback 
loop, as the cognitive effector of the PA, which this loop requires to “run the human engine” 
and to maintain its physical health.  
 
SUGGESTED FOLLOW-UP HYPOTHESES 
The strategy, the principles and the tools presented and tested with this study, are one 
possible approach. The insights emerging from the experience and interaction with the study 
participants led to the contention that the ELF is an effective facilitator, which engages a self-
correcting feedback loop when four essential conditions are met: 
1. Intention: A cognitive intention to lose weight, as the recognized step to reestablish 
energy homeostasis. 
2. Engagement: A daily recording of body weight, physical activity and dietary habits  
3. Feedback: A daily feedback on body weight trend, averaged in a rolling-window over 
periods from 1 week to several weeks, each ending at the actual date.  
4. Knowledge, Skills and Abilities: knowledge about specific exercise and dietary 
options and the skills and abilities for the practical implementation. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 155 of 239 
Given the feedback to daily engagement with the ELF, the intent mind will be engaged as the 
control center of a self-correcting feedback loop. It will drive the individual to consciously and 
subconsciously search for and select those suitable exercise and dietary strategies, which he 
finds at his personal disposal.  
Based on this insight, the ELF is currently undergoing further development to include dietary 
monitoring and to facilitate the monitoring of PA volume to a greater precision. The initial 
experience with several overweight and obese “beta-Testers” strongly suggests the testing of 
the following hypotheses in randomized controlled trials: 
• Daily use of the ELF in a weight reduction intervention leads to significantly larger 
weight loss in overweight and obese adults,a nd to larger intervention effects on risk 
parameters, than conventional strategies 
• Continued post-intervention utilization of the ELF will facilitate the long-term 
maintenance of larger weight losses, and the long-term maintenance of larger 
intervention effects on risk parameters, than discontinuation of ELF utilization.  
 
Taken to their logical conclusion, the considerations and results presented herein advocate 
the abolition of myopic medical attempts to merely correct risk factors and vital signs to within 
their normal ranges, in favor of a strategy of reestablishing the salutogenic homeostatic 
balance as the foundation of health. This is no news to health science. On this subject, 
Hippocrates is being quoted as having said that “It is more important to know the person who 
has a disease, than to know the disease a person has.”  
From the vantage point of today’s knowledge about human physiology, coupled with the 
understanding of its evolutionary origins, Hippocrates’ aphorism could be made even more 
appropriate to today’s patient:  
 
It is more important to correct a person’s bio-behavioral malfunction that manifests in disease, 
than to correct the physiological malfunction with which the disease manifests. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 156 of 239 
REFERENCES 
 
1. Lastra-Gonzalez, G., et al., Insights into the emerging cardiometabolic prevention and 
management of diabetes mellitus. Expert Opin Pharmacother, 2005. 6(13): p. 2209-
21. 
2. Li, Y. and P. Agarwal, A Pathway-Based View of Human Diseases and Disease 
Relationships. PLoS ONE, 2009. 4(2): p. e4346. 
3. Govindarajan, G., et al., The cardiometabolic syndrome as a cardiovascular risk 
factor. Am J Med Sci, 2005. 330(6): p. 311-8. 
4. Gewaltig, M.T. and G. Kojda, Vasoprotection by nitric oxide: mechanisms and 
therapeutic potential. Cardiovasc Res, 2002. 55(2): p. 250-60. 
5. Physical Activity Guidelines Advisory Committee, Physical Activity Guidelines 
Advisory Committee Report. 2008, U.S. Department of Health and Human Services: 
Washington, D.C. 
6. Dunn, A.L., Effectiveness of Lifestyle Physical Activity Interventions to Reduce 
Cardiovascular Disease. American Journal of Lifestyle Medicine, 2009: p. 
1559827609336067. 
7. Cordain, L., et al., Physical activity, energy expenditure and fitness: an evolutionary 
perspective. Int J Sports Med, 1998. 19(5): p. 328-35. 
8. Booth, F.W., et al., Waging war on physical inactivity: using modern molecular 
ammunition against an ancient enemy. J Appl Physiol, 2002. 93(1): p. 3-30. 
9. Booth, F., et al., Reduced physical activity and risk of chronic disease: the biology 
behind the consequences. European Journal of Applied Physiology, 2008. 102(4): p. 
381-390. 
10. Neel, J.V., The "thrifty genotype" in 1998. Nutr Rev, 1999. 57(5 Pt 2): p. S2-9. 
11. Neel, J.V., Diabetes mellitus: a "thrifty" genotype rendered detrimental by "progress"? 
Am J Hum Genet, 1962. 14: p. 353-62. 
12. Lederberg, J., Molecular biology, eugenics and euphenics. Nature, 1963. 198: p. 428-
9. 
13. Troiano, R.P., et al., Physical activity in the United States measured by 
accelerometer. Med Sci Sports Exerc, 2008. 40(1): p. 181-8. 
14. Sjöström, M., et al., Health-enhancing physical activity across European Union 
countries: the Eurobarometer study. Journal of Public Health, 2006. 14(5): p. 291-
300. 
15. Weitkunat, R. and M. Moretti, Health and behavior, in ABC of Behavior Change, J. 
Kerr, R. Weitkunat, and M. Moretti, Editors. 2005, Elsevier: Edinburgh. p. 17-27. 
16. Veerman, J.L., et al., Stemming the Obesity Epidemic: A Tantalizing Prospect. 
Obesity, 2007. 15(9): p. 2365-2370. 
17. Christakis, N.A. and J.H. Fowler, The Spread of Obesity in a Large Social Network 
over 32 Years. N Engl J Med, 2007. 357(4): p. 370-379. 
18. Booth, M.L., et al., Trends in the Prevalence of Overweight and Obesity among 
Young Australians, 1985, 1997, and 2004. Obesity, 2007. 15(5): p. 1089-1095. 
19. Flegal, K.M., et al., Prevalence and Trends in Obesity Among US Adults, 1999-2000. 
JAMA, 2002. 288(14): p. 1723-1727. 
20. Apovian, C.M., The causes, prevalence and treatment of obesity revisited in 2009: 
what have we learned so far? Am J Clin Nutr, 2009: p. ajcn.2009.28473A. 
21. Bosy-Westphal, A., et al., Contribution of individual organ mass loss to weight loss-
associated decline in resting energy expenditure. Am J Clin Nutr, 2009: p. 
ajcn.2008.27402. 
22. Sodersten, P., et al., Behavioral neuroendocrinology and treatment of anorexia 
nervosa. Front Neuroendocrinol, 2008. 29(4): p. 445-62. 
23. Wannamethee, S.G. and A.G. Shaper, Physical activity in the prevention of 
cardiovascular disease: an epidemiological perspective. Sports Med, 2001. 31(2): p. 
101-14. 
24. Sandison, A.T., Degenerative vascular disease in the Egyptian mummy. Med Hist, 
1962. 6: p. 77-81. 
25. Zimmerman, M.R., The paleopathology of the cardiovascular system. Tex Heart Inst 
J, 1993. 20(4): p. 252-7. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 157 of 239 
26. Oeppen, J. and J.W. Vaupel, Demography. Broken limits to life expectancy. Science, 
2002. 296(5570): p. 1029-31. 
27. Lietava, J., M. Thurzo, and A. Dukat, Paleodiet and its relation to atherosclerosis. 
Ann NY Acad Sci, 1997. 827(1): p. 382-391. 
28. Beaglehole, R., A. Irwin, and T. Prentice, The World Health Report 2003; Shaping the 
Future, in The World Health Report. 2003, World Health Organization. p. 204. 
29. CDC, A Public Health Action Plan to Prevent Heart Disease and Stroke. 2003, U.S. 
Department of Health and Human Services. p. 132. 
30. OECD (2004) Health Spending in Most OECD Countries Rises, with the U.S. far 
Outstripping all Others. 
31. OECD, Health at a Glance: OECD Indicators 2005. 2005: OECD. 
32. Healthy People 2010: Understanding and Improving Health. 2000, Washington, DC: 
U.S. Department of Health and Human Services. 
33. Ford, E.S., et al., Trends in the Prevalence of Low Risk Factor Burden for 
Cardiovascular Disease Among United States Adults. Circulation, 2009. 
34. Virmani, R., et al., Pathology of the Vulnerable Plaque. Journal of the American 
College of Cardiology, 2006. 47(8, Supplement 1): p. C13-C18. 
35. Lightwood, J., et al., Forecasting the Future Economic Burden of Current Adolescent 
Overweight: An Estimate of the Coronary Heart Disease Policy Model. Am J Public 
Health, 2009: p. AJPH.2008.152595. 
36. Bassuk, S.S. and J.E. Manson, Epidemiological evidence for the role of physical 
activity in reducing risk of type 2 diabetes and cardiovascular disease. J Appl Physiol, 
2005. 99(3): p. 1193-1204. 
37. Powell, K.E., et al., Physical activity and the incidence of coronary heart disease. 
Annu Rev Public Health, 1987. 8: p. 253-87. 
38. Thompson, P.D., et al., Exercise and physical activity in the prevention and treatment 
of atherosclerotic cardiovascular disease: a statement from the Council on Clinical 
Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the 
Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical 
Activity). Circulation, 2003. 107(24): p. 3109-16. 
39. U.S. Department of Health and Human Services, Physical Activity and Health: A 
Report of the Surgeon General. 1996, Centers for Disease Control and Prevention, 
National Center for Chronic Disease Prevention and Health Promotion: Atlanta. p. 
300. 
40. Hamer, M., E. Stamatakis, and J.M. Saxton, The impact of physical activity on all-
cause mortality in men and women after a cancer diagnosis. Cancer Causes Control, 
2009. 20(2): p. 225-31. 
41. Apullan, F.J., et al., Usefulness of Self-Reported Leisure-Time Physical Activity to 
Predict Long-Term Survival in Patients With Coronary Heart Disease. The American 
Journal of Cardiology, 2008. 102(4): p. 375-379. 
42. Hakim, A.A., et al., Effects of walking on coronary heart disease in elderly men: the 
Honolulu Heart Program. Circulation, 1999. 100(1): p. 9-13. 
43. Sesso, H.D., R.S. Paffenbarger, Jr., and I.M. Lee, Physical activity and coronary 
heart disease in men: The Harvard Alumni Health Study. Circulation, 2000. 102(9): p. 
975-80. 
44. Heitmann, B.L., et al., Obesity, Leanness, and Mortality: Effect Modification by 
Physical Activity in Men and Women. Obesity, 2008. 17(1): p. 136-142. 
45. Orsini, N., et al., Combined effects of obesity and physical activity in predicting 
mortality among men. Journal of Internal Medicine, 2008. 264(5): p. 442-451. 
46. Koster, A., et al., Joint Associations of Adiposity and Physical Activity With Mortality: 
The National Institutes of Health-AARP Diet and Health Study. Am. J. Epidemiol., 
2009. 169(11): p. 1344-1351. 
47. Mora, S., et al., Association of Physical Activity and Body Mass Index With Novel and 
Traditional Cardiovascular Biomarkers in Women. JAMA, 2006. 295(12): p. 1412-
1419. 
48. von Bonsdorff, M.B., et al., Physical Activity History and End-of-Life Hospital and 
Long-Term Care. J Gerontol A Biol Sci Med Sci, 2009: p. glp029. 
49. Stessman, J., et al., Physical Activity, Function, and Longevity Among the Very Old. 
Arch Intern Med, 2009. 169(16): p. 1476-1483. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 158 of 239 
50. Mustelin, L., et al., Physical activity reduces the influence of genetic effects on BMI 
and waist circumference: a study in young adult twins. Int J Obes (Lond), 2008. 
51. Silventoinen, K., et al., Modification effects of physical activity and protein intake on 
heritability of body size and composition. Am J Clin Nutr, 2009: p. ajcn.2009.27689. 
52. Kottke, T.E., et al., The Comparative Effectiveness of Heart Disease Prevention and 
Treatment Strategies. American Journal of Preventive Medicine, 2009. 36(1): p. 82-
88.e5. 
53. Mora, S., et al., Physical Activity and Reduced Risk of Cardiovascular Events. 
Potential Mediating Mechanisms. Circulation, 2007: p. 
CIRCULATIONAHA.107.729939. 
54. Lamon, B.D. and D.P. Hajjar, Inflammation at the Molecular Interface of 
Atherogenesis: An Anthropological Journey. Am J Pathol, 2008. 173(5): p. 1253-
1264. 
55. Braunwald, E., Shattuck lecture--cardiovascular medicine at the turn of the 
millennium: triumphs, concerns, and opportunities. N Engl J Med, 1997. 337(19): p. 
1360-9. 
56. McNeill, A.M., et al., The metabolic syndrome and 11-year risk of incident 
cardiovascular disease in the atherosclerosis risk in communities study. Diabetes 
Care, 2005. 28(2): p. 385-90. 
57. Wannamethee, S.G., et al., Metabolic syndrome vs Framingham Risk Score for 
prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern 
Med, 2005. 165(22): p. 2644-50. 
58. Alberti, G., Introduction to the metabolic syndrome. Eur Heart J Suppl, 2005. 
7(suppl_D): p. D3-5. 
59. Conen, D., et al., Metabolic Syndrome, Inflammation, and Risk of Symptomatic 
Peripheral Artery Disease in Women. A Prospective Study. Circulation, 2009: p. 
CIRCULATIONAHA.109.863092. 
60. Hansson, G.K., Inflammation, atherosclerosis, and coronary artery disease. N Engl J 
Med, 2005. 352(16): p. 1685-95. 
61. Mach, F., Inflammation is a crucial feature of atherosclerosis and a potential target to 
reduce cardiovascular events. Handb Exp Pharmacol, 2005(170): p. 697-722. 
62. Kasapis, C. and P.D. Thompson, The effects of physical activity on serum C-reactive 
protein and inflammatory markers: a systematic review. J Am Coll Cardiol, 2005. 
45(10): p. 1563-9. 
63. Wannamethee, S.G., et al., Physical activity and hemostatic and inflammatory 
variables in elderly men. Circulation, 2002. 105(15): p. 1785-90. 
64. Kadoglou, N.P., et al., The anti-inflammatory effects of exercise training in patients 
with type 2 diabetes mellitus. Eur J Cardiovasc Prev Rehabil, 2007. 14(6): p. 837-43. 
65. Autenrieth, C., et al., Association between different domains of physical activity and 
markers of inflammation. Med Sci Sports Exerc, 2009. 41(9): p. 1706-13. 
66. Kunsch, C. and R.M. Medford, Oxidative Stress as a Regulator of Gene Expression 
in the Vasculature. Circ Res, 1999. 85(8): p. 753-766. 
67. Ross, R., Atherosclerosis--an inflammatory disease. N Engl J Med, 1999. 340(2): p. 
115-26. 
68. Clinton, S.K., et al., Macrophage colony-stimulating factor gene expression in 
vascular cells and in experimental and human atherosclerosis. Am J Pathol, 1992. 
140(2): p. 301-16. 
69. Virmani, R., et al., Coronary artery atherosclerosis revisited in Korean war combat 
casualties. Arch Pathol Lab Med, 1987. 111(10): p. 972-6. 
70. Tuzcu, E.M., et al., High prevalence of coronary atherosclerosis in asymptomatic 
teenagers and young adults: evidence from intravascular ultrasound. Circulation, 
2001. 103(22): p. 2705-10. 
71. Virmani, R., et al., Lessons from sudden coronary death: a comprehensive 
morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb 
Vasc Biol, 2000. 20(5): p. 1262-75. 
72. Arbustini, E., et al., Plaque erosion is a major substrate for coronary thrombosis in 
acute myocardial infarction. Heart, 1999. 82(3): p. 269-72. 
73. Stary, H.C., The sequence of cell and matrix changes in atherosclerotic lesions of 
coronary arteries in the first forty years of life. Eur Heart J, 1990. 11 Suppl E: p. 3-19. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 159 of 239 
74. Tedgui, A. and Z. Mallat, Cytokines in atherosclerosis: pathogenic and regulatory 
pathways. Physiol Rev, 2006. 86(2): p. 515-81. 
75. Insull Jr, W., The Pathology of Atherosclerosis: Plaque Development and Plaque 
Responses to Medical Treatment. The American Journal of Medicine, 2009. 122(1, 
Supplement 1): p. S3-S14. 
76. Busse, R. and I. Fleming, Endothelial dysfunction in atherosclerosis. J Vasc Res, 
1996. 33(3): p. 181-94. 
77. Furchgott, R.F. and J.V. Zawadzki, The obligatory role of endothelial cells in the 
relaxation of arterial smooth muscle by acetylcholine. Nature, 1980. 288(5789): p. 
373-6. 
78. Palmer, R.M., A.G. Ferrige, and S. Moncada, Nitric oxide release accounts for the 
biological activity of endothelium-derived relaxing factor. Nature, 1987. 327(6122): p. 
524-6. 
79. Ignarro, L.J., et al., Endothelium-derived relaxing factor produced and released from 
artery and vein is nitric oxide. Proc Natl Acad Sci U S A, 1987. 84(24): p. 9265-9. 
80. Freedman, J.E., et al., Deficient platelet-derived nitric oxide and enhanced 
hemostasis in mice lacking the NOSIII gene. Circ Res, 1999. 84(12): p. 1416-21. 
81. Lefer, D.J., et al., Leukocyte-endothelial cell interactions in nitric oxide synthase-
deficient mice. Am J Physiol, 1999. 276(6 Pt 2): p. H1943-50. 
82. Garg, U.C. and A. Hassid, Nitric oxide-generating vasodilators and 8-bromo-cyclic 
guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat 
vascular smooth muscle cells. J Clin Invest, 1989. 83(5): p. 1774-7. 
83. Alderton, W.K., C.E. Cooper, and R.G. Knowles, Nitric oxide synthases: structure, 
function and inhibition. Biochem J, 2001. 357(Pt 3): p. 593-615. 
84. Murray, R.K., et al., Harper's Biochemistry. 2000: McGraw-Hill. 
85. Kuhlencordt, P.J., et al., Accelerated atherosclerosis, aortic aneurysm formation, and 
ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-
knockout mice. Circulation, 2001. 104(4): p. 448-54. 
86. Kuhlencordt, P.J., et al., Genetic deficiency of inducible nitric oxide synthase reduces 
atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. 
Circulation, 2001. 103(25): p. 3099-104. 
87. Turko, I.V. and F. Murad, Protein Nitration in Cardiovascular Diseases. Pharmacol 
Rev, 2002. 54(4): p. 619-634. 
88. Patel, R.P., et al., Cell signaling by reactive nitrogen and oxygen species in 
atherosclerosis. Free Radic Biol Med, 2000. 28(12): p. 1780-94. 
89. Schopfer, F.J., P.R. Baker, and B.A. Freeman, NO-dependent protein nitration: a cell 
signaling event or an oxidative inflammatory response? Trends Biochem Sci, 2003. 
28(12): p. 646-54. 
90. Fridovich, I., Superoxide anion radical (O2-.), superoxide dismutases, and related 
matters. J Biol Chem, 1997. 272(30): p. 18515-7. 
91. Pacher, P., J.S. Beckman, and L. Liaudet, Nitric oxide and peroxynitrite in health and 
disease. Physiol Rev, 2007. 87(1): p. 315-424. 
92. Rubbo, H., et al., Nitric oxide regulation of superoxide and peroxynitrite-dependent 
lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J 
Biol Chem, 1994. 269(42): p. 26066-75. 
93. Ji, L.L., Antioxidants and oxidative stress in exercise. Proc Soc Exp Biol Med, 1999. 
222(3): p. 283-92. 
94. Gielen, S., G. Schuler, and R. Hambrecht, Exercise training in coronary artery 
disease and coronary vasomotion. Circulation, 2001. 103(1): p. E1-6. 
95. Joyner, M.J. and D.J. Green, Excersise protects the cardiovascular system: effects 
beyond traditional risk factors. The Journal of Physiology, 2009: p. -. 
96. Svindland, A., The localization of sudanophilic and fibrous plaques in the main left 
coronary bifurcation. Atherosclerosis, 1983. 48(2): p. 139-145. 
97. Ku, D.N., et al., Pulsatile flow and atherosclerosis in the human carotid bifurcation. 
Positive correlation between plaque location and low oscillating shear stress. 
Arteriosclerosis, 1985. 5(3): p. 293-302. 
98. Zarins, C.K., et al., Carotid bifurcation atherosclerosis. Quantitative correlation of 
plaque localization with flow velocity profiles and wall shear stress. Circ Res, 1983. 
53(4): p. 502-14. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 160 of 239 
99. Nagel, T., et al., Shear stress selectively upregulates intercellular adhesion molecule-
1 expression in cultured human vascular endothelial cells. J Clin Invest, 1994. 94(2): 
p. 885-91. 
100. Urbich, C., et al., Laminar shear stress upregulates integrin expression: role in 
endothelial cell adhesion and apoptosis. Circ Res, 2000. 87(8): p. 683-9. 
101. Chien, S., Mechanotransduction and endothelial cell homeostasis: the wisdom of the 
cell. Am J Physiol Heart Circ Physiol, 2007. 292(3): p. H1209-24. 
102. Taylor, C.A., T.J. Hughes, and C.K. Zarins, Effect of exercise on hemodynamic 
conditions in the abdominal aorta. J Vasc Surg, 1999. 29(6): p. 1077-89. 
103. Pepine, C.J., The impact of nitric oxide in cardiovascular medicine: untapped 
potential utility. Am J Med, 2009. 122(5 Suppl): p. S10-5. 
104. Fukai, T., et al., Regulation of the vascular extracellular superoxide dismutase by 
nitric oxide and exercise training. J Clin Invest, 2000. 105(11): p. 1631-9. 
105. Hambrecht, R., et al., Percutaneous coronary angioplasty compared with exercise 
training in patients with stable coronary artery disease: a randomized trial. 
Circulation, 2004. 109(11): p. 1371-8. 
106. Miyaki, A., et al., Effect of habitual aerobic exercise on body weight and arterial 
function in overweight and obese men. Am J Cardiol, 2009. 104(6): p. 823-8. 
107. Widlansky, M.E., et al., The clinical implications of endothelial dysfunction. J Am Coll 
Cardiol, 2003. 42(7): p. 1149-60. 
108. Bonetti, P.O., L.O. Lerman, and A. Lerman, Endothelial dysfunction: a marker of 
atherosclerotic risk. Arterioscler Thromb Vasc Biol, 2003. 23(2): p. 168-75. 
109. Walther, C., S. Gielen, and R. Hambrecht, The effect of exercise training on 
endothelial function in cardiovascular disease in humans. Exerc Sport Sci Rev, 2004. 
32(4): p. 129-34. 
110. Kojda, G. and R. Hambrecht, Molecular mechanisms of vascular adaptations to 
exercise. Physical activity as an effective antioxidant therapy? Cardiovasc Res, 2005. 
67(2): p. 187-97. 
111. Jakicic, J.M., et al., American College of Sports Medicine position stand. Appropriate 
intervention strategies for weight loss and prevention of weight regain for adults. Med 
Sci Sports Exerc, 2001. 33(12): p. 2145-56. 
112. Talbot, L.A., J.L. Fleg, and E.J. Metter, Secular trends in leisure-time physical activity 
in men and women across four decades. Prev Med, 2003. 37(1): p. 52-60. 
113. Luepker, R.V., et al., Community education for cardiovascular disease prevention. 
Morbidity and mortality results from the Minnesota Heart Health Program. Am J 
Epidemiol, 1996. 144(4): p. 351-62. 
114. Hoffmeister, H., et al., Reduction of coronary heart disease risk factors in the German 
cardiovascular prevention study. Prev Med, 1996. 25(2): p. 135-45. 
115. Hillsdon, M., et al., National level promotion of physical activity: results from 
England's ACTIVE for LIFE campaign. J Epidemiol Community Health, 2001. 55(10): 
p. 755-761. 
116. Gidlow, C., et al., Socio-demographic patterning of referral, uptake and attendance in 
Physical Activity Referral Schemes. J Public Health (Oxf), 2007. 29(2): p. 107-13. 
117. Gidlow, C., et al., Attendance of exercise referral schemes in the UK: A systematic 
review. Health Education Journal, 2005. 64(2): p. 168-186. 
118. Robison, J.I. and M.A. Rogers, Adherence to exercise programmes. 
Recommendations. Sports Med, 1994. 17(1): p. 39-52. 
119. O'Neil, H.A. and S.N. Blair, Enhancing adherence in clinical exercise trials. Quest, 
2001. 53: p. 310-317. 
120. Graffagnino, C.L., et al., Effect of a community-based weight management program 
on weight loss and cardiovascular disease risk factors. Obesity (Silver Spring), 2006. 
14(2): p. 280-8. 
121. Miller, W.C., How effective are traditional dietary and exercise interventions for weight 
loss? Med Sci Sports Exerc, 1999. 31(8): p. 1129-34. 
122. Wing, R.R., et al., Behavioral science research in diabetes: lifestyle changes related 
to obesity, eating behavior, and physical activity. Diabetes Care, 2001. 24(1): p. 117-
23. 
123. Wing, R.R. and J.O. Hill, SUCCESSFUL WEIGHT LOSS MAINTENANCE. Annual 
Review of Nutrition, 2001. 21(1): p. 323-341. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 161 of 239 
124. Brandstrom, Y., et al., Physical activity six months after a myocardial infarction. Int J 
Nurs Pract, 2009. 15(3): p. 191-7. 
125. Wanner, M., et al., Effectiveness of active-online, an individually tailored physical 
activity intervention, in a real-life setting: randomized controlled trial. J Med Internet 
Res, 2009. 11(3): p. e23. 
126. De Cocker, K.A., I.M. De Bourdeaudhuij, and G.M. Cardon, The effect of a multi-
strategy workplace physical activity intervention promoting pedometer use and step 
count increase. Health Educ. Res., 2009: p. cyp052. 
127. World Health Organization: Adherence to long-term therapies: evidence for action.  . 
2003: Geneva. 
128. Stewart, M.A., Effective physician-patient communication and health outcomes: a 
review. CMAJ, 1995. 152(9): p. 1423-33. 
129. Boon, H. and M. Stewart, Patient-physician communication assessment instruments: 
1986 to 1996 in review. Patient Educ Couns, 1998. 35(3): p. 161-76. 
130. Eden, K.B., et al., Does counseling by clinicians improve physical activity? A 
summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern 
Med, 2002. 137(3): p. 208-15. 
131. Marcus, B.H., et al., Efficacy of an individualized, motivationally-tailored physical 
activity intervention. Ann Behav Med, 1998. 20(3): p. 174-80. 
132. Winzenberg, T., P. Reid, and K. Shaw, Assessing physical activity in general 
practice: a disconnect between clinical practice and public health? Br J Gen Pract, 
2009. 
133. WHO, Integrating prevention into health care, W.H. Organization, Editor. 2002. 
134. Delamater, A.M., Improving Patient Adherence. Clinical Diabetes, 2006. 24(2): p. 71-
77. 
135. Leventhal, H. and L. Cameron, Behavioral theories and the problem of compliance. 
Patient Education and Counseling, 1987. 10(2): p. 117-138. 
136. Janz, N.K. and M.H. Becker, The Health Belief Model: a decade later. Health Educ Q, 
1984. 11(1): p. 1-47. 
137. Harrison, J.A., P.D. Mullen, and L.W. Green, A meta-analysis of studies of the Health 
Belief Model with adults. Health Educ Res, 1992. 7(1): p. 107-16. 
138. Taggart, H.M. and S.E. Connor, The relation of exercise habits to health beliefs and 
knowledge about osteoporosis. J Am Coll Health, 1995. 44(3): p. 127-30. 
139. Wallace, L.S., Osteoporosis prevention in college women: application of the 
expanded health belief model. Am J Health Behav, 2002. 26(3): p. 163-72. 
140. Wdowik, M.J., et al., Expanded health belief model predicts diabetes self-
management in college students. J Nutr Educ, 2001. 33(1): p. 17-23. 
141. Pham, D.T., F. Fortin, and M.F. Thibaudeau, The role of the Health Belief Model in 
amputees' self-evaluation of adherence to diabetes self-care behaviors. Diabetes 
Educ, 1996. 22(2): p. 126-32. 
142. Mirotznik, J., L. Feldman, and R. Stein, The health belief model and adherence with a 
community center-based, supervised coronary heart disease exercise program. J 
Community Health, 1995. 20(3): p. 233-47. 
143. Montano, D. and D. Kasprzyk, The theory of reasoned action and the theory of 
planned behavior, in Health behavior and health education:  theory, research, and 
practice., K. Glanz, B. Rimer, and F. Lewis, Editors. 2002, Jossey-Bass publishing: 
San Francisco. 
144. Ajzen, I. and M. Fishbein, Understanding attitudes and predicting social behavior. 
1980, Englewood Cliffs: Prentice-Hall. 
145. Prochaska, J.O., C.C. DiClemente, and J.C. Norcross, In search of how people 
change. Applications to addictive behaviors. Am Psychol, 1992. 47(9): p. 1102-14. 
146. Hutchison, A.J., J.D. Breckon, and L.H. Johnston, Physical Activity Behavior Change 
Interventions Based on the Transtheoretical Model: A Systematic Review. Health 
Educ Behav, 2008. 
147. Callaghan, P., E. Khalil, and I. Morres, A prospective evaluation of the 
Transtheoretical Model of Change applied to exercise in young people. Int J Nurs 
Stud, 2009. 
148. Holden, G., The relationship of self-efficacy appraisals to subsequent health related 
outcomes: a meta-analysis. Soc Work Health Care, 1991. 16(1): p. 53-93. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 162 of 239 
149. Martin, M.Y., et al., Characteristics of insufficiently active hypertensive Black women 
who volunteer to be in a physical activity promotion intervention: an application of 
social cognitive theory and the transtheoretical model. Ethn Dis, 2007. 17(4): p. 604-
10. 
150. Rogers, L.Q., et al., Social cognitive theory and physical activity during breast cancer 
treatment. Oncol Nurs Forum, 2005. 32(4): p. 807-15. 
151. Ince, M.L., Use of a social cognitive theory-based physical-activity intervention on 
health-promoting behaviors of university students. Percept Mot Skills, 2008. 107(3): 
p. 833-6. 
152. Petosa, R.L., R. Suminski, and B. Hortz, Predicting vigorous physical activity using 
social cognitive theory. Am J Health Behav, 2003. 27(4): p. 301-10. 
153. Schwarzer, R., Modeling Health Behavior Change: How to Predict and Modify the 
Adoption and Maintenance of Health Behaviors. Applied Psychology, 2008. 57(1): p. 
1-29. 
154. Schwimmer, J.B., T.M. Burwinkle, and J.W. Varni, Health-Related Quality of Life of 
Severely Obese Children and Adolescents. JAMA, 2003. 289(14): p. 1813-1819. 
155. Storch, E.A., et al., Peer Victimization, Psychosocial Adjustment, and Physical 
Activity in Overweight and At-Risk-For-Overweight Youth. J. Pediatr. Psychol., 2007. 
32(1): p. 80-89. 
156. CDC. Overweight and Obesity: Childhood Overweight: Overweight Prevalence.  2007  
20.03.2007]; Available from: 
http://www.cdc.gov/nccdphp/dnpa/obesity/childhood/prevalence.htm. 
157. Latner, J.D. and A.J. Stunkard, Getting Worse: The Stigmatization of Obese Children. 
Obesity Res, 2003. 11(3): p. 452-456. 
158. Staffieri, J.R., A study of social stereotype of body image in children. J Pers Soc 
Psychol, 1967. 7(1): p. 101-4. 
159. Pearce, M.J., J. Boergers, and M.J. Prinstein, Adolescent Obesity, Overt and 
Relational Peer Victimization, and Romantic Relationships. Obesity Res, 2002. 10(5): 
p. 386-393. 
160. Pierce, J.W. and J. Wardle, Cause and effect beliefs and self-esteem of overweight 
children. J Child Psychol Psychiatry, 1997. 38(6): p. 645-50. 
161. Schur, E.A., M. Sanders, and H. Steiner, Body dissatisfaction and dieting in young 
children. Int J Eat Disord, 2000. 27(1): p. 74-82. 
162. Ritchie, L., et al., Pediatric Overweight: A Rreview of the Literature. 2001, University 
of California, Berkeley. p. 130. 
163. Carr, D. and M.A. Friedman, Is obesity stigmatizing? Body weight, perceived 
discrimination, and psychological well-being in the United States. J Health Soc 
Behav, 2005. 46(3): p. 244-59. 
164. Puhl, R. and K.D. Brownell, Bias, Discrimination, and Obesity. Obesity Res, 2001. 
9(12): p. 788-805. 
165. Brown, I., Nurses' attitudes towards adult patients who are obese: literature review. 
Journal of Advanced Nursing, 2006. 53(2): p. 221-232. 
166. Charles L. Baum Ii, W.F.F., The wage effects of obesity: a longitudinal study. Health 
Economics, 2004. 13(9): p. 885-899. 
167. Chen, E.Y. and M. Brown, Obesity Stigma in Sexual Relationships. Obesity Res, 
2005. 13(8): p. 1393-1397. 
168. Chambliss, H.O., C.E. Finley, and S.N. Blair, Attitudes toward obese individuals 
among exercise science students. Med Sci Sports Exerc, 2004. 36(3): p. 468-74. 
169. Geier, A.B., M.B. Schwartz, and K.D. Brownell, "Before and after" diet advertisements 
escalate weight stigma. Eat Weight Disord, 2003. 8(4): p. 282-8. 
170. Wang, S.S., K.D. Brownell, and T.A. Wadden, The influence of the stigma of obesity 
on overweight individuals. Int J Obes Relat Metab Disord, 2004. 28(10): p. 1333-7. 
171. Kirby, K.N., Bidding on the Future: Evidence Against Normative Discounting of 
Delayed Rewards. Journal of Experimental Psychology: General, 1997. 126(1): p. 54-
70. 
172. Green, L. and J. Myerson, A Discounting Framework for Choice With Delayed and 
Probabilistic Rewards. Psychological Bulletin, 2004. 130(5): p. 769-792. 
173. Ainslie, G., Breakdown of Will. 1 ed. 2001, Cambridge: Cambridge University Press. 
270. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 163 of 239 
174. Kirby, K.N. and B. Guastello, Making Choices in Anticipation of Similar Future 
Choices Can Increase Self-Control. Journal of Experimental Psychology: Applied, 
2001. 7(2): p. 154-164. 
175. Ainslie, G. and J.R. Monterosso, Building blocks of self-control: increased tolerance 
for delay with bundled rewards. J Exp Anal Behav, 2003. 79(1): p. 37-48. 
176. Wade, T.R., H. de Wit, and J.B. Richards, Effects of dopaminergic drugs on delayed 
reward as a measure of impulsive behavior in rats. Psychopharmacology (Berl), 
2000. 150(1): p. 90-101. 
177. Green, L., et al., Discounting of delayed food rewards in pigeons and rats: is there a 
magnitude effect? J Exp Anal Behav, 2004. 81(1): p. 39-50. 
178. Green, L., et al., Temporal discounting in choice between delayed rewards: the role 
of age and income. Psychol Aging, 1996. 11(1): p. 79-84. 
179. Robinson, T.E. and K.C. Berridge, The neural basis of drug craving: an incentive-
sensitization theory of addiction. Brain Res Brain Res Rev, 1993. 18(3): p. 247-91. 
180. Berridge, K.C., Food reward: brain substrates of wanting and liking. Neurosci 
Biobehav Rev, 1996. 20(1): p. 1-25. 
181. Levine, A.S., C.M. Kotz, and B.A. Gosnell, Sugars and Fats: The Neurobiology of 
Preference. J. Nutr., 2003. 133(3): p. 831S-834. 
182. Beauchamp, G.K. and B.J. Cowart, Congenital and experiential factors in the 
development of human flavor preferences. Appetite, 1985. 6(4): p. 357-72. 
183. Ueno, A., Y. Ueno, and M. Tomonaga, Facial responses to four basic tastes in 
newborn rhesus macaques (Macaca mulatta) and chimpanzees (Pan troglodytes). 
Behav Brain Res, 2004. 154(1): p. 261-71. 
184. Carlsen, M., et al., The total antioxidant content of more than 3100 foods, beverages, 
spices, herbs and supplements used worldwide. Nutrition Journal, 2010. 9(1): p. 3. 
185. Pecina, S., et al., Hyperdopaminergic Mutant Mice Have Higher "Wanting" But Not 
"Liking" for Sweet Rewards. J. Neurosci., 2003. 23(28): p. 9395-9402. 
186. Avena, N.M., et al., Sucrose sham feeding on a binge schedule releases accumbens 
dopamine repeatedly and eliminates the acetylcholine satiety response. 
Neuroscience, 2006. 139(3): p. 813-20. 
187. Cannon, C.M. and M.R. Bseikri, Is dopamine required for natural reward? Physiol 
Behav, 2004. 81(5): p. 741-8. 
188. Pecina, S., J. Schulkin, and K.C. Berridge, Nucleus accumbens corticotropin-
releasing factor increases cue-triggered motivation for sucrose reward: paradoxical 
positive incentive effects in stress? BMC Biol, 2006. 4: p. 8. 
189. Dallman, M.F., et al., Chronic stress and obesity: A new view of "comfort food". 
PNAS, 2003. 100(20): p. 11696-11701. 
190. Seymour, B., Carry on Eating: Neural Pathways Mediating Conditioned Potentiation 
of Feeding. J. Neurosci., 2006. 26(4): p. 1061-1062. 
191. Kiefer, F. and M. Grosshans, [What can addiction research contribute towards the 
understanding of obesity?]. Nervenarzt, 2009. 
192. Finer, N., Sibutramine: its mode of action and efficacy. Int J Obes Relat Metab 
Disord, 2002. 26 Suppl 4: p. S29-33. 
193. Craig, W., Appetites and Aversions as Constituents of Instincts. Proc Natl Acad Sci U 
S A, 1917. 3(12): p. 685-8. 
194. Tatemoto, K., Neuropeptide Y: complete amino acid sequence of the brain peptide. 
Proc Natl Acad Sci U S A, 1982. 79(18): p. 5485-9. 
195. Kalra, S.P., et al., Interacting Appetite-Regulating Pathways in the Hypothalamic 
Regulation of Body Weight. Endocr Rev, 1999. 20(1): p. 68-100. 
196. Ammar, A.A., et al., NPY-leptin: opposing effects on appetitive and consummatory 
ingestive behavior and sexual behavior. Am J Physiol Regul Integr Comp Physiol, 
2000. 278(6): p. R1627-33. 
197. Harris, R.B., Role of set-point theory in regulation of body weight. FASEB J, 1990. 
4(15): p. 3310-8. 
198. Berthoud, H.R., Multiple neural systems controlling food intake and body weight. 
Neurosci Biobehav Rev, 2002. 26(4): p. 393-428. 
199. Larhammar, D. and E. Salaneck, Molecular evolution of NPY receptor subtypes. 
Neuropeptides, 2004. 38(4): p. 141-51. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 164 of 239 
200. Cerda-Reverter, J.M., et al., Molecular evolution of the neuropeptide Y (NPY) family 
of peptides: cloning of three NPY-related peptides from the sea bass (Dicentrarchus 
labrax). Regul Pept, 2000. 95(1-3): p. 25-34. 
201. Nergardh, R., et al., Neuropeptide Y facilitates activity-based-anorexia. 
Psychoneuroendocrinology, 2007. 32(5): p. 493-502. 
202. Spatz, C. and S.D. Jones, Starvation anorexia as an explanation of "self-starvation" 
of rats living in activity wheels. J Comp Physiol Psychol, 1971. 77(2): p. 313-7. 
203. Naslund, E., et al., Associations of leptin, insulin resistance and thyroid function with 
long-term weight loss in dieting obese men. J Intern Med, 2000. 248(4): p. 299-308. 
204. Eek, J.F. and P.-O. Ostergren, Factors associated with BMI change over five years in 
a Swedish adult population. Results from the Scania Public Health Cohort Study. 
Scand J Public Health, 2009: p. 1403494809104359. 
205. Wing, R.R. and S. Phelan, Long-term weight loss maintenance. Am J Clin Nutr, 2005. 
82(1): p. 222S-225. 
206. Wing, R.R., et al., A Self-Regulation Program for Maintenance of Weight Loss. N 
Engl J Med, 2006. 355(15): p. 1563-1571. 
207. Stubbe, J.H., et al., Genetic influences on exercise participation in 37,051 twin pairs 
from seven countries. PLoS ONE, 2006. 1: p. e22. 
208. Stefan, N., et al., The Gln223Arg polymorphism of the leptin receptor in Pima Indians: 
influence on energy expenditure, physical activity and lipid metabolism. Int J Obes 
Relat Metab Disord, 2002. 26(12): p. 1629-32. 
209. DE MOOR, M.H.M., et al., Genome-Wide Association Study of Exercise Behavior in 
Dutch and American Adults. Medicine & Science in Sports & Exercise, 2009. 41(10): 
p. 1887-1895. 
210. Johnson, F.R., et al., High-Risk Individuals' Willingness to Pay for Diabetes Risk-
Reduction Programs. Diabetes Care, 2006. 29(6): p. 1351-1356. 
211. Venditti, E.M., et al., First versus repeat treatment with a lifestyle intervention 
program: attendance and weight loss outcomes. Int J Obes (Lond), 2008. 
212. King, N.A., et al., Individual variability following 12 weeks of supervised exercise: 
identification and characterization of compensation for exercise-induced weight loss. 
Int J Obes (Lond), 2007. 
213. Dionne, F.T., et al., Mitochondrial DNA sequence polymorphism, VO2max, and 
response to endurance training. Med Sci Sports Exerc, 1993. 25(7): p. 766-74. 
214. Bouchard, C. and T. Rankinen, Individual differences in response to regular physical 
activity. Med Sci Sports Exerc, 2001. 33(6 Suppl): p. S446-51; discussion S452-3. 
215. Koenig, W., et al., C-reactive protein modulates risk prediction based on the 
Framingham Score: implications for future risk assessment: results from a large 
cohort study in southern Germany. Circulation, 2004. 109(11): p. 1349-53. 
216. Kraushaar, L. and A. Kramer, Are we losing the battle against cardiometabolic 
disease? The case for a paradigm shift in primary prevention. BMC Public Health, 
2009. 9(1): p. 64. 
217. Stevens, V., Learning habits and skills, in The ABC of Behavior Change, J. Kerr, R. 
Weitkunat, and M. Moretti, Editors. 2005, Elsevier: Edinburgh. 
218. Izawa, K.P., et al., Effect of the self-monitoring approach on exercise maintenance 
during cardiac rehabilitation: a randomized, controlled trial. Am J Phys Med Rehabil, 
2005. 84(5): p. 313-21. 
219. Gregory, S., Y. Bostock, and K. Backett-Milburn, Recovering from a heart attack: a 
qualitative study into lay experiences and the struggle to make lifestyle changes. Fam 
Pract, 2006. 23(2): p. 220-5. 
220. Shepich, J., J.M. Slowiak, and A. Keniston, Do subsidization and monitoring enhance 
adherence to prescribed exercise? Am J Health Promot, 2007. 22(1): p. 2-5. 
221. Burke, L.E., et al., SMART trial: A randomized clinical trial of self-monitoring in 
behavioral weight management-design and baseline findings. Contemp Clin Trials, 
2009. 
222. Maric, B., et al., A systematic review of telemonitoring technologies in heart failure. 
Eur J Heart Fail, 2009. 11(5): p. 506-17. 
223. Sehnert, W. and T. Mengden, Möglichkeiten der Telemedizin bei 
Hochdruckpatienten. Medizinische Klinik, 2009. 104(4): p. 314–22. 
224. Bateson, M., D. Nettle, and G. Roberts, Cues of being watched enhance cooperation 
in a real-world setting. Biol Lett, 2006. 2(3): p. 412-4. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 165 of 239 
225. Haselton, M.G. and D.M. Buss, Error management theory: A new perspective on 
biases in cross-sex mind reading. Journal of Personality and Social Psychology, 
2000. 78(1): p. 81-91. 
226. Nowak, M.A. and K. Sigmund, Evolution of indirect reciprocity. Nature, 2005. 
437(7063): p. 1291-1298. 
227. Kraushaar, L. and A. Krämer, Individualized primary prevention of chronic cardio-
metabolic disease - a paradigm change long overdue, in Evidenzbasierte 
Primärversorgung und Pflege; 9. Jahrestagung Deutsches Netzwerk Evidenzbasierte 
Medizin und Kongress der Deutschen Gesellschaft für Pflegewissenschaft. 2008: 
Witten. 
228. O'Donovan, G., et al., Changes in cardiorespiratory fitness and coronary heart 
disease risk factors following 24 wk of moderate- or high-intensity exercise of equal 
energy cost. J Appl Physiol, 2005. 98(5): p. 1619-1625. 
229. Dishman, R., The Problem of Exercise Adherence: Fighting Sloth in Nations With 
Market Economies. Quest, 2001. 53(3): p. 279-294. 
230. Christen, A., et al., Rate of change and instability in body mass index, insulin 
resistance and lipid metabolism as predictors of atherosclerotic vascular disease. J 
Clin Endocrinol Metab, 2007: p. jc.2006-2267. 
231. Hernan, W.H., et al., Costs associated with the primary prevention of type 2 diabetes 
mellitus in the diabetes prevention program. Diabetes Care, 2003. 26(1): p. 36-47. 
232. Eddy, D.M., L. Schlessinger, and R. Kahn, Clinical outcomes and cost-effectiveness 
of strategies for managing people at high risk for diabetes. Ann Intern Med, 2005. 
143(4): p. 251-64. 
233. Hanna Tolonen, Kari Kuulasmaa, and E. Ruokokoski. MONICA Population Survey 
Data Book.  2000; Available from: 
http://www.ktl.fi/publications/monica/surveydb/title.htm. 
234. Mikrozensus - Fragen zur Gesundheit.  Körpermaße der Bevölkerung. 2006, 
Statistisches Bundesamt: Wiesbaden. 
235. Atlantis, E., et al., Worksite intervention effects on physical health: a randomized 
controlled trial. Health Promot Int, 2006. 21(3): p. 191-200. 
236. Laukkanen, J.A., et al., The predictive value of cardiorespiratory fitness for 
cardiovascular events in men with various risk profiles: a prospective population-
based cohort study. Eur Heart J, 2004. 25(16): p. 1428-37. 
237. Ainsworth, B.E., et al., Compendium of physical activities: an update of activity codes 
and MET intensities. Med Sci Sports Exerc, 2000. 32(9 Suppl): p. S498-504. 
238. Balady, G.J., et al., ACSM's Guidelines for Exercise Testing and Prescription. 6 ed, 
ed. B. Franklin. 2000, Philadelphia: Lippincott Williams & Wilins. 
239. Miller, E.R., 3rd, et al., Results of the Diet, Exercise, and Weight Loss Intervention 
Trial (DEW-IT). Hypertension, 2002. 40(5): p. 612-618. 
240. Kraus, W.E., et al., Effects of the amount and intensity of exercise on plasma 
lipoproteins. N Engl J Med, 2002. 347(19): p. 1483-92. 
241. Leon, A.S. and O.A. Sanchez, Response of blood lipids to exercise training alone or 
combined with dietary intervention. Med Sci Sports Exerc, 2001. 33(6 Suppl): p. 
S502-15; discussion S528-9. 
242. Thompson, P.D., et al., The acute versus the chronic response to exercise. Med Sci 
Sports Exerc, 2001. 33(6 Suppl): p. S438-45; discussion S452-3. 
243. Ades, P.A., et al., High-Calorie-Expenditure Exercise. A New Approach to Cardiac 
Rehabilitation for Overweight Coronary Patients. Circulation, 2009: p. 
CIRCULATIONAHA.108.834184. 
244. King, A.C., et al., Long-term effects of varying intensities and formats of physical 
activity on participation rates, fitness, and lipoproteins in men and women aged 50 to 
65 years. Circulation, 1995. 91(10): p. 2596-604. 
245. Frison, L. and S.J. Pocock, Repeated measures in clinical trials: analysis using mean 
summary statistics and its implications for design. Stat Med, 1992. 11(13): p. 1685-
704. 
246. Washburn, R.A., et al., The validity of the Stanford Seven-Day Physical Activity 
Recall in young adults. Med Sci Sports Exerc, 2003. 35(8): p. 1374-80. 
247. Marc Bonnefoy, et al., Simultaneous Validation of Ten Physical Activity 
Questionnaires in Older Men: A Doubly Labeled Water Study. Journal of the 
American Geriatrics Society, 2001. 49(1): p. 28-35. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 166 of 239 
248. Westerterp, K.R., Assessment of physical activity: a critical appraisal. Eur J Appl 
Physiol, 2009. 
249. Wareham, N.J., et al., Validity and repeatability of a simple index derived from the 
short physical activity questionnaire used in the European Prospective Investigation 
into Cancer and Nutrition (EPIC) study. Public Health Nutr, 2003. 6(4): p. 407-13. 
250. Seale, J., C. Miles, and C.E. Bodwell, Sensitivity of methods for calculating energy 
expenditure by use of doubly labeled water. J Appl Physiol, 1989. 66(2): p. 644-52. 
251. Conway, J.M., et al., Comparison of energy expenditure estimates from doubly 
labeled water, a physical activity questionnaire, and physical activity records. Am J 
Clin Nutr, 2002. 75(3): p. 519-525. 
252. Bosy-Westphal, A., et al., Phase Angle From Bioelectrical Impedance Analysis: 
Population Reference Values by Age, Sex, and Body Mass Index. JPEN J Parenter 
Enteral Nutr, 2006. 30(4): p. 309-316. 
253. Bosy-Westphal, A., et al., Patterns of bioelectrical impedance vector distribution by 
body mass index and age: implications for body-composition analysis. Am J Clin 
Nutr, 2005. 82(1): p. 60-68. 
254. van Dokkum, W., J. Schrijver, and J.A. Wesstra, Variability in man of the levels of 
some indices of nutritional status over a 60-d period on a constant diet. Eur J Clin 
Nutr, 1990. 44(9): p. 665-74. 
255. Nazir, D.J., et al., Monthly intra-individual variation in lipids over a 1-year period in 22 
normal subjects. Clinical Biochemistry, 1999. 32(5): p. 381-389. 
256. Aguzzi, F., N. Poggi, and M. Maggi, Some data on intra-individual variability in high-
density-lipoprotein cholesterol. Clin Chem, 1979. 25(9): p. 1671. 
257. Holzel, W.G., Intra-individual variation of some analytes in serum of patients with 
insulin-dependent diabetes mellitus. Clin Chem, 1987. 33(1): p. 57-61. 
258. Garnotel, R., et al., Long-term variability of serum lipoprotein(a) concentrations in 
healthy fertile women. Clin Chem Lab Med, 1998. 36(5): p. 317-21. 
259. Marcovina, S.M., V.P. Gaur, and J.J. Albers, Biological variability of cholesterol, 
triglyceride, low- and high-density lipoprotein cholesterol, lipoprotein(a), and 
apolipoproteins A-I and B. Clin Chem, 1994. 40(4): p. 574-8. 
260. Smith, S.J., et al., Biological variability in concentrations of serum lipids: sources of 
variation among results from published studies and composite predicted values. Clin 
Chem, 1993. 39(6): p. 1012-22. 
261. Fan, A., et al., Validation of reported physical activity for cholesterol control using two 
different physical activity instruments. Vasc Health Risk Manag, 2009. 5: p. 649-61. 
262. McConnell, T., Cardiorespiratory Assessment of Apparently Healthy Populations, in 
ACSM’s Resource Manual for Guidelines for Exercise Testing and Prescription. 2001, 
LWW: Philadelphia. p. 361-365. 
263. Rolf F. Kroidl, S. Schwarz, and B. Lehnigk, Technische und formale Grundlagen, in 
Kursbuch Spiroergometrie. 2007, Thieme: Stuttgart. p. 16. 
264. Meyer, T., et al., Reliability of gas exchange measurements from two different 
spiroergometry systems. Int J Sports Med, 2001. 22(8): p. 593-7. 
265. Wasserman, K., et al., Principles of Exercise Testing and Interpretation. 4 ed. 2005, 
Philadelphia: Lippincott Williams & Wilkins. 
266. Altman, D.G., Practical Statistics For Medical Research. 1991, Boca Raton, Florida: 
Chapman & Hall/CRC. 
267. Rosner, B., Fundamentals of Biostatistics. 6th Edition ed. 2006, Belmont, CA: 
Thomson Brooks/Cole. 
268. Cohen, J., Statistical power analysis for the behavioral sciences. 2nd ed. 1988, New 
York :: Academic Press. 
269. Bland, M., Significance Tests, in An Introduction to Medical Statistics. 2000, Oxford 
University Press: Oxford. p. 137-155. 
270. Perneger, T.V., What's wrong with Bonferroni adjustments. BMJ, 1998. 316(7139): p. 
1236-8. 
271. Levene, H., Robust tests for equality of variances, in Contributions to Probability and 
Statistics, I. Olkin, Editor. 1960, Stanford University Press: Palo Alto, California. p. 
278–292. 
272. Brown, M.B. and A.B. Forsythe, Robust Tests for the Equality of Variances. Journal 
of the American Statistical Association, 1974. 69(346): p. 364-367. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 167 of 239 
273. Courneya, K.S., et al., A longitudinal study of exercise barriers in colorectal cancer 
survivors participating in a randomized controlled trial. Ann Behav Med, 2005. 29(2): 
p. 147-53. 
274. Ziebland, S., et al., Lack of willpower or lack of wherewithal? "Internal" and "external" 
barriers to changing diet and exercise in a three year follow-up of participants in a 
health check. Soc Sci Med, 1998. 46(4-5): p. 461-5. 
275. El Ansari, W. and G. Lovell, Barriers to exercise in younger and older non-exercising 
adult women: a cross sectional study in London, United Kingdom. Int J Environ Res 
Public Health, 2009. 6(4): p. 1443-55. 
276. Mudd, L.M., et al., Physical activity recommendations: an alternative approach using 
energy expenditure. Med Sci Sports Exerc, 2008. 40(10): p. 1757-63. 
277. Donnelly, J.E., et al., American College of Sports Medicine Position Stand. 
Appropriate physical activity intervention strategies for weight loss and prevention of 
weight regain for adults. Med Sci Sports Exerc, 2009. 41(2): p. 459-71. 
278. Brooks, G.A., et al., Chronicle of the Institute of Medicine physical activity 
recommendation: how a physical activity recommendation came to be among dietary 
recommendations. Am J Clin Nutr, 2004. 79(5): p. 921S-930. 
279. Leitzmann, M.F., et al., Physical activity recommendations and decreased risk of 
mortality. Arch Intern Med, 2007. 167(22): p. 2453-60. 
280. Hamer, M. and E. Stamatakis, Physical activity and risk of cardiovascular disease 
events: inflammatory and metabolic mechanisms. Med Sci Sports Exerc, 2009. 41(6): 
p. 1206-11. 
281. Babraj J, et al., Extremely short duration high intensity training substantially improves 
insulin action in young sedentary males BMC Endocrine Disorders, 2009. 9(3). 
282. Fairchild, T.J., et al., Glycogen synthesis in muscle fibers during active recovery from 
intense exercise. Med Sci Sports Exerc, 2003. 35(4): p. 595-602. 
283. Tjonna, A.E., et al., Aerobic Interval Training Versus Continuous Moderate Exercise 
as a Treatment for the Metabolic Syndrome. A Pilot Study. Circulation, 2008: p. 
CIRCULATIONAHA.108.772822. 
284. Wisloff, U., et al., Superior cardiovascular effect of aerobic interval training versus 
moderate continuous training in heart failure patients: a randomized study. 
Circulation, 2007. 115(24): p. 3086-94. 
285. Nilsson, B.B., et al., Group-based aerobic interval training in patients with chronic 
heart failure: Norwegian Ullevaal Model. Phys Ther, 2008. 88(4): p. 523-35. 
286. Markovitch, D., R.M. Tyrrell, and D. Thompson, Acute moderate-intensity exercise in 
middle-aged men has neither an anti- nor proinflammatory effect. J Appl Physiol, 
2008. 105(1): p. 260-265. 
287. Tyldum, G.A., et al., Endothelial Dysfunction Induced by Post-Prandial Lipemia: 
Complete Protection Afforded by High-Intensity Aerobic Interval Exercise. Journal of 
the American College of Cardiology, 2009. 53(2): p. 200-206. 
288. US Department of Health and Human Services, Objectives 22-2 and 22-3. In: Healthy 
people 2010 (conference ed, in 2 vols), US Department of Health and Human 
Services: Washington, DC. 
289. Solomon, T.P.J., et al., Effects of exercise training and diet on lipid kinetics during 
free fatty acid-induced insulin resistance in older obese humans with impaired 
glucose tolerance. Am J Physiol Endocrinol Metab, 2009. 297(2): p. E552-559. 
290. Robertson, R.J., Perceived Exertion for Practitioners. Rating Effort With the OMNI 
Picture System. 2004, Champaign, Ill.: Human Kinetics. 
291. Utter, A.C., et al., Validation of the Adult OMNI Scale of perceived exertion for 
walking/running exercise. Med Sci Sports Exerc, 2004. 36(10): p. 1776-80. 
292. Robertson, R.J., et al., Concurrent validation of the OMNI perceived exertion scale for 
resistance exercise. Med Sci Sports Exerc, 2003. 35(2): p. 333-41. 
293. Bundesamt, S., Mikrozensus - Fragen zur Gesundheit, Körpermasse der 
Bevölkerung, S. Bundesamt, Editor. 2006: Wiesbaden. 
294. Anshel, M.H. and M. Kang, An outcome-based action study on changes in fitness, 
blood lipids, and exercise adherence, using the disconnected values (intervention) 
model. Behav Med, 2007. 33(3): p. 85-100. 
295. Flegal, K.E., et al., Adherence to yoga and exercise interventions in a 6-month clinical 
trial. BMC Complement Altern Med, 2007. 7: p. 37. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 168 of 239 
296. Colley, R.C., et al., Variability in adherence to an unsupervised exercise prescription 
in obese women. Int J Obes (Lond), 2008. 32(5): p. 837-44. 
297. Cooper, C.B. and T.W. Storer, Exercise testing and interpretation. A practical 
approach. 2001, Cambridge: Cambridge University Press. 
298. Stevens, V.J., et al., Long-term weight loss and changes in blood pressure: results of 
the Trials of Hypertension Prevention, phase II. Ann Intern Med, 2001. 134(1): p. 1-
11. 
299. Moore, L.L., et al., Weight loss in overweight adults and the long-term risk of 
hypertension: the Framingham study. Arch Intern Med, 2005. 165(11): p. 1298-303. 
300. Wood, P.D., et al., Changes in plasma lipids and lipoproteins in overweight men 
during weight loss through dieting as compared with exercise. N Engl J Med, 1988. 
319(18): p. 1173-9. 
301. Ross, R., et al., Reduction in obesity and related comorbid conditions after diet-
induced weight loss or exercise-induced weight loss in men. A randomized, controlled 
trial. Ann Intern Med, 2000. 133(2): p. 92-103. 
302. Bland, M., The Analysis of Cross-Tabulations, in An Introduction to Medical Statistics. 
2000, Oxford University Press: Oxford. p. 230-256. 
303. Carretero, O.A. and S. Oparil, Essential Hypertension : Part I: Definition and Etiology. 
Circulation, 2000. 101(3): p. 329-335. 
304. Neter, J.E., et al., Influence of weight reduction on blood pressure: a meta-analysis of 
randomized controlled trials. Hypertension, 2003. 42(5): p. 878-84. 
305. Wang, J., et al., Asians have lower body mass index (BMI) but higher percent body 
fat than do whites: comparisons of anthropometric measurements. Am J Clin Nutr, 
1994. 60(1): p. 23-8. 
306. Kagawa, M., et al., Differences in the relationship between BMI and percentage body 
fat between Japanese and Australian-Caucasian young men. Br J Nutr, 2006. 95(5): 
p. 1002-7. 
307. Lee, K.L., et al., Clinical judgment and statistics. Lessons from a simulated 
randomized trial in coronary artery disease. Circulation, 1980. 61(3): p. 508-15. 
308. Bland, M., Comparing the Means of Small Samples, in An Introduction To Medical 
Statistics. 2000, Oxford University Press: Oxford. p. 156-184. 
309. Kriska, A.M., et al., A randomized exercise trial in older women: increased activity 
over two years and the factors associated with compliance. Med Sci Sports Exerc, 
1986. 18(5): p. 557-62. 
310. King, A.C., et al., Can we identify who will adhere to long-term physical activity? 
Signal detection methodology as a potential aid to clinical decision making. Health 
Psychol, 1997. 16(4): p. 380-9. 
311. Carter, W.B., et al., Participation of older adults in health programs and research: a 
critical review of the literature. Gerontologist, 1991. 31(5): p. 584-92. 
312. Lissner, L., B.L. Heitmann, and C. Bengtsson, Population studies of diet and obesity. 
Br J Nutr, 2000. 83 Suppl 1: p. S21-4. 
313. Remington, R.D., H.L. Taylor, and E.R. Buskirk, A method for assessing volunteer 
bias and its application to a cardiovascular disease prevention progamme involving 
physical activity. J Epidemiol Community Health, 1978. 32(4): p. 250-5. 
314. McMichael, A.J., R. Spirtas, and L.L. Kupper, An epidemiologic study of mortality 
within a cohort of rubber workers, 1964-72. J Occup Med, 1974. 16(7): p. 458-64. 
315. Li, C.-Y. and F.-C. Sung, A review of the healthy worker effect in occupational 
epidemiology. Occup Med (Lond), 1999. 49(4): p. 225-229. 
316. Myers, J., et al., Exercise capacity and mortality among men referred for exercise 
testing. N Engl J Med, 2002. 346(11): p. 793-801. 
317. Michie, S., et al., Effective techniques in healthy eating and physical activity 
interventions: a meta-regression. Health Psychol, 2009. 28(6): p. 690-701. 
318. Welsh, E., et al., Is frequent self-weighing associated with poorer body satisfaction? 
Findings from a phone-based weight loss trial. J Nutr Educ Behav, 2009. 41(6): p. 
425-8. 
319. Roger, V.L., et al., Prognostic value of treadmill exercise testing: a population-based 
study in Olmsted County, Minnesota. Circulation, 1998. 98(25): p. 2836-41. 
320. Amati, F., et al., Separate and combined effects of exercise training and weight loss 
on exercise efficiency and substrate oxidation. J Appl Physiol, 2008: p. 90384.2008. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 169 of 239 
321. Field, A.E., et al., Weight-control behaviors and subsequent weight change among 
adolescents and young adult females. Am J Clin Nutr, 2010. 91(1): p. 147-153. 
322. Goldsmith, R., et al., Effects of experimental weight perturbation on skeletal muscle 
work efficiency, fuel utilization, and biochemistry in human subjects. Am J Physiol 
Regul Integr Comp Physiol, 2010. 298(1): p. R79-88. 
323. Manini, T.M., Energy expenditure and aging. Ageing Research Reviews, 2010. 9(1): 
p. 1-11. 
324. Weinert, D., Circadian temperature variation and ageing. Ageing Research Reviews, 
2010. 9(1): p. 51-60. 
325. Hu, G., et al., Joint Effects of Physical Activity, Body Mass Index, Waist 
Circumference, and Waist-to-Hip Ratio on the Risk of Heart Failure. Circulation, 
2010: p. CIRCULATIONAHA.109.887893. 
326. Varady, K., et al., Degree of weight loss required to improve adipokine concentrations 
and decrease fat cell size in severely obese women. Metabolism, 2009. 
327. Anderson, J.W., et al., Long-term weight-loss maintenance: a meta-analysis of US 
studies. Am J Clin Nutr, 2001. 74(5): p. 579-84. 
328. Festa, A., et al., The relation of body fat mass and distribution to markers of chronic 
inflammation. Int J Obes Relat Metab Disord, 2001. 25(10): p. 1407-15. 
329. Snijder, M.B., et al., What aspects of body fat are particularly hazardous and how do 
we measure them? Int. J. Epidemiol., 2006. 35(1): p. 83-92. 
330. Arnlov, J., et al., Impact of Body Mass Index and the Metabolic Syndrome on the Risk 
of Cardiovascular Disease and Death in Middle-Aged Men. Circulation, 2009: p. 
CIRCULATIONAHA.109.887521. 
331. Briel, M., et al., Association between change in high density lipoprotein cholesterol 
and cardiovascular disease morbidity and mortality: systematic review and meta-
regression analysis. BMJ, 2009. 338(feb16_1): p. b92-. 
332. Kinosian, B., H. Glick, and G. Garland, Cholesterol and Coronary Heart Disease: 
Predicting Risks by Levels and Ratios. Annals of Internal Medicine, 1994. 121(9): p. 
641-647. 
333. Perkins, G.M., et al., Biomarkers of cardiovascular disease risk in 40-65-year-old men 
performing recommended levels of physical activity, compared with sedentary men. 
Br J Sports Med, 2009. 43(2): p. 136-141. 
334. Nam, B.-H., W.B. Kannel, and R.B. D'Agostino, Search for an Optimal Atherogenic 
Lipid Risk Profile: From the Framingham Study. The American Journal of Cardiology, 
2006. 97(3): p. 372-375. 
335. Sniderman, A.D., et al., Errors that result from using the TC/HDL C ratio rather than 
the apoB/apoA-I ratio to identify the lipoprotein-related risk of vascular disease. J 
Intern Med, 2006. 259(5): p. 455-61. 
336. Hennekens, C.H., et al., Modest Dietary Reductions in Blood Cholesterol Have 
Important Public Health Benefits. Journal of Cardiovascular Pharmacology and 
Therapeutics, 2009. 14(2): p. 85-88. 
337. Lin, C.Y., et al., Effects of obesity, physical activity, and cardiorespiratory fitness on 
blood pressure, inflammation, and insulin resistance in the National Health and 
Nutrition Survey 1999-2002. Nutr Metab Cardiovasc Dis, 2009. 
338. Arsenault, B.J., et al., Effect of exercise training on cardiometabolic risk markers 
among sedentary, but metabolically healthy overweight or obese post-menopausal 
women with elevated blood pressure. Atherosclerosis, 2009. 207(2): p. 530-533. 
339. Elmer, P.J., et al., Lifestyle Intervention: Results of the Treatment of Mild 
Hypertension Study (TOMHS). Preventive Medicine, 1995. 24(4): p. 378-388. 
340. Staessen, J., R. Fagard, and A. Amery, The relationship between body weight and 
blood pressure. J Hum Hypertens, 1988. 2(4): p. 207-17. 
341. Stamler, J., et al., INTERSALT study findings. Public health and medical care 
implications. Hypertension, 1989. 14(5): p. 570-7. 
342. Hense, H.W., et al., Framingham risk function overestimates risk of coronary heart 
disease in men and women from Germany--results from the MONICA Augsburg and 
the PROCAM cohorts. Eur Heart J, 2003. 24(10): p. 937-45. 
343. Assmann, G., et al., Assessing risk of myocardial infarction and stroke: new data from 
the Prospective Cardiovascular Munster (PROCAM) study. Eur J Clin Invest, 2007. 
37(12): p. 925-32. 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 170 of 239 
344. Assmann, G., H. Schulte, and U. Seedorf, Cardiovascular risk assessment in the 
metabolic syndrome: results from the Prospective Cardiovascular Munster 
(PROCAM) Study. Int J Obes (Lond), 2008. 32 Suppl 2: p. S11-6. 
345. Messier, V., et al., Anthropometric, metabolic, psychosocial and dietary factors 
associated with dropout in overweight and obese postmenopausal women engaged 
in a 6-month weight loss programme: a MONET study. Br J Nutr, 2009: p. 1-6. 
346. Oja, P., et al., Physical activity recommendations for health: what should Europe do? 
BMC Public Health, 2010. 10(1): p. 10. 
347. Haskell, W.L., et al., Physical Activity and Public Health. Updated Recommendation 
for Adults From the American College of Sports Medicine and the American Heart 
Association. Circulation, 2007: p. CIRCULATIONAHA.107.185649. 
348. Kruger, J., H.M. Blanck, and C. Gillespie, Dietary and physical activity behaviors 
among adults successful at weight loss maintenance. Int J Behav Nutr Phys Act, 
2006. 3(1): p. 17. 
349. Nusselder, W., et al., Living healthier for longer: Comparative effects of three heart-
healthy behaviors on life expectancy with and without cardiovascular disease. BMC 
Public Health, 2009. 9(1): p. 487. 
350. Lee, C.-D., X. Sui, and S.N. Blair, Combined Effects of Cardiorespiratory Fitness, Not 
Smoking, and Normal Waist Girth on Morbidity and Mortality in Men. Arch Intern Med, 
2009. 169(22): p. 2096-2101. 
351. Bernard, C., An Introduction to the Study of Experimental Medicine. 1865. 
352. Cannon, W.B., ORGANIZATION FOR PHYSIOLOGICAL HOMEOSTASIS. Physiol. 
Rev., 1929. 9(3): p. 399-431. 
353. McEwen, B.S. and J.C. Wingfield, The concept of allostasis in biology and 
biomedicine. Horm Behav, 2003. 43(1): p. 2-15. 
354. Nonogaki, K., New insights into sympathetic regulation of glucose and fat 
metabolism. Diabetologia, 2000. 43(5): p. 533-49. 
 
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 171 of 239 
APPENDICES 
APPENDIX 1 STATA PROTOCOLS 
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STATA Protocol for Table 2 
. sampsi 0.75 0.6, alpha(0.05) onesample onesided 
 
Estimated sample size for one-sample comparison of proportion to hypothesized value 
Test Ho: p = 0.7500, where p is the proportion in the population 
Assumptions: 
         alpha =   0.0500  (one-sided) 
         power =   0.9000 
 alternative p =   0.6000 
Estimated required sample size: 
             n =       80 
 
 
. sampsi 0 3.5, sd1(4) sd2(4) alpha(0.05) ratio(3) pre(1) post(1) r01(0.7) onesided 
method(change) 
 
Estimated sample size for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                      power =   0.9000 
                                         m1 =        0 
                                         m2 =      3.5 
                                        sd1 =        4 
                                        sd2 =        4 
                                      n2/n1 =     3.00 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    3.098 
        adjusted sd2 =    3.098 
 
 Estimated required sample sizes: 
                  n1 =        9 
                  n2 =       27 
 
. sampsi 0 3.5, sd1(4) sd2(4) alpha(0.05) n1(35) n2(85) pre(1) post(1) r01(0.7) 
onesided method(change) 
 
Estimated power for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                         m1 =        0 
                                         m2 =      3.5 
                                        sd1 =        4 
                                        sd2 =        4 
                             sample size n1 =       35 
                                         n2 =       85 
                                      n2/n1 =     2.43 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 173 of 239 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    3.098 
        adjusted sd2 =    3.098 
 Estimated power: 
               power =    1.000 
 
. sampsi 0 0.8, sd1(1.2) sd2(1.2) alpha(0.05) ratio(3) pre(1) post(1) r01(0.7) 
onesided method(change) 
 
Estimated sample size for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                      power =   0.9000 
                                         m1 =        0 
                                         m2 =       .8 
                                        sd1 =      1.2 
                                        sd2 =      1.2 
                                      n2/n1 =     3.00 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    0.930 
        adjusted sd2 =    0.930 
 Estimated required sample sizes: 
                  n1 =       16 
                  n2 =       48 
 
. sampsi 0 0.8, sd1(1.2) sd2(1.2) alpha(0.05) n1(35) n2(85) pre(1) post(1) r01(0.7) 
onesided method(change) 
 
Estimated power for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                         m1 =        0 
                                         m2 =       .8 
                                        sd1 =      1.2 
                                        sd2 =      1.2 
                             sample size n1 =       35 
                                         n2 =       85 
                                      n2/n1 =     2.43 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    0.930 
        adjusted sd2 =    0.930 
 Estimated power: 
               power =    0.996 
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. sampsi 0 4, sd1(9) sd2(9) alpha(0.05) ratio(3) pre(1) post(1) r01(0.7) onesided 
method(change) 
 
Estimated sample size for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                      power =   0.9000 
                                         m1 =        0 
                                         m2 =        4 
                                        sd1 =        9 
                                        sd2 =        9 
                                      n2/n1 =     3.00 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    6.971 
        adjusted sd2 =    6.971 
 Estimated required sample sizes: 
                  n1 =       35 
                  n2 =      105 
 
. sampsi 0 4, sd1(9) sd2(9) alpha(0.05) n1(35) n2(85) pre(1) post(1) r01(0.7) onesided 
method(change) 
 
Estimated power for two samples with repeated measures 
Assumptions: 
                                      alpha =   0.0500  (one-sided) 
                                         m1 =        0 
                                         m2 =        4 
                                        sd1 =        9 
                                        sd2 =        9 
                             sample size n1 =       35 
                                         n2 =       85 
                                      n2/n1 =     2.43 
           number of follow-up measurements =        1 
            number of baseline measurements =        1 
   correlation between baseline & follow-up =    0.700 
Method: CHANGE 
 relative efficiency =    1.667 
    adjustment to sd =    0.775 
        adjusted sd1 =    6.971 
        adjusted sd2 =    6.971 
 Estimated power: 
               power =    0.887 
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STATA Protocol for Table 4a 
. by cflstatus_adj, sort : summarize age1 weight1 bmi1 percent_fat1 vo2peakpweight1 
tch1 hdl1 ldl1 tch_hdl1 tg1 syst1 dia1 procam_risk1 
 
-> cflstatus_adj = inactive 
    Variable |       Obs        Mean    Std. Dev.       Min        Max 
-------------+-------------------------------------------------------- 
        age1 |        28    48.28571    7.551586         27         58 
     weight1 |        28      92.975    13.57644         71      118.1 
        bmi1 |        28    29.77857    4.420856       23.1       41.4 
percent_fat1 |        28    28.69002     8.18574   16.00512   47.66607 
vo2peakpwe~1 |        28    31.76539     7.70059   18.69838   51.76687 
-------------+-------------------------------------------------------- 
        tch1 |        28    221.2143    54.52445        119        355 
        hdl1 |        28      55.175    16.33215         26         89 
        ldl1 |        28    137.3107    47.45202       41.4        255 
    tch_hdl1 |        28    4.218355    1.152234   2.333333   6.371428 
         tg1 |        28    143.6429     71.6877         47        333 
-------------+-------------------------------------------------------- 
       syst1 |        27    136.0741    11.95802        115        162 
        dia1 |        27    82.88889    8.491323         67         98 
procam_risk1 |        27    3.756808    4.649846   .0092389   20.78417 
 
-> cflstatus_adj = active 
    Variable |       Obs        Mean    Std. Dev.       Min        Max 
-------------+-------------------------------------------------------- 
        age1 |        89    50.44944    9.648376         25         72 
     weight1 |        89    86.67528    15.02062       56.8      120.6 
        bmi1 |        89    28.57978    4.037809       19.9       41.7 
percent_fat1 |        89    28.87336    7.459166         10   48.65546 
vo2peakpwe~1 |        89    31.97881    8.108567   14.79339   52.35294 
-------------+-------------------------------------------------------- 
        tch1 |        87     223.977    49.10832         87        370 
        hdl1 |        87    54.45977    12.97296         32        105 
        ldl1 |        87    138.4667    44.58913       36.6      274.2 
    tch_hdl1 |        87    4.270923    1.153065   2.023256   7.619048 
         tg1 |        87    155.2529    104.8056         37        748 
-------------+-------------------------------------------------------- 
       syst1 |        83    142.5181    16.27235        112        191 
        dia1 |        83    82.75904    9.956724         57        108 
procam_risk1 |        82    5.159766    6.537022   .0005913   38.28459 
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STATA Protocol for Table 7 
-> cflstatus_adj = inactive 
Paired t test 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
vo2peak1 |      23    32.51456     1.66091    7.965444    29.07004  35.95907 
vo2peak2 |      23    32.09135    1.652626    7.925716    28.66401  35.51869 
---------+-------------------------------------------------------------------- 
    diff |      23    .4232075    .4705596    2.256725   -.5526734  1.399088 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpweight1 - vo2peakpweight9)         t =   0.8994 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.8109         Pr(|T| > |t|) = 0.3782          Pr(T > t) = 0.1891 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
vo2peak1 |      73     32.7894    .9466564    8.088236    30.90227    34.67652 
vo2peak2 |      73    36.13564      1.0843     9.26426    33.97413    38.29715 
---------+-------------------------------------------------------------------- 
    diff |      73   -3.346244    .4691694    4.008585   -4.281516   -2.410971 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpweight1 - vo2peakpweight9)         t =  -7.1323 
 Ho: mean(diff) = 0                              degrees of freedom =       72 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23   -.4232075    .4705596    2.256725   -1.399088    .5526734 
  active |      73    3.346244    .4691694    4.008585    2.410971    4.281516 
---------+-------------------------------------------------------------------- 
combined |      96    2.443146    .4079121    3.996706    1.633338    3.252954 
---------+-------------------------------------------------------------------- 
    diff |           -3.769451    .8785688                -5.51387   -2.025032 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -4.2904 
Ho: diff = 0                                     degrees of freedom =       94 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
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STATA Protocol For Table 8 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
VO2/BCM1 |      23    85.12461    2.937223    14.08643    79.03318    91.21604 
VO2/BCM2 |      23    83.25456    2.937826    14.08932    77.16188    89.34724 
---------+-------------------------------------------------------------------- 
    diff |      23    1.870049     1.30982    6.281674   -.8463501    4.586449 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpbcm1 - vo2peakpbcm9)               t =   1.4277 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9163         Pr(|T| > |t|) = 0.1674          Pr(T > t) = 0.0837 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
VO2/BCM1 |      73    86.78714    1.887497    16.12678    83.02448    90.54979 
VO2/BCM2 |      73    92.10266    1.935488    16.53682    88.24433    95.96098 
---------+-------------------------------------------------------------------- 
    diff |      73   -5.315524    1.040199    8.887467   -7.389124   -3.241925 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpbcm1 - vo2peakpbcm9)               t =  -5.1101 
 Ho: mean(diff) = 0                              degrees of freedom =       72 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23   -1.870049     1.30982    6.281674   -4.586449    .8463501 
  active |      73    5.315524    1.040199    8.887467    3.241925    7.389124 
---------+-------------------------------------------------------------------- 
combined |      96    3.593981    .9043151    8.860442    1.798688    5.389273 
---------+-------------------------------------------------------------------- 
    diff |           -7.185574    1.996818                -11.1503   -3.220844 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -3.5985 
Ho: diff = 0                                     degrees of freedom =       94 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0003         Pr(|T| > |t|) = 0.0005          Pr(T > t) = 0.9997 
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STATA Protocol For Table 9 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
VO2peak1 |      23    32.51456     1.66091    7.965444    29.07004    35.95907 
VO2peak2 |      23    32.09135    1.652626    7.925716    28.66401    35.51869 
---------+-------------------------------------------------------------------- 
    diff |      23    .4232075    .4705596    2.256725   -.5526734    1.399088 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpweight1 - vo2peakpweight9)         t =   0.8994 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.8109         Pr(|T| > |t|) = 0.3782          Pr(T > t) = 0.1891 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
VO2peak1 |      71    32.68572    .9683816    8.159728    30.75434    34.61709 
VO2peak2 |      71    35.71592     1.07049     9.02011     33.5809    37.85095 
---------+-------------------------------------------------------------------- 
    diff |      71   -3.030205    .4250104    3.581201   -3.877861   -2.182548 
------------------------------------------------------------------------------ 
     mean(diff) = mean(vo2peakpweight1 - vo2peakpweight9)         t =  -7.1297 
 Ho: mean(diff) = 0                              degrees of freedom =       70 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23   -.4232075    .4705596    2.256725   -1.399088    .5526734 
  active |      71    3.030205    .4250104    3.581201    2.182548    3.877861 
---------+-------------------------------------------------------------------- 
combined |      94    2.185221    .3731088    3.617424    1.444301    2.926141 
---------+-------------------------------------------------------------------- 
    diff |           -3.453412     .794864               -5.032081   -1.874743 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -4.3447 
Ho: diff = 0                                     degrees of freedom =       92 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
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STATA Protocol For Table 10 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    male |      72    35.41231    .8081056    6.857004      33.801    37.02363 
  female |      29     25.3562    1.003456    5.403778    23.30071    27.41169 
---------+-------------------------------------------------------------------- 
combined |     101    32.52492    .7864275    7.903498    30.96467    34.08517 
---------+-------------------------------------------------------------------- 
    diff |            10.05611    1.424991                7.228621    12.88361 
------------------------------------------------------------------------------ 
    diff = mean(male) - mean(female)                              t =   7.0570 
Ho: diff = 0                                     degrees of freedom =       99 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    male |      72    88.45455    1.831318    15.53925      84.803    92.10609 
  female |      29    81.14998    2.555582    13.76223    75.91511    86.38485 
---------+-------------------------------------------------------------------- 
combined |     101     86.3572    1.527001    15.34617    83.32767    89.38672 
---------+-------------------------------------------------------------------- 
    diff |            7.304569    3.311777                 .733285    13.87585 
------------------------------------------------------------------------------ 
    diff = mean(male) - mean(female)                              t =   2.2056 
Ho: diff = 0                                     degrees of freedom =       99 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9851         Pr(|T| > |t|) = 0.0297          Pr(T > t) = 0.0149 
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STATA Log for Table 11 
 
CFL90 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23    1.092901    .0407071    .1952243    1.008479    1.177322 
  active |      73    1.150922    .0256102     .218814    1.099869    1.201975 
---------+-------------------------------------------------------------------- 
combined |      96    1.137021    .0218264     .213854     1.09369    1.180352 
---------+-------------------------------------------------------------------- 
    diff |           -.0580217    .0510579               -.1593983    .0433549 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -1.1364 
Ho: diff = 0                                     degrees of freedom =       94 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.1293         Pr(|T| > |t|) = 0.2587          Pr(T > t) = 0.8707 
 
CFL120 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
       0 |      26    1.097781    .0411152    .2096471    1.013102    1.182459 
       1 |      70    1.151596    .0257033    .2150491     1.10032    1.202873 
---------+-------------------------------------------------------------------- 
combined |      96    1.137021    .0218264     .213854     1.09369    1.180352 
---------+-------------------------------------------------------------------- 
    diff |           -.0538156    .0490629               -.1512312    .0435999 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =  -1.0969 
Ho: diff = 0                                     degrees of freedom =       94 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.1378         Pr(|T| > |t|) = 0.2755          Pr(T > t) = 0.8622 
 
CFL150 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
       0 |      42    1.120636    .0329983    .2138536    1.053995    1.187278 
       1 |      54    1.149765    .0292557    .2149844    1.091085    1.208444 
---------+-------------------------------------------------------------------- 
combined |      96    1.137021    .0218264     .213854     1.09369    1.180352 
---------+-------------------------------------------------------------------- 
    diff |           -.0291284    .0441291               -.1167477     .058491 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =  -0.6601 
Ho: diff = 0                                     degrees of freedom =       94 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.2554         Pr(|T| > |t|) = 0.5108          Pr(T > t) = 0.7446 
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STATA Protocol For Table 12 
 
CFL90 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23   -.0133943    .0161481    .0774436   -.0468834    .0200948 
  active |      73    .1160251    .0162604    .1389287    .0836106    .1484395 
---------+-------------------------------------------------------------------- 
combined |      96    .0850184    .0141055    .1382054    .0570153    .1130214 
---------+-------------------------------------------------------------------- 
    diff |           -.1294194    .0304229               -.1898248   -.0690139 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -4.2540 
Ho: diff = 0                                     degrees of freedom =       94 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 1.0000 
 
CFL120 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      26    .0083206    .0187448      .09558    -.030285    .0469262 
  active |      70    .1135061    .0168812    .1412381    .0798291    .1471832 
---------+-------------------------------------------------------------------- 
combined |      96    .0850184    .0141055    .1382054    .0570153    .1130214 
---------+-------------------------------------------------------------------- 
    diff |           -.1051855    .0300088               -.1647687   -.0456024 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =  -3.5052 
Ho: diff = 0                                     degrees of freedom =       94 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0004         Pr(|T| > |t|) = 0.0007          Pr(T > t) = 0.9996 
 
CFL150 Strata 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      42    .0342825    .0205733    .1333303   -.0072662    .0758311 
  active |      54    .1244796    .0176691    .1298412    .0890398    .1599194 
---------+-------------------------------------------------------------------- 
combined |      96    .0850184    .0141055    .1382054    .0570153    .1130214 
---------+-------------------------------------------------------------------- 
    diff |           -.0901972    .0270287               -.1438632   -.0365311 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =  -3.3371 
Ho: diff = 0                                     degrees of freedom =       94 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0006         Pr(|T| > |t|) = 0.0012          Pr(T > t) = 0.9994 
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STATA Protocol For Table 13 
+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ |   VO2change 
       adj |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        23          0 |        23  
           |      15.3        7.7 |      23.0  
           |    100.00       0.00 |    100.00  
-----------+----------------------+---------- 
    active |        41         32 |        73  
           |      48.7       24.3 |      73.0  
           |     56.16      43.84 |    100.00  
-----------+----------------------+---------- 
     Total |        64         32 |        96  
           |      64.0       32.0 |      96.0  
           |     66.67      33.33 |    100.00  
 
          Pearson chi2(1) =  15.1233   Pr = 0.000 
           Fisher's exact =                 0.000 
   1-sided Fisher's exact =                 0.000 
 
+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus1 |   VO2change 
         6 |         0          1 |     Total 
-----------+----------------------+---------- 
         0 |        23          3 |        26  
           |      17.3        8.7 |      26.0  
           |     88.46      11.54 |    100.00  
-----------+----------------------+---------- 
         1 |        41         29 |        70  
           |      46.7       23.3 |      70.0  
           |     58.57      41.43 |    100.00  
-----------+----------------------+---------- 
     Total |        64         32 |        96  
           |      64.0       32.0 |      96.0  
           |     66.67      33.33 |    100.00  
 
          Pearson chi2(1) =   7.6220   Pr = 0.006 
           Fisher's exact =                 0.007 
   1-sided Fisher's exact =                 0.004 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus2 |   VO2change 
         0 |         0          1 |     Total 
-----------+----------------------+---------- 
         0 |        34          8 |        42  
           |      28.0       14.0 |      42.0  
           |     80.95      19.05 |    100.00  
-----------+----------------------+---------- 
         1 |        30         24 |        54  
           |      36.0       18.0 |      54.0  
           |     55.56      44.44 |    100.00  
-----------+----------------------+---------- 
     Total |        64         32 |        96  
           |      64.0       32.0 |      96.0  
           |     66.67      33.33 |    100.00  
 
          Pearson chi2(1) =   6.8571   Pr = 0.009 
           Fisher's exact =                 0.010 
   1-sided Fisher's exact =                 0.007 
 
 
Logistic regression                               Number of obs   =         96 
                                                  LR chi2(1)      =       8.64 
                                                  Prob > chi2     =     0.0033 
Log likelihood = -56.784939                       Pseudo R2       =     0.0707 
 
------------------------------------------------------------------------------ 
vo2peakpw~35 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 cflstatus16 |   5.422764   3.579372     2.56   0.010     1.487213    19.77281 
------------------------------------------------------------------------------ 
 
. logistic VO2changecflstatus20 if study==0 & vo2peakvalid1==0 & vo2peakvalid9==0 & 
vo2peakpweightp!=. 
 
Logistic regression                               Number of obs   =         96 
                                                  LR chi2(1)      =       7.12 
                                                  Prob > chi2     =     0.0076 
Log likelihood = -57.546259                       Pseudo R2       =     0.0582 
 
------------------------------------------------------------------------------ 
vo2peakpw~35 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 cflstatus20 |        3.4   1.628496     2.56   0.011     1.329779    8.693176 
------------------------------------------------------------------------------ 
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STATA Protocol For Table 14 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 weight1 |      24    94.15833    2.782502    13.63142    88.40229    99.91438 
 weight2 |      24    92.62083    2.479145    12.14528    87.49233    97.74933 
---------+-------------------------------------------------------------------- 
    diff |      24      1.5375    .5581676    2.734452    .3828421    2.692157 
------------------------------------------------------------------------------ 
     mean(diff) = mean(weight1 - weight9)                         t =   2.7545 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9944         Pr(|T| > |t|) = 0.0113          Pr(T > t) = 0.0056 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 weight1 |      73    90.80137    1.529061     13.0643    87.75324     93.8495 
 weight2 |      73    86.47534    1.451398    12.40075    83.58203    89.36865 
---------+-------------------------------------------------------------------- 
    diff |      73    4.326027    .5901366    5.042129    3.149612    5.502443 
------------------------------------------------------------------------------ 
     mean(diff) = mean(weight1 - weight9)                         t =   7.3306 
 Ho: mean(diff) = 0                              degrees of freedom =       72 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24     -1.5375    .5581676    2.734452   -2.692157   -.3828421 
  active |      73   -4.326027    .5901366    5.042129   -5.502443   -3.149612 
---------+-------------------------------------------------------------------- 
combined |      97   -3.636082     .479709    4.724585   -4.588297   -2.683868 
---------+-------------------------------------------------------------------- 
    diff |            2.788528     1.08028                .6439002    4.933155 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.5813 
Ho: diff = 0                                     degrees of freedom =       95 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9943         Pr(|T| > |t|) = 0.0114          Pr(T > t) = 0.0057 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    bmi1 |      24    30.38333    .8790984    4.306685    28.56478    32.20189 
    bmi2 |      24      29.925    .8065235    3.951142    28.25658    31.59342 
---------+-------------------------------------------------------------------- 
    diff |      24    .4583331    .1811713    .8875547    .0835516    .8331146 
------------------------------------------------------------------------------ 
     mean(diff) = mean(bmi1 - bmi9)                               t =   2.5298 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9906         Pr(|T| > |t|) = 0.0187          Pr(T > t) = 0.0094 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    bmi1 |      73    29.75616     .398131    3.401633     28.9625    30.54982 
    bmi2 |      73    28.34795    .3901231    3.333213    27.57025    29.12564 
---------+-------------------------------------------------------------------- 
    diff |      73    1.408219    .1921178    1.641455    1.025239    1.791199 
------------------------------------------------------------------------------ 
     mean(diff) = mean(bmi1 - bmi9)                               t =   7.3300 
 Ho: mean(diff) = 0                              degrees of freedom =       72 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -.4583331    .1811713    .8875547   -.8331146   -.0835516 
  active |      73   -1.408219    .1921178    1.641455   -1.791199   -1.025239 
---------+-------------------------------------------------------------------- 
combined |      97   -1.173196    .1566161    1.542489   -1.484076   -.8623153 
---------+-------------------------------------------------------------------- 
    diff |             .949886    .3515937                .2518844    1.647888 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.7017 
Ho: diff = 0                                     degrees of freedom =       95 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9959         Pr(|T| > |t|) = 0.0082          Pr(T > t) = 0.0041 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 fat_kg1 |      24    28.60417    2.054506    10.06498     24.3541    32.85424 
 fat_kg2 |      24    27.39583    1.860346    9.113796    23.54741    31.24425 
---------+-------------------------------------------------------------------- 
    diff |      24    1.208333      .43924    2.151828    .2996958     2.11697 
------------------------------------------------------------------------------ 
     mean(diff) = mean(fat_kg1 - fat_kg9)                         t =   2.7510 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9943         Pr(|T| > |t|) = 0.0114          Pr(T > t) = 0.0057 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 fat_kg1 |      73    27.37397    .9559018    8.167228    25.46842    29.27953 
 fat_kg2 |      73    24.09178    .9667666    8.260057    22.16457    26.01899 
---------+-------------------------------------------------------------------- 
    diff |      73    3.282192     .442145    3.777688    2.400792    4.163592 
------------------------------------------------------------------------------ 
     mean(diff) = mean(fat_kg1 - fat_kg9)                         t =   7.4233 
 Ho: mean(diff) = 0                              degrees of freedom =       72 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -1.208333      .43924    2.151828    -2.11697   -.2996958 
  active |      73   -3.282192     .442145    3.777688   -4.163592   -2.400792 
---------+-------------------------------------------------------------------- 
combined |      97   -2.769072    .3607229    3.552709   -3.485101   -2.053043 
---------+-------------------------------------------------------------------- 
    diff |            2.073859    .8129513                .4599465    3.687771 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.5510 
Ho: diff = 0                                     degrees of freedom =       95 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9938         Pr(|T| > |t|) = 0.0123          Pr(T > t) = 0.0062 
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 187 of 239 
STATA Protocol For Table 15 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 weight1 |      24    94.15833    2.782502    13.63142    88.40229    99.91438 
 weight2 |      24    92.62083    2.479145    12.14528    87.49233    97.74933 
---------+-------------------------------------------------------------------- 
    diff |      24      1.5375    .5581676    2.734452    .3828421    2.692157 
------------------------------------------------------------------------------ 
     mean(diff) = mean(weight1 - weight9)                         t =   2.7545 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9944         Pr(|T| > |t|) = 0.0113          Pr(T > t) = 0.0056 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 weight1 |      70    90.16429    1.530661    12.80643     87.1107    93.21787 
 weight2 |      70       86.51    1.492079    12.48363    83.53338    89.48662 
---------+-------------------------------------------------------------------- 
    diff |      70    3.654286    .4398366    3.679937    2.776836    4.531736 
------------------------------------------------------------------------------ 
     mean(diff) = mean(weight1 - weight9)                         t =   8.3083 
 Ho: mean(diff) = 0                              degrees of freedom =       69 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24     -1.5375    .5581676    2.734452   -2.692157   -.3828421 
  active |      70   -3.654286    .4398366    3.679937   -4.531736   -2.776836 
---------+-------------------------------------------------------------------- 
combined |      94    -3.11383       .3684    3.571771   -3.845399    -2.38226 
---------+-------------------------------------------------------------------- 
    diff |            2.116786    .8202864                .4876262    3.745946 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.5805 
Ho: diff = 0                                     degrees of freedom =       92 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9943         Pr(|T| > |t|) = 0.0114          Pr(T > t) = 0.0057 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    bmi1 |      24    30.38333    .8790984    4.306685    28.56478    32.20189 
    bmi2 |      24      29.925    .8065235    3.951142    28.25658    31.59342 
---------+-------------------------------------------------------------------- 
    diff |      24    .4583331    .1811713    .8875547    .0835516    .8331146 
------------------------------------------------------------------------------ 
     mean(diff) = mean(bmi1 - bmi9)                               t =   2.5298 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9906         Pr(|T| > |t|) = 0.0187          Pr(T > t) = 0.0094 
 
--------------------------------------------------------------------------------------
--------------------------------- 
-> cflstatus_adj = active 
 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    bmi1 |      70    29.57143     .383992    3.212708    28.80539    30.33747 
    bmi2 |      70    28.38143    .3937466    3.294321    27.59593    29.16693 
---------+-------------------------------------------------------------------- 
    diff |      70        1.19    .1406455    1.176725    .9094199     1.47058 
------------------------------------------------------------------------------ 
     mean(diff) = mean(bmi1 - bmi9)                               t =   8.4610 
 Ho: mean(diff) = 0                              degrees of freedom =       69 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -.4583331    .1811713    .8875547   -.8331146   -.0835516 
  active |      70       -1.19    .1406455    1.176725    -1.47058   -.9094199 
---------+-------------------------------------------------------------------- 
combined |      94   -1.003191    .1187274    1.151105   -1.238961   -.7674222 
---------+-------------------------------------------------------------------- 
    diff |            .7316669    .2629189                .2094874    1.253846 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.7829 
Ho: diff = 0                                     degrees of freedom =       92 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9967         Pr(|T| > |t|) = 0.0065          Pr(T > t) = 0.0033 
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-> cflstatus_adj = inactive 
 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 fat_kg1 |      24    28.60417    2.054506    10.06498     24.3541    32.85424 
 fat_kg2 |      24    27.39583    1.860346    9.113796    23.54741    31.24425 
---------+-------------------------------------------------------------------- 
    diff |      24    1.208333      .43924    2.151828    .2996958     2.11697 
------------------------------------------------------------------------------ 
     mean(diff) = mean(fat_kg1 - fat_kg9)                         t =   2.7510 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9943         Pr(|T| > |t|) = 0.0114          Pr(T > t) = 0.0057 
 
--------------------------------------------------------------------------------------
--------------------------------- 
-> cflstatus_adj = active 
 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
 fat_kg1 |      70    27.16571    .9782371    8.184519    25.21418    29.11724 
 fat_kg2 |      70    24.39571     .981663    8.213182    22.43735    26.35408 
---------+-------------------------------------------------------------------- 
    diff |      70        2.77    .3235629    2.707122     2.12451     3.41549 
------------------------------------------------------------------------------ 
     mean(diff) = mean(fat_kg1 - fat_kg9)                         t =   8.5609 
 Ho: mean(diff) = 0                              degrees of freedom =       69 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -1.208333      .43924    2.151828    -2.11697   -.2996958 
  active |      70       -2.77    .3235629    2.707122    -3.41549    -2.12451 
---------+-------------------------------------------------------------------- 
combined |      94   -2.371277    .2738827    2.655391   -2.915153     -1.8274 
---------+-------------------------------------------------------------------- 
    diff |            1.561667    .6101684                .3498199    2.773514 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.5594 
Ho: diff = 0                                     degrees of freedom =       92 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9939         Pr(|T| > |t|) = 0.0121          Pr(T > t) = 0.0061 
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STATA Protocol For Table 16 
+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ |    weightloss≥5% 
       adj |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        22          2 |        24  
           |      15.8        8.2 |      24.0  
           |     91.67       8.33 |    100.00  
-----------+----------------------+---------- 
    active |        42         31 |        73  
           |      48.2       24.8 |      73.0  
           |     57.53      42.47 |    100.00  
-----------+----------------------+---------- 
     Total |        64         33 |        97  
           |      64.0       33.0 |      97.0  
           |     65.98      34.02 |    100.00  
 
          Pearson chi2(1) =   9.3745   Pr = 0.002 
           Fisher's exact =                 0.002 
   1-sided Fisher's exact =                 0.001 
 
Logistic regression                               Number of obs   =         97 
                                                  LR chi2(1)      =      11.08 
                                                  Prob > chi2     =     0.0009 
Log likelihood = -56.651875                       Pseudo R2       =     0.0891 
 
------------------------------------------------------------------------------ 
weightloss   | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cfl          |   8.119047   6.296959     2.70   0.007     1.775544    37.12605 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus1 | weightloss≥5% 
         6 |         0          1 |     Total 
-----------+----------------------+---------- 
         0 |        23          4 |        27  
           |      17.8        9.2 |      27.0  
           |     85.19      14.81 |    100.00  
-----------+----------------------+---------- 
         1 |        41         29 |        70  
           |      46.2       23.8 |      70.0  
           |     58.57      41.43 |    100.00  
-----------+----------------------+---------- 
     Total |        64         33 |        97  
           |      64.0       33.0 |      97.0  
           |     65.98      34.02 |    100.00  
 
          Pearson chi2(1) =   6.1483   Pr = 0.013 
           Fisher's exact =                 0.016 
   1-sided Fisher's exact =                 0.010 
 
 
Logistic regression                               Number of obs   =         97 
                                                  LR chi2(1)      =       6.76 
                                                  Prob > chi2     =     0.0093 
Log likelihood = -58.812684                       Pseudo R2       =     0.0544 
 
------------------------------------------------------------------------------ 
weightloss   | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 cfl         |   4.067073   2.414181     2.36   0.018      1.27062    13.01812 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus2 | weightloss≥5% 
         0 |         0          1 |     Total 
-----------+----------------------+---------- 
         0 |        34          9 |        43  
           |      28.4       14.6 |      43.0  
           |     79.07      20.93 |    100.00  
-----------+----------------------+---------- 
         1 |        30         24 |        54  
           |      35.6       18.4 |      54.0  
           |     55.56      44.44 |    100.00  
-----------+----------------------+---------- 
     Total |        64         33 |        97  
           |      64.0       33.0 |      97.0  
           |     65.98      34.02 |    100.00  
 
          Pearson chi2(1) =   5.8966   Pr = 0.015 
           Fisher's exact =                 0.018 
   1-sided Fisher's exact =                 0.013 
 
. logistic weightchange05 cflstatus20 if study==0 & bmi1>25 & bmi1!=. & bmi9!=. 
 
Logistic regression                               Number of obs   =         97 
                                                  LR chi2(1)      =       6.07 
                                                  Prob > chi2     =     0.0137 
Log likelihood = -59.156251                       Pseudo R2       =     0.0488 
 
------------------------------------------------------------------------------ 
weightloss   | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
 cfl         |   3.022222    1.40305     2.38   0.017     1.216636    7.507441 
------------------------------------------------------------------------------ 
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STATA Protocol For Table17a 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    TCH1 |      23     225.913    11.34509    54.40915    202.3848    249.4413 
    TCH2 |      23    228.4783    11.72576    56.23479    204.1605     252.796 
---------+-------------------------------------------------------------------- 
    diff |      23   -2.565217    4.829842    23.16311    -12.5817    7.451262 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch1 - tch9)                               t =  -0.5311 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.3003         Pr(|T| > |t|) = 0.6007          Pr(T > t) = 0.6997 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    TCH1 |      87     223.977    5.264965    49.10832    213.5106    234.4434 
    TCH2 |      87         215     4.93505    46.03108    205.1894    224.8106 
---------+-------------------------------------------------------------------- 
    diff |      87    8.977011    2.561459     23.8917    3.884999    14.06902 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch1 - tch9)                               t =   3.5046 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9996         Pr(|T| > |t|) = 0.0007          Pr(T > t) = 0.0004 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23   -2.565217    4.829842    23.16311    -12.5817    7.451262 
  active |      87    8.977011    2.561459     23.8917    3.884999    14.06902 
---------+-------------------------------------------------------------------- 
combined |     110    6.563636    2.298004    24.10167    2.009067    11.11821 
---------+-------------------------------------------------------------------- 
    diff |           -11.54223    5.567327               -22.57764     -.50682 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -2.0732 
Ho: diff = 0                                     degrees of freedom =      108 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0203         Pr(|T| > |t|) = 0.0405          Pr(T > t) = 0.9797 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    TCH1 |      17    247.7647    10.72159    44.20623     225.036    270.4935 
    TCH2 |      17    250.1765    11.33391    46.73093    226.1496    274.2033 
---------+-------------------------------------------------------------------- 
    diff |      17   -2.411765    6.397988    26.37958   -15.97489    11.15136 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch1 - tch9)                               t =  -0.3770 
 Ho: mean(diff) = 0                              degrees of freedom =       16 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.3556         Pr(|T| > |t|) = 0.7112          Pr(T > t) = 0.6444 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    TCH1 |      67    241.3582    4.810836    39.37839    231.7531    250.9634 
    TCH2 |      67    229.7761    4.811453    39.38344    220.1697    239.3825 
---------+-------------------------------------------------------------------- 
    diff |      67    11.58209    3.105862    25.42258    5.381035    17.78314 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch1 - tch9)                               t =   3.7291 
 Ho: mean(diff) = 0                              degrees of freedom =       66 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9998         Pr(|T| > |t|) = 0.0004          Pr(T > t) = 0.0002 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      17   -2.411765    6.397988    26.37958   -15.97489    11.15136 
  active |      67    11.58209    3.105862    25.42258    5.381035    17.78314 
---------+-------------------------------------------------------------------- 
combined |      84        8.75    2.845358    26.07814    3.090697     14.4093 
---------+-------------------------------------------------------------------- 
    diff |           -13.99385    6.955419                -27.8304   -.1573099 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -2.0119 
Ho: diff = 0                                     degrees of freedom =       82 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0238         Pr(|T| > |t|) = 0.0475          Pr(T > t) = 0.9762 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    hdl1 |      24    57.20417    3.338459    16.35504    50.29804    64.11029 
    hdl2 |      24      55.875    3.167608    15.51805     49.3223     62.4277 
---------+-------------------------------------------------------------------- 
    diff |      24    1.329167    1.345827    6.593177   -1.454888    4.113221 
------------------------------------------------------------------------------ 
     mean(diff) = mean(hdl1 - hdl9)                               t =   0.9876 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.8332         Pr(|T| > |t|) = 0.3336          Pr(T > t) = 0.1668 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    hdl1 |      87    54.45977    1.390848    12.97296    51.69486    57.22468 
    hdl2 |      87     55.4023    1.293731    12.06712    52.83045    57.97415 
---------+-------------------------------------------------------------------- 
    diff |      87   -.9425287    .7736914    7.216513   -2.480576    .5955188 
------------------------------------------------------------------------------ 
     mean(diff) = mean(hdl1 - hdl9)                               t =  -1.2182 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.1132         Pr(|T| > |t|) = 0.2265          Pr(T > t) = 0.8868 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -1.329167    1.345827    6.593177   -4.113221    1.454888 
  active |      87    .9425287    .7736914    7.216513   -.5955188    2.480576 
---------+-------------------------------------------------------------------- 
combined |     111    .4513513    .6757528    7.119498   -.8878321    1.790535 
---------+-------------------------------------------------------------------- 
    diff |           -2.271695    1.634612               -5.511443    .9680525 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -1.3897 
Ho: diff = 0                                     degrees of freedom =      109 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0837         Pr(|T| > |t|) = 0.1674          Pr(T > t) = 0.9163 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    hdl1 |      18        54.5    3.572087    15.15508    46.96356    62.03644 
    hdl2 |      18    53.61111    3.602957    15.28605    46.00954    61.21269 
---------+-------------------------------------------------------------------- 
    diff |      18    .8888889    1.516551    6.434182   -2.310754    4.088532 
------------------------------------------------------------------------------ 
     mean(diff) = mean(hdl1 - hdl9)                               t =   0.5861 
 Ho: mean(diff) = 0                              degrees of freedom =       17 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.7173         Pr(|T| > |t|) = 0.5655          Pr(T > t) = 0.2827 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    hdl1 |      62    50.16129    1.158098    9.118875    47.84553    52.47705 
    hdl2 |      62    52.48387    1.263895     9.95192    49.95656    55.01119 
---------+-------------------------------------------------------------------- 
    diff |      62   -2.322581    .8612875    6.781784   -4.044831   -.6003299 
------------------------------------------------------------------------------ 
     mean(diff) = mean(hdl1 - hdl9)                               t =  -2.6966 
 Ho: mean(diff) = 0                              degrees of freedom =       61 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.0045         Pr(|T| > |t|) = 0.0090          Pr(T > t) = 0.9955 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      18   -.8888889    1.516551    6.434182   -4.088532    2.310754 
  active |      62    2.322581    .8612875    6.781784    .6003299    4.044831 
---------+-------------------------------------------------------------------- 
combined |      80         1.6    .7602881    6.800223    .0866844    3.113316 
---------+-------------------------------------------------------------------- 
    diff |            -3.21147    1.795881               -6.786793    .3638541 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -1.7882 
Ho: diff = 0                                     degrees of freedom =       78 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.0388         Pr(|T| > |t|) = 0.0776          Pr(T > t) = 0.9612 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
tch/hdl1 |      23    4.178725    .2422847    1.161956    3.676258    4.681193 
tch/hdl2 |      23    4.290586    .2503259    1.200521    3.771442     4.80973 
---------+-------------------------------------------------------------------- 
    diff |      23   -.1118606    .1221191    .5856626   -.3651201    .1413989 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch_hdl1 - tch_hdl9)                       t =  -0.9160 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.1848         Pr(|T| > |t|) = 0.3696          Pr(T > t) = 0.8152 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
tch/hdl1 |      87    4.270923    .1236215    1.153065    4.025172    4.516675 
tch/hdl2 |      87    4.034917    .1136416    1.059978    3.809005    4.260829 
---------+-------------------------------------------------------------------- 
    diff |      87    .2360062    .0648678    .6050464    .1070534    .3649591 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch_hdl1 - tch_hdl9)                       t =   3.6383 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9998         Pr(|T| > |t|) = 0.0005          Pr(T > t) = 0.0002 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23    .1118606    .1221191    .5856626   -.1413989    .3651201 
  active |      87   -.2360062    .0648678    .6050464   -.3649591   -.1070534 
---------+-------------------------------------------------------------------- 
combined |     110   -.1632704    .0586406    .6150281   -.2794943   -.0470466 
---------+-------------------------------------------------------------------- 
    diff |            .3478669    .1409466                .0684863    .6272475 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.4681 
Ho: diff = 0                                     degrees of freedom =      108 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9924         Pr(|T| > |t|) = 0.0152          Pr(T > t) = 0.0076 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
tch/hdl1 |      12    5.049463    .2419347    .8380863    4.516968    5.581958 
tch/hdl2 |      12    5.120836    .2656228    .9201445    4.536204    5.705468 
---------+-------------------------------------------------------------------- 
    diff |      12   -.0713727    .1561417    .5408908   -.4150383     .272293 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch_hdl1 - tch_hdl9)                       t =  -0.4571 
 Ho: mean(diff) = 0                              degrees of freedom =       11 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.3282         Pr(|T| > |t|) = 0.6565          Pr(T > t) = 0.6718 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
tch/hdl1 |      51    5.033791    .1144265    .8171685    4.803959    5.263623 
tch/hdl2 |      51     4.61454    .1273608    .9095384    4.358728    4.870351 
---------+-------------------------------------------------------------------- 
    diff |      51    .4192513    .0928977    .6634224    .2326608    .6058419 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tch_hdl1 - tch_hdl9)                       t =   4.5130 
 Ho: mean(diff) = 0                              degrees of freedom =       50 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      12    .0713727    .1561417    .5408908    -.272293    .4150383 
  active |      51   -.4192513    .0928977    .6634224   -.6058419   -.2326608 
---------+-------------------------------------------------------------------- 
combined |      63   -.3257991    .0840035    .6667567   -.4937196   -.1578786 
---------+-------------------------------------------------------------------- 
    diff |             .490624    .2063205                .0780608    .9031873 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.3780 
Ho: diff = 0                                     degrees of freedom =       61 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9897         Pr(|T| > |t|) = 0.0206          Pr(T > t) = 0.0103 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    ldl1 |      23    141.9957    10.16953    48.77134    120.9053     163.086 
    ldl2 |      23    145.4609    9.745638    46.73844    125.2497    165.6721 
---------+-------------------------------------------------------------------- 
    diff |      23   -3.465217    3.899061    18.69924   -11.55137     4.62094 
------------------------------------------------------------------------------ 
     mean(diff) = mean(ldl1 - ldl9)                               t =  -0.8887 
 Ho: mean(diff) = 0                              degrees of freedom =       22 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.1919         Pr(|T| > |t|) = 0.3838          Pr(T > t) = 0.8081 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    ldl1 |      87    138.4667    4.780456    44.58913    128.9634    147.9699 
    ldl2 |      87    133.2851    4.487243    41.85422    124.3647    142.2054 
---------+-------------------------------------------------------------------- 
    diff |      87    5.181609    2.541944    23.70967    .1283926    10.23483 
------------------------------------------------------------------------------ 
     mean(diff) = mean(ldl1 - ldl9)                               t =   2.0384 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9777         Pr(|T| > |t|) = 0.0446          Pr(T > t) = 0.0223 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      23    3.465217    3.899061    18.69924    -4.62094    11.55137 
  active |      87   -5.181609    2.541944    23.70967   -10.23483   -.1283926 
---------+-------------------------------------------------------------------- 
combined |     110   -3.373637    2.187946    22.94737   -7.710074    .9628011 
---------+-------------------------------------------------------------------- 
    diff |            8.646826    5.340718               -1.939403    19.23305 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   1.6190 
Ho: diff = 0                                     degrees of freedom =      108 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9458         Pr(|T| > |t|) = 0.1084          Pr(T > t) = 0.0542 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    ldl1 |      18    142.5667    12.30063    52.18714    116.6146    168.5187 
    ldl2 |      18       148.1    12.03566    51.06297     122.707     173.493 
---------+-------------------------------------------------------------------- 
    diff |      18   -5.533332    4.470587    18.96709   -14.96545    3.898781 
------------------------------------------------------------------------------ 
     mean(diff) = mean(ldl1 - ldl9)                               t =  -1.2377 
 Ho: mean(diff) = 0                              degrees of freedom =       17 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.1163         Pr(|T| > |t|) = 0.2326          Pr(T > t) = 0.8837 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    ldl1 |      62    142.3452    5.652035    44.50416    131.0432    153.6471 
    ldl2 |      62    136.8097    5.194109    40.89846    126.4234    147.1959 
---------+-------------------------------------------------------------------- 
    diff |      62    5.535484    3.210011    25.27566   -.8833302     11.9543 
------------------------------------------------------------------------------ 
     mean(diff) = mean(ldl1 - ldl9)                               t =   1.7244 
 Ho: mean(diff) = 0                              degrees of freedom =       61 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9552         Pr(|T| > |t|) = 0.0897          Pr(T > t) = 0.0448 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      18    5.533332    4.470587    18.96709   -3.898781    14.96545 
  active |      62   -5.535484    3.210011    25.27566    -11.9543    .8833302 
---------+-------------------------------------------------------------------- 
combined |      80   -3.045001    2.721087    24.33815    -8.46119    2.371188 
---------+-------------------------------------------------------------------- 
    diff |            11.06882    6.437054               -1.746373    23.88401 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   1.7195 
Ho: diff = 0                                     degrees of freedom =       78 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9553         Pr(|T| > |t|) = 0.0895          Pr(T > t) = 0.0447 
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STATA Protocol Table 17b 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
  logtg1 |      24    4.777137    .1006159     .492915    4.568998    4.985277 
  logtg2 |      24    4.735161    .1095542    .5367036    4.508531    4.961791 
---------+-------------------------------------------------------------------- 
    diff |      24    .0419767    .0804298    .3940241   -.1244051    .2083585 
------------------------------------------------------------------------------ 
     mean(diff) = mean(logtg1 - logtg9)                           t =   0.5219 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.6966         Pr(|T| > |t|) = 0.6067          Pr(T > t) = 0.3034 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
  logtg1 |      87     4.88529    .0583837    .5445668    4.769227    5.001353 
  logtg2 |      87      4.7163    .0589333    .5496928    4.599144    4.833455 
---------+-------------------------------------------------------------------- 
    diff |      87    .1689901    .0432095    .4030316    .0830924    .2548877 
------------------------------------------------------------------------------ 
     mean(diff) = mean(logtg1 - logtg9)                           t =   3.9109 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9999         Pr(|T| > |t|) = 0.0002          Pr(T > t) = 0.0001 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -.0419767    .0804298    .3940241   -.2083585    .1244051 
  active |      87   -.1689901    .0432095    .4030316   -.2548877   -.0830924 
---------+-------------------------------------------------------------------- 
combined |     111   -.1415277    .0382283    .4027597   -.2172872   -.0657683 
---------+-------------------------------------------------------------------- 
    diff |            .1270133    .0924913               -.0563013     .310328 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   1.3732 
Ho: diff = 0                                     degrees of freedom =      109 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9138         Pr(|T| > |t|) = 0.1725          Pr(T > t) = 0.0862 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
     tg1 |      24     132.625    12.49635    61.21936    106.7743    158.4757 
     tg2 |      24    133.4583     18.8273    92.23457    94.51109    172.4056 
---------+-------------------------------------------------------------------- 
    diff |      24   -.8333333    14.74084    72.21506   -31.32708    29.66041 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tg1 - tg9)                                 t =  -0.0565 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.4777         Pr(|T| > |t|) = 0.9554          Pr(T > t) = 0.5223 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
     tg1 |      87    155.2529    11.23634    104.8056    132.9158      177.59 
     tg2 |      87    131.5632    9.989244    93.17347    111.7053    151.4212 
---------+-------------------------------------------------------------------- 
    diff |      87    23.68966    8.147814    75.99775    7.492336    39.88697 
------------------------------------------------------------------------------ 
     mean(diff) = mean(tg1 - tg9)                                 t =   2.9075 
 Ho: mean(diff) = 0                              degrees of freedom =       86 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9977         Pr(|T| > |t|) = 0.0046          Pr(T > t) = 0.0023 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24    .8333333    14.74084    72.21506   -29.66041    31.32708 
  active |      87   -23.68966    8.147814    75.99775   -39.88697   -7.492336 
---------+-------------------------------------------------------------------- 
combined |     111   -18.38739    7.171494    75.55638   -32.59961   -4.175169 
---------+-------------------------------------------------------------------- 
    diff |            24.52299    17.34215               -9.848598    58.89457 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   1.4141 
Ho: diff = 0                                     degrees of freedom =      109 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9199         Pr(|T| > |t|) = 0.1602          Pr(T > t) = 0.0801 
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STATA Protocol For Table 19 
+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ |   TCH decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        21          2 |        23  
           |      18.4        4.6 |      23.0  
           |     91.30       8.70 |    100.00  
-----------+----------------------+---------- 
    active |        67         20 |        87  
           |      69.6       17.4 |      87.0  
           |     77.01      22.99 |    100.00  
-----------+----------------------+---------- 
     Total |        88         22 |       110  
           |      88.0       22.0 |     110.0  
           |     80.00      20.00 |    100.00  
 
          Pearson chi2(1) =   2.3226   Pr = 0.128 
           Fisher's exact =                 0.154 
   1-sided Fisher's exact =                 0.105 
 
 
Logistic regression                               Number of obs   =        110 
                                                  LR chi2(1)      =       2.69 
                                                  Prob > chi2     =     0.1011 
Log likelihood = -53.700057                       Pseudo R2       =     0.0244 
 
------------------------------------------------------------------------------ 
   oddstch10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   3.134328   2.453089     1.46   0.144     .6760048    14.53246 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | TCH decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        15          2 |        17  
           |      13.0        4.0 |      17.0  
           |     88.24      11.76 |    100.00  
-----------+----------------------+---------- 
    active |        49         18 |        67  
           |      51.0       16.0 |      67.0  
           |     73.13      26.87 |    100.00  
-----------+----------------------+---------- 
     Total |        64         20 |        84  
           |      64.0       20.0 |      84.0  
           |     76.19      23.81 |    100.00  
 
          Pearson chi2(1) =   1.7045   Pr = 0.192 
           Fisher's exact =                 0.338 
   1-sided Fisher's exact =                 0.162 
 
 
Logistic regression                               Number of obs   =         84 
                                                  LR chi2(1)      =       1.92 
                                                  Prob > chi2     =     0.1660 
Log likelihood = -45.146099                       Pseudo R2       =     0.0208 
 
------------------------------------------------------------------------------ 
   oddstch10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   2.755102   2.208606     1.26   0.206      .572504    13.25858 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | HDL increase ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        21          3 |        24  
           |      19.0        5.0 |      24.0  
           |     87.50      12.50 |    100.00  
-----------+----------------------+---------- 
    active |        67         20 |        87  
           |      69.0       18.0 |      87.0  
           |     77.01      22.99 |    100.00  
-----------+----------------------+---------- 
     Total |        88         23 |       111  
           |      88.0       23.0 |     111.0  
           |     79.28      20.72 |    100.00  
 
          Pearson chi2(1) =   1.2597   Pr = 0.262 
           Fisher's exact =                 0.395 
   1-sided Fisher's exact =                 0.204 
 
 
Logistic regression                               Number of obs   =        111 
                                                  LR chi2(1)      =       1.38 
                                                  Prob > chi2     =     0.2406 
Log likelihood = -55.947439                       Pseudo R2       =     0.0122 
 
------------------------------------------------------------------------------ 
   oddshdl10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   2.089552   1.395279     1.10   0.270     .5645094    7.734551 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | HDL increase ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        16          2 |        18  
           |      13.5        4.5 |      18.0  
           |     88.89      11.11 |    100.00  
-----------+----------------------+---------- 
    active |        44         18 |        62  
           |      46.5       15.5 |      62.0  
           |     70.97      29.03 |    100.00  
-----------+----------------------+---------- 
     Total |        60         20 |        80  
           |      60.0       20.0 |      80.0  
           |     75.00      25.00 |    100.00  
 
          Pearson chi2(1) =   2.3895   Pr = 0.122 
           Fisher's exact =                 0.214 
   1-sided Fisher's exact =                 0.104 
 
 
Logistic regression                               Number of obs   =         80 
                                                  LR chi2(1)      =       2.71 
                                                  Prob > chi2     =     0.0995 
Log likelihood = -43.630274                       Pseudo R2       =     0.0302 
 
------------------------------------------------------------------------------ 
   oddshdl10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   3.272727   2.619783     1.48   0.139     .6816042    15.71402 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | TCH/HDL decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        20          3 |        23  
           |      16.3        6.7 |      23.0  
           |     86.96      13.04 |    100.00  
-----------+----------------------+---------- 
    active |        58         29 |        87  
           |      61.7       25.3 |      87.0  
           |     66.67      33.33 |    100.00  
-----------+----------------------+---------- 
     Total |        78         32 |       110  
           |      78.0       32.0 |     110.0  
           |     70.91      29.09 |    100.00  
 
          Pearson chi2(1) =   3.6304   Pr = 0.057 
           Fisher's exact =                 0.072 
   1-sided Fisher's exact =                 0.045 
 
 
Logistic regression                               Number of obs   =        110 
                                                  LR chi2(1)      =       4.09 
                                                  Prob > chi2     =     0.0432 
Log likelihood = -64.282617                       Pseudo R2       =     0.0308 
 
------------------------------------------------------------------------------ 
oddstch/hdl  | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   3.333333    2.19863     1.83   0.068     .9150307    12.14288 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | TCH/HDL decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        11          1 |        12  
           |       7.4        4.6 |      12.0  
           |     91.67       8.33 |    100.00  
-----------+----------------------+---------- 
    active |        28         23 |        51  
           |      31.6       19.4 |      51.0  
           |     54.90      45.10 |    100.00  
-----------+----------------------+---------- 
     Total |        39         24 |        63  
           |      39.0       24.0 |      63.0  
           |     61.90      38.10 |    100.00  
 
          Pearson chi2(1) =   5.5677   Pr = 0.018 
           Fisher's exact =                 0.022 
   1-sided Fisher's exact =                 0.017 
 
 
Logistic regression                               Number of obs   =         63 
                                                  LR chi2(1)      =       6.64 
                                                  Prob > chi2     =     0.0100 
Log likelihood = -38.547046                       Pseudo R2       =     0.0793 
 
------------------------------------------------------------------------------ 
oddstch/hdl  | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   9.035714   9.774044     2.03   0.042     1.084444    75.28661 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ |   LDL decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        18          5 |        23  
           |      16.3        6.7 |      23.0  
           |     78.26      21.74 |    100.00  
-----------+----------------------+---------- 
    active |        60         27 |        87  
           |      61.7       25.3 |      87.0  
           |     68.97      31.03 |    100.00  
-----------+----------------------+---------- 
     Total |        78         32 |       110  
           |      78.0       32.0 |     110.0  
           |     70.91      29.09 |    100.00  
 
          Pearson chi2(1) =   0.7620   Pr = 0.383 
           Fisher's exact =                 0.449 
   1-sided Fisher's exact =                 0.274 
 
 
Logistic regression                               Number of obs   =        110 
                                                  LR chi2(1)      =       0.80 
                                                  Prob > chi2     =     0.3724 
Log likelihood = -65.928223                       Pseudo R2       =     0.0060 
 
------------------------------------------------------------------------------ 
   oddsldl10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |       1.62   .9008996     0.87   0.386      .544694    4.818118 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | LDL decrease ≥10% 
       adj |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        14          4 |        18  
           |      13.1        5.0 |      18.0  
           |     77.78      22.22 |    100.00  
-----------+----------------------+---------- 
    active |        44         18 |        62  
           |      45.0       17.1 |      62.0  
           |     70.97      29.03 |    100.00  
-----------+----------------------+---------- 
     Total |        58         22 |        80  
           |      58.0       22.0 |      80.0  
           |     72.50      27.50 |    100.00  
 
          Pearson chi2(1) =   0.3245   Pr = 0.569 
           Fisher's exact =                 0.766 
   1-sided Fisher's exact =                 0.403 
 
 
Logistic regression                               Number of obs   =         80 
                                                  LR chi2(1)      =       0.33 
                                                  Prob > chi2     =     0.5627 
Log likelihood = -46.886008                       Pseudo R2       =     0.0036 
 
------------------------------------------------------------------------------ 
   oddsldl10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   1.431818   .9052346     0.57   0.570     .4147009    4.943571 
------------------------------------------------------------------------------ 
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+--------------------+ 
| Key                | 
|--------------------| 
|     frequency      | 
| expected frequency | 
|   row percentage   | 
+--------------------+ 
 
cflstatus_ | TG decrease ≥10% 
           |         0          1 |     Total 
-----------+----------------------+---------- 
  inactive |        13         11 |        24  
           |      11.9       12.1 |      24.0  
           |     54.17      45.83 |    100.00  
-----------+----------------------+---------- 
    active |        42         45 |        87  
           |      43.1       43.9 |      87.0  
           |     48.28      51.72 |    100.00  
-----------+----------------------+---------- 
     Total |        55         56 |       111  
           |      55.0       56.0 |     111.0  
           |     49.55      50.45 |    100.00  
 
          Pearson chi2(1) =   0.2611   Pr = 0.609 
           Fisher's exact =                 0.651 
   1-sided Fisher's exact =                 0.390 
 
 
Logistic regression                               Number of obs   =        111 
                                                  LR chi2(1)      =       0.26 
                                                  Prob > chi2     =     0.6092 
Log likelihood = -76.804173                       Pseudo R2       =     0.0017 
 
------------------------------------------------------------------------------ 
   tg_odds10 | Odds Ratio   Std. Err.      z    P>|z|     [95% Conf. Interval] 
-------------+---------------------------------------------------------------- 
cflstatus    |   1.266234   .5855752     0.51   0.610     .5115312    3.134409 
------------------------------------------------------------------------------ 
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STATA Protocol Table 20 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      24     136.125    2.493697    12.21657    130.9664    141.2836 
   syst2 |      24    135.0833    1.823673    8.934139    131.3108    138.8559 
---------+-------------------------------------------------------------------- 
    diff |      24    1.041667    2.044327    10.01512   -3.187346    5.270679 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   0.5095 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.6924         Pr(|T| > |t|) = 0.6152          Pr(T > t) = 0.3076 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      80     143.325    1.775784     15.8831    139.7904    146.8596 
   syst2 |      80      142.05    1.423459     12.7318    139.2167    144.8833 
---------+-------------------------------------------------------------------- 
    diff |      80       1.275    1.278099    11.43166   -1.268992    3.818992 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   0.9976 
 Ho: mean(diff) = 0                              degrees of freedom =       79 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.8392         Pr(|T| > |t|) = 0.3215          Pr(T > t) = 0.1608 
 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -1.041667    2.044327    10.01512   -5.270679    3.187346 
  active |      80      -1.275    1.278099    11.43166   -3.818992    1.268992 
---------+-------------------------------------------------------------------- 
combined |     104   -1.221154    1.085924    11.07429   -3.374827    .9325196 
---------+-------------------------------------------------------------------- 
    diff |            .2333333    2.589902               -4.903724    5.370391 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   0.0901 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.5358         Pr(|T| > |t|) = 0.9284          Pr(T > t) = 0.4642 
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-> cflstatus16 = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      27    136.9259    2.345467     12.1874    132.1048    141.7471 
   syst2 |      27    136.6296    1.900029    9.872838    132.7241    140.5352 
---------+-------------------------------------------------------------------- 
    diff |      27    .2962963    2.084958    10.83376   -3.989397    4.581989 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   0.1421 
 Ho: mean(diff) = 0                              degrees of freedom =       26 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.5560         Pr(|T| > |t|) = 0.8881          Pr(T > t) = 0.4440 
 
-> cflstatus16 = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      77    143.3247    1.831919    16.07502    139.6761    146.9733 
   syst2 |      77    141.7792    1.459949      12.811    138.8715     144.687 
---------+-------------------------------------------------------------------- 
    diff |      77    1.545455    1.277406    11.20919   -.9987194    4.089629 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   1.2098 
 Ho: mean(diff) = 0                              degrees of freedom =       76 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.8850         Pr(|T| > |t|) = 0.2301          Pr(T > t) = 0.1150 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
       0 |      27   -.2962963    2.084958    10.83376   -4.581989    3.989397 
       1 |      77   -1.545455    1.277406    11.20919   -4.089629    .9987194 
---------+-------------------------------------------------------------------- 
combined |     104   -1.221154    1.085924    11.07429   -3.374827    .9325196 
---------+-------------------------------------------------------------------- 
    diff |            1.249158    2.485919               -3.681651    6.179967 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   0.5025 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.6918         Pr(|T| > |t|) = 0.6164          Pr(T > t) = 0.3082 
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-> cflstatus20 = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      46    138.9783    1.915986    12.99485    135.1193    142.8373 
   syst2 |      46    139.4348    1.542209    10.45977    136.3286     142.541 
---------+-------------------------------------------------------------------- 
    diff |      46   -.4565217    1.771134    12.01241   -4.023768    3.110725 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =  -0.2578 
 Ho: mean(diff) = 0                              degrees of freedom =       45 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.3989         Pr(|T| > |t|) = 0.7978          Pr(T > t) = 0.6011 
 
-> cflstatus20 = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      58    143.7931    2.208541    16.81974    139.3706    148.2156 
   syst2 |      58    141.2414    1.784742    13.59219    137.6675    144.8153 
---------+-------------------------------------------------------------------- 
    diff |      58    2.551724     1.33662     10.1794   -.1248114     5.22826 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   1.9091 
 Ho: mean(diff) = 0                              degrees of freedom =       57 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9694         Pr(|T| > |t|) = 0.0613          Pr(T > t) = 0.0306 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
       0 |      46    .4565217    1.771134    12.01241   -3.110725    4.023768 
       1 |      58   -2.551724     1.33662     10.1794    -5.22826    .1248114 
---------+-------------------------------------------------------------------- 
combined |     104   -1.221154    1.085924    11.07429   -3.374827    .9325196 
---------+-------------------------------------------------------------------- 
    diff |            3.008246    2.176859               -1.309543    7.326035 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   1.3819 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9150         Pr(|T| > |t|) = 0.1700          Pr(T > t) = 0.0850 
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-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      24    83.29167    1.575951    7.720549    80.03156    86.55177 
    dia2 |      24    77.33333    1.695761    8.307496    73.82539    80.84128 
---------+-------------------------------------------------------------------- 
    diff |      24    5.958333    1.802252    8.829196    2.230091    9.686576 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   3.3060 
 Ho: mean(diff) = 0                              degrees of freedom =       23 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9985         Pr(|T| > |t|) = 0.0031          Pr(T > t) = 0.0015 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      80     82.9875     1.11683    9.989227    80.76451    85.21049 
    dia2 |      80      79.575     1.06435    9.519833    77.45647    81.69353 
---------+-------------------------------------------------------------------- 
    diff |      80      3.4125    .9511309    8.507173    1.519321    5.305679 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   3.5878 
 Ho: mean(diff) = 0                              degrees of freedom =       79 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9997         Pr(|T| > |t|) = 0.0006          Pr(T > t) = 0.0003 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      24   -5.958333    1.802252    8.829196   -9.686576   -2.230091 
  active |      80     -3.4125    .9511309    8.507173   -5.305679   -1.519321 
---------+-------------------------------------------------------------------- 
combined |     104          -4      .84397    8.606839   -5.673815   -2.326185 
---------+-------------------------------------------------------------------- 
    diff |           -2.545833    1.997082               -6.507036     1.41537 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =  -1.2748 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.1026         Pr(|T| > |t|) = 0.2053          Pr(T > t) = 0.8974 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 216 of 239 
-> cflstatus16 = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      27     83.7037    1.442946    7.497768    80.73769    86.66972 
    dia2 |      27    78.44444    1.761679    9.153954    74.82326    82.06563 
---------+-------------------------------------------------------------------- 
    diff |      27    5.259259    1.740741    9.045154    1.681115    8.837403 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   3.0213 
 Ho: mean(diff) = 0                              degrees of freedom =       26 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9972         Pr(|T| > |t|) = 0.0056          Pr(T > t) = 0.0028 
 
-> cflstatus16 = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      77    82.83117    1.152934    10.11695     80.5349    85.12744 
    dia2 |      77    79.27273    1.065785    9.352225    77.15003    81.39542 
---------+-------------------------------------------------------------------- 
    diff |      77    3.558442    .9645978    8.464311    1.637279    5.479605 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   3.6890 
 Ho: mean(diff) = 0                              degrees of freedom =       76 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9998         Pr(|T| > |t|) = 0.0004          Pr(T > t) = 0.0002 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      27   -5.259259    1.740741    9.045154   -8.837403   -1.681115 
  active |      77   -3.558442    .9645978    8.464311   -5.479605   -1.637279 
---------+-------------------------------------------------------------------- 
combined |     104          -4      .84397    8.606839   -5.673815   -2.326185 
---------+-------------------------------------------------------------------- 
    diff |           -1.700818    1.927079                -5.52317    2.121535 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =  -0.8826 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.1898         Pr(|T| > |t|) = 0.3795          Pr(T > t) = 0.8102 
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-> cflstatus20 = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      46    81.34783     1.50401    10.20069    78.31859    84.37706 
    dia2 |      46     78.3913    1.492486    10.12253    75.38528    81.39733 
---------+-------------------------------------------------------------------- 
    diff |      46    2.956522    1.375759    9.330849    .1856018    5.727442 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   2.1490 
 Ho: mean(diff) = 0                              degrees of freedom =       45 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9815         Pr(|T| > |t|) = 0.0370          Pr(T > t) = 0.0185 
 
-> cflstatus20 = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      58    84.41379    1.144712    8.717867    82.12155    86.70604 
    dia2 |      58    79.58621    1.126063    8.575842     77.3313    81.84111 
---------+-------------------------------------------------------------------- 
    diff |      58    4.827586    1.046741    7.971744    2.731523    6.923649 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   4.6120 
 Ho: mean(diff) = 0                              degrees of freedom =       57 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 1.0000         Pr(|T| > |t|) = 0.0000          Pr(T > t) = 0.0000 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      46   -2.956522    1.375759    9.330849   -5.727442   -.1856018 
  active |      58   -4.827586    1.046741    7.971744   -6.923649   -2.731523 
---------+-------------------------------------------------------------------- 
combined |     104          -4      .84397    8.606839   -5.673815   -2.326185 
---------+-------------------------------------------------------------------- 
    diff |            1.871064     1.69752               -1.495958    5.238086 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   1.1022 
Ho: diff = 0                                     degrees of freedom =      102 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.8635         Pr(|T| > |t|) = 0.2730          Pr(T > t) = 0.1365 
 
 
 
 
 
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 218 of 239 
 
STATA Protocol Table 21 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      16    147.4375    2.983243    11.93297    141.0789    153.7961 
   syst2 |      16    148.6875    2.861699     11.4468    142.5879    154.7871 
---------+-------------------------------------------------------------------- 
    diff |      16       -1.25     3.02283    12.09132   -7.693009    5.193009 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =  -0.4135 
 Ho: mean(diff) = 0                              degrees of freedom =       15 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.3425         Pr(|T| > |t|) = 0.6851          Pr(T > t) = 0.6575 
 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
   syst1 |      52    147.1923    1.560262    11.25121      144.06    150.3247 
   syst2 |      52    142.8269    1.316653    9.494521    140.1836    145.4702 
---------+-------------------------------------------------------------------- 
    diff |      52    4.365385    1.435656    10.35266    1.483185    7.247584 
------------------------------------------------------------------------------ 
     mean(diff) = mean(syst1 - syst9)                             t =   3.0407 
 Ho: mean(diff) = 0                              degrees of freedom =       51 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9981         Pr(|T| > |t|) = 0.0037          Pr(T > t) = 0.0019 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      16        1.25     3.02283    12.09132   -5.193009    7.693009 
  active |      52   -4.365385    1.435656    10.35266   -7.247584   -1.483185 
---------+-------------------------------------------------------------------- 
combined |      68   -3.044118    1.328824    10.95777   -5.696462    -.391773 
---------+-------------------------------------------------------------------- 
    diff |            5.615385    3.079701                -.533436    11.76421 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   1.8234 
Ho: diff = 0                                     degrees of freedom =       66 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9636         Pr(|T| > |t|) = 0.0728          Pr(T > t) = 0.0364 
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Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      13    90.15385    .7666624    2.764241    88.48343    91.82426 
    dia2 |      13    86.76923    1.687639     6.08487    83.09218    90.44628 
---------+-------------------------------------------------------------------- 
    diff |      13    3.384615    1.752429    6.318471   -.4335985    7.202829 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   1.9314 
 Ho: mean(diff) = 0                              degrees of freedom =       12 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9613         Pr(|T| > |t|) = 0.0774          Pr(T > t) = 0.0387 
 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
    dia1 |      21    93.33333    1.051831    4.820097    91.13925    95.52742 
    dia2 |      21     82.7619    2.542875    11.65292    77.45756    88.06625 
---------+-------------------------------------------------------------------- 
    diff |      21    10.57143    2.378046    10.89758    5.610912    15.53195 
------------------------------------------------------------------------------ 
     mean(diff) = mean(dia1 - dia9)                               t =   4.4454 
 Ho: mean(diff) = 0                              degrees of freedom =       20 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9999         Pr(|T| > |t|) = 0.0002          Pr(T > t) = 0.0001 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      13   -3.384615    1.752429    6.318471   -7.202829    .4335985 
  active |      21   -10.57143    2.378046    10.89758   -15.53195   -5.610912 
---------+-------------------------------------------------------------------- 
combined |      34   -7.823529    1.706896     9.95283   -11.29624   -4.350823 
---------+-------------------------------------------------------------------- 
    diff |            7.186813    3.332935                .3978466    13.97578 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   2.1563 
Ho: diff = 0                                     degrees of freedom =       32 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9807         Pr(|T| > |t|) = 0.0387          Pr(T > t) = 0.0193 
 
Improving the Efficiency of Lifestyle Change Interventions for the Prevention of Cardiometabolic Disease 
gedruckt auf alterungsbeständigem Papier DIN ISO 9706                                                                     page 220 of 239 
STATA Protocol For Table 22a 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
procam~1 |      15    5.729833    1.338338    5.183362    2.859382    8.600283 
procam~2 |      15    6.500762    1.402058    5.430148    3.493646    9.507877 
---------+-------------------------------------------------------------------- 
    diff |      15   -.7709293    .5056975    1.958558   -1.855542    .3136839 
------------------------------------------------------------------------------ 
     mean(diff) = mean(procam_risk1 - procam_risk9)               t =  -1.5245 
 Ho: mean(diff) = 0                              degrees of freedom =       14 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.0748         Pr(|T| > |t|) = 0.1497          Pr(T > t) = 0.9252 
 
-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
procam~1 |      56    6.800217    .7178748    5.372083    5.361564    8.238871 
procam~2 |      56    5.506427     .635204    4.753432     4.23345    6.779405 
---------+-------------------------------------------------------------------- 
    diff |      56     1.29379    .4270802    3.195976    .4379021    2.149678 
------------------------------------------------------------------------------ 
     mean(diff) = mean(procam_risk1 - procam_risk9)               t =   3.0294 
 Ho: mean(diff) = 0                              degrees of freedom =       55 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9981         Pr(|T| > |t|) = 0.0037          Pr(T > t) = 0.0019 
 
-> cflstatus_adj = inactive 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
logpro~1 |      15    1.473493     .186121    .7208436    1.074303    1.872683 
logpro~2 |      15    1.555692    .2196713    .8507835    1.084544    2.026841 
---------+-------------------------------------------------------------------- 
    diff |      15   -.0821996    .0952766    .3690045   -.2865475    .1221483 
------------------------------------------------------------------------------ 
     mean(diff) = mean(logprocam1 - logprocam9)                   t =  -0.8627 
 Ho: mean(diff) = 0                              degrees of freedom =       14 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.2014         Pr(|T| > |t|) = 0.4028          Pr(T > t) = 0.7986 
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-> cflstatus_adj = active 
Paired t test 
------------------------------------------------------------------------------ 
Variable |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
logpro~1 |      56    1.657313    .0977249    .7313061    1.461468    1.853158 
logpro~2 |      56    1.419398    .1010052    .7558537    1.216979    1.621817 
---------+-------------------------------------------------------------------- 
    diff |      56     .237915    .0581929    .4354761    .1212938    .3545363 
------------------------------------------------------------------------------ 
     mean(diff) = mean(logprocam1 - logprocam9)                   t =   4.0884 
 Ho: mean(diff) = 0                              degrees of freedom =       55 
 
 Ha: mean(diff) < 0           Ha: mean(diff) != 0           Ha: mean(diff) > 0 
 Pr(T < t) = 0.9999         Pr(|T| > |t|) = 0.0001          Pr(T > t) = 0.0001 
 
Two-sample t test with unequal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      15    .0821996    .0952766    .3690045   -.1221483    .2865475 
  active |      56    -.237915    .0581929    .4354761   -.3545363   -.1212938 
---------+-------------------------------------------------------------------- 
combined |      71   -.1702852    .0522123    .4399485   -.2744193   -.0661511 
---------+-------------------------------------------------------------------- 
    diff |            .3201146    .1116425                .0904069    .5498223 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.8673 
Ho: diff = 0                     Satterthwaite's degrees of freedom =  25.4908 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9959         Pr(|T| > |t|) = 0.0082          Pr(T > t) = 0.0041 
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STATA Protocol For Table 22b 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      15    16.64974    13.80337    53.46024   -12.95555    46.25503 
  active |      56   -14.69046    4.086486    30.58046   -22.87996   -6.500959 
---------+-------------------------------------------------------------------- 
combined |      71   -8.069291     4.55387    38.37159    -17.1517    1.013116 
---------+-------------------------------------------------------------------- 
    diff |             31.3402    10.58394                10.22582    52.45459 
------------------------------------------------------------------------------ 
    diff = mean(inactive) - mean(active)                          t =   2.9611 
Ho: diff = 0                                     degrees of freedom =       69 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9979         Pr(|T| > |t|) = 0.0042          Pr(T > t) = 0.0021 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      18     13.0761    11.84238    50.24297   -11.90914    38.06134 
  active |      53   -15.25074    4.232484    30.81295   -23.74385   -6.757643 
---------+-------------------------------------------------------------------- 
combined |      71   -8.069291     4.55387    38.37159    -17.1517    1.013116 
---------+-------------------------------------------------------------------- 
    diff |            28.32684      9.9769                8.423474    48.23021 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   2.8392 
Ho: diff = 0                                     degrees of freedom =       69 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9970         Pr(|T| > |t|) = 0.0059          Pr(T > t) = 0.0030 
 
Two-sample t test with equal variances 
------------------------------------------------------------------------------ 
   Group |     Obs        Mean    Std. Err.   Std. Dev.   [95% Conf. Interval] 
---------+-------------------------------------------------------------------- 
inactive |      30    8.055295    7.993236    43.78076   -8.292709     24.4033 
  active |      41   -19.86777    4.551413    29.14326   -29.06652   -10.66902 
---------+-------------------------------------------------------------------- 
combined |      71   -8.069291     4.55387    38.37159    -17.1517    1.013116 
---------+-------------------------------------------------------------------- 
    diff |            27.92306    8.655793                10.65523     45.1909 
------------------------------------------------------------------------------ 
    diff = mean(0) - mean(1)                                      t =   3.2259 
Ho: diff = 0                                     degrees of freedom =       69 
 
    Ha: diff < 0                 Ha: diff != 0                 Ha: diff > 0 
 Pr(T < t) = 0.9990         Pr(|T| > |t|) = 0.0019          Pr(T > t) = 0.0010 
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APPENDIX 2: DESCRIPTION OF THE ELECTRONIC LIFESTYLE FILE (ELF) 
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APPENDIX 3: ETHICS APPROVAL & PARTICIPANT FORMS 
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PROBANDEN INFORMATION 
 
Verbesserung der Effizienz und Adhärenz in Verhaltensänderungsinterventionen für 
die Prävention chronischer lebensstilbedingter kardiometaboler Erkrankungen. 
 
 
 
 
 
Liebe Studienteilnehmerin, lieber Studienteilnehmer 
 
Freundlicherweise haben Sie sich bereit erklärt, an diesem Interventionsprojekt teilzunehmen, 
das die Universität Bielefeld in Kooperation mit der Siemens Betriebskrankenkasse, der 
Siemens AG Karlsruhe und der adiphea GmbH durchführt. Das Projekt beschäftigt sich mit 
der Verhütung der Herz-Kreislauferkrankungen durch individualisierte 
Bewegungsprogramme. Ziel der Intervention ist es, (a) ein auf Ihr Risikoprofil 
zugeschnittenes Bewegungsverhalten in ein stabiles Gewohnheitsverhalten zu überführen, 
um damit (b) Ihr Risiko für die lebensstilbedingten Herz-Kreislauferkrankungen und den 
Diabetes Mellitus Typ 2 nachhaltig zu verringern.  Neu an dieser Intervention ist die 
Kombination aus ärztlicher Betreuung und einer internetbasierten Anwendung zur Motivation 
und für die Adhärenz- und Fortschrittskontrolle. 
 
Hintergrund 
Wissenschaftliche Studien belegen einen ursächlichen Zusammenhang zwischen 
Bewegungsmangel und chronischen Erkrankungen des Herz-Kreislaufsystems (z.B. 
Atherosklerose, Bluthochdruck, Herzinfarkt, Schlaganfall) und des Stoffwechsels 
(Insulinresistenz, Diabetes).  
Wissenschaftliche Studien bestätigen auch, dass die Aufnahme von Ausdauer- und Kraftsport 
das Risiko für diese Krankheiten bei bislang bewegungsarmen Menschen signifikant 
reduzieren kann. Deshalb haben medizinische Gesellschaften und Gesundheits-
organisationen, wie beispielsweise die American Heart Association (AHA), das American 
College of Sports Medicine (ACSM), das Institute of Medicine (IOM) und die 
Weltgesundheitsbehörde (WHO), Konsensusempfehlungen für ein risikoreduzierendes  
Mindestmass an Ausdauersport formuliert. Trotz dieser mittlerweile zum Allgemeinwissen 
gewordenen Erkenntnisse fällt es den meisten Menschen schwer, mehr Bewegung in ihr 
Leben zu bringen. Somit erreichen weniger als 20% der erwachsenen Deutschen das 
empfohlene Minimum von 150 Minuten moderater bis intensiver Bewegung pro Woche. 
 
Damit das angestrebte Mehr an Bewegung wirksam und nachhaltig in die persönlichen 
Lebensroutinen eingebaut werden kann, muss es sowohl auf das individuelle Risikoprofil des 
Einzelnen zugeschnitten werden, als auch auf dessen Fähigkeiten, Neigungen und 
Lebenswelt. Der dafür notwendige Aufwand übersteigt meist die dem betreuenden Arzt zur 
Verfügung stehenden Resourcen. Demgegenüber bieten Internet-basierte Programme die 
Möglichkeit der Individualisierung, ihnen fehlt aber die notwendige medizinische Betreuung.  
In der Primärprävention der chronischen lebensstilbedingten Erkrankungen wird bislang keine 
Kombination dieser beiden Strategien angeboten. 
 
In diesem Projekt möchten wir eine in die ärztliche Praxis eingebundene internetbasierte 
telemetrische Anwendung erproben. Ziel ist es, klinische Betreuung und Individualisierung 
teilnehmer- und praxisgerecht so zu verknüpfen, dass das auf das individuelle 
Teilnehmerprofil zugeschnittene Bewegungsprogramm zu einer effizienten, nachhaltigen und 
signifikanten Reduzierung des Krankheitsrisikos führt. 
 
Probanden-Information 
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Nutzen und Risiken der Teilnahme 
Ihr Nutzen: Sie erhalten die Möglichkeit durch die Teilnahme an einem auf Ihr persönliches 
Gesundheitsprofil zugeschnittenen Bewegungsprogramm, Ihr Risiko für die 
lebensstilbedingten chronischen Herz-Kreislauferkrankungen und den Diabetes Mellitus zu 
verringern. 
 
Ihr Risiko: Bewegung ungewohnter und höherer Intensität birgt ein Verletzungsrisiko des 
Bewegungsapparats, beispielsweise der Bänder, Sehnen, Gelenke und Muskeln. In 
Abhängigkeit von Trainingszustand und Trainingsintensität besteht beim Neu- oder 
Wiedereinsteiger in ein aktiveres Leben ein Risiko für kardiale Zwischenfälle, z. B. Herzinfarkt 
oder plötzlicher Herztod.  
Allerdings reduziert ein aktiver Lebensstil diese Risiken so substantiell und nachhaltig, dass 
der zu erwartende Nutzen das tatsächliche Risiko, das mit der Aufnahme eines aktiveren 
Lebensstils zunächst verbunden ist, deutlich übersteigt.    
 
Bei der Blutentnahme bestehen Risiken für Infektion, Hämatom, Blutverlust. Diese Risiken 
können aber bei sach- und leitliniengerechter Durchführung weitgehend ausgeschlossen 
werden. 
 
Durchführung der Projekts: 
 
Untersuchungen 
Vor dem Beginn der Intervention und nach Abschluss der 6-monatigen Interventionsperiode 
werden folgende Messungen durchgeführt:  
• Ermittlung der Körperzusammensetzung durch Bioimpedanzanalyse 
• Ermittlung des Bewegungsverhaltens 
• Ermittlung Ihres Gesundheitszustandes mittels Blutentnahme aus der Armvene 
• Messung Ihres Blutdrucks 
 
Messung der Körperzusammensetzung  
Bei der phasensensitiven multifrequenten Bioimpedanzanalyse wird über 4 Hautelektroden 
an Fuss und Hand ein homogenes elektrisches Wechselstromfeld mit konstanter Stromstärke 
erzeugt und anschließend der Gesamtwiderstand des Körpers gemessen. Mit dieser 
ungefährlichen, schmerzfreien und genauen Methode lässt sich der Körperwassergehalt 
bestimmen und daraus der Fettgehalt des Körpers ableiten. Zusätzlich wird Ihr Körpergewicht 
und Ihre Körpergröße gemessen.  
 
Ermittlung des Bewegungsverhaltens 
Zur Ermittlung des Bewegungsverhaltens tragen Sie für 48 Stunden einen leichten (82 
Gramm) und unauffälligen Armbandsensor über dem Trizepsmuskel des dominanten 
Oberarms. Die im Armband eingebauten Beschleunigungsmesser, Hauttemperatur- und 
Hautwiderstandssensoren nehmen im Minutentakt Messwerte auf und speichern diese im 
Datenspeicher des Armbands. Nach Abschluss der Tragezeit werden diese Daten auf einem 
PC ausgewertet. Sie geben Aufschluss über das Bewegungsverhalten, das in Metabolischen 
Äquivalenten und geleisteten Schritten dargestellt wird.  
 
Blutentnahme 
Eine Nüchtern-Blutentnahme aus Ihrer Vene (ca. 20 ml) dient zur Bestimmung des 
Blutzuckers, der Cholesterinfraktionen, der Triglyzeride, des CRP und der Bestimmung eines 
kleinen Blutbildes. 
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Messung des Blutdrucks 
Ihr Blutdruck wird liegend an beiden Oberarmen mit einem oszillometrischen automatischen 
Messverfahren gemessen.  
 
Intervention 
Basierend auf den Ergebnissen der Eingangsuntersuchung erstellen wir in der 
Ergebnisbesprechung gemeinsam mit Ihnen einen Bewegungsplan, der aus Ausdauer- 
und/oder Krafttrainingskomponenten bestehen wird. Ziel der gemeinsamen Ausarbeitung des 
Trainingsplans ist es, Ihren Trainingsplan auf Ihr Gesundheitsprofil sowie auf Ihre 
Fähigkeiten, Neigungen und Ihre Lebenswelt anzupassen. Dem gemeinsam verabschiedeten 
Plan legen wir ein Punktesystem zugrunde, das es Ihnen ermöglicht, Ihr abgeleistetes 
Bewegungsvolumen jeweils mit einer Anzahl von Punkten zu bewerten. Durch regelmässige 
Eingabe in eine Internet-basierte telemetrische Anwendung können Sie und wir Ihren 
Fortschritt im Soll-Ist Vergleich erkennen. In diese telemetrische Anwendung können Sie 
auch Ihr Körpergewicht, sowie gegebenenfalls zu Hause gemessene Werte für Blutdruck und 
Blutzucker eingeben. Bei Abweichungen von den Sollwerten des Trainingsplans kontaktieren 
wir Sie um Ihnen bei der Lösung eventueller Probleme mit der Umsetzung des Plans zu 
helfen. 
 
 
Ablauf 
 
Phase 1 Eingangsuntersuchung 
Termin 1:  Nüchtern-Blutentnahme (durch betriebsärztliche Dienststelle 
oder Ihren Hausarzt)  
Termin 2:  Bestimmung von Körperzusammensetzung, -größe, Gewicht 
Bauchumfang und Blutdruck, sowie Anlegen des 
Armbandsensors (adiphea Gesundheitslabor) 
Termin 3:  Rückgabe des Armbandsensors (adiphea Gesundheitslabor) 
Termin 4:  Ergebnisbesprechung und Erstellung des Trainingsplans 
(adiphea Gesundheitslabor) 
Phase 2 Interventionsphase: Umsetzung des Trainingsplans mit telemetrischer 
Fortschrittserfassung und -kontrolle 
Phase 3 Abschlussuntersuchung, Ergebnisauswertung und -besprechung 
Termin 1:  Nüchtern-Blutentnahme (durch betriebsärztliche Dienststelle 
oder Ihren Hausarzt)  
Termin 2:  Bestimmung von Körperzusammensetzung, -größe, Gewicht 
Bauchumfang und Blutdruck, sowie Anlegen des 
Armbandsensors (adiphea Gesundheitslabor) 
Termin 3: Rückgabe des Armbandsensors (adiphea Gesundheitslabor) 
Termin 4:  Ergebnisbesprechung und weiterführende Empfehlung (adiphea 
Gesundheitslabor) 
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Die Termine für Phase 1 und Phase 3 sollten jeweils innerhalb von 7-10 Tagen durchgeführt 
werden.  
 
Freiwilligkeit der Teilnahme 
Ihre Teilnahme an diesem Projekt ist freiwillig und kann jederzeit ohne Angabe von Gründen 
abgebrochen werden. Im Falle eines Rücktritts wird bereits gewonnenes Datenmaterial 
vernichtet, sofern Sie das wünschen.  
 
Datenschutz und Vertraulichkeit 
Die Vorschriften über die ärztliche Schweigepflicht und den Datenschutz werden eingehalten. 
Es werden gegebenenfalls nur anonymisierte Datenbögen ohne Namensnennung 
weitergegeben. Die Internet-basierte Anwendung ist nur über Passwort und Benutzername 
zugänglich und wird auf einem dezidierten Server verschlüsselungszertifiziert 
zugangsgesichert. Personenbezogene Daten verbleiben bei der Projektleitung des adiphea 
Gesundheitslabors und werden nach Abschluss des Projekts 10 Jahre aufbewahrt (gemäß 
den Regeln zur „Sicherung guter wissenschaftlicher Praxis“ der deutschen 
Forschungsgemeinschaft).   
 
Wir bedanken uns für Ihre Teilnahme und Kooperation. 
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DECLARATION INFORMED CONSENT 
Einverständniserklärung 
 
Name: ______________________________________________________ 
 
Geburtsdatum: ______________________________________________________ 
 
Das Original dieser Einwilligungserklärung verbleibt bei den Unterlagen. Eine Kopie  der Einwilligungserklärung 
wird dem Patienten ausgehändigt. 
Ich  _____________________________________________________________ 
 (Vorname, Name)  
erkläre, dass ich die Probanden/Patienteninformation zur wissenschaftlichen Untersuchung: 
 
„ Verbesserung der Effizienz und Adhärenz in Verhaltensänderungsinterventionen für die Prävention 
chronischer lebensstilbedingter kardiometaboler Erkrankungen. “ 
und diese Einwilligungserklärung erhalten habe. 
 
• Ich wurde für mich ausreichend mündlich und schriftlich über die wissenschaftliche Untersuchung informiert. 
  
• Ich erkläre, dass ich damit einverstanden bin, dass Blut, Urin und/oder Gewebe, welches entnommen wird und 
nicht für die Routineuntersuchung nötig ist, für die o. g. wissenschaftliche Untersuchung genutzt werden kann.  
 
• Ich weiss, dass ich jederzeit meine Einwilligung ohne Angaben von Gründen, widerrufen kann, ohne dass dies 
für mich nachteilige Folgen hat. 
 
• Ich bin damit einverstanden, dass die im Rahmen der wissenschaftlichen Untersuchung über mich 
erhobenen Krankheitsdaten sowie meine sonstigen mit dieser Untersuchung zusammenhängenden 
personenbezogenen Daten aufgezeichnet werden. Es wird gewährleistet, dass meine 
personenbezogenen Daten nicht an Dritte weitergegeben werden. Bei der Veröffentlichung in einer 
wissenschaftlichen Zeitung wird aus den Daten nicht hervorgehen, wer an dieser Untersuchung 
teilgenommen hat. Meine persönlichen Daten unterliegen dem Datenschutzgesetz. 
 
Mit der vorstehend geschilderten Vorgehensweise bin ich einverstanden und bestätige dies mit meiner 
Unterschrift. 
_________________ den, ____________________ _______________________ 
(Ort) (Datum) (Teilnehmer) 
 
_________________ den, ____________________ ______________________ 
(Ort) (Datum) (Projektleiter) 
 
  ______________________ 
  (Name des Projektleiters) 
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HEALTH HISTORY QUESTIONNAIRE 
Eingangsfragebogen zur Teilnahme an einer Bewegungsintervention 
Ich garantiere die ehrliche Beantwortung der folgenden Fragen. adiphea garantiert die 
vertrauliche Behandlung meiner Angaben.  
 
Leiden Sie an folgenden Krankheiten, bzw. haben Sie folgende Krankheiten schon einmal 
gehabt? 
Ja Nein  
☐	 ☐	 Herzerkrankung  
☐	 ☐	 Operation am Herzen: Katheterisierung, Angioplastie, Herzschrittmacher, 
Herzverpflanzung 
☐ ☐ Schlaganfall oder TIA 
☐ ☐ Bluthochdruck (>140 mmHg systolisch und/oder >90 mmHg diastolisch) oder nehmen 
Sie verschreibungspflichtige Blutdruckmedikamente? 
☐ ☐ Diabetes: wenn ja bitte ankreuzen ob  Typ 1 ☐	 	 oder Typ 2 ☐ 
☐ ☐ Asthma oder nehmen Sie Medikamente für Asthma? 
☐ ☐ Andere Lungenerkrankung 
☐ ☐ Andere Erkrankung die Sie von der Teilnahme an einem Bewegungsprogramm abhält 
(Krebs, Osteoporose, Arthrose, Erkrankung von Leber, Niere, Schilddrüse) 
☐ ☐ Sind Sie schwanger oder haben Sie Grund zur Annahme schwanger zu sein? 
   
Leiden Sie an folgenden Zeichen oder Symptomen oder sind diese jemals bei Ihnen aufgetreten? 
Ja Nein 
☐	 ☐	 Schwindel, Ohnmacht, Bewusstlosigkeit, Luftnot 
☐ ☐ Schmerzen am Herzen oder im Brustbereich 
☐ ☐ Herzstolpern, Herzaussetzer, Herzrasen 
☐ ☐ Wurden bei Ihnen Herzgeräusche diagnostiziert? 
☐ ☐ Nächtliche Anfälle von Atemnot oder Kurzatmigkeit 
☐ ☐ Schwellungen oder Wasseransammlungen im Bereich der Fussgelenke 
☐ ☐ Gehschmerzen oder Missempfindungen in den Beinen nach kurzem Gehen 
☐ ☐ Erkrankungen oder Behinderungen des Bewegungsapparates 
 
Bestehen bei Ihnen folgende Risikofaktoren? 
Ja Nein 
☐	 ☐	 Sie rauchen oder haben mit dem Rauchen innerhalb der letzten 6 Monate aufgehört 
☐	 ☐ Erkrankung (Herzkrankheit, Herzinfarkt, Schlaganfall, Herzoperation, Herzschrittmacher) 
oder plötzlicher Tod des Vaters oder Bruders vor dem 55. Lebensjahr, oder der Mutter 
oder Schwester vor dem 65. Lebensjahr? 
☐ ☐ Alkohol- oder Medikamentenmissbrauch 
 
 
 
____________ _____________________________________ ______________________________ 
Datum  Name     Unterschrift 
